id	sid	tid	token	lemma	pos
chd-224	1	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-224	1	2	e1	e1	NOUN
chd-224	1	3	cancer	cancer	NOUN
chd-224	1	4	health	health	NOUN
chd-224	1	5	disparities	disparity	NOUN
chd-224	1	6	research	research	VERB
chd-224	1	7	racial	racial	ADJ
chd-224	1	8	/	/	SYM
chd-224	1	9	ethnic	ethnic	ADJ
chd-224	1	10	disparities	disparity	NOUN
chd-224	1	11	in	in	ADP
chd-224	1	12	thyroid	thyroid	NOUN
chd-224	1	13	cancer	cancer	NOUN
chd-224	1	14	stratified	stratify	VERB
chd-224	1	15	by	by	ADP
chd-224	1	16	risk	risk	NOUN
chd-224	1	17	factors	factor	NOUN
chd-224	1	18	:	:	PUNCT
chd-224	1	19	a	a	DET
chd-224	1	20	literature	literature	PROPN
chd-224	1	21	review	review	PROPN
chd-224	1	22	kristiana	kristiana	PROPN
chd-224	1	23	rood1,2,3	rood1,2,3	PROPN
chd-224	1	24	,	,	PUNCT
chd-224	1	25	*	*	PUNCT
chd-224	1	26	*	*	PUNCT
chd-224	1	27	,	,	PUNCT
chd-224	1	28	ria	ria	PROPN
chd-224	1	29	t.	t.	PROPN
chd-224	1	30	laxa1	laxa1	PROPN
chd-224	1	31	,	,	PUNCT
chd-224	1	32	*	*	PUNCT
chd-224	1	33	*	*	PUNCT
chd-224	1	34	,	,	PUNCT
chd-224	1	35	andrea	andrea	PROPN
chd-224	1	36	shields4	shields4	PROPN
chd-224	1	37	,	,	PUNCT
chd-224	1	38	hae	hae	PROPN
chd-224	1	39	-	-	PUNCT
chd-224	1	40	soo	soo	PROPN
chd-224	1	41	kim1,2	kim1,2	PROPN
chd-224	1	42	,	,	PUNCT
chd-224	1	43	salma	salma	NOUN
chd-224	1	44	khan1,2,3,5	khan1,2,3,5	NOUN
chd-224	1	45	,	,	PUNCT
chd-224	1	46	*	*	PROPN
chd-224	1	47	1division	1division	NUM
chd-224	1	48	of	of	ADP
chd-224	1	49	biochemistry	biochemistry	NOUN
chd-224	1	50	,	,	PUNCT
chd-224	1	51	loma	loma	PROPN
chd-224	1	52	linda	linda	PROPN
chd-224	1	53	university	university	PROPN
chd-224	1	54	school	school	NOUN
chd-224	1	55	of	of	ADP
chd-224	1	56	medicine	medicine	NOUN
chd-224	1	57	,	,	PUNCT
chd-224	1	58	loma	loma	PROPN
chd-224	1	59	linda	linda	PROPN
chd-224	1	60	,	,	PUNCT
chd-224	1	61	ca	ca	PROPN
chd-224	1	62	92350	92350	NUM
chd-224	1	63	,	,	PUNCT
chd-224	1	64	usa	usa	PROPN
chd-224	1	65	.	.	PROPN
chd-224	2	1	2division	2division	NUM
chd-224	2	2	of	of	ADP
chd-224	2	3	otolaryngology	otolaryngology	NOUN
chd-224	2	4	,	,	PUNCT
chd-224	2	5	loma	loma	PROPN
chd-224	2	6	linda	linda	PROPN
chd-224	2	7	university	university	PROPN
chd-224	2	8	school	school	NOUN
chd-224	2	9	of	of	ADP
chd-224	2	10	medicine	medicine	NOUN
chd-224	2	11	,	,	PUNCT
chd-224	2	12	loma	loma	PROPN
chd-224	2	13	linda	linda	PROPN
chd-224	2	14	,	,	PUNCT
chd-224	2	15	ca	ca	PROPN
chd-224	2	16	92350	92350	NUM
chd-224	2	17	,	,	PUNCT
chd-224	2	18	usa	usa	PROPN
chd-224	2	19	.	.	PROPN
chd-224	3	1	3center	3center	NUM
chd-224	3	2	for	for	ADP
chd-224	3	3	health	health	NOUN
chd-224	3	4	disparities	disparity	NOUN
chd-224	3	5	&	&	CCONJ
chd-224	3	6	molecular	molecular	ADJ
chd-224	3	7	medicine	medicine	NOUN
chd-224	3	8	,	,	PUNCT
chd-224	3	9	loma	loma	PROPN
chd-224	3	10	linda	linda	PROPN
chd-224	3	11	university	university	PROPN
chd-224	3	12	school	school	NOUN
chd-224	3	13	of	of	ADP
chd-224	3	14	medicine	medicine	NOUN
chd-224	3	15	,	,	PUNCT
chd-224	3	16	loma	loma	PROPN
chd-224	3	17	linda	linda	PROPN
chd-224	3	18	,	,	PUNCT
chd-224	3	19	ca	ca	PROPN
chd-224	3	20	92350	92350	NUM
chd-224	3	21	,	,	PUNCT
chd-224	3	22	usa	usa	PROPN
chd-224	3	23	.	.	PROPN
chd-224	4	1	4department	4department	NUM
chd-224	4	2	of	of	ADP
chd-224	4	3	pathology	pathology	PROPN
chd-224	4	4	&	&	CCONJ
chd-224	4	5	human	human	PROPN
chd-224	4	6	anatomy	anatomy	PROPN
chd-224	4	7	,	,	PUNCT
chd-224	4	8	loma	loma	PROPN
chd-224	4	9	linda	linda	PROPN
chd-224	4	10	university	university	PROPN
chd-224	4	11	school	school	NOUN
chd-224	4	12	of	of	ADP
chd-224	4	13	medicine	medicine	NOUN
chd-224	4	14	,	,	PUNCT
chd-224	4	15	loma	loma	PROPN
chd-224	4	16	linda	linda	PROPN
chd-224	4	17	,	,	PUNCT
chd-224	4	18	ca	ca	PROPN
chd-224	4	19	92350	92350	NUM
chd-224	4	20	,	,	PUNCT
chd-224	4	21	usa	usa	PROPN
chd-224	4	22	.	.	PROPN
chd-224	5	1	5department	5department	NUM
chd-224	5	2	of	of	ADP
chd-224	5	3	internal	internal	ADJ
chd-224	5	4	medicine	medicine	NOUN
chd-224	5	5	,	,	PUNCT
chd-224	5	6	loma	loma	PROPN
chd-224	5	7	linda	linda	PROPN
chd-224	5	8	university	university	PROPN
chd-224	5	9	school	school	NOUN
chd-224	5	10	of	of	ADP
chd-224	5	11	medicine	medicine	NOUN
chd-224	5	12	,	,	PUNCT
chd-224	5	13	loma	loma	PROPN
chd-224	5	14	linda	linda	PROPN
chd-224	5	15	,	,	PUNCT
chd-224	5	16	ca	ca	PROPN
chd-224	5	17	92354	92354	NUM
chd-224	5	18	,	,	PUNCT
chd-224	5	19	usa	usa	PROPN
chd-224	5	20	.	.	PROPN
chd-224	5	21	loma	loma	PROPN
chd-224	5	22	linda	linda	PROPN
chd-224	5	23	university	university	PROPN
chd-224	5	24	,	,	PUNCT
chd-224	5	25	mortensen	mortensen	PROPN
chd-224	5	26	hall	hall	PROPN
chd-224	5	27	,	,	PUNCT
chd-224	5	28	11085	11085	NUM
chd-224	5	29	campus	campus	PROPN
chd-224	5	30	st	st	PROPN
chd-224	5	31	,	,	PUNCT
chd-224	5	32	loma	loma	PROPN
chd-224	5	33	linda	linda	PROPN
chd-224	5	34	,	,	PUNCT
chd-224	5	35	ca	ca	NOUN
chd-224	5	36	92350	92350	NUM
chd-224	5	37	.	.	PUNCT
chd-224	6	1	*	*	PUNCT
chd-224	6	2	corresponding	correspond	VERB
chd-224	6	3	author	author	NOUN
chd-224	6	4	:	:	PUNCT
chd-224	6	5	salma	salma	PROPN
chd-224	6	6	khan	khan	PROPN
chd-224	6	7	:	:	PUNCT
chd-224	6	8	salmakhan@llu.edu	salmakhan@llu.edu	PROPN
chd-224	6	9	.	.	PUNCT
chd-224	7	1	*	*	PUNCT
chd-224	7	2	*	*	PUNCT
chd-224	7	3	equally	equally	ADV
chd-224	7	4	contributed	contribute	VERB
chd-224	7	5	.	.	PUNCT
chd-224	8	1	abstract	abstract	ADV
chd-224	8	2	in	in	ADP
chd-224	8	3	the	the	DET
chd-224	8	4	united	united	PROPN
chd-224	8	5	states	states	PROPN
chd-224	8	6	,	,	PUNCT
chd-224	8	7	thyroid	thyroid	NOUN
chd-224	8	8	cancer	cancer	NOUN
chd-224	8	9	incidence	incidence	NOUN
chd-224	8	10	has	have	AUX
chd-224	8	11	increased	increase	VERB
chd-224	8	12	dramatically	dramatically	ADV
chd-224	8	13	within	within	ADP
chd-224	8	14	the	the	DET
chd-224	8	15	last	last	ADJ
chd-224	8	16	few	few	ADJ
chd-224	8	17	decades	decade	NOUN
chd-224	8	18	.	.	PUNCT
chd-224	9	1	recent	recent	ADJ
chd-224	9	2	research	research	NOUN
chd-224	9	3	suggests	suggest	VERB
chd-224	9	4	that	that	SCONJ
chd-224	9	5	this	this	DET
chd-224	9	6	incidence	incidence	NOUN
chd-224	9	7	along	along	ADP
chd-224	9	8	with	with	ADP
chd-224	9	9	cancer	cancer	NOUN
chd-224	9	10	stage	stage	NOUN
chd-224	9	11	and	and	CCONJ
chd-224	9	12	mortality	mortality	NOUN
chd-224	9	13	vary	vary	VERB
chd-224	9	14	by	by	ADP
chd-224	9	15	race	race	NOUN
chd-224	9	16	/	/	SYM
chd-224	9	17	ethnicity	ethnicity	NOUN
chd-224	9	18	,	,	PUNCT
chd-224	9	19	highlighting	highlight	VERB
chd-224	9	20	health	health	NOUN
chd-224	9	21	disparities	disparity	NOUN
chd-224	9	22	in	in	ADP
chd-224	9	23	the	the	DET
chd-224	9	24	united	united	PROPN
chd-224	9	25	states	states	PROPN
chd-224	9	26	.	.	PUNCT
chd-224	10	1	there	there	PRON
chd-224	10	2	are	be	VERB
chd-224	10	3	several	several	ADJ
chd-224	10	4	risk	risk	NOUN
chd-224	10	5	factors	factor	NOUN
chd-224	10	6	for	for	ADP
chd-224	10	7	thyroid	thyroid	NOUN
chd-224	10	8	cancer	cancer	NOUN
chd-224	10	9	incidence	incidence	NOUN
chd-224	10	10	that	that	PRON
chd-224	10	11	may	may	AUX
chd-224	10	12	contribute	contribute	VERB
chd-224	10	13	to	to	ADP
chd-224	10	14	these	these	DET
chd-224	10	15	disparities	disparity	NOUN
chd-224	10	16	.	.	PUNCT
chd-224	11	1	the	the	DET
chd-224	11	2	goal	goal	NOUN
chd-224	11	3	of	of	ADP
chd-224	11	4	this	this	DET
chd-224	11	5	literature	literature	NOUN
chd-224	11	6	review	review	NOUN
chd-224	11	7	is	be	AUX
chd-224	11	8	to	to	PART
chd-224	11	9	analyze	analyze	VERB
chd-224	11	10	whether	whether	SCONJ
chd-224	11	11	these	these	DET
chd-224	11	12	potential	potential	ADJ
chd-224	11	13	risk	risk	NOUN
chd-224	11	14	factors	factor	NOUN
chd-224	11	15	impact	impact	VERB
chd-224	11	16	incidence	incidence	NOUN
chd-224	11	17	and	and	CCONJ
chd-224	11	18	aggressiveness	aggressiveness	NOUN
chd-224	11	19	differently	differently	ADV
chd-224	11	20	by	by	ADP
chd-224	11	21	race	race	NOUN
chd-224	11	22	/	/	SYM
chd-224	11	23	ethnicity	ethnicity	NOUN
chd-224	11	24	,	,	PUNCT
chd-224	11	25	implicating	implicate	VERB
chd-224	11	26	their	their	PRON
chd-224	11	27	possible	possible	ADJ
chd-224	11	28	role	role	NOUN
chd-224	11	29	in	in	ADP
chd-224	11	30	influencing	influence	VERB
chd-224	11	31	thyroid	thyroid	NOUN
chd-224	11	32	cancer	cancer	NOUN
chd-224	11	33	disparities	disparity	NOUN
chd-224	11	34	in	in	ADP
chd-224	11	35	the	the	DET
chd-224	11	36	united	united	PROPN
chd-224	11	37	states	states	PROPN
chd-224	11	38	.	.	PUNCT
chd-224	12	1	through	through	ADP
chd-224	12	2	pubmed	pubmed	PROPN
chd-224	12	3	searches	search	NOUN
chd-224	12	4	,	,	PUNCT
chd-224	12	5	we	we	PRON
chd-224	12	6	have	have	AUX
chd-224	12	7	reviewed	review	VERB
chd-224	12	8	recent	recent	ADJ
chd-224	12	9	literature	literature	NOUN
chd-224	12	10	on	on	ADP
chd-224	12	11	u.s	u.s	PROPN
chd-224	12	12	.	.	PROPN
chd-224	12	13	populations	population	NOUN
chd-224	12	14	.	.	PUNCT
chd-224	13	1	we	we	PRON
chd-224	13	2	found	find	VERB
chd-224	13	3	that	that	SCONJ
chd-224	13	4	chromosomal	chromosomal	ADJ
chd-224	13	5	alterations	alteration	NOUN
chd-224	13	6	/	/	SYM
chd-224	13	7	nonhereditary	nonhereditary	ADJ
chd-224	13	8	conditions	condition	NOUN
chd-224	13	9	,	,	PUNCT
chd-224	13	10	autoimmunity	autoimmunity	NOUN
chd-224	13	11	,	,	PUNCT
chd-224	13	12	thyroid	thyroid	NOUN
chd-224	13	13	nodules	nodule	NOUN
chd-224	13	14	,	,	PUNCT
chd-224	13	15	and	and	CCONJ
chd-224	13	16	socioeconomic	socioeconomic	ADJ
chd-224	13	17	differences	difference	NOUN
chd-224	13	18	potentially	potentially	ADV
chd-224	13	19	impacted	impact	VERB
chd-224	13	20	thyroid	thyroid	NOUN
chd-224	13	21	cancer	cancer	NOUN
chd-224	13	22	incidence	incidence	NOUN
chd-224	13	23	and	and	CCONJ
chd-224	13	24	aggressiveness	aggressiveness	NOUN
chd-224	13	25	by	by	ADP
chd-224	13	26	race	race	NOUN
chd-224	13	27	/	/	SYM
chd-224	13	28	ethnicity	ethnicity	NOUN
chd-224	13	29	,	,	PUNCT
chd-224	13	30	whereas	whereas	SCONJ
chd-224	13	31	sex	sex	NOUN
chd-224	13	32	disparities	disparity	NOUN
chd-224	13	33	did	do	VERB
chd-224	13	34	not	not	PART
chd-224	13	35	.	.	PUNCT
chd-224	14	1	several	several	ADJ
chd-224	14	2	potential	potential	ADJ
chd-224	14	3	risk	risk	NOUN
chd-224	14	4	factors	factor	NOUN
chd-224	14	5	showed	show	VERB
chd-224	14	6	some	some	DET
chd-224	14	7	variations	variation	NOUN
chd-224	14	8	by	by	ADP
chd-224	14	9	race	race	NOUN
chd-224	14	10	/	/	SYM
chd-224	14	11	ethnicity	ethnicity	NOUN
chd-224	14	12	but	but	CCONJ
chd-224	14	13	either	either	CCONJ
chd-224	14	14	did	do	AUX
chd-224	14	15	not	not	PART
chd-224	14	16	specifically	specifically	ADV
chd-224	14	17	examine	examine	VERB
chd-224	14	18	their	their	PRON
chd-224	14	19	relationship	relationship	NOUN
chd-224	14	20	to	to	PART
chd-224	14	21	thyroid	thyroid	VERB
chd-224	14	22	cancer	cancer	NOUN
chd-224	14	23	or	or	CCONJ
chd-224	14	24	did	do	AUX
chd-224	14	25	not	not	PART
chd-224	14	26	impact	impact	VERB
chd-224	14	27	thyroid	thyroid	NOUN
chd-224	14	28	cancer	cancer	NOUN
chd-224	14	29	incidence	incidence	NOUN
chd-224	14	30	and	and	CCONJ
chd-224	14	31	aggressiveness	aggressiveness	NOUN
chd-224	14	32	.	.	PUNCT
chd-224	15	1	other	other	ADJ
chd-224	15	2	potential	potential	ADJ
chd-224	15	3	risk	risk	NOUN
chd-224	15	4	factors	factor	NOUN
chd-224	15	5	have	have	AUX
chd-224	15	6	not	not	PART
chd-224	15	7	yet	yet	ADV
chd-224	15	8	been	be	AUX
chd-224	15	9	studied	study	VERB
chd-224	15	10	regarding	regard	VERB
chd-224	15	11	their	their	PRON
chd-224	15	12	influence	influence	NOUN
chd-224	15	13	on	on	ADP
chd-224	15	14	thyroid	thyroid	NOUN
chd-224	15	15	cancer	cancer	NOUN
chd-224	15	16	incidence	incidence	NOUN
chd-224	15	17	and	and	CCONJ
chd-224	15	18	outcomes	outcome	NOUN
chd-224	15	19	for	for	ADP
chd-224	15	20	racial	racial	ADJ
chd-224	15	21	/	/	SYM
chd-224	15	22	ethnic	ethnic	ADJ
chd-224	15	23	groups	group	NOUN
chd-224	15	24	in	in	ADP
chd-224	15	25	the	the	DET
chd-224	15	26	united	united	PROPN
chd-224	15	27	states	states	PROPN
chd-224	15	28	.	.	PUNCT
chd-224	16	1	therefore	therefore	ADV
chd-224	16	2	,	,	PUNCT
chd-224	16	3	we	we	PRON
chd-224	16	4	identify	identify	VERB
chd-224	16	5	a	a	DET
chd-224	16	6	critical	critical	ADJ
chd-224	16	7	need	need	NOUN
chd-224	16	8	for	for	ADP
chd-224	16	9	subsequent	subsequent	ADJ
chd-224	16	10	research	research	NOUN
chd-224	16	11	to	to	PART
chd-224	16	12	examine	examine	VERB
chd-224	16	13	these	these	DET
chd-224	16	14	potential	potential	ADJ
chd-224	16	15	risk	risk	NOUN
chd-224	16	16	factors	factor	NOUN
chd-224	16	17	for	for	ADP
chd-224	16	18	different	different	ADJ
chd-224	16	19	racial	racial	ADJ
chd-224	16	20	/	/	SYM
chd-224	16	21	ethnic	ethnic	ADJ
chd-224	16	22	groups	group	NOUN
chd-224	16	23	and	and	CCONJ
chd-224	16	24	contribute	contribute	VERB
chd-224	16	25	to	to	ADP
chd-224	16	26	our	our	PRON
chd-224	16	27	understanding	understanding	NOUN
chd-224	16	28	of	of	ADP
chd-224	16	29	racial	racial	ADJ
chd-224	16	30	/	/	SYM
chd-224	16	31	ethnic	ethnic	ADJ
chd-224	16	32	health	health	NOUN
chd-224	16	33	disparities	disparity	NOUN
chd-224	16	34	in	in	ADP
chd-224	16	35	the	the	DET
chd-224	16	36	united	united	PROPN
chd-224	16	37	states	states	PROPN
chd-224	16	38	.	.	PUNCT
chd-224	17	1	we	we	PRON
chd-224	17	2	also	also	ADV
chd-224	17	3	present	present	VERB
chd-224	17	4	several	several	ADJ
chd-224	17	5	research	research	NOUN
chd-224	17	6	areas	area	NOUN
chd-224	17	7	relating	relate	VERB
chd-224	17	8	to	to	PART
chd-224	17	9	thyroid	thyroid	VERB
chd-224	17	10	cancer	cancer	NOUN
chd-224	17	11	health	health	NOUN
chd-224	17	12	disparities	disparity	NOUN
chd-224	17	13	that	that	PRON
chd-224	17	14	require	require	VERB
chd-224	17	15	further	further	ADJ
chd-224	17	16	study	study	NOUN
chd-224	17	17	.	.	PUNCT
chd-224	18	1	keywords	keyword	NOUN
chd-224	18	2	:	:	PUNCT
chd-224	18	3	thyroid	thyroid	NOUN
chd-224	18	4	cancer	cancer	NOUN
chd-224	18	5	,	,	PUNCT
chd-224	18	6	health	health	NOUN
chd-224	18	7	disparities	disparity	NOUN
chd-224	18	8	,	,	PUNCT
chd-224	18	9	incidence	incidence	NOUN
chd-224	18	10	,	,	PUNCT
chd-224	18	11	mortality	mortality	NOUN
chd-224	18	12	.	.	PUNCT
chd-224	19	1	citation	citation	NOUN
chd-224	19	2	:	:	PUNCT
chd-224	19	3	rood	rood	PROPN
chd-224	19	4	k	k	PROPN
chd-224	19	5	et	et	PROPN
chd-224	19	6	al	al	PROPN
chd-224	19	7	(	(	PUNCT
chd-224	19	8	2023	2023	NUM
chd-224	19	9	)	)	PUNCT
chd-224	19	10	racial	racial	ADJ
chd-224	19	11	/	/	SYM
chd-224	19	12	ethnic	ethnic	ADJ
chd-224	19	13	disparities	disparity	NOUN
chd-224	19	14	in	in	ADP
chd-224	19	15	thyroid	thyroid	NOUN
chd-224	19	16	cancer	cancer	NOUN
chd-224	19	17	stratified	stratify	VERB
chd-224	19	18	by	by	ADP
chd-224	19	19	risk	risk	NOUN
chd-224	19	20	factors	factor	NOUN
chd-224	19	21	:	:	PUNCT
chd-224	19	22	a	a	DET
chd-224	19	23	literature	literature	NOUN
chd-224	19	24	review	review	NOUN
chd-224	19	25	.	.	PUNCT
chd-224	20	1	cancer	cancer	NOUN
chd-224	20	2	health	health	NOUN
chd-224	20	3	disparities	disparity	NOUN
chd-224	20	4	7	7	NUM
chd-224	20	5	:	:	PUNCT
chd-224	20	6	e1	e1	NOUN
chd-224	20	7	-	-	PUNCT
chd-224	20	8	20	20	NUM
chd-224	20	9	.	.	PUNCT
chd-224	21	1	doi:10.9777	doi:10.9777	PROPN
chd-224	21	2	/	/	SYM
chd-224	21	3	chd.2023.1004	chd.2023.1004	PROPN
chd-224	21	4	mailto:salmakhan@llu.edu	mailto:salmakhan@llu.edu	PROPN
chd-224	21	5	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PART
chd-224	21	6	e2	e2	PROPN
chd-224	21	7	cancer	cancer	NOUN
chd-224	21	8	health	health	NOUN
chd-224	21	9	disparities	disparity	NOUN
chd-224	21	10	research	research	VERB
chd-224	21	11	1	1	NUM
chd-224	21	12	.	.	PUNCT
chd-224	22	1	introduction	introduction	NOUN
chd-224	22	2	thyroid	thyroid	NOUN
chd-224	22	3	cancer	cancer	NOUN
chd-224	22	4	incidence	incidence	NOUN
chd-224	22	5	has	have	AUX
chd-224	22	6	increased	increase	VERB
chd-224	22	7	dramatically	dramatically	ADV
chd-224	22	8	over	over	ADP
chd-224	22	9	the	the	DET
chd-224	22	10	last	last	ADJ
chd-224	22	11	30	30	NUM
chd-224	22	12	years	year	NOUN
chd-224	22	13	,	,	PUNCT
chd-224	22	14	and	and	CCONJ
chd-224	22	15	epidemiologists	epidemiologist	NOUN
chd-224	22	16	predict	predict	VERB
chd-224	22	17	this	this	DET
chd-224	22	18	cancer	cancer	NOUN
chd-224	22	19	will	will	AUX
chd-224	22	20	become	become	VERB
chd-224	22	21	the	the	DET
chd-224	22	22	fourth	fourth	ADJ
chd-224	22	23	most	most	ADV
chd-224	22	24	prevalent	prevalent	ADJ
chd-224	22	25	cancer	cancer	NOUN
chd-224	22	26	in	in	ADP
chd-224	22	27	the	the	DET
chd-224	22	28	united	united	PROPN
chd-224	22	29	states	states	PROPN
chd-224	22	30	by	by	ADP
chd-224	22	31	2030	2030	NUM
chd-224	22	32	(	(	PUNCT
chd-224	22	33	krook	krook	NOUN
chd-224	22	34	et	et	PROPN
chd-224	22	35	al	al	PROPN
chd-224	22	36	.	.	PROPN
chd-224	22	37	,	,	PUNCT
chd-224	22	38	2015	2015	NUM
chd-224	22	39	;	;	PUNCT
chd-224	22	40	la	la	PROPN
chd-224	22	41	vecchia	vecchia	PROPN
chd-224	22	42	et	et	PROPN
chd-224	22	43	al	al	PROPN
chd-224	22	44	.	.	PROPN
chd-224	22	45	,	,	PUNCT
chd-224	22	46	2015	2015	NUM
chd-224	22	47	;	;	PUNCT
chd-224	22	48	rahib	rahib	NOUN
chd-224	22	49	et	et	PROPN
chd-224	22	50	al	al	PROPN
chd-224	22	51	.	.	PROPN
chd-224	22	52	,	,	PUNCT
chd-224	22	53	2014	2014	NUM
chd-224	22	54	;	;	PUNCT
chd-224	22	55	reitzel	reitzel	PROPN
chd-224	22	56	et	et	PROPN
chd-224	22	57	al	al	PROPN
chd-224	22	58	.	.	PROPN
chd-224	22	59	,	,	PUNCT
chd-224	22	60	2014	2014	NUM
chd-224	22	61	;	;	PUNCT
chd-224	22	62	weeks	week	NOUN
chd-224	22	63	et	et	PROPN
chd-224	22	64	al	al	PROPN
chd-224	22	65	.	.	PROPN
chd-224	22	66	,	,	PUNCT
chd-224	22	67	2018	2018	NUM
chd-224	22	68	)	)	PUNCT
chd-224	22	69	.	.	PUNCT
chd-224	23	1	one	one	NUM
chd-224	23	2	study	study	NOUN
chd-224	23	3	found	find	VERB
chd-224	23	4	that	that	SCONJ
chd-224	23	5	by	by	ADP
chd-224	23	6	2008	2008	NUM
chd-224	23	7	,	,	PUNCT
chd-224	23	8	thyroid	thyroid	NOUN
chd-224	23	9	cancer	cancer	NOUN
chd-224	23	10	had	have	AUX
chd-224	23	11	already	already	ADV
chd-224	23	12	been	be	AUX
chd-224	23	13	one	one	NUM
chd-224	23	14	of	of	ADP
chd-224	23	15	the	the	DET
chd-224	23	16	top	top	ADJ
chd-224	23	17	five	five	NUM
chd-224	23	18	cancers	cancer	NOUN
chd-224	23	19	in	in	ADP
chd-224	23	20	asian	asian	PROPN
chd-224	23	21	indian	indian	PROPN
chd-224	23	22	/	/	SYM
chd-224	23	23	pakistani	pakistani	ADJ
chd-224	23	24	,	,	PUNCT
chd-224	23	25	chinese	chinese	ADJ
chd-224	23	26	,	,	PUNCT
chd-224	23	27	filipina	filipina	PROPN
chd-224	23	28	,	,	PUNCT
chd-224	23	29	korean	korean	ADJ
chd-224	23	30	,	,	PUNCT
chd-224	23	31	and	and	CCONJ
chd-224	23	32	vietnamese	vietnamese	ADJ
chd-224	23	33	women	woman	NOUN
chd-224	23	34	(	(	PUNCT
chd-224	23	35	gomez	gomez	PROPN
chd-224	23	36	et	et	PROPN
chd-224	23	37	al	al	PROPN
chd-224	23	38	.	.	PROPN
chd-224	23	39	,	,	PUNCT
chd-224	23	40	2013	2013	NUM
chd-224	23	41	)	)	PUNCT
chd-224	23	42	.	.	PUNCT
chd-224	24	1	furthermore	furthermore	ADV
chd-224	24	2	,	,	PUNCT
chd-224	24	3	recent	recent	ADJ
chd-224	24	4	research	research	NOUN
chd-224	24	5	suggests	suggest	VERB
chd-224	24	6	that	that	SCONJ
chd-224	24	7	this	this	DET
chd-224	24	8	incidence	incidence	NOUN
chd-224	24	9	varies	vary	VERB
chd-224	24	10	by	by	ADP
chd-224	24	11	race	race	NOUN
chd-224	24	12	/	/	SYM
chd-224	24	13	ethnicity	ethnicity	NOUN
chd-224	24	14	(	(	PUNCT
chd-224	24	15	table	table	NOUN
chd-224	24	16	1	1	NUM
chd-224	24	17	)	)	PUNCT
chd-224	24	18	(	(	PUNCT
chd-224	24	19	magreni	magreni	NOUN
chd-224	24	20	et	et	NOUN
chd-224	24	21	al	al	PROPN
chd-224	24	22	.	.	PROPN
chd-224	24	23	,	,	PUNCT
chd-224	24	24	2015	2015	NUM
chd-224	24	25	;	;	PUNCT
chd-224	24	26	suresh	suresh	PROPN
chd-224	24	27	et	et	PROPN
chd-224	24	28	al	al	PROPN
chd-224	24	29	.	.	PROPN
chd-224	24	30	,	,	PUNCT
chd-224	24	31	2015	2015	NUM
chd-224	24	32	;	;	PUNCT
chd-224	24	33	weeks	week	NOUN
chd-224	24	34	et	et	PROPN
chd-224	24	35	al	al	PROPN
chd-224	24	36	.	.	PROPN
chd-224	24	37	,	,	PUNCT
chd-224	24	38	2018	2018	NUM
chd-224	24	39	)	)	PUNCT
chd-224	24	40	.	.	PUNCT
chd-224	25	1	in	in	ADP
chd-224	25	2	the	the	DET
chd-224	25	3	united	united	PROPN
chd-224	25	4	states	states	PROPN
chd-224	25	5	,	,	PUNCT
chd-224	25	6	thyroid	thyroid	NOUN
chd-224	25	7	cancer	cancer	NOUN
chd-224	25	8	incidence	incidence	NOUN
chd-224	25	9	rates	rate	NOUN
chd-224	25	10	are	be	AUX
chd-224	25	11	the	the	DET
chd-224	25	12	highest	high	ADJ
chd-224	25	13	in	in	ADP
chd-224	25	14	non	non	ADJ
chd-224	25	15	-	-	ADJ
chd-224	25	16	hispanic	hispanic	ADJ
chd-224	25	17	european	european	ADJ
chd-224	25	18	americans	americans	PROPN
chd-224	25	19	and	and	CCONJ
chd-224	25	20	the	the	DET
chd-224	25	21	lowest	low	ADJ
chd-224	25	22	in	in	ADP
chd-224	25	23	non	non	ADJ
chd-224	25	24	-	-	ADJ
chd-224	25	25	hispanic	hispanic	ADJ
chd-224	25	26	african	african	ADJ
chd-224	25	27	americans	americans	PROPN
chd-224	25	28	(	(	PUNCT
chd-224	25	29	lim	lim	PROPN
chd-224	25	30	et	et	PROPN
chd-224	25	31	al	al	PROPN
chd-224	25	32	.	.	PROPN
chd-224	25	33	,	,	PUNCT
chd-224	25	34	2017	2017	NUM
chd-224	25	35	;	;	PUNCT
chd-224	25	36	magreni	magreni	NOUN
chd-224	25	37	et	et	NOUN
chd-224	25	38	al	al	PROPN
chd-224	25	39	.	.	PROPN
chd-224	25	40	,	,	PUNCT
chd-224	25	41	2015	2015	NUM
chd-224	25	42	;	;	PUNCT
chd-224	25	43	reitzel	reitzel	PROPN
chd-224	25	44	et	et	PROPN
chd-224	25	45	al	al	PROPN
chd-224	25	46	.	.	PROPN
chd-224	25	47	,	,	PUNCT
chd-224	25	48	2014	2014	NUM
chd-224	25	49	;	;	PUNCT
chd-224	25	50	tortolero	tortolero	NUM
chd-224	25	51	-	-	PUNCT
chd-224	25	52	luna	luna	PROPN
chd-224	25	53	et	et	PROPN
chd-224	25	54	al	al	PROPN
chd-224	25	55	.	.	PROPN
chd-224	25	56	,	,	PUNCT
chd-224	25	57	2019	2019	NUM
chd-224	25	58	;	;	PUNCT
chd-224	25	59	weeks	week	NOUN
chd-224	25	60	et	et	PROPN
chd-224	25	61	al	al	PROPN
chd-224	25	62	.	.	PROPN
chd-224	25	63	,	,	PUNCT
chd-224	25	64	2018	2018	NUM
chd-224	25	65	;	;	PUNCT
chd-224	25	66	yu	yu	PROPN
chd-224	25	67	et	et	PROPN
chd-224	25	68	al	al	PROPN
chd-224	25	69	.	.	PROPN
chd-224	25	70	,	,	PUNCT
chd-224	25	71	2010	2010	NUM
chd-224	25	72	)	)	PUNCT
chd-224	25	73	.	.	PUNCT
chd-224	26	1	however	however	ADV
chd-224	26	2	,	,	PUNCT
chd-224	26	3	when	when	SCONJ
chd-224	26	4	separating	separate	VERB
chd-224	26	5	asian	asian	ADJ
chd-224	26	6	americans	americans	PROPN
chd-224	26	7	by	by	ADP
chd-224	26	8	subgroups	subgroup	NOUN
chd-224	26	9	,	,	PUNCT
chd-224	26	10	vietnamese	vietnamese	PROPN
chd-224	26	11	,	,	PUNCT
chd-224	26	12	cambodian	cambodian	PROPN
chd-224	26	13	,	,	PUNCT
chd-224	26	14	and	and	CCONJ
chd-224	26	15	filipino	filipino	PROPN
chd-224	26	16	americans	americans	PROPN
chd-224	26	17	are	be	AUX
chd-224	26	18	shown	show	VERB
chd-224	26	19	to	to	PART
chd-224	26	20	have	have	VERB
chd-224	26	21	elevated	elevate	VERB
chd-224	26	22	thyroid	thyroid	NOUN
chd-224	26	23	cancer	cancer	NOUN
chd-224	26	24	incidence	incidence	NOUN
chd-224	26	25	rates	rate	NOUN
chd-224	26	26	;	;	PUNCT
chd-224	26	27	filipino	filipino	PROPN
chd-224	26	28	americans	americans	PROPN
chd-224	26	29	,	,	PUNCT
chd-224	26	30	in	in	ADP
chd-224	26	31	particular	particular	ADJ
chd-224	26	32	,	,	PUNCT
chd-224	26	33	have	have	VERB
chd-224	26	34	higher	high	ADJ
chd-224	26	35	thyroid	thyroid	NOUN
chd-224	26	36	cancer	cancer	NOUN
chd-224	26	37	incidence	incidence	NOUN
chd-224	26	38	rates	rate	NOUN
chd-224	26	39	than	than	ADP
chd-224	26	40	non	non	ADJ
chd-224	26	41	-	-	ADJ
chd-224	26	42	filipino	filipino	ADJ
chd-224	26	43	asians	asians	PROPN
chd-224	26	44	and	and	CCONJ
chd-224	26	45	non	non	ADJ
chd-224	26	46	-	-	ADJ
chd-224	26	47	hispanic	hispanic	ADJ
chd-224	26	48	european	european	ADJ
chd-224	26	49	americans	americans	PROPN
chd-224	26	50	(	(	PUNCT
chd-224	26	51	gomez	gomez	PROPN
chd-224	26	52	et	et	PROPN
chd-224	26	53	al	al	PROPN
chd-224	26	54	.	.	PROPN
chd-224	26	55	,	,	PUNCT
chd-224	26	56	2013	2013	NUM
chd-224	26	57	;	;	PUNCT
chd-224	26	58	horn	horn	PROPN
chd-224	26	59	-	-	PUNCT
chd-224	26	60	ross	ross	PROPN
chd-224	26	61	et	et	PROPN
chd-224	26	62	al	al	PROPN
chd-224	26	63	.	.	PROPN
chd-224	26	64	,	,	PUNCT
chd-224	26	65	2011	2011	NUM
chd-224	26	66	;	;	PUNCT
chd-224	26	67	jin	jin	PROPN
chd-224	26	68	et	et	PROPN
chd-224	26	69	al	al	PROPN
chd-224	26	70	.	.	PROPN
chd-224	26	71	,	,	PUNCT
chd-224	26	72	2016	2016	NUM
chd-224	26	73	;	;	PUNCT
chd-224	26	74	megwalu	megwalu	PROPN
chd-224	26	75	et	et	PROPN
chd-224	26	76	al	al	PROPN
chd-224	26	77	.	.	PROPN
chd-224	26	78	,	,	PUNCT
chd-224	26	79	2021	2021	NUM
chd-224	26	80	;	;	PUNCT
chd-224	26	81	nguyen	nguyen	NOUN
chd-224	26	82	et	et	PROPN
chd-224	26	83	al	al	PROPN
chd-224	26	84	.	.	PROPN
chd-224	26	85	,	,	PUNCT
chd-224	26	86	2017	2017	NUM
chd-224	26	87	)	)	PUNCT
chd-224	26	88	.	.	PUNCT
chd-224	27	1	table	table	NOUN
chd-224	27	2	1	1	NUM
chd-224	27	3	.	.	PUNCT
chd-224	27	4	age	age	NOUN
chd-224	27	5	-	-	PUNCT
chd-224	27	6	adjusted	adjust	VERB
chd-224	27	7	thyroid	thyroid	NOUN
chd-224	27	8	cancer	cancer	NOUN
chd-224	27	9	incidence	incidence	NOUN
chd-224	27	10	rates	rate	NOUN
chd-224	27	11	and	and	CCONJ
chd-224	27	12	95	95	NUM
chd-224	27	13	%	%	NOUN
chd-224	27	14	confidence	confidence	NOUN
chd-224	27	15	intervals	interval	NOUN
chd-224	27	16	(	(	PUNCT
chd-224	27	17	cis	cis	NOUN
chd-224	27	18	)	)	PUNCT
chd-224	27	19	by	by	ADP
chd-224	27	20	asian	asian	ADJ
chd-224	27	21	subgroup	subgroup	PROPN
chd-224	27	22	and	and	CCONJ
chd-224	27	23	non	non	ADJ
chd-224	27	24	-	-	ADJ
chd-224	27	25	hispanic	hispanic	ADJ
chd-224	27	26	(	(	PUNCT
chd-224	27	27	nh	nh	NOUN
chd-224	27	28	)	)	PUNCT
chd-224	27	29	whites	white	NOUN
chd-224	27	30	,	,	PUNCT
chd-224	27	31	2009	2009	NUM
chd-224	27	32	-	-	SYM
chd-224	27	33	2011	2011	NUM
chd-224	27	34	*	*	PUNCT
chd-224	27	35	(	(	PUNCT
chd-224	27	36	jin	jin	NOUN
chd-224	27	37	et	et	PROPN
chd-224	27	38	al	al	PROPN
chd-224	27	39	.	.	PROPN
chd-224	27	40	,	,	PUNCT
chd-224	27	41	2016	2016	NUM
chd-224	27	42	)	)	PUNCT
chd-224	27	43	.	.	PUNCT
chd-224	28	1	chinese	chinese	ADJ
chd-224	28	2	filipino	filipino	ADJ
chd-224	28	3	japanese	japanese	ADJ
chd-224	28	4	korean	korean	ADJ
chd-224	28	5	south	south	ADJ
chd-224	28	6	asian	asian	ADJ
chd-224	28	7	vietnamese	vietnamese	ADJ
chd-224	28	8	asian	asian	PROPN
chd-224	28	9	total	total	ADJ
chd-224	28	10	nh	nh	PROPN
chd-224	28	11	white	white	PROPN
chd-224	28	12	n	n	PROPN
chd-224	28	13	rate	rate	NOUN
chd-224	28	14	(	(	PUNCT
chd-224	28	15	95	95	NUM
chd-224	28	16	%	%	NOUN
chd-224	28	17	ci	ci	NOUN
chd-224	28	18	)	)	PUNCT
chd-224	28	19	n	n	NOUN
chd-224	28	20	rate	rate	NOUN
chd-224	28	21	(	(	PUNCT
chd-224	28	22	95	95	NUM
chd-224	28	23	%	%	NOUN
chd-224	28	24	ci	ci	NOUN
chd-224	28	25	)	)	PUNCT
chd-224	28	26	n	n	NOUN
chd-224	28	27	rate	rate	NOUN
chd-224	28	28	(	(	PUNCT
chd-224	28	29	95	95	NUM
chd-224	28	30	%	%	NOUN
chd-224	28	31	ci	ci	NOUN
chd-224	28	32	)	)	PUNCT
chd-224	28	33	n	n	NOUN
chd-224	28	34	rate	rate	NOUN
chd-224	28	35	(	(	PUNCT
chd-224	28	36	95	95	NUM
chd-224	28	37	%	%	NOUN
chd-224	28	38	ci	ci	NOUN
chd-224	28	39	)	)	PUNCT
chd-224	28	40	n	n	NOUN
chd-224	28	41	rate	rate	NOUN
chd-224	28	42	(	(	PUNCT
chd-224	28	43	95	95	NUM
chd-224	28	44	%	%	NOUN
chd-224	28	45	ci	ci	NOUN
chd-224	28	46	)	)	PUNCT
chd-224	28	47	n	n	NOUN
chd-224	28	48	rate	rate	NOUN
chd-224	28	49	(	(	PUNCT
chd-224	28	50	95	95	NUM
chd-224	28	51	%	%	NOUN
chd-224	28	52	ci	ci	NOUN
chd-224	28	53	)	)	PUNCT
chd-224	28	54	n	n	NOUN
chd-224	28	55	rate	rate	NOUN
chd-224	28	56	(	(	PUNCT
chd-224	28	57	95	95	NUM
chd-224	28	58	%	%	NOUN
chd-224	28	59	ci	ci	NOUN
chd-224	28	60	)	)	PUNCT
chd-224	28	61	n	n	NOUN
chd-224	28	62	rate	rate	NOUN
chd-224	28	63	(	(	PUNCT
chd-224	28	64	95	95	NUM
chd-224	28	65	%	%	NOUN
chd-224	28	66	ci	ci	NOUN
chd-224	28	67	)	)	PUNCT
chd-224	28	68	men	man	NOUN
chd-224	28	69	263	263	NUM
chd-224	28	70	6.9	6.9	NUM
chd-224	28	71	(	(	PUNCT
chd-224	28	72	6.17.8	6.17.8	NUM
chd-224	28	73	)	)	PUNCT
chd-224	28	74	271	271	NUM
chd-224	28	75	9.7	9.7	NUM
chd-224	28	76	(	(	PUNCT
chd-224	28	77	8.511.0	8.511.0	NUM
chd-224	28	78	)	)	PUNCT
chd-224	28	79	41	41	NUM
chd-224	28	80	3.7	3.7	NUM
chd-224	28	81	(	(	PUNCT
chd-224	28	82	2.65.2	2.65.2	NUM
chd-224	28	83	)	)	PUNCT
chd-224	28	84	108	108	NUM
chd-224	28	85	8.3	8.3	NUM
chd-224	28	86	(	(	PUNCT
chd-224	28	87	6.810.1	6.810.1	NUM
chd-224	28	88	)	)	PUNCT
chd-224	28	89	186	186	NUM
chd-224	28	90	5.8	5.8	NUM
chd-224	28	91	(	(	PUNCT
chd-224	28	92	4.96.8	4.96.8	NUM
chd-224	28	93	)	)	PUNCT
chd-224	28	94	75	75	NUM
chd-224	28	95	5.3	5.3	NUM
chd-224	28	96	(	(	PUNCT
chd-224	28	97	4.16.7	4.16.7	NUM
chd-224	28	98	)	)	PUNCT
chd-224	28	99	974	974	NUM
chd-224	28	100	6.8	6.8	NUM
chd-224	28	101	(	(	PUNCT
chd-224	28	102	6.47.3	6.47.3	NUM
chd-224	28	103	)	)	PUNCT
chd-224	28	104	9,425	9,425	NUM
chd-224	28	105	8.1	8.1	NUM
chd-224	28	106	(	(	PUNCT
chd-224	28	107	7.98.3	7.98.3	NUM
chd-224	28	108	)	)	PUNCT
chd-224	28	109	women	woman	NOUN
chd-224	28	110	920	920	NUM
chd-224	28	111	20.8	20.8	NUM
chd-224	28	112	(	(	PUNCT
chd-224	28	113	19.422.2	19.422.2	NUM
chd-224	28	114	)	)	PUNCT
chd-224	28	115	1,108	1,108	NUM
chd-224	28	116	28.5	28.5	NUM
chd-224	28	117	(	(	PUNCT
chd-224	28	118	26.830.3	26.830.3	NUM
chd-224	28	119	)	)	PUNCT
chd-224	28	120	153	153	NUM
chd-224	28	121	(	(	PUNCT
chd-224	28	122	11.6	11.6	NUM
chd-224	28	123	(	(	PUNCT
chd-224	28	124	9.713.9	9.713.9	NUM
chd-224	28	125	)	)	PUNCT
chd-224	28	126	408	408	NUM
chd-224	28	127	23.2	23.2	NUM
chd-224	28	128	(	(	PUNCT
chd-224	28	129	21.025.6	21.025.6	NOUN
chd-224	28	130	)	)	PUNCT
chd-224	28	131	624	624	NUM
chd-224	28	132	19.9	19.9	NUM
chd-224	28	133	(	(	PUNCT
chd-224	28	134	18.321.7	18.321.7	NUM
chd-224	28	135	)	)	PUNCT
chd-224	28	136	318	318	NUM
chd-224	28	137	19.3	19.3	NUM
chd-224	28	138	(	(	PUNCT
chd-224	28	139	17.221.7	17.221.7	NUM
chd-224	28	140	)	)	PUNCT
chd-224	28	141	3,670	3,670	NUM
chd-224	28	142	21.5	21.5	NUM
chd-224	28	143	(	(	PUNCT
chd-224	28	144	20.822.2	20.822.2	NUM
chd-224	28	145	)	)	PUNCT
chd-224	28	146	25,325	25,325	NUM
chd-224	28	147	22.4	22.4	NUM
chd-224	28	148	(	(	PUNCT
chd-224	28	149	22.122.7	22.122.7	NUM
chd-224	28	150	)	)	PUNCT
chd-224	28	151	*	*	NOUN
chd-224	28	152	rates	rate	NOUN
chd-224	28	153	are	be	AUX
chd-224	28	154	average	average	ADJ
chd-224	28	155	annual	annual	ADJ
chd-224	28	156	per	per	ADP
chd-224	28	157	100,000	100,000	NUM
chd-224	28	158	age	age	NOUN
chd-224	28	159	-	-	PUNCT
chd-224	28	160	standardized	standardize	VERB
chd-224	28	161	to	to	ADP
chd-224	28	162	the	the	DET
chd-224	28	163	2000	2000	NUM
chd-224	28	164	us	us	PROPN
chd-224	28	165	population	population	NOUN
chd-224	28	166	;	;	PUNCT
chd-224	28	167	the	the	DET
chd-224	28	168	number	number	NOUN
chd-224	28	169	of	of	ADP
chd-224	28	170	cases	case	NOUN
chd-224	28	171	may	may	AUX
chd-224	28	172	not	not	PART
chd-224	28	173	add	add	VERB
chd-224	28	174	up	up	ADP
chd-224	28	175	to	to	ADP
chd-224	28	176	the	the	DET
chd-224	28	177	total	total	NOUN
chd-224	28	178	due	due	ADJ
chd-224	28	179	to	to	ADP
chd-224	28	180	rounding	round	VERB
chd-224	28	181	.	.	PUNCT
chd-224	29	1	there	there	PRON
chd-224	29	2	are	be	VERB
chd-224	29	3	several	several	ADJ
chd-224	29	4	risk	risk	NOUN
chd-224	29	5	factors	factor	NOUN
chd-224	29	6	for	for	ADP
chd-224	29	7	thyroid	thyroid	NOUN
chd-224	29	8	cancer	cancer	NOUN
chd-224	29	9	incidence	incidence	NOUN
chd-224	29	10	that	that	PRON
chd-224	29	11	may	may	AUX
chd-224	29	12	contribute	contribute	VERB
chd-224	29	13	to	to	ADP
chd-224	29	14	these	these	DET
chd-224	29	15	disparities	disparity	NOUN
chd-224	29	16	(	(	PUNCT
chd-224	29	17	konturek	konturek	NOUN
chd-224	29	18	et	et	PROPN
chd-224	29	19	al	al	PROPN
chd-224	29	20	.	.	PROPN
chd-224	29	21	,	,	PUNCT
chd-224	29	22	2016	2016	NUM
chd-224	29	23	;	;	PUNCT
chd-224	29	24	la	la	PROPN
chd-224	29	25	vecchia	vecchia	PROPN
chd-224	29	26	et	et	PROPN
chd-224	29	27	al	al	PROPN
chd-224	29	28	.	.	PROPN
chd-224	29	29	,	,	PUNCT
chd-224	29	30	2015	2015	NUM
chd-224	29	31	;	;	PUNCT
chd-224	29	32	weeks	week	NOUN
chd-224	29	33	et	et	PROPN
chd-224	29	34	al	al	PROPN
chd-224	29	35	.	.	PROPN
chd-224	29	36	,	,	PUNCT
chd-224	29	37	2018	2018	NUM
chd-224	29	38	)	)	PUNCT
chd-224	29	39	.	.	PUNCT
chd-224	30	1	a	a	DET
chd-224	30	2	recent	recent	ADJ
chd-224	30	3	study	study	NOUN
chd-224	30	4	by	by	ADP
chd-224	30	5	bogović	bogović	NOUN
chd-224	30	6	et	et	PROPN
chd-224	30	7	al	al	PROPN
chd-224	30	8	.	.	PROPN
chd-224	30	9	categorized	categorize	VERB
chd-224	30	10	the	the	DET
chd-224	30	11	potential	potential	ADJ
chd-224	30	12	risk	risk	NOUN
chd-224	30	13	factors	factor	NOUN
chd-224	30	14	as	as	ADP
chd-224	30	15	either	either	CCONJ
chd-224	30	16	“	"	PUNCT
chd-224	30	17	high	high	ADJ
chd-224	30	18	risk	risk	NOUN
chd-224	30	19	,	,	PUNCT
chd-224	30	20	”	"	PUNCT
chd-224	30	21	“	"	PUNCT
chd-224	30	22	low	low	ADJ
chd-224	30	23	risk	risk	NOUN
chd-224	30	24	,	,	PUNCT
chd-224	30	25	”	"	PUNCT
chd-224	30	26	or	or	CCONJ
chd-224	30	27	“	"	PUNCT
chd-224	30	28	unclear	unclear	ADJ
chd-224	30	29	”	"	PUNCT
chd-224	30	30	(	(	PUNCT
chd-224	30	31	bogović	bogović	VERB
chd-224	30	32	crnčić	crnčić	PROPN
chd-224	30	33	et	et	PROPN
chd-224	30	34	al	al	PROPN
chd-224	30	35	.	.	PROPN
chd-224	30	36	,	,	PUNCT
chd-224	30	37	2020	2020	NUM
chd-224	30	38	)	)	PUNCT
chd-224	30	39	.	.	PUNCT
chd-224	31	1	high	high	ADJ
chd-224	31	2	-	-	PUNCT
chd-224	31	3	risk	risk	NOUN
chd-224	31	4	factors	factor	NOUN
chd-224	31	5	included	include	VERB
chd-224	31	6	external	external	ADJ
chd-224	31	7	radiation	radiation	NOUN
chd-224	31	8	exposure	exposure	NOUN
chd-224	31	9	(	(	PUNCT
chd-224	31	10	especially	especially	ADV
chd-224	31	11	during	during	ADP
chd-224	31	12	infancy	infancy	NOUN
chd-224	31	13	and	and	CCONJ
chd-224	31	14	childhood	childhood	NOUN
chd-224	31	15	)	)	PUNCT
chd-224	31	16	,	,	PUNCT
chd-224	31	17	chromosomal	chromosomal	ADJ
chd-224	31	18	alterations	alteration	NOUN
chd-224	31	19	,	,	PUNCT
chd-224	31	20	and	and	CCONJ
chd-224	31	21	hereditary	hereditary	ADJ
chd-224	31	22	conditions	condition	NOUN
chd-224	31	23	.	.	PUNCT
chd-224	32	1	low	low	ADJ
chd-224	32	2	-	-	PUNCT
chd-224	32	3	risk	risk	NOUN
chd-224	32	4	factors	factor	NOUN
chd-224	32	5	included	include	VERB
chd-224	32	6	thyroid	thyroid	NOUN
chd-224	32	7	imaging	imaging	NOUN
chd-224	32	8	with	with	ADP
chd-224	32	9	iodine	iodine	NOUN
chd-224	32	10	,	,	PUNCT
chd-224	32	11	iodine	iodine	NOUN
chd-224	32	12	deficiency	deficiency	NOUN
chd-224	32	13	,	,	PUNCT
chd-224	32	14	high	high	ADJ
chd-224	32	15	thyroidstimulating	thyroidstimulating	ADJ
chd-224	32	16	hormone	hormone	NOUN
chd-224	32	17	(	(	PUNCT
chd-224	32	18	tsh	tsh	NOUN
chd-224	32	19	)	)	PUNCT
chd-224	32	20	level	level	NOUN
chd-224	32	21	,	,	PUNCT
chd-224	32	22	autoimmunity	autoimmunity	NOUN
chd-224	32	23	,	,	PUNCT
chd-224	32	24	thyroid	thyroid	NOUN
chd-224	32	25	nodules	nodule	NOUN
chd-224	32	26	,	,	PUNCT
chd-224	32	27	environmental	environmental	ADJ
chd-224	32	28	pollutants	pollutant	NOUN
chd-224	32	29	,	,	PUNCT
chd-224	32	30	lifestyle	lifestyle	NOUN
chd-224	32	31	/	/	SYM
chd-224	32	32	diet	diet	NOUN
chd-224	32	33	,	,	PUNCT
chd-224	32	34	and	and	CCONJ
chd-224	32	35	obesity	obesity	NOUN
chd-224	32	36	/	/	SYM
chd-224	32	37	high	high	ADJ
chd-224	32	38	bmi	bmi	NOUN
chd-224	32	39	.	.	PUNCT
chd-224	33	1	the	the	DET
chd-224	33	2	only	only	ADJ
chd-224	33	3	unclear	unclear	ADJ
chd-224	33	4	risk	risk	NOUN
chd-224	33	5	factor	factor	NOUN
chd-224	33	6	included	include	VERB
chd-224	33	7	was	be	AUX
chd-224	33	8	estrogen	estrogen	NOUN
chd-224	33	9	.	.	PUNCT
chd-224	34	1	another	another	DET
chd-224	34	2	recent	recent	ADJ
chd-224	34	3	study	study	NOUN
chd-224	34	4	by	by	ADP
chd-224	34	5	yildirim	yildirim	PROPN
chd-224	34	6	et	et	PROPN
chd-224	34	7	al	al	PROPN
chd-224	34	8	.	.	PROPN
chd-224	34	9	mentioned	mention	VERB
chd-224	34	10	metabolic	metabolic	NOUN
chd-224	34	11	syndrome	syndrome	NOUN
chd-224	34	12	and	and	CCONJ
chd-224	34	13	insulin	insulin	NOUN
chd-224	34	14	resistance	resistance	NOUN
chd-224	34	15	as	as	ADP
chd-224	34	16	important	important	ADJ
chd-224	34	17	risk	risk	NOUN
chd-224	34	18	factors	factor	NOUN
chd-224	34	19	(	(	PUNCT
chd-224	34	20	yildirim	yildirim	PROPN
chd-224	34	21	simsir	simsir	VERB
chd-224	34	22	et	et	PROPN
chd-224	34	23	al	al	PROPN
chd-224	34	24	.	.	PROPN
chd-224	34	25	,	,	PUNCT
chd-224	34	26	2020	2020	NUM
chd-224	34	27	)	)	PUNCT
chd-224	34	28	.	.	PUNCT
chd-224	35	1	additionally	additionally	ADV
chd-224	35	2	,	,	PUNCT
chd-224	35	3	sex	sex	NOUN
chd-224	35	4	and	and	CCONJ
chd-224	35	5	socioeconomic	socioeconomic	ADJ
chd-224	35	6	status	status	NOUN
chd-224	35	7	may	may	AUX
chd-224	35	8	also	also	ADV
chd-224	35	9	be	be	AUX
chd-224	35	10	considered	consider	VERB
chd-224	35	11	risk	risk	NOUN
chd-224	35	12	factors	factor	NOUN
chd-224	35	13	.	.	PUNCT
chd-224	36	1	the	the	DET
chd-224	36	2	goal	goal	NOUN
chd-224	36	3	of	of	ADP
chd-224	36	4	this	this	DET
chd-224	36	5	literature	literature	NOUN
chd-224	36	6	review	review	NOUN
chd-224	36	7	is	be	AUX
chd-224	36	8	to	to	PART
chd-224	36	9	analyze	analyze	VERB
chd-224	36	10	whether	whether	SCONJ
chd-224	36	11	these	these	DET
chd-224	36	12	potential	potential	ADJ
chd-224	36	13	risk	risk	NOUN
chd-224	36	14	factors	factor	NOUN
chd-224	36	15	impact	impact	VERB
chd-224	36	16	incidence	incidence	NOUN
chd-224	36	17	and	and	CCONJ
chd-224	36	18	aggressiveness	aggressiveness	NOUN
chd-224	36	19	differently	differently	ADV
chd-224	36	20	by	by	ADP
chd-224	36	21	race	race	NOUN
chd-224	36	22	/	/	SYM
chd-224	36	23	ethnicity	ethnicity	NOUN
chd-224	36	24	,	,	PUNCT
chd-224	36	25	implicating	implicate	VERB
chd-224	36	26	their	their	PRON
chd-224	36	27	possible	possible	ADJ
chd-224	36	28	role	role	NOUN
chd-224	36	29	in	in	ADP
chd-224	36	30	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-224	36	31	e3	e3	NOUN
chd-224	36	32	cancer	cancer	NOUN
chd-224	36	33	health	health	NOUN
chd-224	36	34	disparities	disparity	NOUN
chd-224	36	35	research	research	NOUN
chd-224	36	36	influencing	influence	VERB
chd-224	36	37	thyroid	thyroid	NOUN
chd-224	36	38	cancer	cancer	NOUN
chd-224	36	39	racial	racial	ADJ
chd-224	36	40	/	/	SYM
chd-224	36	41	ethnic	ethnic	ADJ
chd-224	36	42	disparities	disparity	NOUN
chd-224	36	43	in	in	ADP
chd-224	36	44	the	the	DET
chd-224	36	45	united	united	PROPN
chd-224	36	46	states	states	PROPN
chd-224	36	47	.	.	PUNCT
chd-224	37	1	2	2	X
chd-224	37	2	.	.	X
chd-224	37	3	materials	material	NOUN
chd-224	37	4	and	and	CCONJ
chd-224	37	5	methods	method	NOUN
chd-224	37	6	to	to	PART
chd-224	37	7	review	review	VERB
chd-224	37	8	recent	recent	ADJ
chd-224	37	9	research	research	NOUN
chd-224	37	10	,	,	PUNCT
chd-224	37	11	a	a	DET
chd-224	37	12	pubmed	pubmed	PROPN
chd-224	37	13	search	search	NOUN
chd-224	37	14	was	be	AUX
chd-224	37	15	used	use	VERB
chd-224	37	16	,	,	PUNCT
chd-224	37	17	including	include	VERB
chd-224	37	18	articles	article	NOUN
chd-224	37	19	published	publish	VERB
chd-224	37	20	since	since	SCONJ
chd-224	37	21	2010	2010	NUM
chd-224	37	22	.	.	PUNCT
chd-224	38	1	each	each	DET
chd-224	38	2	identified	identify	VERB
chd-224	38	3	thyroid	thyroid	NOUN
chd-224	38	4	cancer	cancer	NOUN
chd-224	38	5	risk	risk	NOUN
chd-224	38	6	factor	factor	NOUN
chd-224	38	7	,	,	PUNCT
chd-224	38	8	as	as	SCONJ
chd-224	38	9	informed	inform	VERB
chd-224	38	10	by	by	ADP
chd-224	38	11	bogović	bogović	NOUN
chd-224	38	12	et	et	PROPN
chd-224	38	13	al	al	PROPN
chd-224	38	14	.	.	PUNCT
chd-224	39	1	(	(	PUNCT
chd-224	39	2	bogović	bogović	VERB
chd-224	39	3	crnčić	crnčić	PROPN
chd-224	39	4	et	et	PROPN
chd-224	39	5	al	al	PROPN
chd-224	39	6	.	.	PROPN
chd-224	39	7	,	,	PUNCT
chd-224	39	8	2020	2020	NUM
chd-224	39	9	)	)	PUNCT
chd-224	39	10	and	and	CCONJ
chd-224	39	11	yildirim	yildirim	PROPN
chd-224	39	12	et	et	PROPN
chd-224	39	13	al	al	PROPN
chd-224	39	14	.	.	PUNCT
chd-224	40	1	(	(	PUNCT
chd-224	40	2	yildirim	yildirim	PROPN
chd-224	40	3	simsir	simsir	VERB
chd-224	40	4	et	et	PROPN
chd-224	40	5	al	al	PROPN
chd-224	40	6	.	.	PROPN
chd-224	40	7	,	,	PUNCT
chd-224	40	8	2020	2020	NUM
chd-224	40	9	)	)	PUNCT
chd-224	40	10	,	,	PUNCT
chd-224	40	11	was	be	AUX
chd-224	40	12	used	use	VERB
chd-224	40	13	as	as	ADP
chd-224	40	14	a	a	DET
chd-224	40	15	keyword	keyword	NOUN
chd-224	40	16	:	:	PUNCT
chd-224	40	17	‘	'	PUNCT
chd-224	40	18	radiation	radiation	NOUN
chd-224	40	19	exposure	exposure	NOUN
chd-224	40	20	’	'	PUNCT
chd-224	40	21	or	or	CCONJ
chd-224	40	22	‘	'	PUNCT
chd-224	40	23	ionizing	ionize	VERB
chd-224	40	24	radiation	radiation	NOUN
chd-224	40	25	’	'	PUNCT
chd-224	40	26	,	,	PUNCT
chd-224	40	27	‘	'	PUNCT
chd-224	40	28	chromosomal	chromosomal	ADJ
chd-224	40	29	alterations	alteration	NOUN
chd-224	40	30	’	'	PUNCT
chd-224	40	31	,	,	PUNCT
chd-224	40	32	‘	'	PUNCT
chd-224	40	33	nonhereditary	nonhereditary	ADJ
chd-224	40	34	conditions	condition	NOUN
chd-224	40	35	’	'	PUNCT
chd-224	40	36	,	,	PUNCT
chd-224	40	37	‘	'	PUNCT
chd-224	40	38	hereditary	hereditary	ADJ
chd-224	40	39	conditions	condition	NOUN
chd-224	40	40	’	'	PUNCT
chd-224	40	41	,	,	PUNCT
chd-224	40	42	‘	'	PUNCT
chd-224	40	43	iodine	iodine	NOUN
chd-224	40	44	’	'	PUNCT
chd-224	40	45	,	,	PUNCT
chd-224	40	46	‘	'	PUNCT
chd-224	40	47	tsh	tsh	NOUN
chd-224	40	48	’	'	PUNCT
chd-224	40	49	,	,	PUNCT
chd-224	40	50	‘	'	PUNCT
chd-224	40	51	autoimmunity	autoimmunity	NOUN
chd-224	40	52	’	'	PUNCT
chd-224	40	53	,	,	PUNCT
chd-224	40	54	‘	'	PUNCT
chd-224	40	55	thyroid	thyroid	NOUN
chd-224	40	56	nodules	nodule	NOUN
chd-224	40	57	’	'	PUNCT
chd-224	40	58	,	,	PUNCT
chd-224	40	59	‘	'	PUNCT
chd-224	40	60	environmental	environmental	ADJ
chd-224	40	61	pollutants	pollutant	NOUN
chd-224	40	62	’	'	PUNCT
chd-224	40	63	and	and	CCONJ
chd-224	40	64	‘	'	PUNCT
chd-224	40	65	geospatial	geospatial	NOUN
chd-224	40	66	’	'	PUNCT
chd-224	40	67	,	,	PUNCT
chd-224	40	68	‘	'	PUNCT
chd-224	40	69	lifestyle	lifestyle	NOUN
chd-224	40	70	and	and	CCONJ
chd-224	40	71	diet	diet	NOUN
chd-224	40	72	’	'	PUNCT
chd-224	40	73	,	,	PUNCT
chd-224	40	74	‘	'	PUNCT
chd-224	40	75	bmi	bmi	PROPN
chd-224	40	76	’	'	PUNCT
chd-224	40	77	,	,	PUNCT
chd-224	40	78	‘	'	PUNCT
chd-224	40	79	metabolic	metabolic	NOUN
chd-224	40	80	syndrome	syndrome	NOUN
chd-224	40	81	’	'	PUNCT
chd-224	40	82	,	,	PUNCT
chd-224	40	83	‘	'	PUNCT
chd-224	40	84	insulin	insulin	NOUN
chd-224	40	85	resistance	resistance	NOUN
chd-224	40	86	’	'	PUNCT
chd-224	40	87	,	,	PUNCT
chd-224	40	88	‘	'	PUNCT
chd-224	40	89	sex	sex	NOUN
chd-224	40	90	’	'	PUNCT
chd-224	40	91	,	,	PUNCT
chd-224	40	92	and	and	CCONJ
chd-224	40	93	‘	'	PUNCT
chd-224	40	94	socioeconomic	socioeconomic	ADJ
chd-224	40	95	’	'	PUNCT
chd-224	40	96	.	.	PUNCT
chd-224	41	1	other	other	ADJ
chd-224	41	2	keywords	keyword	NOUN
chd-224	41	3	included	include	VERB
chd-224	41	4	:	:	PUNCT
chd-224	41	5	‘	'	PUNCT
chd-224	41	6	effects	effect	NOUN
chd-224	41	7	of	of	ADP
chd-224	41	8	’	'	PUNCT
chd-224	41	9	,	,	PUNCT
chd-224	41	10	‘	'	PUNCT
chd-224	41	11	thyroid	thyroid	NOUN
chd-224	41	12	’	'	PUNCT
chd-224	41	13	,	,	PUNCT
chd-224	41	14	‘	'	PUNCT
chd-224	41	15	thyroid	thyroid	NOUN
chd-224	41	16	cancer	cancer	NOUN
chd-224	41	17	’	'	PUNCT
chd-224	41	18	,	,	PUNCT
chd-224	41	19	‘	'	PUNCT
chd-224	41	20	united	united	ADJ
chd-224	41	21	states	states	PROPN
chd-224	41	22	’	'	PUNCT
chd-224	41	23	,	,	PUNCT
chd-224	41	24	‘	'	PUNCT
chd-224	41	25	health	health	NOUN
chd-224	41	26	disparities	disparity	NOUN
chd-224	41	27	’	'	PUNCT
chd-224	41	28	,	,	PUNCT
chd-224	41	29	‘	'	PUNCT
chd-224	41	30	risk	risk	NOUN
chd-224	41	31	factors	factor	NOUN
chd-224	41	32	’	'	PUNCT
chd-224	41	33	,	,	PUNCT
chd-224	41	34	and	and	CCONJ
chd-224	41	35	‘	'	PUNCT
chd-224	41	36	race	race	NOUN
chd-224	41	37	and	and	CCONJ
chd-224	41	38	ethnicity	ethnicity	NOUN
chd-224	41	39	’	'	PUNCT
chd-224	41	40	.	.	PUNCT
chd-224	42	1	articles	article	NOUN
chd-224	42	2	were	be	AUX
chd-224	42	3	selected	select	VERB
chd-224	42	4	after	after	ADP
chd-224	42	5	screening	screen	VERB
chd-224	42	6	titles	title	NOUN
chd-224	42	7	and	and	CCONJ
chd-224	42	8	abstracts	abstract	NOUN
chd-224	42	9	for	for	ADP
chd-224	42	10	relevancy	relevancy	NOUN
chd-224	42	11	,	,	PUNCT
chd-224	42	12	with	with	ADP
chd-224	42	13	a	a	DET
chd-224	42	14	particular	particular	ADJ
chd-224	42	15	focus	focus	NOUN
chd-224	42	16	on	on	ADP
chd-224	42	17	research	research	NOUN
chd-224	42	18	done	do	VERB
chd-224	42	19	in	in	ADP
chd-224	42	20	the	the	DET
chd-224	42	21	united	united	PROPN
chd-224	42	22	states	states	PROPN
chd-224	42	23	.	.	PUNCT
chd-224	43	1	afterwards	afterwards	ADV
chd-224	43	2	,	,	PUNCT
chd-224	43	3	the	the	DET
chd-224	43	4	full	full	ADJ
chd-224	43	5	text	text	NOUN
chd-224	43	6	for	for	ADP
chd-224	43	7	each	each	DET
chd-224	43	8	article	article	NOUN
chd-224	43	9	was	be	AUX
chd-224	43	10	acquired	acquire	VERB
chd-224	43	11	.	.	PUNCT
chd-224	44	1	some	some	DET
chd-224	44	2	potential	potential	ADJ
chd-224	44	3	risk	risk	NOUN
chd-224	44	4	factors	factor	NOUN
chd-224	44	5	such	such	ADJ
chd-224	44	6	as	as	ADP
chd-224	44	7	radiation	radiation	NOUN
chd-224	44	8	exposure	exposure	NOUN
chd-224	44	9	,	,	PUNCT
chd-224	44	10	autoimmunity	autoimmunity	NOUN
chd-224	44	11	,	,	PUNCT
chd-224	44	12	chromosomal	chromosomal	ADJ
chd-224	44	13	alterations	alteration	NOUN
chd-224	44	14	/	/	SYM
chd-224	44	15	non	non	ADJ
chd-224	44	16	-	-	ADJ
chd-224	44	17	hereditary	hereditary	ADJ
chd-224	44	18	conditions	condition	NOUN
chd-224	44	19	,	,	PUNCT
chd-224	44	20	hereditary	hereditary	ADJ
chd-224	44	21	conditions	condition	NOUN
chd-224	44	22	,	,	PUNCT
chd-224	44	23	and	and	CCONJ
chd-224	44	24	thyroid	thyroid	NOUN
chd-224	44	25	nodules	nodule	NOUN
chd-224	44	26	included	include	VERB
chd-224	44	27	publications	publication	NOUN
chd-224	44	28	since	since	SCONJ
chd-224	44	29	2000	2000	NUM
chd-224	44	30	as	as	SCONJ
chd-224	44	31	the	the	DET
chd-224	44	32	findings	finding	NOUN
chd-224	44	33	for	for	ADP
chd-224	44	34	these	these	DET
chd-224	44	35	risk	risk	NOUN
chd-224	44	36	factors	factor	NOUN
chd-224	44	37	are	be	AUX
chd-224	44	38	less	less	ADV
chd-224	44	39	likely	likely	ADJ
chd-224	44	40	to	to	PART
chd-224	44	41	change	change	VERB
chd-224	44	42	significantly	significantly	ADV
chd-224	44	43	within	within	ADP
chd-224	44	44	the	the	DET
chd-224	44	45	last	last	ADJ
chd-224	44	46	20	20	NUM
chd-224	44	47	years	year	NOUN
chd-224	44	48	compared	compare	VERB
chd-224	44	49	to	to	ADP
chd-224	44	50	the	the	DET
chd-224	44	51	others	other	NOUN
chd-224	44	52	.	.	PUNCT
chd-224	45	1	each	each	DET
chd-224	45	2	potential	potential	ADJ
chd-224	45	3	risk	risk	NOUN
chd-224	45	4	factor	factor	NOUN
chd-224	45	5	was	be	AUX
chd-224	45	6	reviewed	review	VERB
chd-224	45	7	for	for	ADP
chd-224	45	8	whether	whether	SCONJ
chd-224	45	9	they	they	PRON
chd-224	45	10	may	may	AUX
chd-224	45	11	impact	impact	VERB
chd-224	45	12	thyroid	thyroid	NOUN
chd-224	45	13	cancer	cancer	NOUN
chd-224	45	14	incidence	incidence	NOUN
chd-224	45	15	and	and	CCONJ
chd-224	45	16	aggressiveness	aggressiveness	NOUN
chd-224	45	17	differently	differently	ADV
chd-224	45	18	by	by	ADP
chd-224	45	19	racial	racial	ADJ
chd-224	45	20	/	/	SYM
chd-224	45	21	ethnic	ethnic	ADJ
chd-224	45	22	group	group	NOUN
chd-224	45	23	,	,	PUNCT
chd-224	45	24	if	if	SCONJ
chd-224	45	25	no	no	DET
chd-224	45	26	difference	difference	NOUN
chd-224	45	27	exists	exist	VERB
chd-224	45	28	,	,	PUNCT
chd-224	45	29	or	or	CCONJ
chd-224	45	30	if	if	SCONJ
chd-224	45	31	further	further	ADJ
chd-224	45	32	research	research	NOUN
chd-224	45	33	is	be	AUX
chd-224	45	34	necessary	necessary	ADJ
chd-224	45	35	to	to	PART
chd-224	45	36	examine	examine	VERB
chd-224	45	37	their	their	PRON
chd-224	45	38	relationship	relationship	NOUN
chd-224	45	39	to	to	ADP
chd-224	45	40	health	health	NOUN
chd-224	45	41	disparities	disparity	NOUN
chd-224	45	42	.	.	PUNCT
chd-224	46	1	3	3	X
chd-224	46	2	.	.	X
chd-224	46	3	risk	risk	NOUN
chd-224	46	4	factors	factor	NOUN
chd-224	46	5	potentially	potentially	ADV
chd-224	46	6	contributing	contribute	VERB
chd-224	46	7	to	to	ADP
chd-224	46	8	tc	tc	NUM
chd-224	46	9	health	health	NOUN
chd-224	46	10	disparities	disparity	NOUN
chd-224	46	11	3.1	3.1	NUM
chd-224	46	12	.	.	PUNCT
chd-224	47	1	genetic	genetic	ADJ
chd-224	47	2	factors	factor	NOUN
chd-224	47	3	hereditary	hereditary	ADJ
chd-224	47	4	conditions	condition	NOUN
chd-224	47	5	influencing	influence	VERB
chd-224	47	6	tc	tc	NUM
chd-224	47	7	health	health	NOUN
chd-224	47	8	disparities	disparity	NOUN
chd-224	47	9	although	although	SCONJ
chd-224	47	10	more	more	ADJ
chd-224	47	11	than	than	ADP
chd-224	47	12	90	90	NUM
chd-224	47	13	%	%	NOUN
chd-224	47	14	of	of	ADP
chd-224	47	15	thyroid	thyroid	NOUN
chd-224	47	16	cancers	cancer	NOUN
chd-224	47	17	are	be	AUX
chd-224	47	18	sporadic	sporadic	ADJ
chd-224	47	19	,	,	PUNCT
chd-224	47	20	thyroid	thyroid	NOUN
chd-224	47	21	cancer	cancer	NOUN
chd-224	47	22	has	have	AUX
chd-224	47	23	been	be	AUX
chd-224	47	24	shown	show	VERB
chd-224	47	25	to	to	PART
chd-224	47	26	have	have	VERB
chd-224	47	27	a	a	DET
chd-224	47	28	significant	significant	ADJ
chd-224	47	29	hereditary	hereditary	ADJ
chd-224	47	30	component	component	NOUN
chd-224	47	31	with	with	ADP
chd-224	47	32	many	many	ADJ
chd-224	47	33	hereditary	hereditary	ADJ
chd-224	47	34	forms	form	NOUN
chd-224	47	35	exhibiting	exhibit	VERB
chd-224	47	36	more	more	ADV
chd-224	47	37	aggressive	aggressive	ADJ
chd-224	47	38	courses	course	NOUN
chd-224	47	39	.	.	PUNCT
chd-224	48	1	hereditary	hereditary	ADJ
chd-224	48	2	thyroid	thyroid	NOUN
chd-224	48	3	neoplasms	neoplasm	NOUN
chd-224	48	4	are	be	AUX
chd-224	48	5	divided	divide	VERB
chd-224	48	6	into	into	ADP
chd-224	48	7	those	those	PRON
chd-224	48	8	that	that	PRON
chd-224	48	9	arise	arise	VERB
chd-224	48	10	from	from	ADP
chd-224	48	11	follicular	follicular	ADJ
chd-224	48	12	cells	cell	NOUN
chd-224	48	13	,	,	PUNCT
chd-224	48	14	familial	familial	ADJ
chd-224	48	15	non	non	ADJ
chd-224	48	16	-	-	ADJ
chd-224	48	17	medullary	medullary	ADJ
chd-224	48	18	thyroid	thyroid	NOUN
chd-224	48	19	carcinoma	carcinoma	NOUN
chd-224	48	20	(	(	PUNCT
chd-224	48	21	fnmtc	fnmtc	NOUN
chd-224	48	22	)	)	PUNCT
chd-224	48	23	and	and	CCONJ
chd-224	48	24	those	those	PRON
chd-224	48	25	arising	arise	VERB
chd-224	48	26	from	from	ADP
chd-224	48	27	calcitonin	calcitonin	NOUN
chd-224	48	28	-	-	PUNCT
chd-224	48	29	producing	produce	VERB
chd-224	48	30	c	c	NOUN
chd-224	48	31	cells	cell	NOUN
chd-224	48	32	,	,	PUNCT
chd-224	48	33	familial	familial	ADJ
chd-224	48	34	medullary	medullary	ADJ
chd-224	48	35	thyroid	thyroid	NOUN
chd-224	48	36	carcinomas	carcinoma	NOUN
chd-224	48	37	(	(	PUNCT
chd-224	48	38	fmtcs	fmtcs	NOUN
chd-224	48	39	)	)	PUNCT
chd-224	48	40	.	.	PUNCT
chd-224	49	1	fnmtcs	fnmtcs	PROPN
chd-224	49	2	are	be	AUX
chd-224	49	3	further	far	ADV
chd-224	49	4	divided	divide	VERB
chd-224	49	5	into	into	ADP
chd-224	49	6	syndromes	syndrome	NOUN
chd-224	49	7	where	where	SCONJ
chd-224	49	8	non	non	ADJ
chd-224	49	9	-	-	ADJ
chd-224	49	10	thyroid	thyroid	ADJ
chd-224	49	11	tumors	tumor	NOUN
chd-224	49	12	predominate	predominate	VERB
chd-224	49	13	,	,	PUNCT
chd-224	49	14	and	and	CCONJ
chd-224	49	15	those	those	PRON
chd-224	49	16	where	where	SCONJ
chd-224	49	17	non	non	ADJ
chd-224	49	18	-	-	ADJ
chd-224	49	19	medullary	medullary	ADJ
chd-224	49	20	thyroid	thyroid	NOUN
chd-224	49	21	tumors	tumor	NOUN
chd-224	49	22	predominate	predominate	VERB
chd-224	49	23	.	.	PUNCT
chd-224	50	1	the	the	DET
chd-224	50	2	former	former	ADJ
chd-224	50	3	includes	include	VERB
chd-224	50	4	familial	familial	ADJ
chd-224	50	5	adenomatous	adenomatous	ADJ
chd-224	50	6	polyposis	polyposis	NOUN
chd-224	50	7	(	(	PUNCT
chd-224	50	8	fap	fap	NOUN
chd-224	50	9	)	)	PUNCT
chd-224	50	10	,	,	PUNCT
chd-224	50	11	cowden	cowden	PROPN
chd-224	50	12	syndrome	syndrome	PROPN
chd-224	50	13	(	(	PUNCT
chd-224	50	14	cs	cs	PROPN
chd-224	50	15	)	)	PUNCT
chd-224	50	16	,	,	PUNCT
chd-224	50	17	carney	carney	NOUN
chd-224	50	18	complex	complex	NOUN
chd-224	50	19	(	(	PUNCT
chd-224	50	20	cnc	cnc	PROPN
chd-224	50	21	)	)	PUNCT
chd-224	50	22	,	,	PUNCT
chd-224	50	23	werner	werner	PROPN
chd-224	50	24	syndrome	syndrome	PROPN
chd-224	50	25	(	(	PUNCT
chd-224	50	26	ws	ws	PROPN
chd-224	50	27	)	)	PUNCT
chd-224	50	28	,	,	PUNCT
chd-224	50	29	mccune	mccune	PROPN
chd-224	50	30	-	-	PUNCT
chd-224	50	31	albright	albright	PROPN
chd-224	50	32	syndrome	syndrome	PROPN
chd-224	50	33	,	,	PUNCT
chd-224	50	34	pendred	pendre	VERB
chd-224	50	35	syndrome	syndrome	NOUN
chd-224	50	36	,	,	PUNCT
chd-224	50	37	and	and	CCONJ
chd-224	50	38	dicer1	dicer1	NOUN
chd-224	50	39	syndrome	syndrome	NOUN
chd-224	50	40	.	.	PUNCT
chd-224	51	1	the	the	DET
chd-224	51	2	latter	latter	ADJ
chd-224	51	3	group	group	NOUN
chd-224	51	4	includes	include	VERB
chd-224	51	5	pure	pure	ADJ
chd-224	51	6	familial	familial	ADJ
chd-224	51	7	papillary	papillary	ADJ
chd-224	51	8	thyroid	thyroid	NOUN
chd-224	51	9	carcinoma	carcinoma	NOUN
chd-224	51	10	(	(	PUNCT
chd-224	51	11	fptc	fptc	ADV
chd-224	51	12	)	)	PUNCT
chd-224	51	13	,	,	PUNCT
chd-224	51	14	fptc	fptc	VERB
chd-224	51	15	with	with	ADP
chd-224	51	16	multinodular	multinodular	ADJ
chd-224	51	17	goiter	goiter	NOUN
chd-224	51	18	,	,	PUNCT
chd-224	51	19	and	and	CCONJ
chd-224	51	20	fptc	fptc	VERB
chd-224	51	21	with	with	ADP
chd-224	51	22	papillary	papillary	ADJ
chd-224	51	23	renal	renal	ADJ
chd-224	51	24	cell	cell	NOUN
chd-224	51	25	carcinoma	carcinoma	NOUN
chd-224	51	26	(	(	PUNCT
chd-224	51	27	guilmette	guilmette	NOUN
chd-224	51	28	and	and	CCONJ
chd-224	51	29	nosé	nosé	NOUN
chd-224	51	30	,	,	PUNCT
chd-224	51	31	2018	2018	NUM
chd-224	51	32	)	)	PUNCT
chd-224	51	33	.	.	PUNCT
chd-224	52	1	medullary	medullary	ADJ
chd-224	52	2	thyroid	thyroid	NOUN
chd-224	52	3	cancer	cancer	NOUN
chd-224	52	4	(	(	PUNCT
chd-224	52	5	mtc	mtc	NOUN
chd-224	52	6	)	)	PUNCT
chd-224	52	7	is	be	AUX
chd-224	52	8	hereditary	hereditary	ADJ
chd-224	52	9	in	in	ADP
chd-224	52	10	25	25	NUM
chd-224	52	11	%	%	NOUN
chd-224	52	12	of	of	ADP
chd-224	52	13	cases	case	NOUN
chd-224	52	14	,	,	PUNCT
chd-224	52	15	and	and	CCONJ
chd-224	52	16	commonly	commonly	ADV
chd-224	52	17	occurs	occur	VERB
chd-224	52	18	as	as	ADP
chd-224	52	19	part	part	NOUN
chd-224	52	20	of	of	ADP
chd-224	52	21	the	the	DET
chd-224	52	22	multiple	multiple	ADJ
chd-224	52	23	endocrine	endocrine	ADJ
chd-224	52	24	neoplasia	neoplasia	NOUN
chd-224	52	25	ii	ii	PROPN
chd-224	52	26	syndromes	syndrome	NOUN
chd-224	52	27	,	,	PUNCT
chd-224	52	28	although	although	SCONJ
chd-224	52	29	a	a	DET
chd-224	52	30	heritable	heritable	ADJ
chd-224	52	31	mtc	mtc	NOUN
chd-224	52	32	-	-	PUNCT
chd-224	52	33	only	only	ADJ
chd-224	52	34	syndrome	syndrome	NOUN
chd-224	52	35	is	be	AUX
chd-224	52	36	reported	report	VERB
chd-224	52	37	.	.	PUNCT
chd-224	53	1	hereditary	hereditary	ADJ
chd-224	53	2	and	and	CCONJ
chd-224	53	3	sporadic	sporadic	ADJ
chd-224	53	4	mtc	mtc	NOUN
chd-224	53	5	are	be	AUX
chd-224	53	6	both	both	PRON
chd-224	53	7	driven	drive	VERB
chd-224	53	8	by	by	ADP
chd-224	53	9	mutations	mutation	NOUN
chd-224	53	10	in	in	ADP
chd-224	53	11	the	the	DET
chd-224	53	12	ret	ret	PROPN
chd-224	53	13	proto	proto	NOUN
chd-224	53	14	-	-	PUNCT
chd-224	53	15	oncogene	oncogene	NOUN
chd-224	53	16	;	;	PUNCT
chd-224	53	17	however	however	ADV
chd-224	53	18	,	,	PUNCT
chd-224	53	19	hereditary	hereditary	ADJ
chd-224	53	20	forms	form	NOUN
chd-224	53	21	are	be	AUX
chd-224	53	22	more	more	ADV
chd-224	53	23	likely	likely	ADJ
chd-224	53	24	to	to	PART
chd-224	53	25	present	present	VERB
chd-224	53	26	bilaterally	bilaterally	ADV
chd-224	53	27	and	and	CCONJ
chd-224	53	28	arise	arise	VERB
chd-224	53	29	at	at	ADP
chd-224	53	30	an	an	DET
chd-224	53	31	earlier	early	ADJ
chd-224	53	32	age	age	NOUN
chd-224	53	33	,	,	PUNCT
chd-224	53	34	with	with	ADP
chd-224	53	35	menii	menii	NOUN
chd-224	53	36	carrying	carry	VERB
chd-224	53	37	a	a	DET
chd-224	53	38	near	near	ADJ
chd-224	53	39	100	100	NUM
chd-224	53	40	%	%	NOUN
chd-224	53	41	lifetime	lifetime	NOUN
chd-224	53	42	risk	risk	NOUN
chd-224	53	43	of	of	ADP
chd-224	53	44	developing	develop	VERB
chd-224	53	45	mtc	mtc	NOUN
chd-224	53	46	(	(	PUNCT
chd-224	53	47	guilmette	guilmette	NOUN
chd-224	53	48	and	and	CCONJ
chd-224	53	49	nosé	nosé	NOUN
chd-224	53	50	,	,	PUNCT
chd-224	53	51	2018	2018	NUM
chd-224	53	52	)	)	PUNCT
chd-224	53	53	.	.	PUNCT
chd-224	54	1	despite	despite	SCONJ
chd-224	54	2	earlier	early	ADJ
chd-224	54	3	presentation	presentation	NOUN
chd-224	54	4	of	of	ADP
chd-224	54	5	hereditary	hereditary	ADJ
chd-224	54	6	mtc	mtc	NOUN
chd-224	54	7	,	,	PUNCT
chd-224	54	8	one	one	NUM
chd-224	54	9	study	study	NOUN
chd-224	54	10	found	find	VERB
chd-224	54	11	the	the	DET
chd-224	54	12	overall	overall	ADJ
chd-224	54	13	10	10	NUM
chd-224	54	14	-	-	PUNCT
chd-224	54	15	year	year	NOUN
chd-224	54	16	survival	survival	NOUN
chd-224	54	17	to	to	PART
chd-224	54	18	be	be	AUX
chd-224	54	19	100	100	NUM
chd-224	54	20	%	%	NOUN
chd-224	54	21	in	in	ADP
chd-224	54	22	hereditary	hereditary	ADJ
chd-224	54	23	mtc	mtc	NOUN
chd-224	54	24	compared	compare	VERB
chd-224	54	25	to	to	ADP
chd-224	54	26	80	80	NUM
chd-224	54	27	%	%	NOUN
chd-224	54	28	in	in	ADP
chd-224	54	29	sporadic	sporadic	ADJ
chd-224	54	30	mtc	mtc	NOUN
chd-224	54	31	(	(	PUNCT
chd-224	54	32	xu	xu	INTJ
chd-224	54	33	et	et	PROPN
chd-224	54	34	al	al	PROPN
chd-224	54	35	.	.	PROPN
chd-224	54	36	,	,	PUNCT
chd-224	54	37	2012	2012	NUM
chd-224	54	38	)	)	PUNCT
chd-224	54	39	.	.	PUNCT
chd-224	55	1	although	although	SCONJ
chd-224	55	2	hereditary	hereditary	ADJ
chd-224	55	3	mtc	mtc	NOUN
chd-224	55	4	has	have	AUX
chd-224	55	5	been	be	AUX
chd-224	55	6	reported	report	VERB
chd-224	55	7	across	across	ADP
chd-224	55	8	varying	vary	VERB
chd-224	55	9	ethnic	ethnic	ADJ
chd-224	55	10	groups	group	NOUN
chd-224	55	11	,	,	PUNCT
chd-224	55	12	there	there	PRON
chd-224	55	13	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-224	55	14	e4	e4	PROPN
chd-224	55	15	cancer	cancer	NOUN
chd-224	55	16	health	health	NOUN
chd-224	55	17	disparities	disparity	NOUN
chd-224	55	18	research	research	NOUN
chd-224	55	19	is	be	AUX
chd-224	55	20	little	little	ADJ
chd-224	55	21	research	research	NOUN
chd-224	55	22	investigating	investigate	VERB
chd-224	55	23	the	the	DET
chd-224	55	24	racial	racial	ADJ
chd-224	55	25	distribution	distribution	NOUN
chd-224	55	26	of	of	ADP
chd-224	55	27	hereditary	hereditary	ADJ
chd-224	55	28	mtc	mtc	NOUN
chd-224	55	29	.	.	PUNCT
chd-224	56	1	familial	familial	ADJ
chd-224	56	2	adenomatous	adenomatous	ADJ
chd-224	56	3	polyposis	polyposis	NOUN
chd-224	56	4	(	(	PUNCT
chd-224	56	5	fap	fap	NOUN
chd-224	56	6	)	)	PUNCT
chd-224	56	7	is	be	AUX
chd-224	56	8	an	an	DET
chd-224	56	9	autosomal	autosomal	ADJ
chd-224	56	10	disorder	disorder	NOUN
chd-224	56	11	caused	cause	VERB
chd-224	56	12	by	by	ADP
chd-224	56	13	a	a	DET
chd-224	56	14	germline	germline	NOUN
chd-224	56	15	mutation	mutation	NOUN
chd-224	56	16	in	in	ADP
chd-224	56	17	the	the	DET
chd-224	56	18	adenomatous	adenomatous	ADJ
chd-224	56	19	polyposis	polyposis	NOUN
chd-224	56	20	coli	coli	NOUN
chd-224	56	21	(	(	PUNCT
chd-224	56	22	apc	apc	NOUN
chd-224	56	23	)	)	PUNCT
chd-224	56	24	gene	gene	NOUN
chd-224	56	25	.	.	PUNCT
chd-224	57	1	around	around	ADV
chd-224	57	2	2	2	NUM
chd-224	57	3	-	-	SYM
chd-224	57	4	12	12	NUM
chd-224	57	5	%	%	NOUN
chd-224	57	6	of	of	ADP
chd-224	57	7	patients	patient	NOUN
chd-224	57	8	with	with	ADP
chd-224	57	9	fap	fap	NOUN
chd-224	57	10	develop	develop	VERB
chd-224	57	11	ptc	ptc	PROPN
chd-224	57	12	,	,	PUNCT
chd-224	57	13	with	with	ADP
chd-224	57	14	a	a	DET
chd-224	57	15	160	160	NUM
chd-224	57	16	-	-	ADJ
chd-224	57	17	fold	fold	VERB
chd-224	57	18	greater	great	ADJ
chd-224	57	19	risk	risk	NOUN
chd-224	57	20	of	of	ADP
chd-224	57	21	developing	develop	VERB
chd-224	57	22	ptc	ptc	NOUN
chd-224	57	23	than	than	ADP
chd-224	57	24	unaffected	unaffected	ADJ
chd-224	57	25	individuals	individual	NOUN
chd-224	57	26	.	.	PUNCT
chd-224	58	1	more	more	ADJ
chd-224	58	2	than	than	ADP
chd-224	58	3	90	90	NUM
chd-224	58	4	%	%	NOUN
chd-224	58	5	of	of	ADP
chd-224	58	6	the	the	DET
chd-224	58	7	cases	case	NOUN
chd-224	58	8	have	have	VERB
chd-224	58	9	a	a	DET
chd-224	58	10	histologic	histologic	ADJ
chd-224	58	11	variant	variant	NOUN
chd-224	58	12	,	,	PUNCT
chd-224	58	13	called	call	VERB
chd-224	58	14	cribriform	cribriform	NOUN
chd-224	58	15	-	-	PUNCT
chd-224	58	16	morular	morular	ADJ
chd-224	58	17	ptc	ptc	NOUN
chd-224	58	18	(	(	PUNCT
chd-224	58	19	cmv	cmv	NOUN
chd-224	58	20	-	-	PUNCT
chd-224	58	21	ptc	ptc	NOUN
chd-224	58	22	)	)	PUNCT
chd-224	58	23	,	,	PUNCT
chd-224	58	24	and	and	CCONJ
chd-224	58	25	they	they	PRON
chd-224	58	26	are	be	AUX
chd-224	58	27	more	more	ADV
chd-224	58	28	likely	likely	ADJ
chd-224	58	29	to	to	PART
chd-224	58	30	affect	affect	VERB
chd-224	58	31	females	female	NOUN
chd-224	58	32	and	and	CCONJ
chd-224	58	33	present	present	ADJ
chd-224	58	34	bilaterally	bilaterally	ADV
chd-224	58	35	.	.	PUNCT
chd-224	59	1	overall	overall	ADV
chd-224	59	2	,	,	PUNCT
chd-224	59	3	the	the	DET
chd-224	59	4	prognosis	prognosis	NOUN
chd-224	59	5	is	be	AUX
chd-224	59	6	good	good	ADJ
chd-224	59	7	and	and	CCONJ
chd-224	59	8	only	only	ADV
chd-224	59	9	10	10	NUM
chd-224	59	10	%	%	NOUN
chd-224	59	11	of	of	ADP
chd-224	59	12	cmv	cmv	NOUN
chd-224	59	13	-	-	PUNCT
chd-224	59	14	ptc	ptc	NOUN
chd-224	59	15	cases	case	NOUN
chd-224	59	16	are	be	AUX
chd-224	59	17	aggressive	aggressive	ADJ
chd-224	59	18	(	(	PUNCT
chd-224	59	19	guilmette	guilmette	NOUN
chd-224	59	20	and	and	CCONJ
chd-224	59	21	nosé	nosé	NOUN
chd-224	59	22	,	,	PUNCT
chd-224	59	23	2018	2018	NUM
chd-224	59	24	)	)	PUNCT
chd-224	59	25	.	.	PUNCT
chd-224	60	1	fap	fap	NOUN
chd-224	60	2	has	have	AUX
chd-224	60	3	been	be	AUX
chd-224	60	4	described	describe	VERB
chd-224	60	5	in	in	ADP
chd-224	60	6	all	all	DET
chd-224	60	7	races	race	NOUN
chd-224	60	8	but	but	CCONJ
chd-224	60	9	there	there	PRON
chd-224	60	10	is	be	VERB
chd-224	60	11	little	little	ADJ
chd-224	60	12	research	research	NOUN
chd-224	60	13	comparing	compare	VERB
chd-224	60	14	the	the	DET
chd-224	60	15	prevalence	prevalence	NOUN
chd-224	60	16	between	between	ADP
chd-224	60	17	different	different	ADJ
chd-224	60	18	racial	racial	ADJ
chd-224	60	19	groups	group	NOUN
chd-224	60	20	.	.	PUNCT
chd-224	61	1	one	one	NUM
chd-224	61	2	study	study	NOUN
chd-224	61	3	investigated	investigate	VERB
chd-224	61	4	the	the	DET
chd-224	61	5	racial	racial	ADJ
chd-224	61	6	variation	variation	NOUN
chd-224	61	7	in	in	ADP
chd-224	61	8	apc	apc	PROPN
chd-224	61	9	mutations	mutation	NOUN
chd-224	61	10	and	and	CCONJ
chd-224	61	11	found	find	VERB
chd-224	61	12	that	that	SCONJ
chd-224	61	13	the	the	DET
chd-224	61	14	overall	overall	ADJ
chd-224	61	15	apc	apc	PROPN
chd-224	61	16	mutation	mutation	NOUN
chd-224	61	17	rate	rate	NOUN
chd-224	61	18	was	be	AUX
chd-224	61	19	higher	high	ADJ
chd-224	61	20	in	in	ADP
chd-224	61	21	asians	asians	PROPN
chd-224	61	22	and	and	CCONJ
chd-224	61	23	african	african	ADJ
chd-224	61	24	americans	americans	PROPN
chd-224	61	25	compared	compare	VERB
chd-224	61	26	to	to	ADP
chd-224	61	27	europeans	europeans	PROPN
chd-224	61	28	(	(	PUNCT
chd-224	61	29	inra	inra	NOUN
chd-224	61	30	et	et	PROPN
chd-224	61	31	al	al	PROPN
chd-224	61	32	.	.	PROPN
chd-224	61	33	,	,	PUNCT
chd-224	61	34	2015	2015	NUM
chd-224	61	35	)	)	PUNCT
chd-224	61	36	.	.	PUNCT
chd-224	62	1	further	further	ADJ
chd-224	62	2	research	research	NOUN
chd-224	62	3	is	be	AUX
chd-224	62	4	indicated	indicate	VERB
chd-224	62	5	to	to	PART
chd-224	62	6	evaluate	evaluate	VERB
chd-224	62	7	whether	whether	SCONJ
chd-224	62	8	the	the	DET
chd-224	62	9	risk	risk	NOUN
chd-224	62	10	of	of	ADP
chd-224	62	11	thyroid	thyroid	NOUN
chd-224	62	12	cancer	cancer	NOUN
chd-224	62	13	with	with	ADP
chd-224	62	14	fap	fap	NOUN
chd-224	62	15	varies	varie	NOUN
chd-224	62	16	between	between	ADP
chd-224	62	17	racial	racial	ADJ
chd-224	62	18	/	/	SYM
chd-224	62	19	ethnic	ethnic	ADJ
chd-224	62	20	groups	group	NOUN
chd-224	62	21	.	.	PUNCT
chd-224	63	1	out	out	ADP
chd-224	63	2	of	of	ADP
chd-224	63	3	all	all	DET
chd-224	63	4	fnmtc	fnmtc	ADJ
chd-224	63	5	,	,	PUNCT
chd-224	63	6	cowden	cowden	PROPN
chd-224	63	7	syndrome	syndrome	PROPN
chd-224	63	8	(	(	PUNCT
chd-224	63	9	cs	cs	PROPN
chd-224	63	10	)	)	PUNCT
chd-224	63	11	is	be	AUX
chd-224	63	12	an	an	DET
chd-224	63	13	autosomal	autosomal	ADJ
chd-224	63	14	dominant	dominant	ADJ
chd-224	63	15	condition	condition	NOUN
chd-224	63	16	caused	cause	VERB
chd-224	63	17	by	by	ADP
chd-224	63	18	a	a	DET
chd-224	63	19	germline	germline	NOUN
chd-224	63	20	mutation	mutation	NOUN
chd-224	63	21	in	in	ADP
chd-224	63	22	pten	pten	NOUN
chd-224	63	23	.	.	PUNCT
chd-224	64	1	although	although	SCONJ
chd-224	64	2	other	other	ADJ
chd-224	64	3	genes	gene	NOUN
chd-224	64	4	have	have	AUX
chd-224	64	5	also	also	ADV
chd-224	64	6	been	be	AUX
chd-224	64	7	implicated	implicate	VERB
chd-224	64	8	in	in	ADP
chd-224	64	9	cs	cs	PROPN
chd-224	64	10	,	,	PUNCT
chd-224	64	11	intact	intact	ADJ
chd-224	64	12	pten	pten	NOUN
chd-224	64	13	virtually	virtually	ADV
chd-224	64	14	excludes	exclude	VERB
chd-224	64	15	the	the	DET
chd-224	64	16	diagnosis	diagnosis	NOUN
chd-224	64	17	.	.	PUNCT
chd-224	65	1	two	two	NUM
chd-224	65	2	-	-	PUNCT
chd-224	65	3	thirds	third	NOUN
chd-224	65	4	of	of	ADP
chd-224	65	5	cs	cs	ADJ
chd-224	65	6	patients	patient	NOUN
chd-224	65	7	develop	develop	VERB
chd-224	65	8	thyroid	thyroid	NOUN
chd-224	65	9	tumors	tumor	NOUN
chd-224	65	10	,	,	PUNCT
chd-224	65	11	with	with	ADP
chd-224	65	12	the	the	DET
chd-224	65	13	majority	majority	NOUN
chd-224	65	14	of	of	ADP
chd-224	65	15	follicular	follicular	ADJ
chd-224	65	16	origin	origin	NOUN
chd-224	65	17	,	,	PUNCT
chd-224	65	18	including	include	VERB
chd-224	65	19	follicular	follicular	ADJ
chd-224	65	20	adenoma	adenoma	ADJ
chd-224	65	21	and	and	CCONJ
chd-224	65	22	follicular	follicular	ADJ
chd-224	65	23	carcinoma	carcinoma	NOUN
chd-224	65	24	(	(	PUNCT
chd-224	65	25	guilmette	guilmette	NOUN
chd-224	65	26	and	and	CCONJ
chd-224	65	27	nosé	nosé	NOUN
chd-224	65	28	,	,	PUNCT
chd-224	65	29	2018	2018	NUM
chd-224	65	30	)	)	PUNCT
chd-224	65	31	.	.	PUNCT
chd-224	66	1	although	although	SCONJ
chd-224	66	2	most	most	ADJ
chd-224	66	3	of	of	ADP
chd-224	66	4	the	the	DET
chd-224	66	5	patients	patient	NOUN
chd-224	66	6	with	with	ADP
chd-224	66	7	cs	cs	PROPN
chd-224	66	8	reported	report	VERB
chd-224	66	9	in	in	ADP
chd-224	66	10	the	the	DET
chd-224	66	11	literature	literature	NOUN
chd-224	66	12	are	be	AUX
chd-224	66	13	european	european	ADJ
chd-224	66	14	(	(	PUNCT
chd-224	66	15	garofola	garofola	PROPN
chd-224	66	16	et	et	PROPN
chd-224	66	17	al	al	PROPN
chd-224	66	18	.	.	PROPN
chd-224	66	19	,	,	PUNCT
chd-224	66	20	2022	2022	NUM
chd-224	66	21	)	)	PUNCT
chd-224	66	22	,	,	PUNCT
chd-224	66	23	at	at	ADP
chd-224	66	24	present	present	ADJ
chd-224	66	25	,	,	PUNCT
chd-224	66	26	the	the	DET
chd-224	66	27	true	true	ADJ
chd-224	66	28	racial	racial	ADJ
chd-224	66	29	distribution	distribution	NOUN
chd-224	66	30	is	be	AUX
chd-224	66	31	not	not	PART
chd-224	66	32	yet	yet	ADV
chd-224	66	33	well	well	ADV
chd-224	66	34	described	describe	VERB
chd-224	66	35	.	.	PUNCT
chd-224	67	1	carney	carney	PROPN
chd-224	67	2	complex	complex	PROPN
chd-224	67	3	(	(	PUNCT
chd-224	67	4	cnc	cnc	PROPN
chd-224	67	5	)	)	PUNCT
chd-224	67	6	is	be	AUX
chd-224	67	7	a	a	DET
chd-224	67	8	rare	rare	ADJ
chd-224	67	9	autosomal	autosomal	ADJ
chd-224	67	10	dominant	dominant	ADJ
chd-224	67	11	syndrome	syndrome	NOUN
chd-224	67	12	with	with	ADP
chd-224	67	13	the	the	DET
chd-224	67	14	majority	majority	NOUN
chd-224	67	15	harboring	harbor	VERB
chd-224	67	16	mutations	mutation	NOUN
chd-224	67	17	in	in	ADP
chd-224	67	18	the	the	DET
chd-224	67	19	prkar1a	prkar1a	NOUN
chd-224	67	20	gene	gene	NOUN
chd-224	67	21	.	.	PUNCT
chd-224	68	1	up	up	ADP
chd-224	68	2	to	to	PART
chd-224	68	3	75	75	NUM
chd-224	68	4	%	%	NOUN
chd-224	68	5	have	have	VERB
chd-224	68	6	multiple	multiple	ADJ
chd-224	68	7	thyroid	thyroid	NOUN
chd-224	68	8	nodules	nodule	NOUN
chd-224	68	9	but	but	CCONJ
chd-224	68	10	they	they	PRON
chd-224	68	11	are	be	AUX
chd-224	68	12	at	at	ADP
chd-224	68	13	minimal	minimal	ADJ
chd-224	68	14	risk	risk	NOUN
chd-224	68	15	for	for	ADP
chd-224	68	16	developing	develop	VERB
chd-224	68	17	thyroid	thyroid	NOUN
chd-224	68	18	malignancy	malignancy	NOUN
chd-224	68	19	.	.	PUNCT
chd-224	69	1	thyroid	thyroid	NOUN
chd-224	69	2	neoplasms	neoplasm	NOUN
chd-224	69	3	within	within	ADP
chd-224	69	4	cnc	cnc	PROPN
chd-224	69	5	patients	patient	NOUN
chd-224	69	6	are	be	AUX
chd-224	69	7	more	more	ADV
chd-224	69	8	likely	likely	ADJ
chd-224	69	9	to	to	PART
chd-224	69	10	be	be	AUX
chd-224	69	11	found	find	VERB
chd-224	69	12	in	in	ADP
chd-224	69	13	young	young	ADJ
chd-224	69	14	females	female	NOUN
chd-224	69	15	and	and	CCONJ
chd-224	69	16	both	both	DET
chd-224	69	17	follicular	follicular	ADJ
chd-224	69	18	thyroid	thyroid	NOUN
chd-224	69	19	carcinoma	carcinoma	NOUN
chd-224	69	20	and	and	CCONJ
chd-224	69	21	ptc	ptc	NOUN
chd-224	69	22	can	can	AUX
chd-224	69	23	be	be	AUX
chd-224	69	24	seen	see	VERB
chd-224	69	25	(	(	PUNCT
chd-224	69	26	guilmette	guilmette	NOUN
chd-224	69	27	and	and	CCONJ
chd-224	69	28	nosé	nosé	NOUN
chd-224	69	29	,	,	PUNCT
chd-224	69	30	2018	2018	NUM
chd-224	69	31	)	)	PUNCT
chd-224	69	32	.	.	PUNCT
chd-224	70	1	there	there	PRON
chd-224	70	2	have	have	AUX
chd-224	70	3	been	be	AUX
chd-224	70	4	more	more	ADJ
chd-224	70	5	than	than	ADP
chd-224	70	6	750	750	NUM
chd-224	70	7	reported	report	VERB
chd-224	70	8	cases	case	NOUN
chd-224	70	9	with	with	ADP
chd-224	70	10	affected	affected	ADJ
chd-224	70	11	europeans	european	NOUN
chd-224	70	12	,	,	PUNCT
chd-224	70	13	asians	asian	NOUN
chd-224	70	14	(	(	PUNCT
chd-224	70	15	from	from	ADP
chd-224	70	16	all	all	DET
chd-224	70	17	continents	continent	NOUN
chd-224	70	18	)	)	PUNCT
chd-224	70	19	,	,	PUNCT
chd-224	70	20	and	and	CCONJ
chd-224	70	21	african	african	ADJ
chd-224	70	22	americans	americans	PROPN
chd-224	70	23	described	describe	VERB
chd-224	70	24	(	(	PUNCT
chd-224	70	25	correa	correa	PROPN
chd-224	70	26	et	et	PROPN
chd-224	70	27	al	al	PROPN
chd-224	70	28	.	.	PROPN
chd-224	70	29	,	,	PUNCT
chd-224	70	30	2015	2015	NUM
chd-224	70	31	)	)	PUNCT
chd-224	70	32	.	.	PUNCT
chd-224	71	1	werner	werner	PROPN
chd-224	71	2	syndrome	syndrome	PROPN
chd-224	71	3	(	(	PUNCT
chd-224	71	4	ws	ws	NOUN
chd-224	71	5	)	)	PUNCT
chd-224	71	6	is	be	AUX
chd-224	71	7	an	an	DET
chd-224	71	8	autosomal	autosomal	ADJ
chd-224	71	9	recessive	recessive	ADJ
chd-224	71	10	syndrome	syndrome	NOUN
chd-224	71	11	caused	cause	VERB
chd-224	71	12	by	by	ADP
chd-224	71	13	wrn	wrn	CCONJ
chd-224	71	14	mutations	mutation	NOUN
chd-224	71	15	leading	lead	VERB
chd-224	71	16	to	to	ADP
chd-224	71	17	defects	defect	NOUN
chd-224	71	18	in	in	ADP
chd-224	71	19	dna	dna	PROPN
chd-224	71	20	repair	repair	NOUN
chd-224	71	21	and	and	CCONJ
chd-224	71	22	replication	replication	NOUN
chd-224	71	23	that	that	PRON
chd-224	71	24	leads	lead	VERB
chd-224	71	25	to	to	ADP
chd-224	71	26	premature	premature	ADJ
chd-224	71	27	aging	aging	NOUN
chd-224	71	28	.	.	PUNCT
chd-224	72	1	thyroid	thyroid	NOUN
chd-224	72	2	cancer	cancer	NOUN
chd-224	72	3	typically	typically	ADV
chd-224	72	4	presents	present	VERB
chd-224	72	5	in	in	ADP
chd-224	72	6	the	the	DET
chd-224	72	7	third	third	ADJ
chd-224	72	8	decade	decade	NOUN
chd-224	72	9	,	,	PUNCT
chd-224	72	10	with	with	ADP
chd-224	72	11	a	a	DET
chd-224	72	12	lower	low	ADJ
chd-224	72	13	female	female	NOUN
chd-224	72	14	to	to	ADP
chd-224	72	15	male	male	ADJ
chd-224	72	16	ratio	ratio	NOUN
chd-224	72	17	(	(	PUNCT
chd-224	72	18	2:1	2:1	NUM
chd-224	72	19	)	)	PUNCT
chd-224	72	20	.	.	PUNCT
chd-224	73	1	they	they	PRON
chd-224	73	2	carry	carry	VERB
chd-224	73	3	a	a	DET
chd-224	73	4	three	three	NUM
chd-224	73	5	-	-	ADJ
chd-224	73	6	fold	fold	ADJ
chd-224	73	7	increased	increase	VERB
chd-224	73	8	risk	risk	NOUN
chd-224	73	9	for	for	ADP
chd-224	73	10	follicular	follicular	ADJ
chd-224	73	11	carcinoma	carcinoma	NOUN
chd-224	73	12	and	and	CCONJ
chd-224	73	13	a	a	DET
chd-224	73	14	six	six	NUM
chd-224	73	15	-	-	ADJ
chd-224	73	16	fold	fold	ADJ
chd-224	73	17	increased	increased	ADJ
chd-224	73	18	risk	risk	NOUN
chd-224	73	19	for	for	ADP
chd-224	73	20	anaplastic	anaplastic	ADJ
chd-224	73	21	thyroid	thyroid	NOUN
chd-224	73	22	carcinoma	carcinoma	NOUN
chd-224	73	23	(	(	PUNCT
chd-224	73	24	guilmette	guilmette	NOUN
chd-224	73	25	and	and	CCONJ
chd-224	73	26	nosé	nosé	NOUN
chd-224	73	27	,	,	PUNCT
chd-224	73	28	2018	2018	NUM
chd-224	73	29	)	)	PUNCT
chd-224	73	30	.	.	PUNCT
chd-224	74	1	there	there	PRON
chd-224	74	2	is	be	VERB
chd-224	74	3	a	a	DET
chd-224	74	4	high	high	ADJ
chd-224	74	5	prevalence	prevalence	NOUN
chd-224	74	6	of	of	ADP
chd-224	74	7	ws	ws	PROPN
chd-224	74	8	in	in	ADP
chd-224	74	9	japan	japan	PROPN
chd-224	74	10	,	,	PUNCT
chd-224	74	11	where	where	SCONJ
chd-224	74	12	ws	ws	NOUN
chd-224	74	13	has	have	AUX
chd-224	74	14	been	be	AUX
chd-224	74	15	reported	report	VERB
chd-224	74	16	up	up	ADP
chd-224	74	17	to	to	PART
chd-224	74	18	1	1	NUM
chd-224	74	19	in	in	ADP
chd-224	74	20	20,00040,000	20,00040,000	NUM
chd-224	74	21	live	live	ADJ
chd-224	74	22	births	birth	NOUN
chd-224	74	23	compared	compare	VERB
chd-224	74	24	to	to	ADP
chd-224	74	25	1	1	NUM
chd-224	74	26	in	in	ADP
chd-224	74	27	100,000	100,000	NUM
chd-224	74	28	births	birth	NOUN
chd-224	74	29	worldwide	worldwide	ADV
chd-224	74	30	.	.	PUNCT
chd-224	75	1	in	in	ADP
chd-224	75	2	the	the	DET
chd-224	75	3	united	united	PROPN
chd-224	75	4	states	states	PROPN
chd-224	75	5	the	the	DET
chd-224	75	6	prevalence	prevalence	NOUN
chd-224	75	7	is	be	AUX
chd-224	75	8	estimated	estimate	VERB
chd-224	75	9	to	to	PART
chd-224	75	10	be	be	AUX
chd-224	75	11	even	even	ADV
chd-224	75	12	less	less	ADJ
chd-224	75	13	as	as	ADP
chd-224	75	14	1	1	NUM
chd-224	75	15	in	in	ADP
chd-224	75	16	200,000	200,000	NUM
chd-224	75	17	live	live	ADJ
chd-224	75	18	births	birth	NOUN
chd-224	75	19	(	(	PUNCT
chd-224	75	20	sickles	sickle	NOUN
chd-224	75	21	and	and	CCONJ
chd-224	75	22	gross	gross	ADJ
chd-224	75	23	,	,	PUNCT
chd-224	75	24	2022	2022	NUM
chd-224	75	25	)	)	PUNCT
chd-224	75	26	.	.	PUNCT
chd-224	76	1	up	up	ADP
chd-224	76	2	to	to	PART
chd-224	76	3	18	18	NUM
chd-224	76	4	%	%	NOUN
chd-224	76	5	of	of	ADP
chd-224	76	6	japanese	japanese	ADJ
chd-224	76	7	patients	patient	NOUN
chd-224	76	8	with	with	ADP
chd-224	76	9	ws	ws	PROPN
chd-224	76	10	also	also	ADV
chd-224	76	11	develop	develop	VERB
chd-224	76	12	thyroid	thyroid	NOUN
chd-224	76	13	cancer	cancer	NOUN
chd-224	76	14	and	and	CCONJ
chd-224	76	15	europeans	europeans	PROPN
chd-224	76	16	have	have	VERB
chd-224	76	17	an	an	DET
chd-224	76	18	increased	increase	VERB
chd-224	76	19	risk	risk	NOUN
chd-224	76	20	of	of	ADP
chd-224	76	21	ptc	ptc	NOUN
chd-224	76	22	.	.	PUNCT
chd-224	77	1	the	the	DET
chd-224	77	2	median	median	ADJ
chd-224	77	3	life	life	NOUN
chd-224	77	4	expectancy	expectancy	NOUN
chd-224	77	5	of	of	ADP
chd-224	77	6	ws	ws	NOUN
chd-224	77	7	patients	patient	NOUN
chd-224	77	8	is	be	AUX
chd-224	77	9	approximately	approximately	ADV
chd-224	77	10	54	54	NUM
chd-224	77	11	years	year	NOUN
chd-224	77	12	,	,	PUNCT
chd-224	77	13	with	with	ADP
chd-224	77	14	thyroid	thyroid	NOUN
chd-224	77	15	cancers	cancer	NOUN
chd-224	77	16	and	and	CCONJ
chd-224	77	17	cardiac	cardiac	ADJ
chd-224	77	18	diseases	disease	NOUN
chd-224	77	19	being	be	AUX
chd-224	77	20	the	the	DET
chd-224	77	21	most	most	ADV
chd-224	77	22	common	common	ADJ
chd-224	77	23	causes	cause	NOUN
chd-224	77	24	of	of	ADP
chd-224	77	25	death	death	NOUN
chd-224	77	26	(	(	PUNCT
chd-224	77	27	guilmette	guilmette	NOUN
chd-224	77	28	and	and	CCONJ
chd-224	77	29	nosé	nosé	NOUN
chd-224	77	30	,	,	PUNCT
chd-224	77	31	2018	2018	NUM
chd-224	77	32	)	)	PUNCT
chd-224	77	33	.	.	PUNCT
chd-224	78	1	there	there	PRON
chd-224	78	2	are	be	VERB
chd-224	78	3	some	some	DET
chd-224	78	4	cases	case	NOUN
chd-224	78	5	of	of	ADP
chd-224	78	6	fnmtc	fnmtc	NOUN
chd-224	78	7	in	in	ADP
chd-224	78	8	which	which	PRON
chd-224	78	9	genetics	genetics	NOUN
chd-224	78	10	is	be	AUX
chd-224	78	11	not	not	PART
chd-224	78	12	yet	yet	ADV
chd-224	78	13	known	know	VERB
chd-224	78	14	.	.	PUNCT
chd-224	79	1	but	but	CCONJ
chd-224	79	2	it	it	PRON
chd-224	79	3	is	be	AUX
chd-224	79	4	believed	believe	VERB
chd-224	79	5	that	that	SCONJ
chd-224	79	6	these	these	DET
chd-224	79	7	cases	case	NOUN
chd-224	79	8	are	be	AUX
chd-224	79	9	autosomal	autosomal	ADJ
chd-224	79	10	dominant	dominant	ADJ
chd-224	79	11	and	and	CCONJ
chd-224	79	12	six	six	NUM
chd-224	79	13	potential	potential	ADJ
chd-224	79	14	chromosomal	chromosomal	ADJ
chd-224	79	15	regions	region	NOUN
chd-224	79	16	have	have	AUX
chd-224	79	17	been	be	AUX
chd-224	79	18	implicated	implicate	VERB
chd-224	79	19	.	.	PUNCT
chd-224	80	1	this	this	DET
chd-224	80	2	category	category	NOUN
chd-224	80	3	of	of	ADP
chd-224	80	4	fnmtc	fnmtc	ADJ
chd-224	80	5	is	be	AUX
chd-224	80	6	diagnosed	diagnose	VERB
chd-224	80	7	when	when	SCONJ
chd-224	80	8	three	three	NUM
chd-224	80	9	or	or	CCONJ
chd-224	80	10	more	more	ADJ
chd-224	80	11	first	first	ADJ
chd-224	80	12	-	-	PUNCT
chd-224	80	13	degree	degree	NOUN
chd-224	80	14	relatives	relative	NOUN
chd-224	80	15	have	have	VERB
chd-224	80	16	non	non	ADJ
chd-224	80	17	-	-	ADJ
chd-224	80	18	medullary	medullary	ADJ
chd-224	80	19	thyroid	thyroid	NOUN
chd-224	80	20	cancer	cancer	NOUN
chd-224	80	21	,	,	PUNCT
chd-224	80	22	usually	usually	ADV
chd-224	80	23	ptc	ptc	ADJ
chd-224	80	24	.	.	PUNCT
chd-224	81	1	the	the	DET
chd-224	81	2	tumors	tumor	NOUN
chd-224	81	3	are	be	AUX
chd-224	81	4	more	more	ADV
chd-224	81	5	likely	likely	ADJ
chd-224	81	6	to	to	PART
chd-224	81	7	present	present	VERB
chd-224	81	8	at	at	ADP
chd-224	81	9	a	a	DET
chd-224	81	10	younger	young	ADJ
chd-224	81	11	age	age	NOUN
chd-224	81	12	and	and	CCONJ
chd-224	81	13	have	have	VERB
chd-224	81	14	a	a	DET
chd-224	81	15	more	more	ADV
chd-224	81	16	aggressive	aggressive	ADJ
chd-224	81	17	clinical	clinical	ADJ
chd-224	81	18	course	course	NOUN
chd-224	81	19	with	with	ADP
chd-224	81	20	a	a	DET
chd-224	81	21	worse	bad	ADJ
chd-224	81	22	prognosis	prognosis	NOUN
chd-224	81	23	(	(	PUNCT
chd-224	81	24	guilmette	guilmette	NOUN
chd-224	81	25	and	and	CCONJ
chd-224	81	26	nosé	nosé	NOUN
chd-224	81	27	,	,	PUNCT
chd-224	81	28	2018	2018	NUM
chd-224	81	29	)	)	PUNCT
chd-224	81	30	.	.	PUNCT
chd-224	82	1	further	further	ADJ
chd-224	82	2	research	research	NOUN
chd-224	82	3	is	be	AUX
chd-224	82	4	indicated	indicate	VERB
chd-224	82	5	on	on	ADP
chd-224	82	6	the	the	DET
chd-224	82	7	racial	racial	ADJ
chd-224	82	8	distribution	distribution	NOUN
chd-224	82	9	within	within	ADP
chd-224	82	10	all	all	DET
chd-224	82	11	these	these	DET
chd-224	82	12	various	various	ADJ
chd-224	82	13	types	type	NOUN
chd-224	82	14	of	of	ADP
chd-224	82	15	fnmtc	fnmtc	NOUN
chd-224	82	16	.	.	PUNCT
chd-224	83	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-224	83	2	e5	e5	PROPN
chd-224	83	3	cancer	cancer	NOUN
chd-224	83	4	health	health	NOUN
chd-224	83	5	disparities	disparity	NOUN
chd-224	83	6	research	research	VERB
chd-224	83	7	3.2	3.2	NUM
chd-224	83	8	.	.	PUNCT
chd-224	84	1	environmental	environmental	ADJ
chd-224	84	2	factors	factor	NOUN
chd-224	84	3	3.2.1	3.2.1	NUM
chd-224	84	4	.	.	PUNCT
chd-224	85	1	radiation	radiation	NOUN
chd-224	85	2	exposure	exposure	NOUN
chd-224	85	3	in	in	ADP
chd-224	85	4	tc	tc	NOUN
chd-224	85	5	health	health	NOUN
chd-224	85	6	disparities	disparity	NOUN
chd-224	85	7	the	the	DET
chd-224	85	8	radiosensitivity	radiosensitivity	NOUN
chd-224	85	9	of	of	ADP
chd-224	85	10	the	the	DET
chd-224	85	11	thyroid	thyroid	NOUN
chd-224	85	12	gland	gland	NOUN
chd-224	85	13	is	be	AUX
chd-224	85	14	well	well	ADV
chd-224	85	15	documented	document	VERB
chd-224	85	16	(	(	PUNCT
chd-224	85	17	lubin	lubin	PROPN
chd-224	85	18	et	et	PROPN
chd-224	85	19	al	al	PROPN
chd-224	85	20	.	.	PROPN
chd-224	85	21	,	,	PUNCT
chd-224	85	22	2017	2017	NUM
chd-224	85	23	)	)	PUNCT
chd-224	85	24	.	.	PUNCT
chd-224	86	1	radiation	radiation	NOUN
chd-224	86	2	exposure	exposure	NOUN
chd-224	86	3	in	in	ADP
chd-224	86	4	childhood	childhood	NOUN
chd-224	86	5	is	be	AUX
chd-224	86	6	associated	associate	VERB
chd-224	86	7	with	with	ADP
chd-224	86	8	a	a	DET
chd-224	86	9	higher	high	ADJ
chd-224	86	10	risk	risk	NOUN
chd-224	86	11	of	of	ADP
chd-224	86	12	thyroid	thyroid	NOUN
chd-224	86	13	cancer	cancer	NOUN
chd-224	86	14	than	than	ADP
chd-224	86	15	radiation	radiation	NOUN
chd-224	86	16	exposure	exposure	NOUN
chd-224	86	17	in	in	ADP
chd-224	86	18	adults	adult	NOUN
chd-224	86	19	(	(	PUNCT
chd-224	86	20	lee	lee	PROPN
chd-224	86	21	et	et	PROPN
chd-224	86	22	al	al	PROPN
chd-224	86	23	.	.	PROPN
chd-224	86	24	,	,	PUNCT
chd-224	86	25	2019	2019	NUM
chd-224	86	26	)	)	PUNCT
chd-224	86	27	,	,	PUNCT
chd-224	86	28	and	and	CCONJ
chd-224	86	29	the	the	DET
chd-224	86	30	risk	risk	NOUN
chd-224	86	31	increases	increase	VERB
chd-224	86	32	from	from	ADP
chd-224	86	33	about	about	ADV
chd-224	86	34	5	5	NUM
chd-224	86	35	years	year	NOUN
chd-224	86	36	after	after	ADP
chd-224	86	37	exposure	exposure	NOUN
chd-224	86	38	(	(	PUNCT
chd-224	86	39	furukawa	furukawa	PROPN
chd-224	86	40	et	et	PROPN
chd-224	86	41	al	al	PROPN
chd-224	86	42	.	.	PROPN
chd-224	86	43	,	,	PUNCT
chd-224	86	44	2013	2013	NUM
chd-224	86	45	)	)	PUNCT
chd-224	86	46	.	.	PUNCT
chd-224	87	1	radiation	radiation	NOUN
chd-224	87	2	exposure	exposure	NOUN
chd-224	87	3	in	in	ADP
chd-224	87	4	children	child	NOUN
chd-224	87	5	increases	increase	VERB
chd-224	87	6	their	their	PRON
chd-224	87	7	likelihood	likelihood	NOUN
chd-224	87	8	of	of	ADP
chd-224	87	9	developing	develop	VERB
chd-224	87	10	papillary	papillary	ADJ
chd-224	87	11	thyroid	thyroid	NOUN
chd-224	87	12	cancer	cancer	NOUN
chd-224	87	13	later	later	ADV
chd-224	87	14	in	in	ADP
chd-224	87	15	life	life	NOUN
chd-224	87	16	,	,	PUNCT
chd-224	87	17	which	which	PRON
chd-224	87	18	is	be	AUX
chd-224	87	19	the	the	DET
chd-224	87	20	most	most	ADV
chd-224	87	21	common	common	ADJ
chd-224	87	22	type	type	NOUN
chd-224	87	23	of	of	ADP
chd-224	87	24	thyroid	thyroid	NOUN
chd-224	87	25	cancer	cancer	NOUN
chd-224	87	26	(	(	PUNCT
chd-224	87	27	bogović	bogović	NOUN
chd-224	87	28	crnčić	crnčić	NOUN
chd-224	87	29	et	et	PROPN
chd-224	87	30	al	al	PROPN
chd-224	87	31	.	.	PROPN
chd-224	87	32	,	,	PUNCT
chd-224	87	33	2020	2020	NUM
chd-224	87	34	;	;	PUNCT
chd-224	87	35	yildirim	yildirim	PROPN
chd-224	87	36	simsir	simsir	VERB
chd-224	87	37	et	et	PROPN
chd-224	87	38	al	al	PROPN
chd-224	87	39	.	.	PROPN
chd-224	87	40	,	,	PUNCT
chd-224	87	41	2020	2020	NUM
chd-224	87	42	)	)	PUNCT
chd-224	87	43	.	.	PUNCT
chd-224	88	1	children	child	NOUN
chd-224	88	2	and	and	CCONJ
chd-224	88	3	adolescents	adolescent	NOUN
chd-224	88	4	exposed	expose	VERB
chd-224	88	5	to	to	ADP
chd-224	88	6	radioactive	radioactive	ADJ
chd-224	88	7	iodine	iodine	NOUN
chd-224	88	8	from	from	ADP
chd-224	88	9	the	the	DET
chd-224	88	10	chernobyl	chernobyl	PROPN
chd-224	88	11	fallout	fallout	NOUN
chd-224	88	12	have	have	AUX
chd-224	88	13	also	also	ADV
chd-224	88	14	shown	show	VERB
chd-224	88	15	a	a	DET
chd-224	88	16	higher	high	ADJ
chd-224	88	17	risk	risk	NOUN
chd-224	88	18	of	of	ADP
chd-224	88	19	thyroid	thyroid	NOUN
chd-224	88	20	cancer	cancer	NOUN
chd-224	88	21	(	(	PUNCT
chd-224	88	22	furukawa	furukawa	PROPN
chd-224	88	23	et	et	PROPN
chd-224	88	24	al	al	PROPN
chd-224	88	25	.	.	PROPN
chd-224	88	26	,	,	PUNCT
chd-224	88	27	2013	2013	NUM
chd-224	88	28	)	)	PUNCT
chd-224	88	29	.	.	PUNCT
chd-224	89	1	this	this	DET
chd-224	89	2	trend	trend	NOUN
chd-224	89	3	has	have	AUX
chd-224	89	4	also	also	ADV
chd-224	89	5	been	be	AUX
chd-224	89	6	seen	see	VERB
chd-224	89	7	in	in	ADP
chd-224	89	8	animal	animal	NOUN
chd-224	89	9	models	model	NOUN
chd-224	89	10	.	.	PUNCT
chd-224	90	1	it	it	PRON
chd-224	90	2	was	be	AUX
chd-224	90	3	reported	report	VERB
chd-224	90	4	that	that	SCONJ
chd-224	90	5	more	more	ADJ
chd-224	90	6	radiation	radiation	NOUN
chd-224	90	7	-	-	PUNCT
chd-224	90	8	induced	induce	VERB
chd-224	90	9	thyroid	thyroid	NOUN
chd-224	90	10	tumors	tumor	NOUN
chd-224	90	11	developed	develop	VERB
chd-224	90	12	in	in	ADP
chd-224	90	13	10	10	NUM
chd-224	90	14	-	-	PUNCT
chd-224	90	15	day	day	NOUN
chd-224	90	16	-	-	PUNCT
chd-224	90	17	old	old	ADJ
chd-224	90	18	infant	infant	NOUN
chd-224	90	19	rats	rat	NOUN
chd-224	90	20	than	than	ADP
chd-224	90	21	in	in	ADP
chd-224	90	22	adult	adult	NOUN
chd-224	90	23	rats	rat	NOUN
chd-224	90	24	(	(	PUNCT
chd-224	90	25	matsuumatsuyama	matsuumatsuyama	NOUN
chd-224	90	26	et	et	PROPN
chd-224	90	27	al	al	PROPN
chd-224	90	28	.	.	PROPN
chd-224	90	29	,	,	PUNCT
chd-224	90	30	2021	2021	NUM
chd-224	90	31	)	)	PUNCT
chd-224	90	32	.	.	PUNCT
chd-224	91	1	another	another	DET
chd-224	91	2	study	study	NOUN
chd-224	91	3	demonstrated	demonstrate	VERB
chd-224	91	4	that	that	SCONJ
chd-224	91	5	the	the	DET
chd-224	91	6	thyroids	thyroid	NOUN
chd-224	91	7	of	of	ADP
chd-224	91	8	1	1	NUM
chd-224	91	9	-	-	PUNCT
chd-224	91	10	week	week	NOUN
chd-224	91	11	-	-	PUNCT
chd-224	91	12	old	old	ADJ
chd-224	91	13	neonatal	neonatal	ADJ
chd-224	91	14	rats	rat	NOUN
chd-224	91	15	are	be	AUX
chd-224	91	16	more	more	ADV
chd-224	91	17	sensitive	sensitive	ADJ
chd-224	91	18	to	to	ADP
chd-224	91	19	ionizing	ionize	VERB
chd-224	91	20	radiation	radiation	NOUN
chd-224	91	21	at	at	ADP
chd-224	91	22	12	12	NUM
chd-224	91	23	gy	gy	NOUN
chd-224	91	24	compared	compare	VERB
chd-224	91	25	to	to	ADP
chd-224	91	26	those	those	PRON
chd-224	91	27	from	from	ADP
chd-224	91	28	adult	adult	NOUN
chd-224	91	29	rats	rat	NOUN
chd-224	91	30	(	(	PUNCT
chd-224	91	31	matsuu	matsuu	NOUN
chd-224	91	32	-	-	PUNCT
chd-224	91	33	matsuyama	matsuyama	PROPN
chd-224	91	34	et	et	PROPN
chd-224	91	35	al	al	PROPN
chd-224	91	36	.	.	PROPN
chd-224	91	37	,	,	PUNCT
chd-224	91	38	2021	2021	NUM
chd-224	91	39	)	)	PUNCT
chd-224	91	40	.	.	PUNCT
chd-224	92	1	increase	increase	VERB
chd-224	92	2	in	in	ADP
chd-224	92	3	the	the	DET
chd-224	92	4	use	use	NOUN
chd-224	92	5	of	of	ADP
chd-224	92	6	imaging	imaging	NOUN
chd-224	92	7	in	in	ADP
chd-224	92	8	medicine	medicine	NOUN
chd-224	92	9	,	,	PUNCT
chd-224	92	10	such	such	ADJ
chd-224	92	11	as	as	ADP
chd-224	92	12	ct	ct	NUM
chd-224	92	13	examinations	examination	NOUN
chd-224	92	14	,	,	PUNCT
chd-224	92	15	is	be	AUX
chd-224	92	16	believed	believe	VERB
chd-224	92	17	to	to	PART
chd-224	92	18	play	play	VERB
chd-224	92	19	a	a	DET
chd-224	92	20	role	role	NOUN
chd-224	92	21	in	in	ADP
chd-224	92	22	the	the	DET
chd-224	92	23	increased	increase	VERB
chd-224	92	24	incidence	incidence	NOUN
chd-224	92	25	of	of	ADP
chd-224	92	26	thyroid	thyroid	NOUN
chd-224	92	27	cancer	cancer	NOUN
chd-224	92	28	in	in	ADP
chd-224	92	29	the	the	DET
chd-224	92	30	united	united	PROPN
chd-224	92	31	states	states	PROPN
chd-224	92	32	(	(	PUNCT
chd-224	92	33	yildirim	yildirim	PROPN
chd-224	92	34	simsir	simsir	VERB
chd-224	92	35	et	et	PROPN
chd-224	92	36	al	al	PROPN
chd-224	92	37	.	.	PROPN
chd-224	92	38	,	,	PUNCT
chd-224	92	39	2020	2020	NUM
chd-224	92	40	)	)	PUNCT
chd-224	92	41	.	.	PUNCT
chd-224	93	1	this	this	PRON
chd-224	93	2	means	mean	VERB
chd-224	93	3	that	that	SCONJ
chd-224	93	4	differences	difference	NOUN
chd-224	93	5	in	in	ADP
chd-224	93	6	access	access	NOUN
chd-224	93	7	to	to	ADP
chd-224	93	8	healthcare	healthcare	NOUN
chd-224	93	9	between	between	ADP
chd-224	93	10	patients	patient	NOUN
chd-224	93	11	of	of	ADP
chd-224	93	12	different	different	ADJ
chd-224	93	13	ethnic	ethnic	ADJ
chd-224	93	14	groups	group	NOUN
chd-224	93	15	may	may	AUX
chd-224	93	16	affect	affect	VERB
chd-224	93	17	the	the	DET
chd-224	93	18	population	population	NOUN
chd-224	93	19	’s	’s	PART
chd-224	93	20	exposure	exposure	NOUN
chd-224	93	21	to	to	ADP
chd-224	93	22	radiation	radiation	NOUN
chd-224	93	23	,	,	PUNCT
chd-224	93	24	and	and	CCONJ
chd-224	93	25	therefore	therefore	ADV
chd-224	93	26	incidence	incidence	NOUN
chd-224	93	27	of	of	ADP
chd-224	93	28	thyroid	thyroid	NOUN
chd-224	93	29	cancer	cancer	NOUN
chd-224	93	30	.	.	PUNCT
chd-224	94	1	for	for	ADP
chd-224	94	2	example	example	NOUN
chd-224	94	3	,	,	PUNCT
chd-224	94	4	in	in	ADP
chd-224	94	5	the	the	DET
chd-224	94	6	1970s	1970	NOUN
chd-224	94	7	and	and	CCONJ
chd-224	94	8	80s	80	NOUN
chd-224	94	9	,	,	PUNCT
chd-224	94	10	there	there	PRON
chd-224	94	11	were	be	VERB
chd-224	94	12	many	many	ADJ
chd-224	94	13	medical	medical	ADJ
chd-224	94	14	professionals	professional	NOUN
chd-224	94	15	who	who	PRON
chd-224	94	16	came	come	VERB
chd-224	94	17	to	to	ADP
chd-224	94	18	the	the	DET
chd-224	94	19	united	united	PROPN
chd-224	94	20	states	states	PROPN
chd-224	94	21	from	from	ADP
chd-224	94	22	the	the	DET
chd-224	94	23	philippines	philippine	NOUN
chd-224	94	24	.	.	PUNCT
chd-224	95	1	this	this	DET
chd-224	95	2	group	group	NOUN
chd-224	95	3	most	most	ADV
chd-224	95	4	likely	likely	ADV
chd-224	95	5	had	have	VERB
chd-224	95	6	better	well	ADJ
chd-224	95	7	access	access	NOUN
chd-224	95	8	to	to	ADP
chd-224	95	9	ct	ct	NOUN
chd-224	95	10	examinations	examination	NOUN
chd-224	95	11	and	and	CCONJ
chd-224	95	12	had	have	VERB
chd-224	95	13	additional	additional	ADJ
chd-224	95	14	occupational	occupational	ADJ
chd-224	95	15	exposure	exposure	NOUN
chd-224	95	16	to	to	ADP
chd-224	95	17	ionizing	ionize	VERB
chd-224	95	18	radiation	radiation	NOUN
chd-224	95	19	.	.	PUNCT
chd-224	96	1	in	in	ADP
chd-224	96	2	fact	fact	NOUN
chd-224	96	3	,	,	PUNCT
chd-224	96	4	one	one	NUM
chd-224	96	5	study	study	NOUN
chd-224	96	6	reported	report	VERB
chd-224	96	7	that	that	SCONJ
chd-224	96	8	highly	highly	ADV
chd-224	96	9	educated	educate	VERB
chd-224	96	10	filipinos	filipino	NOUN
chd-224	96	11	had	have	VERB
chd-224	96	12	higher	high	ADJ
chd-224	96	13	proportionate	proportionate	ADJ
chd-224	96	14	mortality	mortality	NOUN
chd-224	96	15	due	due	ADP
chd-224	96	16	to	to	PART
chd-224	96	17	thyroid	thyroid	VERB
chd-224	96	18	cancer	cancer	NOUN
chd-224	96	19	than	than	ADP
chd-224	96	20	less	less	ADV
chd-224	96	21	educated	educate	VERB
chd-224	96	22	filipinos	filipino	NOUN
chd-224	96	23	(	(	PUNCT
chd-224	96	24	nguyen	nguyen	NOUN
chd-224	96	25	et	et	PROPN
chd-224	96	26	al	al	PROPN
chd-224	96	27	.	.	PROPN
chd-224	96	28	,	,	PUNCT
chd-224	96	29	2017	2017	NUM
chd-224	96	30	)	)	PUNCT
chd-224	96	31	.	.	PUNCT
chd-224	97	1	on	on	ADP
chd-224	97	2	the	the	DET
chd-224	97	3	other	other	ADJ
chd-224	97	4	hand	hand	NOUN
chd-224	97	5	,	,	PUNCT
chd-224	97	6	in	in	ADP
chd-224	97	7	a	a	DET
chd-224	97	8	single	single	ADJ
chd-224	97	9	hospital	hospital	NOUN
chd-224	97	10	study	study	NOUN
chd-224	97	11	of	of	ADP
chd-224	97	12	1,024	1,024	NUM
chd-224	97	13	female	female	ADJ
chd-224	97	14	nurses	nurse	NOUN
chd-224	97	15	and	and	CCONJ
chd-224	97	16	2,631	2,631	NUM
chd-224	97	17	non	non	ADJ
chd-224	97	18	-	-	ADJ
chd-224	97	19	nurse	nurse	ADJ
chd-224	97	20	females	female	NOUN
chd-224	97	21	with	with	ADP
chd-224	97	22	both	both	DET
chd-224	97	23	groups	group	NOUN
chd-224	97	24	receiving	receive	VERB
chd-224	97	25	their	their	PRON
chd-224	97	26	annual	annual	ADJ
chd-224	97	27	health	health	NOUN
chd-224	97	28	examinations	examination	NOUN
chd-224	97	29	over	over	ADP
chd-224	97	30	a	a	DET
chd-224	97	31	period	period	NOUN
chd-224	97	32	of	of	ADP
chd-224	97	33	two	two	NUM
chd-224	97	34	years	year	NOUN
chd-224	97	35	,	,	PUNCT
chd-224	97	36	generally	generally	ADV
chd-224	97	37	no	no	DET
chd-224	97	38	difference	difference	NOUN
chd-224	97	39	was	be	AUX
chd-224	97	40	found	find	VERB
chd-224	97	41	in	in	ADP
chd-224	97	42	incidence	incidence	NOUN
chd-224	97	43	of	of	ADP
chd-224	97	44	thyroid	thyroid	NOUN
chd-224	97	45	cancer	cancer	NOUN
chd-224	97	46	between	between	ADP
chd-224	97	47	the	the	DET
chd-224	97	48	two	two	NUM
chd-224	97	49	groups	group	NOUN
chd-224	97	50	(	(	PUNCT
chd-224	97	51	kim	kim	PROPN
chd-224	97	52	and	and	CCONJ
chd-224	97	53	woo	woo	PROPN
chd-224	97	54	,	,	PUNCT
chd-224	97	55	2016	2016	NUM
chd-224	97	56	)	)	PUNCT
chd-224	97	57	.	.	PUNCT
chd-224	98	1	this	this	PRON
chd-224	98	2	suggests	suggest	VERB
chd-224	98	3	more	more	ADJ
chd-224	98	4	research	research	NOUN
chd-224	98	5	is	be	AUX
chd-224	98	6	needed	need	VERB
chd-224	98	7	to	to	PART
chd-224	98	8	determine	determine	VERB
chd-224	98	9	if	if	SCONJ
chd-224	98	10	this	this	DET
chd-224	98	11	increased	increase	VERB
chd-224	98	12	incidence	incidence	NOUN
chd-224	98	13	among	among	ADP
chd-224	98	14	filipinos	filipino	NOUN
chd-224	98	15	is	be	AUX
chd-224	98	16	due	due	ADJ
chd-224	98	17	to	to	ADP
chd-224	98	18	job	job	NOUN
chd-224	98	19	or	or	CCONJ
chd-224	98	20	socioeconomic	socioeconomic	ADJ
chd-224	98	21	statusrelated	statusrelate	VERB
chd-224	98	22	radiation	radiation	NOUN
chd-224	98	23	exposure	exposure	NOUN
chd-224	98	24	or	or	CCONJ
chd-224	98	25	if	if	SCONJ
chd-224	98	26	it	it	PRON
chd-224	98	27	is	be	AUX
chd-224	98	28	largely	largely	ADV
chd-224	98	29	due	due	ADJ
chd-224	98	30	to	to	ADP
chd-224	98	31	inherent	inherent	ADJ
chd-224	98	32	biological	biological	ADJ
chd-224	98	33	factors	factor	NOUN
chd-224	98	34	within	within	ADP
chd-224	98	35	the	the	DET
chd-224	98	36	filipina	filipina	ADJ
chd-224	98	37	population	population	NOUN
chd-224	98	38	.	.	PUNCT
chd-224	99	1	3.2.2	3.2.2	X
chd-224	99	2	.	.	PUNCT
chd-224	99	3	iodine	iodine	NOUN
chd-224	99	4	deficiency	deficiency	NOUN
chd-224	99	5	in	in	ADP
chd-224	99	6	tc	tc	NOUN
chd-224	99	7	health	health	NOUN
chd-224	99	8	disparities	disparity	NOUN
chd-224	99	9	the	the	DET
chd-224	99	10	thyroid	thyroid	NOUN
chd-224	99	11	gland	gland	NOUN
chd-224	99	12	uses	use	VERB
chd-224	99	13	iodine	iodine	NOUN
chd-224	99	14	to	to	PART
chd-224	99	15	make	make	VERB
chd-224	99	16	thyroid	thyroid	NOUN
chd-224	99	17	hormones	hormone	NOUN
chd-224	99	18	.	.	PUNCT
chd-224	100	1	when	when	SCONJ
chd-224	100	2	the	the	DET
chd-224	100	3	body	body	NOUN
chd-224	100	4	is	be	AUX
chd-224	100	5	low	low	ADJ
chd-224	100	6	on	on	ADP
chd-224	100	7	iodine	iodine	NOUN
chd-224	100	8	and	and	CCONJ
chd-224	100	9	there	there	PRON
chd-224	100	10	is	be	VERB
chd-224	100	11	a	a	DET
chd-224	100	12	decrease	decrease	NOUN
chd-224	100	13	in	in	ADP
chd-224	100	14	the	the	DET
chd-224	100	15	level	level	NOUN
chd-224	100	16	of	of	ADP
chd-224	100	17	thyroid	thyroid	NOUN
chd-224	100	18	hormones	hormone	NOUN
chd-224	100	19	,	,	PUNCT
chd-224	100	20	the	the	DET
chd-224	100	21	pituitary	pituitary	ADJ
chd-224	100	22	gland	gland	NOUN
chd-224	100	23	produces	produce	VERB
chd-224	100	24	more	more	ADJ
chd-224	100	25	tsh	tsh	NOUN
chd-224	100	26	to	to	PART
chd-224	100	27	compensate	compensate	VERB
chd-224	100	28	.	.	PUNCT
chd-224	101	1	however	however	ADV
chd-224	101	2	,	,	PUNCT
chd-224	101	3	tsh	tsh	NOUN
chd-224	101	4	is	be	AUX
chd-224	101	5	a	a	DET
chd-224	101	6	growth	growth	NOUN
chd-224	101	7	stimulating	stimulate	VERB
chd-224	101	8	factor	factor	NOUN
chd-224	101	9	for	for	ADP
chd-224	101	10	thyroid	thyroid	NOUN
chd-224	101	11	follicular	follicular	ADJ
chd-224	101	12	cells	cell	NOUN
chd-224	101	13	.	.	PUNCT
chd-224	102	1	this	this	PRON
chd-224	102	2	suggests	suggest	VERB
chd-224	102	3	that	that	SCONJ
chd-224	102	4	diets	diet	NOUN
chd-224	102	5	with	with	ADP
chd-224	102	6	insufficient	insufficient	ADJ
chd-224	102	7	intake	intake	NOUN
chd-224	102	8	of	of	ADP
chd-224	102	9	iodine	iodine	NOUN
chd-224	102	10	could	could	AUX
chd-224	102	11	play	play	VERB
chd-224	102	12	a	a	DET
chd-224	102	13	role	role	NOUN
chd-224	102	14	in	in	ADP
chd-224	102	15	follicular	follicular	ADJ
chd-224	102	16	thyroid	thyroid	NOUN
chd-224	102	17	cancer	cancer	NOUN
chd-224	102	18	(	(	PUNCT
chd-224	102	19	bogović	bogović	NOUN
chd-224	102	20	crnčić	crnčić	NOUN
chd-224	102	21	et	et	PROPN
chd-224	102	22	al	al	PROPN
chd-224	102	23	.	.	PROPN
chd-224	102	24	,	,	PUNCT
chd-224	102	25	2020	2020	NUM
chd-224	102	26	)	)	PUNCT
chd-224	102	27	.	.	PUNCT
chd-224	103	1	however	however	ADV
chd-224	103	2	,	,	PUNCT
chd-224	103	3	low	low	ADJ
chd-224	103	4	iodine	iodine	NOUN
chd-224	103	5	diets	diet	NOUN
chd-224	103	6	are	be	AUX
chd-224	103	7	necessary	necessary	ADJ
chd-224	103	8	prior	prior	ADV
chd-224	103	9	to	to	ADP
chd-224	103	10	radioactive	radioactive	ADJ
chd-224	103	11	iodine	iodine	NOUN
chd-224	103	12	(	(	PUNCT
chd-224	103	13	rai	rai	NOUN
chd-224	103	14	)	)	PUNCT
chd-224	103	15	treatment	treatment	NOUN
chd-224	103	16	for	for	ADP
chd-224	103	17	thyroid	thyroid	NOUN
chd-224	103	18	cancer	cancer	NOUN
chd-224	103	19	patients	patient	NOUN
chd-224	103	20	with	with	ADP
chd-224	103	21	a	a	DET
chd-224	103	22	thyroidectomy	thyroidectomy	NOUN
chd-224	103	23	(	(	PUNCT
chd-224	103	24	nguyen	nguyen	NOUN
chd-224	103	25	et	et	PROPN
chd-224	103	26	al	al	PROPN
chd-224	103	27	.	.	PROPN
chd-224	103	28	,	,	PUNCT
chd-224	103	29	2017	2017	NUM
chd-224	103	30	)	)	PUNCT
chd-224	103	31	.	.	PUNCT
chd-224	104	1	studies	study	NOUN
chd-224	104	2	showed	show	VERB
chd-224	104	3	that	that	SCONJ
chd-224	104	4	thyroid	thyroid	NOUN
chd-224	104	5	cancer	cancer	NOUN
chd-224	104	6	patients	patient	NOUN
chd-224	104	7	on	on	ADP
chd-224	104	8	low	low	ADJ
chd-224	104	9	-	-	PUNCT
chd-224	104	10	iodine	iodine	NOUN
chd-224	104	11	diets	diet	NOUN
chd-224	104	12	before	before	ADP
chd-224	104	13	radioactive	radioactive	ADJ
chd-224	104	14	iodine	iodine	NOUN
chd-224	104	15	(	(	PUNCT
chd-224	104	16	rai	rai	NOUN
chd-224	104	17	)	)	PUNCT
chd-224	104	18	treatment	treatment	NOUN
chd-224	104	19	experienced	experience	VERB
chd-224	104	20	enhanced	enhance	VERB
chd-224	104	21	uptake	uptake	ADJ
chd-224	104	22	and	and	CCONJ
chd-224	104	23	maximized	maximized	ADJ
chd-224	104	24	destruction	destruction	NOUN
chd-224	104	25	of	of	ADP
chd-224	104	26	thyroid	thyroid	NOUN
chd-224	104	27	cancer	cancer	NOUN
chd-224	104	28	cells	cell	NOUN
chd-224	104	29	(	(	PUNCT
chd-224	104	30	li	li	PROPN
chd-224	104	31	et	et	PROPN
chd-224	104	32	al	al	PROPN
chd-224	104	33	.	.	PROPN
chd-224	104	34	,	,	PUNCT
chd-224	104	35	2016	2016	NUM
chd-224	104	36	;	;	PUNCT
chd-224	104	37	nguyen	nguyen	NOUN
chd-224	104	38	et	et	PROPN
chd-224	104	39	al	al	PROPN
chd-224	104	40	.	.	PROPN
chd-224	104	41	,	,	PUNCT
chd-224	104	42	2017	2017	NUM
chd-224	104	43	)	)	PUNCT
chd-224	104	44	.	.	PUNCT
chd-224	105	1	however	however	ADV
chd-224	105	2	,	,	PUNCT
chd-224	105	3	in	in	ADP
chd-224	105	4	filipino	filipino	PROPN
chd-224	105	5	americans	americans	PROPN
chd-224	105	6	who	who	PRON
chd-224	105	7	have	have	VERB
chd-224	105	8	a	a	DET
chd-224	105	9	higher	high	ADJ
chd-224	105	10	intake	intake	NOUN
chd-224	105	11	of	of	ADP
chd-224	105	12	iodine	iodine	NOUN
chd-224	105	13	-	-	PUNCT
chd-224	105	14	rich	rich	ADJ
chd-224	105	15	foods	food	NOUN
chd-224	105	16	such	such	ADJ
chd-224	105	17	as	as	ADP
chd-224	105	18	seafood	seafood	NOUN
chd-224	105	19	,	,	PUNCT
chd-224	105	20	dairy	dairy	NOUN
chd-224	105	21	,	,	PUNCT
chd-224	105	22	grains	grain	NOUN
chd-224	105	23	,	,	PUNCT
chd-224	105	24	and	and	CCONJ
chd-224	105	25	eggs	egg	NOUN
chd-224	105	26	treatment	treatment	NOUN
chd-224	105	27	was	be	AUX
chd-224	105	28	less	less	ADV
chd-224	105	29	effective	effective	ADJ
chd-224	105	30	compared	compare	VERB
chd-224	105	31	to	to	ADP
chd-224	105	32	other	other	ADJ
chd-224	105	33	patients	patient	NOUN
chd-224	105	34	preparing	prepare	VERB
chd-224	105	35	for	for	ADP
chd-224	105	36	rai	rai	NOUN
chd-224	105	37	treatment	treatment	NOUN
chd-224	105	38	(	(	PUNCT
chd-224	105	39	herrick	herrick	PROPN
chd-224	105	40	et	et	PROPN
chd-224	105	41	al	al	PROPN
chd-224	105	42	.	.	PROPN
chd-224	105	43	,	,	PUNCT
chd-224	105	44	2018	2018	NUM
chd-224	105	45	;	;	PUNCT
chd-224	106	1	nguyen	nguyen	NOUN
chd-224	106	2	et	et	PROPN
chd-224	106	3	al	al	PROPN
chd-224	106	4	.	.	PROPN
chd-224	106	5	,	,	PUNCT
chd-224	106	6	2017	2017	NUM
chd-224	106	7	)	)	PUNCT
chd-224	106	8	.	.	PUNCT
chd-224	107	1	another	another	DET
chd-224	107	2	study	study	NOUN
chd-224	107	3	analyzed	analyze	VERB
chd-224	107	4	the	the	DET
chd-224	107	5	median	median	ADJ
chd-224	107	6	urinary	urinary	ADJ
chd-224	107	7	iodine	iodine	NOUN
chd-224	107	8	concentration	concentration	NOUN
chd-224	107	9	(	(	PUNCT
chd-224	107	10	muic	muic	NOUN
chd-224	107	11	)	)	PUNCT
chd-224	107	12	of	of	ADP
chd-224	107	13	individuals	individual	NOUN
chd-224	107	14	in	in	ADP
chd-224	107	15	the	the	DET
chd-224	107	16	united	united	PROPN
chd-224	107	17	states	states	PROPN
chd-224	107	18	as	as	ADP
chd-224	107	19	a	a	DET
chd-224	107	20	measure	measure	NOUN
chd-224	107	21	of	of	ADP
chd-224	107	22	dietary	dietary	ADJ
chd-224	107	23	iodine	iodine	NOUN
chd-224	107	24	(	(	PUNCT
chd-224	107	25	herrick	herrick	PROPN
chd-224	107	26	et	et	PROPN
chd-224	107	27	al	al	PROPN
chd-224	107	28	.	.	PROPN
chd-224	107	29	,	,	PUNCT
chd-224	107	30	2018	2018	NUM
chd-224	107	31	)	)	PUNCT
chd-224	107	32	.	.	PUNCT
chd-224	108	1	non	non	ADJ
chd-224	108	2	-	-	ADJ
chd-224	108	3	hispanic	hispanic	ADJ
chd-224	108	4	asian	asian	ADJ
chd-224	108	5	women	woman	NOUN
chd-224	108	6	of	of	ADP
chd-224	108	7	reproductive	reproductive	ADJ
chd-224	108	8	age	age	NOUN
chd-224	108	9	had	have	VERB
chd-224	108	10	low	low	ADJ
chd-224	108	11	muic	muic	NOUN
chd-224	108	12	,	,	PUNCT
chd-224	108	13	and	and	CCONJ
chd-224	108	14	therefore	therefore	ADV
chd-224	108	15	mild	mild	ADJ
chd-224	108	16	iodine	iodine	NOUN
chd-224	108	17	deficiency	deficiency	NOUN
chd-224	108	18	,	,	PUNCT
chd-224	108	19	compared	compare	VERB
chd-224	108	20	to	to	ADP
chd-224	108	21	non	non	ADJ
chd-224	108	22	-	-	ADJ
chd-224	108	23	hispanic	hispanic	ADJ
chd-224	108	24	african	african	ADJ
chd-224	108	25	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-224	108	26	e6	e6	NOUN
chd-224	108	27	cancer	cancer	NOUN
chd-224	108	28	health	health	NOUN
chd-224	108	29	disparities	disparity	NOUN
chd-224	108	30	research	research	VERB
chd-224	108	31	american	american	ADJ
chd-224	108	32	women	woman	NOUN
chd-224	108	33	of	of	ADP
chd-224	108	34	reproductive	reproductive	ADJ
chd-224	108	35	age	age	NOUN
chd-224	108	36	despite	despite	SCONJ
chd-224	108	37	both	both	DET
chd-224	108	38	populations	population	NOUN
chd-224	108	39	consuming	consume	VERB
chd-224	108	40	similar	similar	ADJ
chd-224	108	41	amounts	amount	NOUN
chd-224	108	42	of	of	ADP
chd-224	108	43	dairy	dairy	NOUN
chd-224	108	44	and	and	CCONJ
chd-224	108	45	grains	grain	NOUN
chd-224	108	46	(	(	PUNCT
chd-224	108	47	herrick	herrick	PROPN
chd-224	108	48	et	et	PROPN
chd-224	108	49	al	al	PROPN
chd-224	108	50	.	.	PROPN
chd-224	108	51	,	,	PUNCT
chd-224	108	52	2018	2018	NUM
chd-224	108	53	)	)	PUNCT
chd-224	108	54	.	.	PUNCT
chd-224	109	1	when	when	SCONJ
chd-224	109	2	looking	look	VERB
chd-224	109	3	at	at	ADP
chd-224	109	4	the	the	DET
chd-224	109	5	total	total	ADJ
chd-224	109	6	population	population	NOUN
chd-224	109	7	of	of	ADP
chd-224	109	8	individuals	individual	NOUN
chd-224	109	9	ages	age	NOUN
chd-224	109	10	6	6	NUM
chd-224	109	11	years	year	NOUN
chd-224	109	12	and	and	CCONJ
chd-224	109	13	above	above	ADV
chd-224	109	14	,	,	PUNCT
chd-224	109	15	non	non	ADJ
chd-224	109	16	-	-	ADJ
chd-224	109	17	hispanic	hispanic	ADJ
chd-224	109	18	asians	asians	PROPN
chd-224	109	19	consumed	consume	VERB
chd-224	109	20	more	more	ADJ
chd-224	109	21	amounts	amount	NOUN
chd-224	109	22	of	of	ADP
chd-224	109	23	dairy	dairy	NOUN
chd-224	109	24	and	and	CCONJ
chd-224	109	25	grains	grain	NOUN
chd-224	109	26	compared	compare	VERB
chd-224	109	27	to	to	ADP
chd-224	109	28	nonhispanic	nonhispanic	ADJ
chd-224	109	29	african	african	ADJ
chd-224	109	30	americans	americans	PROPN
chd-224	109	31	but	but	CCONJ
chd-224	109	32	continued	continue	VERB
chd-224	109	33	to	to	PART
chd-224	109	34	have	have	VERB
chd-224	109	35	lower	low	ADJ
chd-224	109	36	muic	muic	NOUN
chd-224	109	37	(	(	PUNCT
chd-224	109	38	herrick	herrick	PROPN
chd-224	109	39	et	et	PROPN
chd-224	109	40	al	al	PROPN
chd-224	109	41	.	.	PROPN
chd-224	109	42	,	,	PUNCT
chd-224	109	43	2018	2018	NUM
chd-224	109	44	)	)	PUNCT
chd-224	109	45	.	.	PUNCT
chd-224	110	1	since	since	SCONJ
chd-224	110	2	asian	asian	ADJ
chd-224	110	3	individuals	individual	NOUN
chd-224	110	4	tend	tend	VERB
chd-224	110	5	to	to	PART
chd-224	110	6	consume	consume	VERB
chd-224	110	7	more	more	ADJ
chd-224	110	8	rice	rice	NOUN
chd-224	110	9	than	than	ADP
chd-224	110	10	other	other	ADJ
chd-224	110	11	racial	racial	ADJ
chd-224	110	12	groups	group	NOUN
chd-224	110	13	,	,	PUNCT
chd-224	110	14	it	it	PRON
chd-224	110	15	is	be	AUX
chd-224	110	16	possible	possible	ADJ
chd-224	110	17	that	that	SCONJ
chd-224	110	18	differences	difference	NOUN
chd-224	110	19	in	in	ADP
chd-224	110	20	the	the	DET
chd-224	110	21	type	type	NOUN
chd-224	110	22	of	of	ADP
chd-224	110	23	grain	grain	NOUN
chd-224	110	24	consumed	consume	VERB
chd-224	110	25	by	by	ADP
chd-224	110	26	ethnic	ethnic	ADJ
chd-224	110	27	groups	group	NOUN
chd-224	110	28	could	could	AUX
chd-224	110	29	influence	influence	VERB
chd-224	110	30	iodine	iodine	NOUN
chd-224	110	31	levels	level	NOUN
chd-224	110	32	(	(	PUNCT
chd-224	110	33	herrick	herrick	PROPN
chd-224	110	34	et	et	PROPN
chd-224	110	35	al	al	PROPN
chd-224	110	36	.	.	PROPN
chd-224	110	37	,	,	PUNCT
chd-224	110	38	2018	2018	NUM
chd-224	110	39	)	)	PUNCT
chd-224	110	40	.	.	PUNCT
chd-224	111	1	additionally	additionally	ADV
chd-224	111	2	,	,	PUNCT
chd-224	111	3	this	this	DET
chd-224	111	4	study	study	NOUN
chd-224	111	5	found	find	VERB
chd-224	111	6	that	that	SCONJ
chd-224	111	7	non	non	ADJ
chd-224	111	8	-	-	ADJ
chd-224	111	9	hispanic	hispanic	ADJ
chd-224	111	10	asians	asians	PROPN
chd-224	111	11	consumed	consume	VERB
chd-224	111	12	higher	high	ADJ
chd-224	111	13	amounts	amount	NOUN
chd-224	111	14	of	of	ADP
chd-224	111	15	soy	soy	NOUN
chd-224	111	16	products	product	NOUN
chd-224	111	17	compared	compare	VERB
chd-224	111	18	to	to	ADP
chd-224	111	19	other	other	ADJ
chd-224	111	20	racial	racial	ADJ
chd-224	111	21	groups	group	NOUN
chd-224	111	22	and	and	CCONJ
chd-224	111	23	suggests	suggest	VERB
chd-224	111	24	that	that	SCONJ
chd-224	111	25	substances	substance	NOUN
chd-224	111	26	in	in	ADP
chd-224	111	27	these	these	DET
chd-224	111	28	soy	soy	NOUN
chd-224	111	29	products	product	NOUN
chd-224	111	30	could	could	AUX
chd-224	111	31	inhibit	inhibit	VERB
chd-224	111	32	iodine	iodine	NOUN
chd-224	111	33	uptake	uptake	NOUN
chd-224	111	34	by	by	ADP
chd-224	111	35	the	the	DET
chd-224	111	36	thyroid	thyroid	NOUN
chd-224	111	37	(	(	PUNCT
chd-224	111	38	herrick	herrick	PROPN
chd-224	111	39	et	et	PROPN
chd-224	111	40	al	al	PROPN
chd-224	111	41	.	.	PROPN
chd-224	111	42	,	,	PUNCT
chd-224	111	43	2018	2018	NUM
chd-224	111	44	)	)	PUNCT
chd-224	111	45	.	.	PUNCT
chd-224	112	1	these	these	DET
chd-224	112	2	data	datum	NOUN
chd-224	112	3	suggest	suggest	VERB
chd-224	112	4	that	that	SCONJ
chd-224	112	5	differences	difference	NOUN
chd-224	112	6	in	in	ADP
chd-224	112	7	diet	diet	NOUN
chd-224	112	8	among	among	ADP
chd-224	112	9	racial	racial	ADJ
chd-224	112	10	/	/	SYM
chd-224	112	11	ethnic	ethnic	ADJ
chd-224	112	12	groups	group	NOUN
chd-224	112	13	may	may	AUX
chd-224	112	14	impact	impact	VERB
chd-224	112	15	dietary	dietary	ADJ
chd-224	112	16	iodine	iodine	NOUN
chd-224	112	17	levels	level	NOUN
chd-224	112	18	and	and	CCONJ
chd-224	112	19	,	,	PUNCT
chd-224	112	20	therefore	therefore	ADV
chd-224	112	21	,	,	PUNCT
chd-224	112	22	rai	rai	PROPN
chd-224	112	23	treatment	treatment	NOUN
chd-224	112	24	outcome	outcome	NOUN
chd-224	112	25	.	.	PUNCT
chd-224	113	1	3.2.3	3.2.3	X
chd-224	113	2	.	.	X
chd-224	113	3	environmental	environmental	ADJ
chd-224	113	4	pollutants	pollutant	NOUN
chd-224	113	5	influencing	influence	VERB
chd-224	113	6	tc	tc	NUM
chd-224	113	7	health	health	NOUN
chd-224	113	8	disparities	disparity	NOUN
chd-224	113	9	populations	population	NOUN
chd-224	113	10	are	be	AUX
chd-224	113	11	exposed	expose	VERB
chd-224	113	12	to	to	ADP
chd-224	113	13	varying	vary	VERB
chd-224	113	14	levels	level	NOUN
chd-224	113	15	of	of	ADP
chd-224	113	16	harmful	harmful	ADJ
chd-224	113	17	chemicals	chemical	NOUN
chd-224	113	18	in	in	ADP
chd-224	113	19	the	the	DET
chd-224	113	20	environment	environment	NOUN
chd-224	113	21	through	through	ADP
chd-224	113	22	water	water	NOUN
chd-224	113	23	,	,	PUNCT
chd-224	113	24	air	air	NOUN
chd-224	113	25	,	,	PUNCT
chd-224	113	26	food	food	NOUN
chd-224	113	27	,	,	PUNCT
chd-224	113	28	or	or	CCONJ
chd-224	113	29	soil	soil	NOUN
chd-224	113	30	(	(	PUNCT
chd-224	113	31	yildirim	yildirim	PROPN
chd-224	113	32	simsir	simsir	VERB
chd-224	113	33	et	et	PROPN
chd-224	113	34	al	al	PROPN
chd-224	113	35	.	.	PROPN
chd-224	113	36	,	,	PUNCT
chd-224	113	37	2020	2020	NUM
chd-224	113	38	)	)	PUNCT
chd-224	113	39	.	.	PUNCT
chd-224	114	1	a	a	DET
chd-224	114	2	few	few	ADJ
chd-224	114	3	of	of	ADP
chd-224	114	4	these	these	DET
chd-224	114	5	chemicals	chemical	NOUN
chd-224	114	6	–	–	PUNCT
chd-224	114	7	such	such	ADJ
chd-224	114	8	as	as	ADP
chd-224	114	9	benzene	benzene	NOUN
chd-224	114	10	,	,	PUNCT
chd-224	114	11	formaldehyde	formaldehyde	NOUN
chd-224	114	12	,	,	PUNCT
chd-224	114	13	and	and	CCONJ
chd-224	114	14	pesticides	pesticide	NOUN
chd-224	114	15	–	–	PUNCT
chd-224	114	16	have	have	AUX
chd-224	114	17	been	be	AUX
chd-224	114	18	linked	link	VERB
chd-224	114	19	to	to	ADP
chd-224	114	20	goiter	goiter	NOUN
chd-224	114	21	and	and	CCONJ
chd-224	114	22	nodular	nodular	ADJ
chd-224	114	23	goiter	goiter	NOUN
chd-224	114	24	formation	formation	NOUN
chd-224	114	25	as	as	ADV
chd-224	114	26	well	well	ADV
chd-224	114	27	as	as	ADP
chd-224	114	28	papillary	papillary	ADJ
chd-224	114	29	thyroid	thyroid	NOUN
chd-224	114	30	cancer	cancer	NOUN
chd-224	114	31	(	(	PUNCT
chd-224	114	32	bogović	bogović	NOUN
chd-224	114	33	crnčić	crnčić	NOUN
chd-224	114	34	et	et	PROPN
chd-224	114	35	al	al	PROPN
chd-224	114	36	.	.	PROPN
chd-224	114	37	,	,	PUNCT
chd-224	114	38	2020	2020	NUM
chd-224	114	39	;	;	PUNCT
chd-224	114	40	yildirim	yildirim	PROPN
chd-224	114	41	simsir	simsir	VERB
chd-224	114	42	et	et	PROPN
chd-224	114	43	al	al	PROPN
chd-224	114	44	.	.	PROPN
chd-224	114	45	,	,	PUNCT
chd-224	114	46	2020	2020	NUM
chd-224	114	47	)	)	PUNCT
chd-224	114	48	.	.	PUNCT
chd-224	115	1	another	another	DET
chd-224	115	2	set	set	NOUN
chd-224	115	3	of	of	ADP
chd-224	115	4	chemicals	chemical	NOUN
chd-224	115	5	,	,	PUNCT
chd-224	115	6	nitrates	nitrate	NOUN
chd-224	115	7	,	,	PUNCT
chd-224	115	8	are	be	AUX
chd-224	115	9	commonly	commonly	ADV
chd-224	115	10	found	find	VERB
chd-224	115	11	in	in	ADP
chd-224	115	12	readymade	readymade	NOUN
chd-224	115	13	foods	food	NOUN
chd-224	115	14	and	and	CCONJ
chd-224	115	15	,	,	PUNCT
chd-224	115	16	when	when	SCONJ
chd-224	115	17	at	at	ADP
chd-224	115	18	above	above	ADP
chd-224	115	19	-	-	PUNCT
chd-224	115	20	average	average	ADJ
chd-224	115	21	levels	level	NOUN
chd-224	115	22	,	,	PUNCT
chd-224	115	23	can	can	AUX
chd-224	115	24	affect	affect	VERB
chd-224	115	25	iodine	iodine	NOUN
chd-224	115	26	uptake	uptake	NOUN
chd-224	115	27	and	and	CCONJ
chd-224	115	28	increase	increase	VERB
chd-224	115	29	the	the	DET
chd-224	115	30	risk	risk	NOUN
chd-224	115	31	of	of	ADP
chd-224	115	32	thyroid	thyroid	NOUN
chd-224	115	33	cancer	cancer	NOUN
chd-224	115	34	(	(	PUNCT
chd-224	115	35	bogović	bogović	NOUN
chd-224	115	36	crnčić	crnčić	NOUN
chd-224	115	37	et	et	PROPN
chd-224	115	38	al	al	PROPN
chd-224	115	39	.	.	PROPN
chd-224	115	40	,	,	PUNCT
chd-224	115	41	2020	2020	NUM
chd-224	115	42	)	)	PUNCT
chd-224	115	43	.	.	PUNCT
chd-224	116	1	additionally	additionally	ADV
chd-224	116	2	,	,	PUNCT
chd-224	116	3	polybrominated	polybrominate	VERB
chd-224	116	4	diphenyl	diphenyl	NOUN
chd-224	116	5	ethers	ether	NOUN
chd-224	116	6	(	(	PUNCT
chd-224	116	7	pbdes	pbde	NOUN
chd-224	116	8	)	)	PUNCT
chd-224	116	9	found	find	VERB
chd-224	116	10	in	in	ADP
chd-224	116	11	many	many	ADJ
chd-224	116	12	industrial	industrial	ADJ
chd-224	116	13	materials	material	NOUN
chd-224	116	14	may	may	AUX
chd-224	116	15	induce	induce	VERB
chd-224	116	16	abnormal	abnormal	ADJ
chd-224	116	17	thyroid	thyroid	NOUN
chd-224	116	18	cell	cell	NOUN
chd-224	116	19	proliferation	proliferation	NOUN
chd-224	116	20	leading	lead	VERB
chd-224	116	21	to	to	ADP
chd-224	116	22	a	a	DET
chd-224	116	23	risk	risk	NOUN
chd-224	116	24	of	of	ADP
chd-224	116	25	thyroid	thyroid	NOUN
chd-224	116	26	cancer	cancer	NOUN
chd-224	116	27	(	(	PUNCT
chd-224	116	28	bogović	bogović	NOUN
chd-224	116	29	crnčić	crnčić	NOUN
chd-224	116	30	et	et	PROPN
chd-224	116	31	al	al	PROPN
chd-224	116	32	.	.	PROPN
chd-224	116	33	,	,	PUNCT
chd-224	116	34	2020	2020	NUM
chd-224	116	35	)	)	PUNCT
chd-224	116	36	.	.	PUNCT
chd-224	117	1	considering	consider	VERB
chd-224	117	2	residential	residential	ADJ
chd-224	117	3	segregation	segregation	NOUN
chd-224	117	4	and	and	CCONJ
chd-224	117	5	racial	racial	ADJ
chd-224	117	6	/	/	SYM
chd-224	117	7	ethnic	ethnic	ADJ
chd-224	117	8	diversity	diversity	NOUN
chd-224	117	9	by	by	ADP
chd-224	117	10	geographic	geographic	ADJ
chd-224	117	11	level	level	NOUN
chd-224	117	12	in	in	ADP
chd-224	117	13	the	the	DET
chd-224	117	14	united	united	PROPN
chd-224	117	15	states	states	PROPN
chd-224	117	16	,	,	PUNCT
chd-224	117	17	a	a	DET
chd-224	117	18	geospatial	geospatial	ADJ
chd-224	117	19	approach	approach	NOUN
chd-224	117	20	to	to	ADP
chd-224	117	21	cancer	cancer	NOUN
chd-224	117	22	research	research	NOUN
chd-224	117	23	could	could	AUX
chd-224	117	24	allow	allow	VERB
chd-224	117	25	for	for	ADP
chd-224	117	26	a	a	DET
chd-224	117	27	better	well	ADJ
chd-224	117	28	understanding	understanding	NOUN
chd-224	117	29	of	of	ADP
chd-224	117	30	whether	whether	SCONJ
chd-224	117	31	environmental	environmental	ADJ
chd-224	117	32	pollutants	pollutant	NOUN
chd-224	117	33	differentially	differentially	ADV
chd-224	117	34	impact	impact	VERB
chd-224	117	35	certain	certain	ADJ
chd-224	117	36	racial	racial	ADJ
chd-224	117	37	/	/	SYM
chd-224	117	38	ethnic	ethnic	ADJ
chd-224	117	39	groups	group	NOUN
chd-224	117	40	(	(	PUNCT
chd-224	117	41	korycinski	korycinski	NOUN
chd-224	117	42	et	et	PROPN
chd-224	117	43	al	al	PROPN
chd-224	117	44	.	.	PROPN
chd-224	117	45	,	,	PUNCT
chd-224	117	46	2018	2018	NUM
chd-224	117	47	;	;	PUNCT
chd-224	117	48	sahar	sahar	PROPN
chd-224	117	49	et	et	PROPN
chd-224	117	50	al	al	PROPN
chd-224	117	51	.	.	PROPN
chd-224	117	52	,	,	PUNCT
chd-224	117	53	2019	2019	NUM
chd-224	117	54	)	)	PUNCT
chd-224	117	55	.	.	PUNCT
chd-224	118	1	an	an	DET
chd-224	118	2	example	example	NOUN
chd-224	118	3	of	of	ADP
chd-224	118	4	this	this	DET
chd-224	118	5	approach	approach	NOUN
chd-224	118	6	includes	include	VERB
chd-224	118	7	the	the	DET
chd-224	118	8	application	application	NOUN
chd-224	118	9	of	of	ADP
chd-224	118	10	geographic	geographic	ADJ
chd-224	118	11	information	information	NOUN
chd-224	118	12	science	science	NOUN
chd-224	118	13	(	(	PUNCT
chd-224	118	14	giscience	giscience	NOUN
chd-224	118	15	)	)	PUNCT
chd-224	118	16	to	to	ADP
chd-224	118	17	cancer	cancer	NOUN
chd-224	118	18	research	research	NOUN
chd-224	118	19	.	.	PUNCT
chd-224	119	1	this	this	PRON
chd-224	119	2	allows	allow	VERB
chd-224	119	3	researchers	researcher	NOUN
chd-224	119	4	to	to	PART
chd-224	119	5	analyze	analyze	VERB
chd-224	119	6	spatial	spatial	ADJ
chd-224	119	7	data	datum	NOUN
chd-224	119	8	,	,	PUNCT
chd-224	119	9	visualize	visualize	VERB
chd-224	119	10	cancer	cancer	NOUN
chd-224	119	11	and	and	CCONJ
chd-224	119	12	risk	risk	NOUN
chd-224	119	13	factor	factor	NOUN
chd-224	119	14	data	datum	NOUN
chd-224	119	15	on	on	ADP
chd-224	119	16	a	a	DET
chd-224	119	17	map	map	NOUN
chd-224	119	18	,	,	PUNCT
chd-224	119	19	and	and	CCONJ
chd-224	119	20	investigate	investigate	VERB
chd-224	119	21	geographic	geographic	ADJ
chd-224	119	22	disease	disease	NOUN
chd-224	119	23	patterns	pattern	NOUN
chd-224	119	24	and	and	CCONJ
chd-224	119	25	clusters	cluster	NOUN
chd-224	119	26	(	(	PUNCT
chd-224	119	27	sahar	sahar	PROPN
chd-224	119	28	et	et	PROPN
chd-224	119	29	al	al	PROPN
chd-224	119	30	.	.	PROPN
chd-224	119	31	,	,	PUNCT
chd-224	119	32	2019	2019	NUM
chd-224	119	33	)	)	PUNCT
chd-224	119	34	.	.	PUNCT
chd-224	120	1	most	most	ADJ
chd-224	120	2	geospatial	geospatial	ADJ
chd-224	120	3	cancer	cancer	NOUN
chd-224	120	4	research	research	NOUN
chd-224	120	5	studies	study	NOUN
chd-224	120	6	have	have	AUX
chd-224	120	7	been	be	AUX
chd-224	120	8	published	publish	VERB
chd-224	120	9	after	after	ADP
chd-224	120	10	2010	2010	NUM
chd-224	120	11	and	and	CCONJ
chd-224	120	12	are	be	AUX
chd-224	120	13	affiliated	affiliate	VERB
chd-224	120	14	with	with	ADP
chd-224	120	15	nci	nci	PROPN
chd-224	120	16	-	-	PUNCT
chd-224	120	17	designated	designate	VERB
chd-224	120	18	cancer	cancer	NOUN
chd-224	120	19	centers	center	NOUN
chd-224	120	20	(	(	PUNCT
chd-224	120	21	korycinski	korycinski	NOUN
chd-224	120	22	et	et	PROPN
chd-224	120	23	al	al	PROPN
chd-224	120	24	.	.	PROPN
chd-224	120	25	,	,	PUNCT
chd-224	120	26	2018	2018	NUM
chd-224	120	27	)	)	PUNCT
chd-224	120	28	.	.	PUNCT
chd-224	121	1	additionally	additionally	ADV
chd-224	121	2	,	,	PUNCT
chd-224	121	3	despite	despite	SCONJ
chd-224	121	4	this	this	DET
chd-224	121	5	recently	recently	ADV
chd-224	121	6	growing	grow	VERB
chd-224	121	7	area	area	NOUN
chd-224	121	8	of	of	ADP
chd-224	121	9	research	research	NOUN
chd-224	121	10	,	,	PUNCT
chd-224	121	11	most	most	ADJ
chd-224	121	12	of	of	ADP
chd-224	121	13	these	these	DET
chd-224	121	14	studies	study	NOUN
chd-224	121	15	have	have	AUX
chd-224	121	16	looked	look	VERB
chd-224	121	17	at	at	ADP
chd-224	121	18	other	other	ADJ
chd-224	121	19	cancer	cancer	NOUN
chd-224	121	20	types	type	NOUN
chd-224	121	21	besides	besides	SCONJ
chd-224	121	22	thyroid	thyroid	NOUN
chd-224	121	23	cancer	cancer	NOUN
chd-224	121	24	–	–	PUNCT
chd-224	121	25	such	such	ADJ
chd-224	121	26	as	as	ADP
chd-224	121	27	breast	breast	NOUN
chd-224	121	28	,	,	PUNCT
chd-224	121	29	prostate	prostate	NOUN
chd-224	121	30	,	,	PUNCT
chd-224	121	31	and	and	CCONJ
chd-224	121	32	colorectal	colorectal	ADJ
chd-224	121	33	cancers	cancer	NOUN
chd-224	121	34	(	(	PUNCT
chd-224	121	35	korycinski	korycinski	VERB
chd-224	121	36	et	et	PROPN
chd-224	121	37	al	al	PROPN
chd-224	121	38	.	.	PROPN
chd-224	121	39	,	,	PUNCT
chd-224	121	40	2018	2018	NUM
chd-224	121	41	)	)	PUNCT
chd-224	121	42	.	.	PUNCT
chd-224	122	1	one	one	NUM
chd-224	122	2	study	study	NOUN
chd-224	122	3	done	do	VERB
chd-224	122	4	in	in	ADP
chd-224	122	5	vermont	vermont	PROPN
chd-224	122	6	found	find	VERB
chd-224	122	7	no	no	DET
chd-224	122	8	correlation	correlation	NOUN
chd-224	122	9	between	between	ADP
chd-224	122	10	thyroid	thyroid	NOUN
chd-224	122	11	cancer	cancer	NOUN
chd-224	122	12	incidence	incidence	NOUN
chd-224	122	13	and	and	CCONJ
chd-224	122	14	proximity	proximity	NOUN
chd-224	122	15	to	to	ADP
chd-224	122	16	tertiary	tertiary	ADJ
chd-224	122	17	healthcare	healthcare	NOUN
chd-224	122	18	centers	center	NOUN
chd-224	122	19	or	or	CCONJ
chd-224	122	20	socioeconomic	socioeconomic	ADJ
chd-224	122	21	status	status	NOUN
chd-224	122	22	(	(	PUNCT
chd-224	122	23	hanley	hanley	PROPN
chd-224	122	24	et	et	PROPN
chd-224	122	25	al	al	PROPN
chd-224	122	26	.	.	PROPN
chd-224	122	27	,	,	PUNCT
chd-224	122	28	2015	2015	NUM
chd-224	122	29	)	)	PUNCT
chd-224	122	30	.	.	PUNCT
chd-224	123	1	however	however	ADV
chd-224	123	2	,	,	PUNCT
chd-224	123	3	the	the	DET
chd-224	123	4	researchers	researcher	NOUN
chd-224	123	5	note	note	VERB
chd-224	123	6	that	that	SCONJ
chd-224	123	7	vermont	vermont	PROPN
chd-224	123	8	has	have	VERB
chd-224	123	9	a	a	DET
chd-224	123	10	population	population	NOUN
chd-224	123	11	that	that	PRON
chd-224	123	12	is	be	AUX
chd-224	123	13	>	>	X
chd-224	123	14	95	95	NUM
chd-224	123	15	%	%	NOUN
chd-224	123	16	european	european	PROPN
chd-224	123	17	american	american	PROPN
chd-224	123	18	and	and	CCONJ
chd-224	123	19	has	have	VERB
chd-224	123	20	>	>	X
chd-224	123	21	92	92	NUM
chd-224	123	22	%	%	NOUN
chd-224	123	23	healthcare	healthcare	NOUN
chd-224	123	24	insurance	insurance	NOUN
chd-224	123	25	coverage	coverage	NOUN
chd-224	123	26	,	,	PUNCT
chd-224	123	27	providing	provide	VERB
chd-224	123	28	little	little	ADJ
chd-224	123	29	evidence	evidence	NOUN
chd-224	123	30	for	for	ADP
chd-224	123	31	racial	racial	ADJ
chd-224	123	32	/	/	SYM
chd-224	123	33	ethnic	ethnic	ADJ
chd-224	123	34	minority	minority	NOUN
chd-224	123	35	groups	group	NOUN
chd-224	123	36	(	(	PUNCT
chd-224	123	37	hanley	hanley	PROPN
chd-224	123	38	et	et	PROPN
chd-224	123	39	al	al	PROPN
chd-224	123	40	.	.	PROPN
chd-224	123	41	,	,	PUNCT
chd-224	123	42	2015	2015	NUM
chd-224	123	43	)	)	PUNCT
chd-224	123	44	.	.	PUNCT
chd-224	124	1	another	another	DET
chd-224	124	2	study	study	NOUN
chd-224	124	3	done	do	VERB
chd-224	124	4	in	in	ADP
chd-224	124	5	california	california	PROPN
chd-224	124	6	found	find	VERB
chd-224	124	7	that	that	SCONJ
chd-224	124	8	disadvantaged	disadvantaged	ADJ
chd-224	124	9	communities	community	NOUN
chd-224	124	10	,	,	PUNCT
chd-224	124	11	or	or	CCONJ
chd-224	124	12	dacs	dac	NOUN
chd-224	124	13	,	,	PUNCT
chd-224	124	14	had	have	VERB
chd-224	124	15	higher	high	ADJ
chd-224	124	16	amounts	amount	NOUN
chd-224	124	17	of	of	ADP
chd-224	124	18	nitrate	nitrate	NOUN
chd-224	124	19	well	well	NOUN
chd-224	124	20	contamination	contamination	NOUN
chd-224	124	21	as	as	ADV
chd-224	124	22	well	well	ADV
chd-224	124	23	as	as	ADP
chd-224	124	24	a	a	DET
chd-224	124	25	significant	significant	ADJ
chd-224	124	26	correlation	correlation	NOUN
chd-224	124	27	between	between	ADP
chd-224	124	28	well	well	INTJ
chd-224	124	29	contamination	contamination	NOUN
chd-224	124	30	per	per	ADP
chd-224	124	31	square	square	ADJ
chd-224	124	32	mile	mile	NOUN
chd-224	124	33	and	and	CCONJ
chd-224	124	34	thyroid	thyroid	NOUN
chd-224	124	35	cancer	cancer	NOUN
chd-224	124	36	incidence	incidence	NOUN
chd-224	124	37	(	(	PUNCT
chd-224	124	38	tariqi	tariqi	NOUN
chd-224	124	39	and	and	CCONJ
chd-224	124	40	naughton	naughton	NOUN
chd-224	124	41	,	,	PUNCT
chd-224	124	42	2021	2021	NUM
chd-224	124	43	)	)	PUNCT
chd-224	124	44	.	.	PUNCT
chd-224	125	1	in	in	ADP
chd-224	125	2	particular	particular	ADJ
chd-224	125	3	,	,	PUNCT
chd-224	125	4	there	there	PRON
chd-224	125	5	was	be	VERB
chd-224	125	6	a	a	DET
chd-224	125	7	two	two	NUM
chd-224	125	8	times	time	NOUN
chd-224	125	9	greater	great	ADJ
chd-224	125	10	thyroid	thyroid	NOUN
chd-224	125	11	cancer	cancer	NOUN
chd-224	125	12	incidence	incidence	NOUN
chd-224	125	13	compared	compare	VERB
chd-224	125	14	to	to	ADP
chd-224	125	15	non	non	NOUN
chd-224	125	16	-	-	NOUN
chd-224	125	17	dacs	dac	NOUN
chd-224	125	18	(	(	PUNCT
chd-224	125	19	tariqi	tariqi	NOUN
chd-224	125	20	and	and	CCONJ
chd-224	125	21	naughton	naughton	NOUN
chd-224	125	22	,	,	PUNCT
chd-224	125	23	2021	2021	NUM
chd-224	125	24	)	)	PUNCT
chd-224	125	25	.	.	PUNCT
chd-224	126	1	dacs	dac	NOUN
chd-224	126	2	tend	tend	VERB
chd-224	126	3	to	to	PART
chd-224	126	4	have	have	VERB
chd-224	126	5	a	a	DET
chd-224	126	6	higher	high	ADJ
chd-224	126	7	population	population	NOUN
chd-224	126	8	density	density	NOUN
chd-224	126	9	and	and	CCONJ
chd-224	126	10	amount	amount	NOUN
chd-224	126	11	of	of	ADP
chd-224	126	12	people	people	NOUN
chd-224	126	13	per	per	ADP
chd-224	126	14	well	well	ADV
chd-224	126	15	,	,	PUNCT
chd-224	126	16	exposing	expose	VERB
chd-224	126	17	a	a	DET
chd-224	126	18	larger	large	ADJ
chd-224	126	19	number	number	NOUN
chd-224	126	20	of	of	ADP
chd-224	126	21	people	people	NOUN
chd-224	126	22	to	to	PART
chd-224	126	23	contaminated	contaminated	VERB
chd-224	126	24	drinking	drinking	NOUN
chd-224	126	25	water	water	NOUN
chd-224	126	26	and	and	CCONJ
chd-224	126	27	suggesting	suggest	VERB
chd-224	126	28	that	that	SCONJ
chd-224	126	29	certain	certain	ADJ
chd-224	126	30	populations	population	NOUN
chd-224	126	31	are	be	AUX
chd-224	126	32	disproportionately	disproportionately	ADV
chd-224	126	33	affected	affect	VERB
chd-224	126	34	by	by	ADP
chd-224	126	35	environmental	environmental	ADJ
chd-224	126	36	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-224	126	37	e7	e7	PROPN
chd-224	126	38	cancer	cancer	NOUN
chd-224	126	39	health	health	NOUN
chd-224	126	40	disparities	disparity	NOUN
chd-224	126	41	research	research	NOUN
chd-224	126	42	factors	factor	NOUN
chd-224	126	43	(	(	PUNCT
chd-224	126	44	tariqi	tariqi	NOUN
chd-224	126	45	and	and	CCONJ
chd-224	126	46	naughton	naughton	NOUN
chd-224	126	47	,	,	PUNCT
chd-224	126	48	2021	2021	NUM
chd-224	126	49	)	)	PUNCT
chd-224	126	50	.	.	PUNCT
chd-224	127	1	these	these	DET
chd-224	127	2	studies	study	NOUN
chd-224	127	3	highlight	highlight	VERB
chd-224	127	4	the	the	DET
chd-224	127	5	importance	importance	NOUN
chd-224	127	6	of	of	ADP
chd-224	127	7	further	further	ADJ
chd-224	127	8	geospatial	geospatial	ADJ
chd-224	127	9	research	research	NOUN
chd-224	127	10	on	on	ADP
chd-224	127	11	thyroid	thyroid	NOUN
chd-224	127	12	cancer	cancer	NOUN
chd-224	127	13	to	to	PART
chd-224	127	14	address	address	VERB
chd-224	127	15	geographic	geographic	ADJ
chd-224	127	16	and	and	CCONJ
chd-224	127	17	racial	racial	ADJ
chd-224	127	18	/	/	SYM
chd-224	127	19	ethnic	ethnic	ADJ
chd-224	127	20	cancer	cancer	NOUN
chd-224	127	21	disparities	disparity	NOUN
chd-224	127	22	in	in	ADP
chd-224	127	23	the	the	DET
chd-224	127	24	united	united	PROPN
chd-224	127	25	states	states	PROPN
chd-224	127	26	.	.	PUNCT
chd-224	128	1	another	another	DET
chd-224	128	2	area	area	NOUN
chd-224	128	3	of	of	ADP
chd-224	128	4	consideration	consideration	NOUN
chd-224	128	5	regarding	regard	VERB
chd-224	128	6	environmental	environmental	ADJ
chd-224	128	7	pollutants	pollutant	NOUN
chd-224	128	8	and	and	CCONJ
chd-224	128	9	their	their	PRON
chd-224	128	10	possible	possible	ADJ
chd-224	128	11	contribution	contribution	NOUN
chd-224	128	12	to	to	PART
chd-224	128	13	thyroid	thyroid	VERB
chd-224	128	14	cancer	cancer	NOUN
chd-224	128	15	racial	racial	ADJ
chd-224	128	16	/	/	SYM
chd-224	128	17	ethnic	ethnic	ADJ
chd-224	128	18	disparities	disparity	NOUN
chd-224	128	19	is	be	AUX
chd-224	128	20	birthplace	birthplace	NOUN
chd-224	128	21	.	.	PUNCT
chd-224	129	1	one	one	NUM
chd-224	129	2	study	study	NOUN
chd-224	129	3	–	–	PUNCT
chd-224	129	4	although	although	SCONJ
chd-224	129	5	limited	limit	VERB
chd-224	129	6	by	by	ADP
chd-224	129	7	birthplace	birthplace	NOUN
chd-224	129	8	data	datum	NOUN
chd-224	129	9	–	–	PUNCT
chd-224	129	10	has	have	AUX
chd-224	129	11	looked	look	VERB
chd-224	129	12	at	at	ADP
chd-224	129	13	whether	whether	SCONJ
chd-224	129	14	birthplace	birthplace	NOUN
chd-224	129	15	alters	alter	VERB
chd-224	129	16	incidence	incidence	NOUN
chd-224	129	17	rates	rate	NOUN
chd-224	129	18	of	of	ADP
chd-224	129	19	thyroid	thyroid	NOUN
chd-224	129	20	cancer	cancer	NOUN
chd-224	129	21	among	among	ADP
chd-224	129	22	asians	asians	PROPN
chd-224	129	23	(	(	PUNCT
chd-224	129	24	horn	horn	NOUN
chd-224	129	25	-	-	PUNCT
chd-224	129	26	ross	ross	PROPN
chd-224	129	27	et	et	PROPN
chd-224	129	28	al	al	PROPN
chd-224	129	29	.	.	PROPN
chd-224	129	30	,	,	PUNCT
chd-224	129	31	2011	2011	NUM
chd-224	129	32	)	)	PUNCT
chd-224	129	33	.	.	PUNCT
chd-224	130	1	researchers	researcher	NOUN
chd-224	130	2	found	find	VERB
chd-224	130	3	that	that	SCONJ
chd-224	130	4	us	we	PRON
chd-224	130	5	-	-	PUNCT
chd-224	130	6	born	bear	VERB
chd-224	130	7	chinese	chinese	ADJ
chd-224	130	8	women	woman	NOUN
chd-224	130	9	had	have	VERB
chd-224	130	10	higher	high	ADJ
chd-224	130	11	papillary	papillary	ADJ
chd-224	130	12	thyroid	thyroid	NOUN
chd-224	130	13	cancer	cancer	NOUN
chd-224	130	14	incidence	incidence	NOUN
chd-224	130	15	rates	rate	NOUN
chd-224	130	16	than	than	ADP
chd-224	130	17	chinaborn	chinaborn	VERB
chd-224	130	18	chinese	chinese	ADJ
chd-224	130	19	women	woman	NOUN
chd-224	130	20	,	,	PUNCT
chd-224	130	21	and	and	CCONJ
chd-224	130	22	a	a	DET
chd-224	130	23	reverse	reverse	ADJ
chd-224	130	24	trend	trend	NOUN
chd-224	130	25	was	be	AUX
chd-224	130	26	observed	observe	VERB
chd-224	130	27	among	among	ADP
chd-224	130	28	filipino	filipino	PROPN
chd-224	130	29	american	american	ADJ
chd-224	130	30	and	and	CCONJ
chd-224	130	31	japanese	japanese	ADJ
chd-224	130	32	american	american	ADJ
chd-224	130	33	women	woman	NOUN
chd-224	130	34	(	(	PUNCT
chd-224	130	35	horn	horn	NOUN
chd-224	130	36	-	-	PUNCT
chd-224	130	37	ross	ross	PROPN
chd-224	130	38	et	et	PROPN
chd-224	130	39	al	al	PROPN
chd-224	130	40	.	.	PROPN
chd-224	130	41	,	,	PUNCT
chd-224	130	42	2011	2011	NUM
chd-224	130	43	)	)	PUNCT
chd-224	130	44	.	.	PUNCT
chd-224	131	1	another	another	DET
chd-224	131	2	study	study	NOUN
chd-224	131	3	of	of	ADP
chd-224	131	4	five	five	NUM
chd-224	131	5	asian	asian	ADJ
chd-224	131	6	female	female	ADJ
chd-224	131	7	subgroups	subgroup	NOUN
chd-224	131	8	in	in	ADP
chd-224	131	9	california	california	PROPN
chd-224	131	10	from	from	ADP
chd-224	131	11	1988	1988	NUM
chd-224	131	12	to	to	ADP
chd-224	131	13	2004	2004	NUM
chd-224	131	14	showed	show	VERB
chd-224	131	15	that	that	SCONJ
chd-224	131	16	japan	japan	PROPN
chd-224	131	17	-	-	PUNCT
chd-224	131	18	born	bear	VERB
chd-224	131	19	japanese	japanese	ADJ
chd-224	131	20	women	woman	NOUN
chd-224	131	21	had	have	VERB
chd-224	131	22	a	a	DET
chd-224	131	23	significantly	significantly	ADV
chd-224	131	24	higher	high	ADJ
chd-224	131	25	papillary	papillary	ADJ
chd-224	131	26	thyroid	thyroid	NOUN
chd-224	131	27	cancer	cancer	NOUN
chd-224	131	28	incidence	incidence	NOUN
chd-224	131	29	rate	rate	NOUN
chd-224	131	30	compared	compare	VERB
chd-224	131	31	to	to	ADP
chd-224	131	32	us	we	PRON
chd-224	131	33	-	-	PUNCT
chd-224	131	34	born	bear	VERB
chd-224	131	35	japanese	japanese	ADJ
chd-224	131	36	women	woman	NOUN
chd-224	131	37	,	,	PUNCT
chd-224	131	38	and	and	CCONJ
chd-224	131	39	a	a	DET
chd-224	131	40	reverse	reverse	ADJ
chd-224	131	41	trend	trend	NOUN
chd-224	131	42	was	be	AUX
chd-224	131	43	observed	observe	VERB
chd-224	131	44	among	among	ADP
chd-224	131	45	chinese	chinese	PROPN
chd-224	131	46	and	and	CCONJ
chd-224	131	47	filipina	filipina	ADJ
chd-224	131	48	american	american	ADJ
chd-224	131	49	women	woman	NOUN
chd-224	131	50	(	(	PUNCT
chd-224	131	51	horn	horn	NOUN
chd-224	131	52	-	-	PUNCT
chd-224	131	53	ross	ross	PROPN
chd-224	131	54	et	et	PROPN
chd-224	131	55	al	al	PROPN
chd-224	131	56	.	.	PROPN
chd-224	131	57	,	,	PUNCT
chd-224	131	58	2011	2011	NUM
chd-224	131	59	)	)	PUNCT
chd-224	131	60	.	.	PUNCT
chd-224	132	1	this	this	DET
chd-224	132	2	study	study	NOUN
chd-224	132	3	also	also	ADV
chd-224	132	4	found	find	VERB
chd-224	132	5	that	that	SCONJ
chd-224	132	6	foreign	foreign	ADJ
chd-224	132	7	-	-	PUNCT
chd-224	132	8	born	bear	VERB
chd-224	132	9	chinese	chinese	ADJ
chd-224	132	10	,	,	PUNCT
chd-224	132	11	korean	korean	ADJ
chd-224	132	12	,	,	PUNCT
chd-224	132	13	vietnamese	vietnamese	NOUN
chd-224	132	14	,	,	PUNCT
chd-224	132	15	and	and	CCONJ
chd-224	132	16	filipina	filipina	ADJ
chd-224	132	17	american	american	ADJ
chd-224	132	18	women	woman	NOUN
chd-224	132	19	had	have	VERB
chd-224	132	20	papillary	papillary	ADJ
chd-224	132	21	thyroid	thyroid	NOUN
chd-224	132	22	cancer	cancer	NOUN
chd-224	132	23	incidence	incidence	NOUN
chd-224	132	24	rates	rate	NOUN
chd-224	132	25	that	that	PRON
chd-224	132	26	peaked	peak	VERB
chd-224	132	27	at	at	ADP
chd-224	132	28	70	70	NUM
chd-224	132	29	years	year	NOUN
chd-224	132	30	of	of	ADP
chd-224	132	31	age	age	NOUN
chd-224	132	32	,	,	PUNCT
chd-224	132	33	whereas	whereas	SCONJ
chd-224	132	34	their	their	PRON
chd-224	132	35	us	we	PRON
chd-224	132	36	-	-	PUNCT
chd-224	132	37	born	bear	VERB
chd-224	132	38	asian	asian	ADJ
chd-224	132	39	subgroup	subgroup	NOUN
chd-224	132	40	counterparts	counterpart	NOUN
chd-224	132	41	peaked	peak	VERB
chd-224	132	42	during	during	ADP
chd-224	132	43	reproductive	reproductive	ADJ
chd-224	132	44	and	and	CCONJ
chd-224	132	45	menopausal	menopausal	ADJ
chd-224	132	46	years	year	NOUN
chd-224	132	47	(	(	PUNCT
chd-224	132	48	horn	horn	NOUN
chd-224	132	49	-	-	PUNCT
chd-224	132	50	ross	ross	PROPN
chd-224	132	51	et	et	PROPN
chd-224	132	52	al	al	PROPN
chd-224	132	53	.	.	PROPN
chd-224	132	54	,	,	PUNCT
chd-224	132	55	2011	2011	NUM
chd-224	132	56	)	)	PUNCT
chd-224	132	57	.	.	PUNCT
chd-224	133	1	overall	overall	ADV
chd-224	133	2	,	,	PUNCT
chd-224	133	3	these	these	DET
chd-224	133	4	findings	finding	NOUN
chd-224	133	5	suggest	suggest	VERB
chd-224	133	6	that	that	SCONJ
chd-224	133	7	exposures	exposure	NOUN
chd-224	133	8	related	relate	VERB
chd-224	133	9	to	to	ADP
chd-224	133	10	immigration	immigration	NOUN
chd-224	133	11	and	and	CCONJ
chd-224	133	12	acculturation	acculturation	NOUN
chd-224	133	13	of	of	ADP
chd-224	133	14	these	these	DET
chd-224	133	15	ethnic	ethnic	ADJ
chd-224	133	16	groups	group	NOUN
chd-224	133	17	may	may	AUX
chd-224	133	18	have	have	AUX
chd-224	133	19	impacted	impact	VERB
chd-224	133	20	their	their	PRON
chd-224	133	21	risk	risk	NOUN
chd-224	133	22	of	of	ADP
chd-224	133	23	thyroid	thyroid	NOUN
chd-224	133	24	cancer	cancer	NOUN
chd-224	133	25	(	(	PUNCT
chd-224	133	26	horn	horn	NOUN
chd-224	133	27	-	-	PUNCT
chd-224	133	28	ross	ross	PROPN
chd-224	133	29	et	et	PROPN
chd-224	133	30	al	al	PROPN
chd-224	133	31	.	.	PROPN
chd-224	133	32	,	,	PUNCT
chd-224	133	33	2011)(21	2011)(21	NUM
chd-224	133	34	)	)	PUNCT
chd-224	133	35	.	.	PUNCT
chd-224	134	1	further	further	ADJ
chd-224	134	2	research	research	NOUN
chd-224	134	3	is	be	AUX
chd-224	134	4	needed	need	VERB
chd-224	134	5	that	that	PRON
chd-224	134	6	includes	include	VERB
chd-224	134	7	other	other	ADJ
chd-224	134	8	racial	racial	ADJ
chd-224	134	9	/	/	SYM
chd-224	134	10	ethnic	ethnic	ADJ
chd-224	134	11	groups	group	NOUN
chd-224	134	12	and	and	CCONJ
chd-224	134	13	analyzes	analyze	VERB
chd-224	134	14	how	how	SCONJ
chd-224	134	15	these	these	DET
chd-224	134	16	factors	factor	NOUN
chd-224	134	17	could	could	AUX
chd-224	134	18	affect	affect	VERB
chd-224	134	19	thyroid	thyroid	NOUN
chd-224	134	20	cancer	cancer	NOUN
chd-224	134	21	incidence	incidence	NOUN
chd-224	134	22	.	.	PUNCT
chd-224	135	1	3.3	3.3	NUM
chd-224	135	2	.	.	PUNCT
chd-224	136	1	socioeconomic	socioeconomic	ADJ
chd-224	136	2	factors	factor	NOUN
chd-224	136	3	3.3.1	3.3.1	NUM
chd-224	136	4	.	.	PUNCT
chd-224	137	1	radioiodine	radioiodine	NOUN
chd-224	137	2	treatment	treatment	NOUN
chd-224	137	3	within	within	ADP
chd-224	137	4	the	the	DET
chd-224	137	5	last	last	ADJ
chd-224	137	6	few	few	ADJ
chd-224	137	7	decades	decade	NOUN
chd-224	137	8	,	,	PUNCT
chd-224	137	9	the	the	DET
chd-224	137	10	use	use	NOUN
chd-224	137	11	of	of	ADP
chd-224	137	12	rai	rai	ADJ
chd-224	137	13	treatment	treatment	NOUN
chd-224	137	14	for	for	ADP
chd-224	137	15	thyroid	thyroid	NOUN
chd-224	137	16	cancer	cancer	NOUN
chd-224	137	17	has	have	AUX
chd-224	137	18	increased	increase	VERB
chd-224	137	19	(	(	PUNCT
chd-224	137	20	pasqual	pasqual	PROPN
chd-224	137	21	et	et	PROPN
chd-224	137	22	al	al	PROPN
chd-224	137	23	.	.	PROPN
chd-224	137	24	)	)	PUNCT
chd-224	137	25	.	.	PUNCT
chd-224	138	1	one	one	NUM
chd-224	138	2	study	study	NOUN
chd-224	138	3	found	find	VERB
chd-224	138	4	that	that	SCONJ
chd-224	138	5	patients	patient	NOUN
chd-224	138	6	who	who	PRON
chd-224	138	7	had	have	VERB
chd-224	138	8	a	a	DET
chd-224	138	9	thyroidectomy	thyroidectomy	NOUN
chd-224	138	10	for	for	ADP
chd-224	138	11	low	low	ADJ
chd-224	138	12	-	-	PUNCT
chd-224	138	13	risk	risk	NOUN
chd-224	138	14	papillary	papillary	NOUN
chd-224	138	15	thyroid	thyroid	NOUN
chd-224	138	16	cancer	cancer	NOUN
chd-224	138	17	were	be	AUX
chd-224	138	18	more	more	ADV
chd-224	138	19	likely	likely	ADJ
chd-224	138	20	to	to	PART
chd-224	138	21	undergo	undergo	VERB
chd-224	138	22	rai	rai	NOUN
chd-224	138	23	treatment	treatment	NOUN
chd-224	138	24	if	if	SCONJ
chd-224	138	25	they	they	PRON
chd-224	138	26	had	have	VERB
chd-224	138	27	lower	low	ADJ
chd-224	138	28	healthcare	healthcare	NOUN
chd-224	138	29	access	access	NOUN
chd-224	138	30	(	(	PUNCT
chd-224	138	31	marti	marti	PROPN
chd-224	138	32	et	et	PROPN
chd-224	138	33	al	al	PROPN
chd-224	138	34	.	.	PROPN
chd-224	138	35	,	,	PUNCT
chd-224	138	36	2015	2015	NUM
chd-224	138	37	)	)	PUNCT
chd-224	138	38	.	.	PUNCT
chd-224	139	1	this	this	PRON
chd-224	139	2	includes	include	VERB
chd-224	139	3	those	those	PRON
chd-224	139	4	that	that	PRON
chd-224	139	5	are	be	AUX
chd-224	139	6	uninsured	uninsured	ADJ
chd-224	139	7	,	,	PUNCT
chd-224	139	8	in	in	ADP
chd-224	139	9	poverty	poverty	NOUN
chd-224	139	10	,	,	PUNCT
chd-224	139	11	attained	attain	VERB
chd-224	139	12	only	only	ADV
chd-224	139	13	a	a	DET
chd-224	139	14	high	high	ADJ
chd-224	139	15	school	school	NOUN
chd-224	139	16	education	education	NOUN
chd-224	139	17	,	,	PUNCT
chd-224	139	18	are	be	AUX
chd-224	139	19	nonenglish	nonenglish	ADJ
chd-224	139	20	speaking	speak	VERB
chd-224	139	21	,	,	PUNCT
chd-224	139	22	or	or	CCONJ
chd-224	139	23	unemployed	unemployed	ADJ
chd-224	139	24	.	.	PUNCT
chd-224	140	1	additionally	additionally	ADV
chd-224	140	2	,	,	PUNCT
chd-224	140	3	racial	racial	ADJ
chd-224	140	4	/	/	SYM
chd-224	140	5	ethnic	ethnic	ADJ
chd-224	140	6	minority	minority	NOUN
chd-224	140	7	populations	population	NOUN
chd-224	140	8	are	be	AUX
chd-224	140	9	more	more	ADV
chd-224	140	10	likely	likely	ADJ
chd-224	140	11	to	to	PART
chd-224	140	12	be	be	AUX
chd-224	140	13	uninsured	uninsured	ADJ
chd-224	140	14	and	and	CCONJ
chd-224	140	15	have	have	AUX
chd-224	140	16	decreased	decrease	VERB
chd-224	140	17	access	access	NOUN
chd-224	140	18	to	to	ADP
chd-224	140	19	highquality	highquality	NOUN
chd-224	140	20	care	care	NOUN
chd-224	140	21	,	,	PUNCT
chd-224	140	22	whether	whether	SCONJ
chd-224	140	23	due	due	ADP
chd-224	140	24	to	to	ADP
chd-224	140	25	geographic	geographic	ADJ
chd-224	140	26	area	area	NOUN
chd-224	140	27	or	or	CCONJ
chd-224	140	28	stereotyping	stereotyping	NOUN
chd-224	140	29	by	by	ADP
chd-224	140	30	healthcare	healthcare	NOUN
chd-224	140	31	providers	provider	NOUN
chd-224	140	32	(	(	PUNCT
chd-224	140	33	artiga	artiga	PROPN
chd-224	140	34	s	s	PROPN
chd-224	140	35	,	,	PUNCT
chd-224	140	36	2021	2021	NUM
chd-224	140	37	;	;	PUNCT
chd-224	140	38	national	national	PROPN
chd-224	140	39	research	research	PROPN
chd-224	140	40	council	council	PROPN
chd-224	140	41	panel	panel	NOUN
chd-224	140	42	on	on	ADP
chd-224	140	43	race	race	NOUN
chd-224	140	44	and	and	CCONJ
chd-224	140	45	health	health	NOUN
chd-224	140	46	in	in	ADP
chd-224	140	47	later	later	ADV
chd-224	140	48	,	,	PUNCT
chd-224	140	49	2004	2004	NUM
chd-224	140	50	)	)	PUNCT
chd-224	140	51	.	.	PUNCT
chd-224	141	1	this	this	PRON
chd-224	141	2	suggests	suggest	VERB
chd-224	141	3	that	that	SCONJ
chd-224	141	4	some	some	DET
chd-224	141	5	racial	racial	ADJ
chd-224	141	6	/	/	SYM
chd-224	141	7	ethnic	ethnic	ADJ
chd-224	141	8	minority	minority	NOUN
chd-224	141	9	populations	population	NOUN
chd-224	141	10	of	of	ADP
chd-224	141	11	the	the	DET
chd-224	141	12	united	united	PROPN
chd-224	141	13	states	states	PROPN
chd-224	141	14	may	may	AUX
chd-224	141	15	experience	experience	VERB
chd-224	141	16	inappropriate	inappropriate	ADJ
chd-224	141	17	use	use	NOUN
chd-224	141	18	of	of	ADP
chd-224	141	19	rai	rai	PROPN
chd-224	141	20	treatment	treatment	NOUN
chd-224	141	21	,	,	PUNCT
chd-224	141	22	an	an	DET
chd-224	141	23	aggressive	aggressive	ADJ
chd-224	141	24	therapy	therapy	NOUN
chd-224	141	25	for	for	ADP
chd-224	141	26	low	low	ADJ
chd-224	141	27	-	-	PUNCT
chd-224	141	28	risk	risk	NOUN
chd-224	141	29	ptc	ptc	NOUN
chd-224	141	30	(	(	PUNCT
chd-224	141	31	marti	marti	PROPN
chd-224	141	32	et	et	PROPN
chd-224	141	33	al	al	PROPN
chd-224	141	34	.	.	PROPN
chd-224	141	35	,	,	PUNCT
chd-224	141	36	2015	2015	NUM
chd-224	141	37	)	)	PUNCT
chd-224	141	38	.	.	PUNCT
chd-224	142	1	when	when	SCONJ
chd-224	142	2	using	use	VERB
chd-224	142	3	rai	rai	NOUN
chd-224	142	4	for	for	ADP
chd-224	142	5	differentiated	differentiated	ADJ
chd-224	142	6	thyroid	thyroid	NOUN
chd-224	142	7	cancer	cancer	NOUN
chd-224	142	8	(	(	PUNCT
chd-224	142	9	dtc	dtc	PROPN
chd-224	142	10	)	)	PUNCT
chd-224	142	11	treatment	treatment	NOUN
chd-224	142	12	,	,	PUNCT
chd-224	142	13	one	one	NUM
chd-224	142	14	recent	recent	ADJ
chd-224	142	15	study	study	NOUN
chd-224	142	16	found	find	VERB
chd-224	142	17	that	that	SCONJ
chd-224	142	18	rai	rai	PROPN
chd-224	142	19	treatment	treatment	NOUN
chd-224	142	20	increased	increase	VERB
chd-224	142	21	the	the	DET
chd-224	142	22	risk	risk	NOUN
chd-224	142	23	of	of	ADP
chd-224	142	24	leukemia	leukemia	NOUN
chd-224	142	25	and	and	CCONJ
chd-224	142	26	several	several	ADJ
chd-224	142	27	types	type	NOUN
chd-224	142	28	of	of	ADP
chd-224	142	29	solid	solid	ADJ
chd-224	142	30	cancer	cancer	NOUN
chd-224	142	31	such	such	ADJ
chd-224	142	32	as	as	ADP
chd-224	142	33	breast	breast	NOUN
chd-224	142	34	cancer	cancer	NOUN
chd-224	142	35	,	,	PUNCT
chd-224	142	36	regardless	regardless	ADV
chd-224	142	37	of	of	ADP
chd-224	142	38	racial	racial	ADJ
chd-224	142	39	/	/	SYM
chd-224	142	40	ethnic	ethnic	ADJ
chd-224	142	41	group	group	NOUN
chd-224	142	42	(	(	PUNCT
chd-224	142	43	pasqual	pasqual	PROPN
chd-224	142	44	et	et	PROPN
chd-224	142	45	al	al	PROPN
chd-224	142	46	.	.	PROPN
chd-224	142	47	)	)	PUNCT
chd-224	142	48	.	.	PUNCT
chd-224	143	1	however	however	ADV
chd-224	143	2	,	,	PUNCT
chd-224	143	3	rai	rai	PROPN
chd-224	143	4	treatment	treatment	NOUN
chd-224	143	5	for	for	ADP
chd-224	143	6	dtc	dtc	NOUN
chd-224	143	7	did	do	AUX
chd-224	143	8	not	not	PART
chd-224	143	9	increase	increase	VERB
chd-224	143	10	the	the	DET
chd-224	143	11	risk	risk	NOUN
chd-224	143	12	of	of	ADP
chd-224	143	13	second	second	ADJ
chd-224	143	14	thyroid	thyroid	NOUN
chd-224	143	15	cancer	cancer	NOUN
chd-224	143	16	(	(	PUNCT
chd-224	143	17	pasqual	pasqual	PROPN
chd-224	143	18	et	et	PROPN
chd-224	143	19	al	al	PROPN
chd-224	143	20	.	.	PROPN
chd-224	143	21	)	)	PUNCT
chd-224	143	22	.	.	PUNCT
chd-224	144	1	this	this	PRON
chd-224	144	2	indicates	indicate	VERB
chd-224	144	3	that	that	SCONJ
chd-224	144	4	rai	rai	PROPN
chd-224	144	5	treatment	treatment	NOUN
chd-224	144	6	may	may	AUX
chd-224	144	7	not	not	PART
chd-224	144	8	be	be	AUX
chd-224	144	9	a	a	DET
chd-224	144	10	risk	risk	NOUN
chd-224	144	11	factor	factor	NOUN
chd-224	144	12	for	for	ADP
chd-224	144	13	thyroid	thyroid	NOUN
chd-224	144	14	cancer	cancer	NOUN
chd-224	144	15	which	which	PRON
chd-224	144	16	differentially	differentially	ADV
chd-224	144	17	impacts	impact	VERB
chd-224	144	18	certain	certain	ADJ
chd-224	144	19	racial	racial	ADJ
chd-224	144	20	/	/	SYM
chd-224	144	21	ethnic	ethnic	ADJ
chd-224	144	22	groups	group	NOUN
chd-224	144	23	.	.	PUNCT
chd-224	145	1	further	further	ADJ
chd-224	145	2	studies	study	NOUN
chd-224	145	3	could	could	AUX
chd-224	145	4	examine	examine	VERB
chd-224	145	5	the	the	DET
chd-224	145	6	racial	racial	ADJ
chd-224	145	7	/	/	SYM
chd-224	145	8	ethnic	ethnic	ADJ
chd-224	145	9	variations	variation	NOUN
chd-224	145	10	in	in	ADP
chd-224	145	11	rai	rai	NOUN
chd-224	145	12	treatment	treatment	NOUN
chd-224	145	13	sensitivity	sensitivity	NOUN
chd-224	145	14	or	or	CCONJ
chd-224	145	15	resistance	resistance	NOUN
chd-224	145	16	to	to	PART
chd-224	145	17	determine	determine	VERB
chd-224	145	18	if	if	SCONJ
chd-224	145	19	these	these	PRON
chd-224	145	20	contribute	contribute	VERB
chd-224	145	21	to	to	PART
chd-224	145	22	thyroid	thyroid	VERB
chd-224	145	23	cancer	cancer	NOUN
chd-224	145	24	health	health	NOUN
chd-224	145	25	disparities	disparity	NOUN
chd-224	145	26	.	.	PUNCT
chd-224	146	1	3.3.2	3.3.2	X
chd-224	146	2	.	.	PUNCT
chd-224	147	1	diagnostic	diagnostic	ADJ
chd-224	147	2	differences	difference	NOUN
chd-224	147	3	in	in	ADP
chd-224	147	4	tc	tc	NOUN
chd-224	147	5	health	health	NOUN
chd-224	147	6	disparities	disparity	NOUN
chd-224	147	7	many	many	ADJ
chd-224	147	8	literature	literature	NOUN
chd-224	147	9	suggest	suggest	VERB
chd-224	147	10	that	that	SCONJ
chd-224	147	11	thyroid	thyroid	NOUN
chd-224	147	12	cancer	cancer	NOUN
chd-224	147	13	’s	’s	PART
chd-224	147	14	racial	racial	ADJ
chd-224	147	15	/	/	SYM
chd-224	147	16	ethnic	ethnic	ADJ
chd-224	147	17	differences	difference	NOUN
chd-224	147	18	could	could	AUX
chd-224	147	19	be	be	AUX
chd-224	147	20	related	relate	VERB
chd-224	147	21	to	to	ADP
chd-224	147	22	socioeconomic	socioeconomic	ADJ
chd-224	147	23	status	status	NOUN
chd-224	147	24	and	and	CCONJ
chd-224	147	25	insurance	insurance	NOUN
chd-224	147	26	coverage	coverage	NOUN
chd-224	147	27	impacting	impact	VERB
chd-224	147	28	dissimilar	dissimilar	ADJ
chd-224	147	29	access	access	NOUN
chd-224	147	30	to	to	ADP
chd-224	147	31	us	we	PRON
chd-224	147	32	-	-	PUNCT
chd-224	147	33	guided	guide	VERB
chd-224	147	34	fna	fna	NOUN
chd-224	147	35	and	and	CCONJ
chd-224	147	36	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-224	147	37	e8	e8	PROPN
chd-224	147	38	cancer	cancer	NOUN
chd-224	147	39	health	health	NOUN
chd-224	147	40	disparities	disparity	NOUN
chd-224	147	41	research	research	NOUN
chd-224	147	42	computed	compute	VERB
chd-224	147	43	tomography	tomography	NOUN
chd-224	147	44	(	(	PUNCT
chd-224	147	45	ct	ct	PROPN
chd-224	147	46	)	)	PUNCT
chd-224	147	47	(	(	PUNCT
chd-224	147	48	brown	brown	PROPN
chd-224	147	49	et	et	PROPN
chd-224	147	50	al	al	PROPN
chd-224	147	51	.	.	PROPN
chd-224	147	52	,	,	PUNCT
chd-224	147	53	2010	2010	NUM
chd-224	147	54	;	;	PUNCT
chd-224	148	1	keegan	keegan	PROPN
chd-224	148	2	et	et	PROPN
chd-224	148	3	al	al	PROPN
chd-224	148	4	.	.	PROPN
chd-224	148	5	,	,	PUNCT
chd-224	148	6	2015	2015	NUM
chd-224	148	7	;	;	PUNCT
chd-224	148	8	morris	morris	PROPN
chd-224	148	9	et	et	PROPN
chd-224	148	10	al	al	PROPN
chd-224	148	11	.	.	PROPN
chd-224	148	12	,	,	PUNCT
chd-224	148	13	2013	2013	NUM
chd-224	148	14	;	;	PUNCT
chd-224	148	15	reitzel	reitzel	PROPN
chd-224	148	16	et	et	PROPN
chd-224	148	17	al	al	PROPN
chd-224	148	18	.	.	PROPN
chd-224	148	19	,	,	PUNCT
chd-224	148	20	2014	2014	NUM
chd-224	148	21	;	;	PUNCT
chd-224	148	22	roche	roche	PROPN
chd-224	148	23	et	et	PROPN
chd-224	148	24	al	al	PROPN
chd-224	148	25	.	.	PROPN
chd-224	148	26	,	,	PUNCT
chd-224	148	27	2016	2016	NUM
chd-224	148	28	;	;	PUNCT
chd-224	148	29	stroup	stroup	PROPN
chd-224	148	30	et	et	PROPN
chd-224	148	31	al	al	PROPN
chd-224	148	32	.	.	PROPN
chd-224	148	33	,	,	PUNCT
chd-224	148	34	2012	2012	NUM
chd-224	148	35	;	;	PUNCT
chd-224	148	36	weeks	week	NOUN
chd-224	148	37	et	et	PROPN
chd-224	148	38	al	al	PROPN
chd-224	148	39	.	.	PROPN
chd-224	148	40	,	,	PUNCT
chd-224	148	41	2018	2018	NUM
chd-224	148	42	;	;	PUNCT
chd-224	148	43	zevallos	zevallos	X
chd-224	148	44	et	et	PROPN
chd-224	148	45	al	al	PROPN
chd-224	148	46	.	.	PROPN
chd-224	148	47	,	,	PUNCT
chd-224	148	48	2015	2015	NUM
chd-224	148	49	)	)	PUNCT
chd-224	148	50	.	.	PUNCT
chd-224	149	1	while	while	SCONJ
chd-224	149	2	thyroid	thyroid	NOUN
chd-224	149	3	cancer	cancer	NOUN
chd-224	149	4	incidence	incidence	NOUN
chd-224	149	5	has	have	AUX
chd-224	149	6	been	be	AUX
chd-224	149	7	increasing	increase	VERB
chd-224	149	8	over	over	ADP
chd-224	149	9	time	time	NOUN
chd-224	149	10	irrespective	irrespective	ADV
chd-224	149	11	of	of	ADP
chd-224	149	12	socioeconomic	socioeconomic	ADJ
chd-224	149	13	status	status	NOUN
chd-224	149	14	,	,	PUNCT
chd-224	149	15	a	a	DET
chd-224	149	16	study	study	NOUN
chd-224	149	17	in	in	ADP
chd-224	149	18	texas	texas	PROPN
chd-224	149	19	reports	report	VERB
chd-224	149	20	a	a	DET
chd-224	149	21	difference	difference	NOUN
chd-224	149	22	in	in	ADP
chd-224	149	23	the	the	DET
chd-224	149	24	rate	rate	NOUN
chd-224	149	25	of	of	ADP
chd-224	149	26	increase	increase	NOUN
chd-224	149	27	between	between	ADP
chd-224	149	28	low	low	ADJ
chd-224	149	29	and	and	CCONJ
chd-224	149	30	high	high	ADJ
chd-224	149	31	socioeconomic	socioeconomic	ADJ
chd-224	149	32	status	status	NOUN
chd-224	149	33	ethnic	ethnic	ADJ
chd-224	149	34	groups	group	NOUN
chd-224	149	35	(	(	PUNCT
chd-224	149	36	reitzel	reitzel	PROPN
chd-224	149	37	et	et	PROPN
chd-224	149	38	al	al	PROPN
chd-224	149	39	.	.	PROPN
chd-224	149	40	,	,	PUNCT
chd-224	149	41	2014	2014	NUM
chd-224	149	42	)	)	PUNCT
chd-224	149	43	.	.	PUNCT
chd-224	150	1	in	in	ADP
chd-224	150	2	particular	particular	ADJ
chd-224	150	3	,	,	PUNCT
chd-224	150	4	the	the	DET
chd-224	150	5	study	study	NOUN
chd-224	150	6	found	find	VERB
chd-224	150	7	a	a	DET
chd-224	150	8	low	low	ADJ
chd-224	150	9	thyroid	thyroid	NOUN
chd-224	150	10	cancer	cancer	NOUN
chd-224	150	11	incidence	incidence	NOUN
chd-224	150	12	rate	rate	NOUN
chd-224	150	13	among	among	ADP
chd-224	150	14	low	low	ADJ
chd-224	150	15	socioeconomic	socioeconomic	ADJ
chd-224	150	16	status	status	NOUN
chd-224	150	17	non	non	ADJ
chd-224	150	18	-	-	ADJ
chd-224	150	19	hispanic	hispanic	ADJ
chd-224	150	20	african	african	ADJ
chd-224	150	21	americans	americans	PROPN
chd-224	150	22	and	and	CCONJ
chd-224	150	23	hispanic	hispanic	ADJ
chd-224	150	24	americans	americans	PROPN
chd-224	150	25	and	and	CCONJ
chd-224	150	26	a	a	DET
chd-224	150	27	high	high	ADJ
chd-224	150	28	thyroid	thyroid	NOUN
chd-224	150	29	cancer	cancer	NOUN
chd-224	150	30	incidence	incidence	NOUN
chd-224	150	31	rate	rate	NOUN
chd-224	150	32	among	among	ADP
chd-224	150	33	high	high	ADJ
chd-224	150	34	socioeconomic	socioeconomic	ADJ
chd-224	150	35	status	status	NOUN
chd-224	150	36	non	non	ADJ
chd-224	150	37	-	-	ADJ
chd-224	150	38	hispanic	hispanic	ADJ
chd-224	150	39	african	african	ADJ
chd-224	150	40	americans	americans	PROPN
chd-224	150	41	and	and	CCONJ
chd-224	150	42	hispanic	hispanic	ADJ
chd-224	150	43	americans	americans	PROPN
chd-224	150	44	(	(	PUNCT
chd-224	150	45	reitzel	reitzel	PROPN
chd-224	150	46	et	et	PROPN
chd-224	150	47	al	al	PROPN
chd-224	150	48	.	.	PROPN
chd-224	150	49	,	,	PUNCT
chd-224	150	50	2014	2014	NUM
chd-224	150	51	)	)	PUNCT
chd-224	150	52	.	.	PUNCT
chd-224	151	1	similarly	similarly	ADV
chd-224	151	2	,	,	PUNCT
chd-224	151	3	a	a	DET
chd-224	151	4	study	study	NOUN
chd-224	151	5	in	in	ADP
chd-224	151	6	north	north	PROPN
chd-224	151	7	dakota	dakota	PROPN
chd-224	151	8	found	find	VERB
chd-224	151	9	that	that	SCONJ
chd-224	151	10	counties	county	NOUN
chd-224	151	11	with	with	ADP
chd-224	151	12	higher	high	ADJ
chd-224	151	13	median	median	ADJ
chd-224	151	14	income	income	NOUN
chd-224	151	15	levels	level	NOUN
chd-224	151	16	had	have	AUX
chd-224	151	17	increasing	increase	VERB
chd-224	151	18	incidence	incidence	NOUN
chd-224	151	19	rates	rate	NOUN
chd-224	151	20	,	,	PUNCT
chd-224	151	21	likely	likely	ADJ
chd-224	151	22	due	due	ADP
chd-224	151	23	to	to	ADP
chd-224	151	24	detection	detection	NOUN
chd-224	151	25	bias	bias	NOUN
chd-224	151	26	associated	associate	VERB
chd-224	151	27	with	with	ADP
chd-224	151	28	increased	increase	VERB
chd-224	151	29	access	access	NOUN
chd-224	151	30	to	to	ADP
chd-224	151	31	physicians	physician	NOUN
chd-224	151	32	(	(	PUNCT
chd-224	151	33	schwartz	schwartz	PROPN
chd-224	151	34	and	and	CCONJ
chd-224	151	35	klug	klug	PROPN
chd-224	151	36	,	,	PUNCT
chd-224	151	37	2019	2019	NUM
chd-224	151	38	)	)	PUNCT
chd-224	151	39	.	.	PUNCT
chd-224	152	1	studies	study	NOUN
chd-224	152	2	have	have	AUX
chd-224	152	3	also	also	ADV
chd-224	152	4	shown	show	VERB
chd-224	152	5	that	that	SCONJ
chd-224	152	6	among	among	ADP
chd-224	152	7	thyroid	thyroid	NOUN
chd-224	152	8	cancer	cancer	NOUN
chd-224	152	9	patients	patient	NOUN
chd-224	152	10	,	,	PUNCT
chd-224	152	11	european	european	ADJ
chd-224	152	12	americans	americans	PROPN
chd-224	152	13	(	(	PUNCT
chd-224	152	14	vs.	vs.	ADP
chd-224	152	15	noneuropean	noneuropean	ADJ
chd-224	152	16	americans	americans	PROPN
chd-224	152	17	)	)	PUNCT
chd-224	152	18	have	have	VERB
chd-224	152	19	greater	great	ADJ
chd-224	152	20	odds	odd	NOUN
chd-224	152	21	of	of	ADP
chd-224	152	22	having	have	VERB
chd-224	152	23	tumors	tumor	NOUN
chd-224	152	24	<	<	X
chd-224	152	25	40	40	NUM
chd-224	152	26	mm	mm	NOUN
chd-224	152	27	,	,	PUNCT
chd-224	152	28	and	and	CCONJ
chd-224	152	29	this	this	DET
chd-224	152	30	variability	variability	NOUN
chd-224	152	31	in	in	ADP
chd-224	152	32	diagnosis	diagnosis	NOUN
chd-224	152	33	is	be	AUX
chd-224	152	34	likely	likely	ADJ
chd-224	152	35	due	due	ADP
chd-224	152	36	to	to	ADP
chd-224	152	37	differences	difference	NOUN
chd-224	152	38	between	between	ADP
chd-224	152	39	races	race	NOUN
chd-224	152	40	in	in	ADP
chd-224	152	41	their	their	PRON
chd-224	152	42	access	access	NOUN
chd-224	152	43	to	to	ADP
chd-224	152	44	medical	medical	ADJ
chd-224	152	45	care	care	NOUN
chd-224	152	46	to	to	PART
chd-224	152	47	detect	detect	VERB
chd-224	152	48	these	these	DET
chd-224	152	49	tumors	tumor	NOUN
chd-224	152	50	;	;	PUNCT
chd-224	152	51	particularly	particularly	ADV
chd-224	152	52	,	,	PUNCT
chd-224	152	53	european	european	ADJ
chd-224	152	54	americans	americans	PROPN
chd-224	152	55	tend	tend	VERB
chd-224	152	56	to	to	PART
chd-224	152	57	have	have	VERB
chd-224	152	58	and	and	CCONJ
chd-224	152	59	seek	seek	VERB
chd-224	152	60	more	more	ADJ
chd-224	152	61	access	access	NOUN
chd-224	152	62	to	to	ADP
chd-224	152	63	medical	medical	ADJ
chd-224	152	64	care	care	NOUN
chd-224	152	65	than	than	ADP
chd-224	152	66	racial	racial	ADJ
chd-224	152	67	/	/	SYM
chd-224	152	68	ethnic	ethnic	ADJ
chd-224	152	69	minority	minority	NOUN
chd-224	152	70	patients	patient	NOUN
chd-224	152	71	(	(	PUNCT
chd-224	152	72	national	national	PROPN
chd-224	152	73	research	research	PROPN
chd-224	152	74	council	council	PROPN
chd-224	152	75	panel	panel	NOUN
chd-224	152	76	on	on	ADP
chd-224	152	77	race	race	NOUN
chd-224	152	78	and	and	CCONJ
chd-224	152	79	health	health	NOUN
chd-224	152	80	in	in	ADP
chd-224	152	81	later	later	ADV
chd-224	152	82	,	,	PUNCT
chd-224	152	83	2004	2004	NUM
chd-224	152	84	;	;	PUNCT
chd-224	152	85	weeks	week	NOUN
chd-224	152	86	et	et	PROPN
chd-224	152	87	al	al	PROPN
chd-224	152	88	.	.	PROPN
chd-224	152	89	,	,	PUNCT
chd-224	152	90	2018	2018	NUM
chd-224	152	91	)	)	PUNCT
chd-224	152	92	.	.	PUNCT
chd-224	153	1	however	however	ADV
chd-224	153	2	,	,	PUNCT
chd-224	153	3	once	once	SCONJ
chd-224	153	4	tumors	tumor	NOUN
chd-224	153	5	increase	increase	VERB
chd-224	153	6	to	to	ADP
chd-224	153	7	a	a	DET
chd-224	153	8	size	size	NOUN
chd-224	153	9	≥40	≥40	PROPN
chd-224	153	10	mm	mm	PROPN
chd-224	153	11	in	in	ADP
chd-224	153	12	other	other	ADJ
chd-224	153	13	races	race	NOUN
chd-224	153	14	/	/	SYM
chd-224	153	15	ethnicities	ethnicity	NOUN
chd-224	153	16	,	,	PUNCT
chd-224	153	17	they	they	PRON
chd-224	153	18	become	become	VERB
chd-224	153	19	palpable	palpable	ADJ
chd-224	153	20	,	,	PUNCT
chd-224	153	21	thus	thus	ADV
chd-224	153	22	leading	lead	VERB
chd-224	153	23	patients	patient	NOUN
chd-224	153	24	to	to	PART
chd-224	153	25	seek	seek	VERB
chd-224	153	26	medical	medical	ADJ
chd-224	153	27	attention	attention	NOUN
chd-224	153	28	similarly	similarly	ADV
chd-224	153	29	(	(	PUNCT
chd-224	153	30	weeks	week	NOUN
chd-224	153	31	et	et	PROPN
chd-224	153	32	al	al	PROPN
chd-224	153	33	.	.	PROPN
chd-224	153	34	,	,	PUNCT
chd-224	153	35	2018	2018	NUM
chd-224	153	36	)	)	PUNCT
chd-224	153	37	.	.	PUNCT
chd-224	154	1	regarding	regard	VERB
chd-224	154	2	insurance	insurance	NOUN
chd-224	154	3	coverage	coverage	NOUN
chd-224	154	4	,	,	PUNCT
chd-224	154	5	it	it	PRON
chd-224	154	6	has	have	AUX
chd-224	154	7	been	be	AUX
chd-224	154	8	found	find	VERB
chd-224	154	9	that	that	SCONJ
chd-224	154	10	insured	insured	ADJ
chd-224	154	11	patients	patient	NOUN
chd-224	154	12	were	be	AUX
chd-224	154	13	45	45	NUM
chd-224	154	14	%	%	NOUN
chd-224	154	15	more	more	ADV
chd-224	154	16	likely	likely	ADJ
chd-224	154	17	to	to	PART
chd-224	154	18	be	be	AUX
chd-224	154	19	diagnosed	diagnose	VERB
chd-224	154	20	with	with	ADP
chd-224	154	21	small	small	ADJ
chd-224	154	22	tumors	tumor	NOUN
chd-224	154	23	compared	compare	VERB
chd-224	154	24	to	to	ADP
chd-224	154	25	the	the	DET
chd-224	154	26	uninsured	uninsured	NOUN
chd-224	154	27	(	(	PUNCT
chd-224	154	28	weeks	week	NOUN
chd-224	154	29	et	et	PROPN
chd-224	154	30	al	al	PROPN
chd-224	154	31	.	.	PROPN
chd-224	154	32	,	,	PUNCT
chd-224	154	33	2018	2018	NUM
chd-224	154	34	)	)	PUNCT
chd-224	154	35	.	.	PUNCT
chd-224	155	1	a	a	DET
chd-224	155	2	study	study	NOUN
chd-224	155	3	found	find	VERB
chd-224	155	4	that	that	SCONJ
chd-224	155	5	adolescent	adolescent	ADJ
chd-224	155	6	and	and	CCONJ
chd-224	155	7	young	young	ADJ
chd-224	155	8	adult	adult	NOUN
chd-224	155	9	patients	patient	NOUN
chd-224	155	10	who	who	PRON
chd-224	155	11	were	be	AUX
chd-224	155	12	diagnosed	diagnose	VERB
chd-224	155	13	between	between	ADP
chd-224	155	14	2001	2001	NUM
chd-224	155	15	and	and	CCONJ
chd-224	155	16	2010	2010	NUM
chd-224	155	17	had	have	VERB
chd-224	155	18	a	a	DET
chd-224	155	19	worse	bad	ADJ
chd-224	155	20	overall	overall	ADJ
chd-224	155	21	survival	survival	NOUN
chd-224	155	22	if	if	SCONJ
chd-224	155	23	they	they	PRON
chd-224	155	24	had	have	VERB
chd-224	155	25	no	no	DET
chd-224	155	26	medical	medical	ADJ
chd-224	155	27	insurance	insurance	NOUN
chd-224	155	28	(	(	PUNCT
chd-224	155	29	keegan	keegan	PROPN
chd-224	155	30	et	et	PROPN
chd-224	155	31	al	al	PROPN
chd-224	155	32	.	.	PROPN
chd-224	155	33	,	,	PUNCT
chd-224	155	34	2015	2015	NUM
chd-224	155	35	)	)	PUNCT
chd-224	155	36	.	.	PUNCT
chd-224	156	1	another	another	DET
chd-224	156	2	study	study	NOUN
chd-224	156	3	found	find	VERB
chd-224	156	4	that	that	SCONJ
chd-224	156	5	ageadjusted	ageadjusted	ADJ
chd-224	156	6	thyroid	thyroid	NOUN
chd-224	156	7	cancer	cancer	NOUN
chd-224	156	8	incidence	incidence	NOUN
chd-224	156	9	rates	rate	NOUN
chd-224	156	10	were	be	AUX
chd-224	156	11	2	2	NUM
chd-224	156	12	-	-	SYM
chd-224	156	13	3	3	NUM
chd-224	156	14	times	time	NOUN
chd-224	156	15	greater	great	ADJ
chd-224	156	16	in	in	ADP
chd-224	156	17	uninsured	uninsured	ADJ
chd-224	156	18	hispanic	hispanic	ADJ
chd-224	156	19	americans	americans	PROPN
chd-224	156	20	than	than	ADP
chd-224	156	21	in	in	ADP
chd-224	156	22	uninsured	uninsured	ADJ
chd-224	156	23	european	european	PROPN
chd-224	156	24	americans	americans	PROPN
chd-224	156	25	(	(	PUNCT
chd-224	156	26	weeks	week	NOUN
chd-224	156	27	et	et	PROPN
chd-224	156	28	al	al	PROPN
chd-224	156	29	.	.	PROPN
chd-224	156	30	,	,	PUNCT
chd-224	156	31	2018	2018	NUM
chd-224	156	32	)	)	PUNCT
chd-224	156	33	.	.	PUNCT
chd-224	157	1	the	the	DET
chd-224	157	2	reverse	reverse	ADJ
chd-224	157	3	incidence	incidence	NOUN
chd-224	157	4	rate	rate	NOUN
chd-224	157	5	was	be	AUX
chd-224	157	6	found	find	VERB
chd-224	157	7	in	in	ADP
chd-224	157	8	insured	insured	ADJ
chd-224	157	9	hispanic	hispanic	ADJ
chd-224	157	10	americans	americans	PROPN
chd-224	157	11	compared	compare	VERB
chd-224	157	12	to	to	ADP
chd-224	157	13	insured	insure	VERB
chd-224	157	14	non	non	ADJ
chd-224	157	15	-	-	ADJ
chd-224	157	16	hispanic	hispanic	ADJ
chd-224	157	17	european	european	ADJ
chd-224	157	18	americans	americans	PROPN
chd-224	157	19	(	(	PUNCT
chd-224	157	20	weeks	week	NOUN
chd-224	157	21	et	et	PROPN
chd-224	157	22	al	al	PROPN
chd-224	157	23	.	.	PROPN
chd-224	157	24	,	,	PUNCT
chd-224	157	25	2018	2018	NUM
chd-224	157	26	)	)	PUNCT
chd-224	157	27	.	.	PUNCT
chd-224	158	1	as	as	SCONJ
chd-224	158	2	mentioned	mention	VERB
chd-224	158	3	previously	previously	ADV
chd-224	158	4	,	,	PUNCT
chd-224	158	5	racial	racial	ADJ
chd-224	158	6	/	/	SYM
chd-224	158	7	ethnic	ethnic	ADJ
chd-224	158	8	minority	minority	NOUN
chd-224	158	9	populations	population	NOUN
chd-224	158	10	are	be	AUX
chd-224	158	11	more	more	ADV
chd-224	158	12	likely	likely	ADJ
chd-224	158	13	to	to	PART
chd-224	158	14	be	be	AUX
chd-224	158	15	uninsured	uninsured	ADJ
chd-224	158	16	(	(	PUNCT
chd-224	158	17	artiga	artiga	PROPN
chd-224	158	18	s	s	PROPN
chd-224	158	19	,	,	PUNCT
chd-224	158	20	2021	2021	NUM
chd-224	158	21	;	;	PUNCT
chd-224	158	22	national	national	PROPN
chd-224	158	23	research	research	PROPN
chd-224	158	24	council	council	PROPN
chd-224	158	25	panel	panel	NOUN
chd-224	158	26	on	on	ADP
chd-224	158	27	race	race	NOUN
chd-224	158	28	and	and	CCONJ
chd-224	158	29	health	health	NOUN
chd-224	158	30	in	in	ADP
chd-224	158	31	later	later	ADV
chd-224	158	32	,	,	PUNCT
chd-224	158	33	2004	2004	NUM
chd-224	158	34	)	)	PUNCT
chd-224	158	35	,	,	PUNCT
chd-224	158	36	therefore	therefore	ADV
chd-224	158	37	these	these	DET
chd-224	158	38	findings	finding	NOUN
chd-224	158	39	suggest	suggest	VERB
chd-224	158	40	that	that	SCONJ
chd-224	158	41	access	access	NOUN
chd-224	158	42	to	to	ADP
chd-224	158	43	medical	medical	ADJ
chd-224	158	44	care	care	NOUN
chd-224	158	45	and	and	CCONJ
chd-224	158	46	insurance	insurance	NOUN
chd-224	158	47	could	could	AUX
chd-224	158	48	influence	influence	VERB
chd-224	158	49	incidence	incidence	NOUN
chd-224	158	50	rates	rate	NOUN
chd-224	158	51	among	among	ADP
chd-224	158	52	racial	racial	ADJ
chd-224	158	53	/	/	SYM
chd-224	158	54	ethnic	ethnic	ADJ
chd-224	158	55	groups	group	NOUN
chd-224	158	56	differentially	differentially	ADV
chd-224	158	57	.	.	PUNCT
chd-224	159	1	3.4	3.4	NUM
chd-224	159	2	.	.	PUNCT
chd-224	159	3	metabolic	metabolic	NOUN
chd-224	159	4	factors	factor	NOUN
chd-224	159	5	obesity	obesity	NOUN
chd-224	159	6	,	,	PUNCT
chd-224	159	7	metabolic	metabolic	NOUN
chd-224	159	8	syndrome	syndrome	NOUN
chd-224	159	9	,	,	PUNCT
chd-224	159	10	and	and	CCONJ
chd-224	159	11	insulin	insulin	NOUN
chd-224	159	12	resistance	resistance	NOUN
chd-224	159	13	in	in	ADP
chd-224	159	14	tc	tc	NOUN
chd-224	159	15	health	health	NOUN
chd-224	159	16	disparities	disparity	NOUN
chd-224	159	17	while	while	SCONJ
chd-224	159	18	there	there	PRON
chd-224	159	19	has	have	AUX
chd-224	159	20	been	be	AUX
chd-224	159	21	a	a	DET
chd-224	159	22	rise	rise	NOUN
chd-224	159	23	in	in	ADP
chd-224	159	24	thyroid	thyroid	NOUN
chd-224	159	25	cancer	cancer	NOUN
chd-224	159	26	incidence	incidence	NOUN
chd-224	159	27	,	,	PUNCT
chd-224	159	28	the	the	DET
chd-224	159	29	centers	center	NOUN
chd-224	159	30	for	for	ADP
chd-224	159	31	disease	disease	NOUN
chd-224	159	32	control	control	NOUN
chd-224	159	33	and	and	CCONJ
chd-224	159	34	prevention	prevention	NOUN
chd-224	159	35	(	(	PUNCT
chd-224	159	36	cdc	cdc	PROPN
chd-224	159	37	)	)	PUNCT
chd-224	159	38	reports	report	VERB
chd-224	159	39	that	that	SCONJ
chd-224	159	40	there	there	PRON
chd-224	159	41	has	have	AUX
chd-224	159	42	also	also	ADV
chd-224	159	43	been	be	AUX
chd-224	159	44	a	a	DET
chd-224	159	45	rise	rise	NOUN
chd-224	159	46	in	in	ADP
chd-224	159	47	obesity	obesity	NOUN
chd-224	159	48	in	in	ADP
chd-224	159	49	the	the	DET
chd-224	159	50	united	united	PROPN
chd-224	159	51	states	states	PROPN
chd-224	159	52	;	;	PUNCT
chd-224	159	53	obesity	obesity	NOUN
chd-224	159	54	prevalence	prevalence	NOUN
chd-224	159	55	has	have	AUX
chd-224	159	56	increased	increase	VERB
chd-224	159	57	from	from	ADP
chd-224	159	58	30.5	30.5	NUM
chd-224	159	59	%	%	NOUN
chd-224	159	60	to	to	ADP
chd-224	159	61	42.4	42.4	NUM
chd-224	159	62	%	%	NOUN
chd-224	159	63	from	from	ADP
chd-224	159	64	1999	1999	NUM
chd-224	159	65	-	-	SYM
chd-224	159	66	2000	2000	NUM
chd-224	159	67	through	through	ADP
chd-224	159	68	2017	2017	NUM
chd-224	159	69	-	-	SYM
chd-224	159	70	2018	2018	NUM
chd-224	159	71	,	,	PUNCT
chd-224	159	72	and	and	CCONJ
chd-224	159	73	the	the	DET
chd-224	159	74	prevalence	prevalence	NOUN
chd-224	159	75	of	of	ADP
chd-224	159	76	severe	severe	ADJ
chd-224	159	77	obesity	obesity	NOUN
chd-224	159	78	has	have	AUX
chd-224	159	79	increased	increase	VERB
chd-224	159	80	from	from	ADP
chd-224	159	81	4.7	4.7	NUM
chd-224	159	82	%	%	NOUN
chd-224	159	83	to	to	ADP
chd-224	159	84	9.2	9.2	NUM
chd-224	159	85	%	%	NOUN
chd-224	159	86	(	(	PUNCT
chd-224	159	87	https://www.cdc.gov/obesity/data/	https://www.cdc.gov/obesity/data/	PROPN
chd-224	159	88	adult.html	adult.html	PROPN
chd-224	159	89	)	)	PUNCT
chd-224	159	90	.	.	PUNCT
chd-224	160	1	besides	besides	SCONJ
chd-224	160	2	being	be	AUX
chd-224	160	3	associated	associate	VERB
chd-224	160	4	with	with	ADP
chd-224	160	5	a	a	DET
chd-224	160	6	number	number	NOUN
chd-224	160	7	of	of	ADP
chd-224	160	8	chronic	chronic	ADJ
chd-224	160	9	diseases	disease	NOUN
chd-224	160	10	,	,	PUNCT
chd-224	160	11	such	such	ADJ
chd-224	160	12	as	as	ADP
chd-224	160	13	diabetes	diabetes	NOUN
chd-224	160	14	mellitus	mellitus	NOUN
chd-224	160	15	and	and	CCONJ
chd-224	160	16	cardiovascular	cardiovascular	ADJ
chd-224	160	17	disease	disease	NOUN
chd-224	160	18	,	,	PUNCT
chd-224	160	19	studies	study	NOUN
chd-224	160	20	have	have	AUX
chd-224	160	21	also	also	ADV
chd-224	160	22	shown	show	VERB
chd-224	160	23	that	that	SCONJ
chd-224	160	24	obesity	obesity	NOUN
chd-224	160	25	puts	put	VERB
chd-224	160	26	individuals	individual	NOUN
chd-224	160	27	at	at	ADP
chd-224	160	28	a	a	DET
chd-224	160	29	higher	high	ADJ
chd-224	160	30	risk	risk	NOUN
chd-224	160	31	of	of	ADP
chd-224	160	32	thyroid	thyroid	NOUN
chd-224	160	33	cancer	cancer	NOUN
chd-224	160	34	compared	compare	VERB
chd-224	160	35	to	to	ADP
chd-224	160	36	those	those	PRON
chd-224	160	37	with	with	ADP
chd-224	160	38	normal	normal	ADJ
chd-224	160	39	weight	weight	NOUN
chd-224	160	40	(	(	PUNCT
chd-224	160	41	bogović	bogović	NOUN
chd-224	160	42	crnčić	crnčić	PROPN
chd-224	160	43	et	et	PROPN
chd-224	160	44	al	al	PROPN
chd-224	160	45	.	.	PROPN
chd-224	160	46	,	,	PUNCT
chd-224	160	47	2020	2020	NUM
chd-224	160	48	;	;	PUNCT
chd-224	160	49	clinckspoor	clinckspoor	PROPN
chd-224	160	50	et	et	PROPN
chd-224	160	51	al	al	PROPN
chd-224	160	52	.	.	PROPN
chd-224	160	53	,	,	PUNCT
chd-224	160	54	2011	2011	NUM
chd-224	160	55	;	;	PUNCT
chd-224	160	56	franchini	franchini	PROPN
chd-224	160	57	et	et	PROPN
chd-224	160	58	al	al	PROPN
chd-224	160	59	.	.	PROPN
chd-224	160	60	,	,	PUNCT
chd-224	160	61	2022	2022	NUM
chd-224	160	62	;	;	PUNCT
chd-224	160	63	hales	hales	PROPN
chd-224	160	64	et	et	PROPN
chd-224	160	65	al	al	PROPN
chd-224	160	66	.	.	PROPN
chd-224	160	67	,	,	PUNCT
chd-224	160	68	2020	2020	NUM
chd-224	160	69	;	;	PUNCT
chd-224	160	70	kushchayeva	kushchayeva	VERB
chd-224	160	71	et	et	PROPN
chd-224	160	72	al	al	PROPN
chd-224	160	73	.	.	PROPN
chd-224	160	74	,	,	PUNCT
chd-224	160	75	2022	2022	NUM
chd-224	160	76	;	;	PUNCT
chd-224	160	77	ma	ma	PROPN
chd-224	160	78	et	et	PROPN
chd-224	160	79	al	al	PROPN
chd-224	160	80	.	.	PROPN
chd-224	160	81	,	,	PUNCT
chd-224	160	82	2022	2022	NUM
chd-224	160	83	;	;	PUNCT
chd-224	160	84	zhao	zhao	PROPN
chd-224	160	85	et	et	PROPN
chd-224	160	86	al	al	PROPN
chd-224	160	87	.	.	PROPN
chd-224	160	88	,	,	PUNCT
chd-224	160	89	2019	2019	NUM
chd-224	160	90	)	)	PUNCT
chd-224	160	91	.	.	PUNCT
chd-224	161	1	studies	study	NOUN
chd-224	161	2	found	find	VERB
chd-224	161	3	that	that	SCONJ
chd-224	161	4	high	high	ADJ
chd-224	161	5	bmi	bmi	NOUN
chd-224	161	6	was	be	AUX
chd-224	161	7	significantly	significantly	ADV
chd-224	161	8	associated	associate	VERB
chd-224	161	9	with	with	ADP
chd-224	161	10	the	the	DET
chd-224	161	11	risk	risk	NOUN
chd-224	161	12	of	of	ADP
chd-224	161	13	papillary	papillary	ADJ
chd-224	161	14	,	,	PUNCT
chd-224	161	15	follicular	follicular	ADJ
chd-224	161	16	,	,	PUNCT
chd-224	161	17	and	and	CCONJ
chd-224	161	18	anaplastic	anaplastic	ADJ
chd-224	161	19	,	,	PUNCT
chd-224	161	20	but	but	CCONJ
chd-224	161	21	not	not	PART
chd-224	161	22	medullary	medullary	ADJ
chd-224	161	23	,	,	PUNCT
chd-224	161	24	thyroid	thyroid	NOUN
chd-224	161	25	cancers	cancer	NOUN
chd-224	161	26	(	(	PUNCT
chd-224	161	27	kitahara	kitahara	PROPN
chd-224	161	28	et	et	PROPN
chd-224	161	29	al	al	PROPN
chd-224	161	30	.	.	PROPN
chd-224	161	31	,	,	PUNCT
chd-224	161	32	2016	2016	NUM
chd-224	161	33	;	;	PUNCT
chd-224	161	34	zhao	zhao	PROPN
chd-224	161	35	et	et	PROPN
chd-224	161	36	al	al	PROPN
chd-224	161	37	.	.	PROPN
chd-224	161	38	,	,	PUNCT
chd-224	161	39	2019	2019	NUM
chd-224	161	40	)	)	PUNCT
chd-224	161	41	.	.	PUNCT
chd-224	162	1	furthermore	furthermore	ADV
chd-224	162	2	,	,	PUNCT
chd-224	162	3	studies	study	NOUN
chd-224	162	4	have	have	AUX
chd-224	162	5	shown	show	VERB
chd-224	162	6	that	that	SCONJ
chd-224	162	7	high	high	ADJ
chd-224	162	8	bmi	bmi	NOUN
chd-224	162	9	was	be	AUX
chd-224	162	10	associated	associate	VERB
chd-224	162	11	with	with	ADP
chd-224	162	12	larger	large	ADJ
chd-224	162	13	tumor	tumor	NOUN
chd-224	162	14	size	size	NOUN
chd-224	162	15	,	,	PUNCT
chd-224	162	16	multifocality	multifocality	NOUN
chd-224	162	17	,	,	PUNCT
chd-224	162	18	and	and	CCONJ
chd-224	162	19	https://www.cdc.gov/obesity/data/adult.html	https://www.cdc.gov/obesity/data/adult.html	PROPN
chd-224	162	20	https://www.cdc.gov/obesity/data/adult.html	https://www.cdc.gov/obesity/data/adult.html	AUX
chd-224	162	21	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-224	162	22	e9	e9	PROPN
chd-224	162	23	cancer	cancer	NOUN
chd-224	162	24	health	health	NOUN
chd-224	162	25	disparities	disparity	NOUN
chd-224	162	26	research	research	VERB
chd-224	162	27	advanced	advanced	ADJ
chd-224	162	28	tumor	tumor	NOUN
chd-224	162	29	-	-	PUNCT
chd-224	162	30	node	node	NOUN
chd-224	162	31	-	-	PUNCT
chd-224	162	32	metastasis	metastasis	NOUN
chd-224	162	33	(	(	PUNCT
chd-224	162	34	tnm	tnm	NOUN
chd-224	162	35	)	)	PUNCT
chd-224	162	36	stage	stage	NOUN
chd-224	162	37	(	(	PUNCT
chd-224	162	38	ma	ma	PROPN
chd-224	162	39	et	et	PROPN
chd-224	162	40	al	al	PROPN
chd-224	162	41	.	.	PROPN
chd-224	162	42	,	,	PUNCT
chd-224	162	43	2022	2022	NUM
chd-224	162	44	;	;	PUNCT
chd-224	163	1	zhao	zhao	PROPN
chd-224	163	2	et	et	PROPN
chd-224	163	3	al	al	PROPN
chd-224	163	4	.	.	PROPN
chd-224	163	5	,	,	PUNCT
chd-224	163	6	2019	2019	NUM
chd-224	163	7	)	)	PUNCT
chd-224	163	8	.	.	PUNCT
chd-224	164	1	in	in	ADP
chd-224	164	2	addition	addition	NOUN
chd-224	164	3	to	to	ADP
chd-224	164	4	high	high	ADJ
chd-224	164	5	bmi	bmi	NOUN
chd-224	164	6	,	,	PUNCT
chd-224	164	7	a	a	DET
chd-224	164	8	waist	waist	NOUN
chd-224	164	9	circumference	circumference	NOUN
chd-224	164	10	≥109	≥109	VERB
chd-224	164	11	cm	cm	PROPN
chd-224	164	12	has	have	AUX
chd-224	164	13	also	also	ADV
chd-224	164	14	been	be	AUX
chd-224	164	15	found	find	VERB
chd-224	164	16	as	as	ADP
chd-224	164	17	a	a	DET
chd-224	164	18	strong	strong	ADJ
chd-224	164	19	predictor	predictor	NOUN
chd-224	164	20	of	of	ADP
chd-224	164	21	thyroid	thyroid	NOUN
chd-224	164	22	cancer	cancer	NOUN
chd-224	164	23	(	(	PUNCT
chd-224	164	24	lubin	lubin	PROPN
chd-224	164	25	et	et	PROPN
chd-224	164	26	al	al	PROPN
chd-224	164	27	.	.	PROPN
chd-224	164	28	,	,	PUNCT
chd-224	164	29	2017	2017	NUM
chd-224	164	30	;	;	PUNCT
chd-224	164	31	ma	ma	PROPN
chd-224	164	32	et	et	PROPN
chd-224	164	33	al	al	PROPN
chd-224	164	34	.	.	PROPN
chd-224	164	35	,	,	PUNCT
chd-224	164	36	2022	2022	NUM
chd-224	164	37	)	)	PUNCT
chd-224	164	38	.	.	PUNCT
chd-224	165	1	while	while	SCONJ
chd-224	165	2	one	one	NUM
chd-224	165	3	cohort	cohort	NOUN
chd-224	165	4	study	study	NOUN
chd-224	165	5	found	find	VERB
chd-224	165	6	that	that	SCONJ
chd-224	165	7	higher	high	ADJ
chd-224	165	8	bmi	bmi	NOUN
chd-224	165	9	was	be	AUX
chd-224	165	10	not	not	PART
chd-224	165	11	associated	associate	VERB
chd-224	165	12	with	with	ADP
chd-224	165	13	more	more	ADV
chd-224	165	14	aggressive	aggressive	ADJ
chd-224	165	15	tumor	tumor	NOUN
chd-224	165	16	features	feature	NOUN
chd-224	165	17	and	and	CCONJ
chd-224	165	18	recurrence	recurrence	NOUN
chd-224	165	19	or	or	CCONJ
chd-224	165	20	persistence	persistence	NOUN
chd-224	165	21	,	,	PUNCT
chd-224	165	22	this	this	DET
chd-224	165	23	study	study	NOUN
chd-224	165	24	looked	look	VERB
chd-224	165	25	at	at	ADP
chd-224	165	26	a	a	DET
chd-224	165	27	93	93	NUM
chd-224	165	28	%	%	NOUN
chd-224	165	29	european	european	ADJ
chd-224	165	30	american	american	ADJ
chd-224	165	31	population	population	NOUN
chd-224	165	32	at	at	ADP
chd-224	165	33	a	a	DET
chd-224	165	34	single	single	ADJ
chd-224	165	35	institution	institution	NOUN
chd-224	165	36	,	,	PUNCT
chd-224	165	37	therefore	therefore	ADV
chd-224	165	38	,	,	PUNCT
chd-224	165	39	the	the	DET
chd-224	165	40	results	result	NOUN
chd-224	165	41	may	may	AUX
chd-224	165	42	have	have	AUX
chd-224	165	43	been	be	AUX
chd-224	165	44	limited	limit	VERB
chd-224	165	45	by	by	ADP
chd-224	165	46	the	the	DET
chd-224	165	47	lack	lack	NOUN
chd-224	165	48	of	of	ADP
chd-224	165	49	racial	racial	ADJ
chd-224	165	50	/	/	SYM
chd-224	165	51	ethnic	ethnic	ADJ
chd-224	165	52	and	and	CCONJ
chd-224	165	53	socioeconomic	socioeconomic	ADJ
chd-224	165	54	diversity	diversity	NOUN
chd-224	165	55	(	(	PUNCT
chd-224	165	56	paes	paes	PROPN
chd-224	165	57	et	et	PROPN
chd-224	165	58	al	al	PROPN
chd-224	165	59	.	.	PROPN
chd-224	165	60	,	,	PUNCT
chd-224	165	61	2010	2010	NUM
chd-224	165	62	)	)	PUNCT
chd-224	165	63	.	.	PUNCT
chd-224	166	1	in	in	ADP
chd-224	166	2	these	these	DET
chd-224	166	3	ongoing	ongoing	ADJ
chd-224	166	4	studies	study	NOUN
chd-224	166	5	,	,	PUNCT
chd-224	166	6	it	it	PRON
chd-224	166	7	is	be	AUX
chd-224	166	8	important	important	ADJ
chd-224	166	9	to	to	PART
chd-224	166	10	recognize	recognize	VERB
chd-224	166	11	that	that	SCONJ
chd-224	166	12	obesity	obesity	NOUN
chd-224	166	13	impacts	impact	VERB
chd-224	166	14	some	some	DET
chd-224	166	15	ethnic	ethnic	ADJ
chd-224	166	16	/	/	SYM
chd-224	166	17	racial	racial	ADJ
chd-224	166	18	groups	group	NOUN
chd-224	166	19	more	more	ADJ
chd-224	166	20	than	than	ADP
chd-224	166	21	others	other	NOUN
chd-224	166	22	.	.	PUNCT
chd-224	167	1	in	in	ADP
chd-224	167	2	particular	particular	ADJ
chd-224	167	3	,	,	PUNCT
chd-224	167	4	nonhispanic	nonhispanic	ADJ
chd-224	167	5	african	african	ADJ
chd-224	167	6	american	american	ADJ
chd-224	167	7	adults	adult	NOUN
chd-224	167	8	have	have	VERB
chd-224	167	9	the	the	DET
chd-224	167	10	highest	high	ADJ
chd-224	167	11	prevalence	prevalence	NOUN
chd-224	167	12	of	of	ADP
chd-224	167	13	obesity	obesity	NOUN
chd-224	167	14	(	(	PUNCT
chd-224	167	15	defined	define	VERB
chd-224	167	16	as	as	ADP
chd-224	167	17	a	a	DET
chd-224	167	18	bmi	bmi	NOUN
chd-224	167	19	of	of	ADP
chd-224	167	20	greater	great	ADJ
chd-224	167	21	than	than	ADP
chd-224	167	22	or	or	CCONJ
chd-224	167	23	equal	equal	ADJ
chd-224	167	24	to	to	ADP
chd-224	167	25	30	30	NUM
chd-224	167	26	)	)	PUNCT
chd-224	167	27	and	and	CCONJ
chd-224	167	28	severe	severe	ADJ
chd-224	167	29	obesity	obesity	NOUN
chd-224	167	30	(	(	PUNCT
chd-224	167	31	defined	define	VERB
chd-224	167	32	as	as	ADP
chd-224	167	33	a	a	DET
chd-224	167	34	bmi	bmi	NOUN
chd-224	167	35	greater	great	ADJ
chd-224	167	36	than	than	ADP
chd-224	167	37	or	or	CCONJ
chd-224	167	38	equal	equal	ADJ
chd-224	167	39	to	to	ADP
chd-224	167	40	40	40	NUM
chd-224	167	41	)	)	PUNCT
chd-224	167	42	compared	compare	VERB
chd-224	167	43	to	to	ADP
chd-224	167	44	other	other	ADJ
chd-224	167	45	ethnic	ethnic	ADJ
chd-224	167	46	/	/	SYM
chd-224	167	47	racial	racial	ADJ
chd-224	167	48	groups	group	NOUN
chd-224	167	49	(	(	PUNCT
chd-224	167	50	hales	hales	PROPN
chd-224	167	51	et	et	PROPN
chd-224	167	52	al	al	PROPN
chd-224	167	53	.	.	PROPN
chd-224	167	54	,	,	PUNCT
chd-224	167	55	2020	2020	NUM
chd-224	167	56	)	)	PUNCT
chd-224	167	57	.	.	PUNCT
chd-224	168	1	by	by	ADP
chd-224	168	2	contrast	contrast	NOUN
chd-224	168	3	,	,	PUNCT
chd-224	168	4	non	non	ADJ
chd-224	168	5	-	-	ADJ
chd-224	168	6	hispanic	hispanic	ADJ
chd-224	168	7	asian	asian	ADJ
chd-224	168	8	adults	adult	NOUN
chd-224	168	9	have	have	VERB
chd-224	168	10	the	the	DET
chd-224	168	11	lowest	low	ADJ
chd-224	168	12	prevalence	prevalence	NOUN
chd-224	168	13	of	of	ADP
chd-224	168	14	obesity	obesity	NOUN
chd-224	168	15	(	(	PUNCT
chd-224	168	16	hales	hales	PROPN
chd-224	168	17	et	et	PROPN
chd-224	168	18	al	al	PROPN
chd-224	168	19	.	.	PROPN
chd-224	168	20	,	,	PUNCT
chd-224	168	21	2020	2020	NUM
chd-224	168	22	)	)	PUNCT
chd-224	168	23	.	.	PUNCT
chd-224	169	1	despite	despite	SCONJ
chd-224	169	2	having	have	VERB
chd-224	169	3	lower	low	ADJ
chd-224	169	4	bmi	bmi	NOUN
chd-224	169	5	’s	’s	PART
chd-224	169	6	than	than	ADP
chd-224	169	7	other	other	ADJ
chd-224	169	8	racial	racial	ADJ
chd-224	169	9	/	/	SYM
chd-224	169	10	ethnic	ethnic	ADJ
chd-224	169	11	groups	group	NOUN
chd-224	169	12	,	,	PUNCT
chd-224	169	13	asian	asian	ADJ
chd-224	169	14	americans	americans	PROPN
chd-224	169	15	tend	tend	VERB
chd-224	169	16	to	to	PART
chd-224	169	17	have	have	VERB
chd-224	169	18	high	high	ADJ
chd-224	169	19	prevalence	prevalence	NOUN
chd-224	169	20	rates	rate	NOUN
chd-224	169	21	of	of	ADP
chd-224	169	22	metabolic	metabolic	NOUN
chd-224	169	23	syndrome	syndrome	NOUN
chd-224	169	24	,	,	PUNCT
chd-224	169	25	especially	especially	ADV
chd-224	169	26	amongst	amongst	ADP
chd-224	169	27	filipinos	filipinos	PROPN
chd-224	169	28	and	and	CCONJ
chd-224	169	29	asian	asian	ADJ
chd-224	169	30	indians	indians	PROPN
chd-224	169	31	(	(	PUNCT
chd-224	169	32	palaniappan	palaniappan	NOUN
chd-224	169	33	et	et	PROPN
chd-224	169	34	al	al	PROPN
chd-224	169	35	.	.	PROPN
chd-224	169	36	,	,	PUNCT
chd-224	169	37	2011	2011	NUM
chd-224	169	38	)	)	PUNCT
chd-224	169	39	.	.	PUNCT
chd-224	170	1	filipinos	filipino	NOUN
chd-224	170	2	and	and	CCONJ
chd-224	170	3	asian	asian	ADJ
chd-224	170	4	indians	indians	PROPN
chd-224	170	5	also	also	ADV
chd-224	170	6	tend	tend	VERB
chd-224	170	7	to	to	PART
chd-224	170	8	have	have	VERB
chd-224	170	9	a	a	DET
chd-224	170	10	higher	high	ADJ
chd-224	170	11	prevalence	prevalence	NOUN
chd-224	170	12	of	of	ADP
chd-224	170	13	obesity	obesity	NOUN
chd-224	170	14	than	than	ADP
chd-224	170	15	non	non	ADJ
chd-224	170	16	-	-	ADJ
chd-224	170	17	hispanic	hispanic	ADJ
chd-224	170	18	european	european	ADJ
chd-224	170	19	americans	americans	PROPN
chd-224	170	20	(	(	PUNCT
chd-224	170	21	palaniappan	palaniappan	PROPN
chd-224	170	22	et	et	PROPN
chd-224	170	23	al	al	PROPN
chd-224	170	24	.	.	PROPN
chd-224	170	25	,	,	PUNCT
chd-224	170	26	2011	2011	NUM
chd-224	170	27	)	)	PUNCT
chd-224	170	28	.	.	PUNCT
chd-224	171	1	this	this	PRON
chd-224	171	2	is	be	AUX
chd-224	171	3	particularly	particularly	ADV
chd-224	171	4	interesting	interesting	ADJ
chd-224	171	5	considering	consider	VERB
chd-224	171	6	the	the	DET
chd-224	171	7	disproportionate	disproportionate	ADJ
chd-224	171	8	impact	impact	NOUN
chd-224	171	9	filipinos	filipino	NOUN
chd-224	171	10	face	face	VERB
chd-224	171	11	from	from	ADP
chd-224	171	12	thyroid	thyroid	NOUN
chd-224	171	13	cancer	cancer	NOUN
chd-224	171	14	as	as	ADV
chd-224	171	15	well	well	ADV
chd-224	171	16	.	.	PUNCT
chd-224	172	1	therefore	therefore	ADV
chd-224	172	2	,	,	PUNCT
chd-224	172	3	further	further	ADJ
chd-224	172	4	research	research	NOUN
chd-224	172	5	is	be	AUX
chd-224	172	6	necessary	necessary	ADJ
chd-224	172	7	to	to	PART
chd-224	172	8	determine	determine	VERB
chd-224	172	9	whether	whether	SCONJ
chd-224	172	10	some	some	DET
chd-224	172	11	factors	factor	NOUN
chd-224	172	12	which	which	PRON
chd-224	172	13	may	may	AUX
chd-224	172	14	impact	impact	VERB
chd-224	172	15	obesity	obesity	NOUN
chd-224	172	16	for	for	ADP
chd-224	172	17	a	a	DET
chd-224	172	18	certain	certain	ADJ
chd-224	172	19	ethnic	ethnic	ADJ
chd-224	172	20	/	/	SYM
chd-224	172	21	racial	racial	ADJ
chd-224	172	22	group	group	NOUN
chd-224	172	23	could	could	AUX
chd-224	172	24	impact	impact	VERB
chd-224	172	25	that	that	DET
chd-224	172	26	group	group	NOUN
chd-224	172	27	’s	’s	PART
chd-224	172	28	risk	risk	NOUN
chd-224	172	29	for	for	ADP
chd-224	172	30	thyroid	thyroid	NOUN
chd-224	172	31	cancer	cancer	NOUN
chd-224	172	32	.	.	PUNCT
chd-224	173	1	3.5	3.5	NUM
chd-224	173	2	.	.	PUNCT
chd-224	174	1	behavioral	behavioral	ADJ
chd-224	174	2	factors	factor	NOUN
chd-224	174	3	lifestyle	lifestyle	NOUN
chd-224	174	4	and	and	CCONJ
chd-224	174	5	diet	diet	NOUN
chd-224	174	6	in	in	ADP
chd-224	174	7	tc	tc	NUM
chd-224	174	8	health	health	NOUN
chd-224	174	9	disparities	disparity	NOUN
chd-224	174	10	with	with	ADP
chd-224	174	11	the	the	DET
chd-224	174	12	growing	grow	VERB
chd-224	174	13	evidence	evidence	NOUN
chd-224	174	14	that	that	SCONJ
chd-224	174	15	obesity	obesity	NOUN
chd-224	174	16	may	may	AUX
chd-224	174	17	be	be	AUX
chd-224	174	18	associated	associate	VERB
chd-224	174	19	with	with	ADP
chd-224	174	20	an	an	DET
chd-224	174	21	increased	increase	VERB
chd-224	174	22	risk	risk	NOUN
chd-224	174	23	of	of	ADP
chd-224	174	24	thyroid	thyroid	NOUN
chd-224	174	25	cancer	cancer	NOUN
chd-224	174	26	,	,	PUNCT
chd-224	174	27	it	it	PRON
chd-224	174	28	is	be	AUX
chd-224	174	29	advised	advise	VERB
chd-224	174	30	that	that	SCONJ
chd-224	174	31	individuals	individual	NOUN
chd-224	174	32	adopt	adopt	VERB
chd-224	174	33	a	a	DET
chd-224	174	34	lifestyle	lifestyle	NOUN
chd-224	174	35	that	that	PRON
chd-224	174	36	includes	include	VERB
chd-224	174	37	at	at	ADV
chd-224	174	38	least	least	ADV
chd-224	174	39	60	60	NUM
chd-224	174	40	min	min	NOUN
chd-224	174	41	/	/	SYM
chd-224	174	42	day	day	NOUN
chd-224	174	43	of	of	ADP
chd-224	174	44	moderate	moderate	ADJ
chd-224	174	45	physical	physical	ADJ
chd-224	174	46	activity	activity	NOUN
chd-224	174	47	to	to	PART
chd-224	174	48	reduce	reduce	VERB
chd-224	174	49	the	the	DET
chd-224	174	50	incidence	incidence	NOUN
chd-224	174	51	of	of	ADP
chd-224	174	52	obesity	obesity	NOUN
chd-224	174	53	-	-	PUNCT
chd-224	174	54	related	relate	VERB
chd-224	174	55	thyroid	thyroid	NOUN
chd-224	174	56	cancer	cancer	NOUN
chd-224	174	57	(	(	PUNCT
chd-224	174	58	franchini	franchini	X
chd-224	174	59	et	et	PROPN
chd-224	174	60	al	al	PROPN
chd-224	174	61	.	.	PROPN
chd-224	174	62	,	,	PUNCT
chd-224	174	63	2022	2022	NUM
chd-224	174	64	;	;	PUNCT
chd-224	174	65	ma	ma	PROPN
chd-224	174	66	et	et	PROPN
chd-224	174	67	al	al	PROPN
chd-224	174	68	.	.	PROPN
chd-224	174	69	,	,	PUNCT
chd-224	174	70	2022	2022	NUM
chd-224	174	71	)	)	PUNCT
chd-224	174	72	.	.	PUNCT
chd-224	175	1	some	some	DET
chd-224	175	2	studies	study	NOUN
chd-224	175	3	in	in	ADP
chd-224	175	4	the	the	DET
chd-224	175	5	united	united	PROPN
chd-224	175	6	states	states	PROPN
chd-224	175	7	have	have	AUX
chd-224	175	8	found	find	VERB
chd-224	175	9	that	that	SCONJ
chd-224	175	10	higher	high	ADJ
chd-224	175	11	levels	level	NOUN
chd-224	175	12	of	of	ADP
chd-224	175	13	physical	physical	ADJ
chd-224	175	14	activity	activity	NOUN
chd-224	175	15	could	could	AUX
chd-224	175	16	reduce	reduce	VERB
chd-224	175	17	the	the	DET
chd-224	175	18	risk	risk	NOUN
chd-224	175	19	of	of	ADP
chd-224	175	20	some	some	DET
chd-224	175	21	cancers	cancer	NOUN
chd-224	175	22	(	(	PUNCT
chd-224	175	23	bladder	bladder	NOUN
chd-224	175	24	,	,	PUNCT
chd-224	175	25	breast	breast	NOUN
chd-224	175	26	,	,	PUNCT
chd-224	175	27	colon	colon	NOUN
chd-224	175	28	,	,	PUNCT
chd-224	175	29	endometrial	endometrial	ADJ
chd-224	175	30	,	,	PUNCT
chd-224	175	31	esophageal	esophageal	ADJ
chd-224	175	32	adenocarcinoma	adenocarcinoma	NOUN
chd-224	175	33	,	,	PUNCT
chd-224	175	34	and	and	CCONJ
chd-224	175	35	gastric	gastric	ADJ
chd-224	175	36	cardia	cardia	NOUN
chd-224	175	37	)	)	PUNCT
chd-224	175	38	while	while	SCONJ
chd-224	175	39	increasing	increase	VERB
chd-224	175	40	the	the	DET
chd-224	175	41	risk	risk	NOUN
chd-224	175	42	for	for	ADP
chd-224	175	43	some	some	DET
chd-224	175	44	other	other	ADJ
chd-224	175	45	cancers	cancer	NOUN
chd-224	175	46	(	(	PUNCT
chd-224	175	47	lung	lung	NOUN
chd-224	175	48	,	,	PUNCT
chd-224	175	49	ovarian	ovarian	ADJ
chd-224	175	50	,	,	PUNCT
chd-224	175	51	pancreatic	pancreatic	ADJ
chd-224	175	52	,	,	PUNCT
chd-224	175	53	and	and	CCONJ
chd-224	175	54	renal	renal	ADJ
chd-224	175	55	cancer	cancer	NOUN
chd-224	175	56	)	)	PUNCT
chd-224	175	57	(	(	PUNCT
chd-224	175	58	friedenreich	friedenreich	NOUN
chd-224	175	59	et	et	PROPN
chd-224	175	60	al	al	PROPN
chd-224	175	61	.	.	PROPN
chd-224	175	62	,	,	PUNCT
chd-224	175	63	2021	2021	NUM
chd-224	175	64	)	)	PUNCT
chd-224	175	65	.	.	PUNCT
chd-224	176	1	however	however	ADV
chd-224	176	2	,	,	PUNCT
chd-224	176	3	these	these	DET
chd-224	176	4	studies	study	NOUN
chd-224	176	5	have	have	AUX
chd-224	176	6	not	not	PART
chd-224	176	7	looked	look	VERB
chd-224	176	8	at	at	ADP
chd-224	176	9	the	the	DET
chd-224	176	10	relationship	relationship	NOUN
chd-224	176	11	between	between	ADP
chd-224	176	12	thyroid	thyroid	NOUN
chd-224	176	13	cancer	cancer	NOUN
chd-224	176	14	,	,	PUNCT
chd-224	176	15	specifically	specifically	ADV
chd-224	176	16	,	,	PUNCT
chd-224	176	17	and	and	CCONJ
chd-224	176	18	physical	physical	ADJ
chd-224	176	19	activity	activity	NOUN
chd-224	176	20	(	(	PUNCT
chd-224	176	21	friedenreich	friedenreich	NOUN
chd-224	176	22	et	et	PROPN
chd-224	176	23	al	al	PROPN
chd-224	176	24	.	.	PROPN
chd-224	176	25	,	,	PUNCT
chd-224	176	26	2021	2021	NUM
chd-224	176	27	)	)	PUNCT
chd-224	176	28	.	.	PUNCT
chd-224	177	1	some	some	DET
chd-224	177	2	research	research	NOUN
chd-224	177	3	has	have	AUX
chd-224	177	4	been	be	AUX
chd-224	177	5	done	do	VERB
chd-224	177	6	to	to	PART
chd-224	177	7	examine	examine	VERB
chd-224	177	8	this	this	DET
chd-224	177	9	relationship	relationship	NOUN
chd-224	177	10	in	in	ADP
chd-224	177	11	korea	korea	PROPN
chd-224	177	12	;	;	PUNCT
chd-224	177	13	less	less	ADV
chd-224	177	14	physical	physical	ADJ
chd-224	177	15	activity	activity	NOUN
chd-224	177	16	in	in	ADP
chd-224	177	17	women	woman	NOUN
chd-224	177	18	was	be	AUX
chd-224	177	19	associated	associate	VERB
chd-224	177	20	with	with	ADP
chd-224	177	21	a	a	DET
chd-224	177	22	decreased	decrease	VERB
chd-224	177	23	risk	risk	NOUN
chd-224	177	24	of	of	ADP
chd-224	177	25	thyroid	thyroid	NOUN
chd-224	177	26	cancer	cancer	NOUN
chd-224	177	27	,	,	PUNCT
chd-224	177	28	and	and	CCONJ
chd-224	177	29	a	a	DET
chd-224	177	30	positive	positive	ADJ
chd-224	177	31	correlation	correlation	NOUN
chd-224	177	32	was	be	AUX
chd-224	177	33	found	find	VERB
chd-224	177	34	between	between	ADP
chd-224	177	35	physical	physical	ADJ
chd-224	177	36	exercise	exercise	NOUN
chd-224	177	37	and	and	CCONJ
chd-224	177	38	thyroid	thyroid	NOUN
chd-224	177	39	cancer	cancer	NOUN
chd-224	177	40	(	(	PUNCT
chd-224	177	41	kim	kim	PROPN
chd-224	177	42	et	et	PROPN
chd-224	177	43	al	al	PROPN
chd-224	177	44	.	.	PROPN
chd-224	177	45	,	,	PUNCT
chd-224	177	46	2021	2021	NUM
chd-224	177	47	;	;	PUNCT
chd-224	177	48	lee	lee	PROPN
chd-224	177	49	et	et	PROPN
chd-224	177	50	al	al	PROPN
chd-224	177	51	.	.	PROPN
chd-224	177	52	,	,	PUNCT
chd-224	177	53	2020	2020	NUM
chd-224	177	54	)	)	PUNCT
chd-224	177	55	.	.	PUNCT
chd-224	178	1	further	further	ADJ
chd-224	178	2	research	research	NOUN
chd-224	178	3	is	be	AUX
chd-224	178	4	needed	need	VERB
chd-224	178	5	to	to	PART
chd-224	178	6	examine	examine	VERB
chd-224	178	7	the	the	DET
chd-224	178	8	relationship	relationship	NOUN
chd-224	178	9	between	between	ADP
chd-224	178	10	physical	physical	ADJ
chd-224	178	11	activity	activity	NOUN
chd-224	178	12	and	and	CCONJ
chd-224	178	13	thyroid	thyroid	NOUN
chd-224	178	14	cancer	cancer	NOUN
chd-224	178	15	among	among	ADP
chd-224	178	16	populations	population	NOUN
chd-224	178	17	in	in	ADP
chd-224	178	18	the	the	DET
chd-224	178	19	united	united	PROPN
chd-224	178	20	states	states	PROPN
chd-224	178	21	,	,	PUNCT
chd-224	178	22	especially	especially	ADV
chd-224	178	23	since	since	SCONJ
chd-224	178	24	physical	physical	ADJ
chd-224	178	25	activity	activity	NOUN
chd-224	178	26	in	in	ADP
chd-224	178	27	the	the	DET
chd-224	178	28	united	united	PROPN
chd-224	178	29	states	states	PROPN
chd-224	178	30	varies	vary	VERB
chd-224	178	31	between	between	ADP
chd-224	178	32	racial	racial	ADJ
chd-224	178	33	/	/	SYM
chd-224	178	34	ethnic	ethnic	ADJ
chd-224	178	35	groups	group	NOUN
chd-224	178	36	which	which	PRON
chd-224	178	37	could	could	AUX
chd-224	178	38	impact	impact	VERB
chd-224	178	39	thyroid	thyroid	NOUN
chd-224	178	40	cancer	cancer	NOUN
chd-224	178	41	outcomes	outcome	NOUN
chd-224	178	42	.	.	PUNCT
chd-224	179	1	in	in	ADP
chd-224	179	2	particular	particular	ADJ
chd-224	179	3	,	,	PUNCT
chd-224	179	4	the	the	DET
chd-224	179	5	cdc	cdc	PROPN
chd-224	179	6	reports	report	VERB
chd-224	179	7	that	that	SCONJ
chd-224	179	8	hispanic	hispanic	ADJ
chd-224	179	9	adults	adult	NOUN
chd-224	179	10	have	have	VERB
chd-224	179	11	the	the	DET
chd-224	179	12	lowest	low	ADJ
chd-224	179	13	physical	physical	ADJ
chd-224	179	14	activity	activity	NOUN
chd-224	179	15	outside	outside	ADV
chd-224	179	16	of	of	ADP
chd-224	179	17	work	work	NOUN
chd-224	179	18	and	and	CCONJ
chd-224	179	19	non	non	ADJ
chd-224	179	20	-	-	ADJ
chd-224	179	21	hispanic	hispanic	ADJ
chd-224	179	22	asian	asian	ADJ
chd-224	179	23	adults	adult	NOUN
chd-224	179	24	have	have	VERB
chd-224	179	25	the	the	DET
chd-224	179	26	highest	high	ADJ
chd-224	179	27	.	.	PUNCT
chd-224	180	1	diets	diet	NOUN
chd-224	180	2	can	can	AUX
chd-224	180	3	vary	vary	VERB
chd-224	180	4	by	by	ADP
chd-224	180	5	racial	racial	ADJ
chd-224	180	6	/	/	SYM
chd-224	180	7	ethnic	ethnic	ADJ
chd-224	180	8	group	group	NOUN
chd-224	180	9	due	due	ADP
chd-224	180	10	to	to	ADP
chd-224	180	11	social	social	ADJ
chd-224	180	12	and	and	CCONJ
chd-224	180	13	cultural	cultural	ADJ
chd-224	180	14	differences	difference	NOUN
chd-224	180	15	between	between	ADP
chd-224	180	16	populations	population	NOUN
chd-224	180	17	(	(	PUNCT
chd-224	180	18	satia	satia	NOUN
chd-224	180	19	,	,	PUNCT
chd-224	180	20	2009	2009	NUM
chd-224	180	21	)	)	PUNCT
chd-224	180	22	.	.	PUNCT
chd-224	181	1	variations	variation	NOUN
chd-224	181	2	in	in	ADP
chd-224	181	3	iodine	iodine	NOUN
chd-224	181	4	intake	intake	NOUN
chd-224	181	5	among	among	ADP
chd-224	181	6	racial	racial	ADJ
chd-224	181	7	/	/	SYM
chd-224	181	8	ethnic	ethnic	ADJ
chd-224	181	9	groups	group	NOUN
chd-224	181	10	could	could	AUX
chd-224	181	11	be	be	AUX
chd-224	181	12	from	from	ADP
chd-224	181	13	differences	difference	NOUN
chd-224	181	14	in	in	ADP
chd-224	181	15	the	the	DET
chd-224	181	16	consumption	consumption	NOUN
chd-224	181	17	of	of	ADP
chd-224	181	18	seafood	seafood	NOUN
chd-224	181	19	,	,	PUNCT
chd-224	181	20	dairy	dairy	NOUN
chd-224	181	21	,	,	PUNCT
chd-224	181	22	grains	grain	NOUN
chd-224	181	23	,	,	PUNCT
chd-224	181	24	and	and	CCONJ
chd-224	181	25	eggs	egg	NOUN
chd-224	181	26	(	(	PUNCT
chd-224	181	27	bogović	bogović	NOUN
chd-224	181	28	crnčić	crnčić	PROPN
chd-224	181	29	et	et	PROPN
chd-224	181	30	al	al	PROPN
chd-224	181	31	.	.	PROPN
chd-224	181	32	,	,	PUNCT
chd-224	181	33	2020	2020	NUM
chd-224	181	34	;	;	PUNCT
chd-224	181	35	herrick	herrick	PROPN
chd-224	181	36	et	et	PROPN
chd-224	181	37	al	al	PROPN
chd-224	181	38	.	.	PROPN
chd-224	181	39	,	,	PUNCT
chd-224	181	40	2018	2018	NUM
chd-224	181	41	;	;	PUNCT
chd-224	181	42	nguyen	nguyen	NOUN
chd-224	181	43	et	et	PROPN
chd-224	181	44	al	al	PROPN
chd-224	181	45	.	.	PROPN
chd-224	181	46	,	,	PUNCT
chd-224	181	47	2017	2017	NUM
chd-224	181	48	)	)	PUNCT
chd-224	181	49	.	.	PUNCT
chd-224	182	1	nitrate	nitrate	NOUN
chd-224	182	2	/	/	SYM
chd-224	182	3	nitrite	nitrite	NOUN
chd-224	182	4	intake	intake	NOUN
chd-224	182	5	can	can	AUX
chd-224	182	6	vary	vary	VERB
chd-224	182	7	among	among	ADP
chd-224	182	8	racial	racial	ADJ
chd-224	182	9	/	/	SYM
chd-224	182	10	ethnic	ethnic	ADJ
chd-224	182	11	groups	group	NOUN
chd-224	182	12	due	due	ADP
chd-224	182	13	to	to	ADP
chd-224	182	14	consumption	consumption	NOUN
chd-224	182	15	of	of	ADP
chd-224	182	16	processed	process	VERB
chd-224	182	17	foods	food	NOUN
chd-224	182	18	and	and	CCONJ
chd-224	182	19	meats	meat	NOUN
chd-224	182	20	,	,	PUNCT
chd-224	182	21	which	which	PRON
chd-224	182	22	is	be	AUX
chd-224	182	23	more	more	ADV
chd-224	182	24	common	common	ADJ
chd-224	182	25	in	in	ADP
chd-224	182	26	certain	certain	ADJ
chd-224	182	27	racial	racial	ADJ
chd-224	182	28	/	/	SYM
chd-224	182	29	ethnic	ethnic	ADJ
chd-224	182	30	groups	group	NOUN
chd-224	182	31	than	than	ADP
chd-224	182	32	others	other	NOUN
chd-224	182	33	(	(	PUNCT
chd-224	182	34	said	say	VERB
chd-224	182	35	abasse	abasse	INTJ
chd-224	182	36	et	et	PROPN
chd-224	182	37	al	al	PROPN
chd-224	182	38	.	.	PROPN
chd-224	182	39	,	,	PUNCT
chd-224	182	40	2022	2022	NUM
chd-224	182	41	)	)	PUNCT
chd-224	182	42	.	.	PUNCT
chd-224	183	1	in	in	ADP
chd-224	183	2	particular	particular	ADJ
chd-224	183	3	,	,	PUNCT
chd-224	183	4	one	one	NUM
chd-224	183	5	study	study	NOUN
chd-224	183	6	found	find	VERB
chd-224	183	7	that	that	SCONJ
chd-224	183	8	non	non	ADJ
chd-224	183	9	-	-	ADJ
chd-224	183	10	hispanic	hispanic	ADJ
chd-224	183	11	european	european	ADJ
chd-224	183	12	americans	americans	PROPN
chd-224	183	13	were	be	AUX
chd-224	183	14	more	more	ADV
chd-224	183	15	likely	likely	ADJ
chd-224	183	16	than	than	SCONJ
chd-224	183	17	other	other	ADJ
chd-224	183	18	racial	racial	ADJ
chd-224	183	19	/	/	SYM
chd-224	183	20	ethnic	ethnic	ADJ
chd-224	183	21	groups	group	NOUN
chd-224	183	22	to	to	PART
chd-224	183	23	consume	consume	VERB
chd-224	183	24	excess	excess	ADJ
chd-224	183	25	processed	process	VERB
chd-224	183	26	meats	meat	NOUN
chd-224	183	27	(	(	PUNCT
chd-224	183	28	gudenkauf	gudenkauf	PROPN
chd-224	183	29	and	and	CCONJ
chd-224	183	30	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-224	183	31	e10	e10	NUM
chd-224	183	32	cancer	cancer	NOUN
chd-224	183	33	health	health	NOUN
chd-224	183	34	disparities	disparity	NOUN
chd-224	183	35	research	research	NOUN
chd-224	183	36	thrift	thrift	NOUN
chd-224	183	37	,	,	PUNCT
chd-224	183	38	2021	2021	NUM
chd-224	183	39	)	)	PUNCT
chd-224	183	40	.	.	PUNCT
chd-224	184	1	this	this	DET
chd-224	184	2	study	study	NOUN
chd-224	184	3	also	also	ADV
chd-224	184	4	found	find	VERB
chd-224	184	5	that	that	SCONJ
chd-224	184	6	nonhispanic	nonhispanic	ADJ
chd-224	184	7	african	african	ADJ
chd-224	184	8	americans	americans	PROPN
chd-224	184	9	had	have	VERB
chd-224	184	10	more	more	ADJ
chd-224	184	11	cancer	cancer	NOUN
chd-224	184	12	types	type	NOUN
chd-224	184	13	attributable	attributable	ADJ
chd-224	184	14	to	to	ADP
chd-224	184	15	processed	process	VERB
chd-224	184	16	meat	meat	NOUN
chd-224	184	17	consumption	consumption	NOUN
chd-224	184	18	(	(	PUNCT
chd-224	184	19	gudenkauf	gudenkauf	NOUN
chd-224	184	20	and	and	CCONJ
chd-224	184	21	thrift	thrift	NOUN
chd-224	184	22	,	,	PUNCT
chd-224	184	23	2021	2021	NUM
chd-224	184	24	)	)	PUNCT
chd-224	184	25	.	.	PUNCT
chd-224	185	1	however	however	ADV
chd-224	185	2	,	,	PUNCT
chd-224	185	3	this	this	DET
chd-224	185	4	study	study	NOUN
chd-224	185	5	focused	focus	VERB
chd-224	185	6	on	on	ADP
chd-224	185	7	non	non	ADJ
chd-224	185	8	-	-	ADJ
chd-224	185	9	hispanic	hispanic	ADJ
chd-224	185	10	european	european	ADJ
chd-224	185	11	americans	americans	PROPN
chd-224	185	12	,	,	PUNCT
chd-224	185	13	non	non	ADJ
chd-224	185	14	-	-	ADJ
chd-224	185	15	hispanic	hispanic	ADJ
chd-224	185	16	african	african	ADJ
chd-224	185	17	americans	americans	PROPN
chd-224	185	18	,	,	PUNCT
chd-224	185	19	and	and	CCONJ
chd-224	185	20	hispanics	hispanic	NOUN
chd-224	185	21	while	while	SCONJ
chd-224	185	22	grouping	group	VERB
chd-224	185	23	all	all	DET
chd-224	185	24	other	other	ADJ
chd-224	185	25	racial	racial	ADJ
chd-224	185	26	/	/	SYM
chd-224	185	27	ethnic	ethnic	ADJ
chd-224	185	28	groups	group	NOUN
chd-224	185	29	together	together	ADV
chd-224	185	30	.	.	PUNCT
chd-224	186	1	further	further	ADJ
chd-224	186	2	research	research	NOUN
chd-224	186	3	is	be	AUX
chd-224	186	4	needed	need	VERB
chd-224	186	5	to	to	PART
chd-224	186	6	examine	examine	VERB
chd-224	186	7	differences	difference	NOUN
chd-224	186	8	in	in	ADP
chd-224	186	9	diet	diet	NOUN
chd-224	186	10	practices	practice	NOUN
chd-224	186	11	and	and	CCONJ
chd-224	186	12	nutrient	nutrient	NOUN
chd-224	186	13	intake	intake	NOUN
chd-224	186	14	among	among	ADP
chd-224	186	15	racial	racial	ADJ
chd-224	186	16	/	/	SYM
chd-224	186	17	ethnic	ethnic	ADJ
chd-224	186	18	subgroups	subgroup	NOUN
chd-224	186	19	since	since	SCONJ
chd-224	186	20	certain	certain	ADJ
chd-224	186	21	subgroups	subgroup	NOUN
chd-224	186	22	,	,	PUNCT
chd-224	186	23	such	such	ADJ
chd-224	186	24	as	as	ADP
chd-224	186	25	filipino	filipino	PROPN
chd-224	186	26	americans	americans	PROPN
chd-224	186	27	within	within	ADP
chd-224	186	28	the	the	DET
chd-224	186	29	asian	asian	ADJ
chd-224	186	30	american	american	ADJ
chd-224	186	31	population	population	NOUN
chd-224	186	32	,	,	PUNCT
chd-224	186	33	tend	tend	VERB
chd-224	186	34	to	to	PART
chd-224	186	35	have	have	VERB
chd-224	186	36	high	high	ADJ
chd-224	186	37	consumption	consumption	NOUN
chd-224	186	38	of	of	ADP
chd-224	186	39	processed	process	VERB
chd-224	186	40	foods	food	NOUN
chd-224	186	41	.	.	PUNCT
chd-224	187	1	social	social	ADJ
chd-224	187	2	and	and	CCONJ
chd-224	187	3	cultural	cultural	ADJ
chd-224	187	4	differences	difference	NOUN
chd-224	187	5	in	in	ADP
chd-224	187	6	diet	diet	NOUN
chd-224	187	7	could	could	AUX
chd-224	187	8	,	,	PUNCT
chd-224	187	9	therefore	therefore	ADV
chd-224	187	10	,	,	PUNCT
chd-224	187	11	place	place	VERB
chd-224	187	12	some	some	DET
chd-224	187	13	racial	racial	ADJ
chd-224	187	14	/	/	SYM
chd-224	187	15	ethnic	ethnic	ADJ
chd-224	187	16	groups	group	NOUN
chd-224	187	17	at	at	ADP
chd-224	187	18	a	a	DET
chd-224	187	19	higher	high	ADJ
chd-224	187	20	risk	risk	NOUN
chd-224	187	21	of	of	ADP
chd-224	187	22	thyroid	thyroid	NOUN
chd-224	187	23	cancer	cancer	NOUN
chd-224	187	24	.	.	PUNCT
chd-224	188	1	it	it	PRON
chd-224	188	2	is	be	AUX
chd-224	188	3	worth	worth	ADJ
chd-224	188	4	noting	note	VERB
chd-224	188	5	that	that	SCONJ
chd-224	188	6	socioeconomic	socioeconomic	ADJ
chd-224	188	7	differences	difference	NOUN
chd-224	188	8	can	can	AUX
chd-224	188	9	play	play	VERB
chd-224	188	10	a	a	DET
chd-224	188	11	role	role	NOUN
chd-224	188	12	in	in	ADP
chd-224	188	13	access	access	NOUN
chd-224	188	14	to	to	ADP
chd-224	188	15	ingredients	ingredient	NOUN
chd-224	188	16	and	and	CCONJ
chd-224	188	17	types	type	NOUN
chd-224	188	18	of	of	ADP
chd-224	188	19	foods	food	NOUN
chd-224	188	20	as	as	ADV
chd-224	188	21	well	well	ADV
chd-224	188	22	as	as	ADP
chd-224	188	23	how	how	SCONJ
chd-224	188	24	much	much	ADJ
chd-224	188	25	physical	physical	ADJ
chd-224	188	26	activity	activity	NOUN
chd-224	188	27	individuals	individual	NOUN
chd-224	188	28	can	can	AUX
chd-224	188	29	realistically	realistically	ADV
chd-224	188	30	engage	engage	VERB
chd-224	188	31	in	in	ADP
chd-224	188	32	due	due	ADJ
chd-224	188	33	to	to	ADP
chd-224	188	34	barriers	barrier	NOUN
chd-224	188	35	such	such	ADJ
chd-224	188	36	as	as	ADP
chd-224	188	37	cost	cost	NOUN
chd-224	188	38	and	and	CCONJ
chd-224	188	39	time	time	NOUN
chd-224	188	40	,	,	PUNCT
chd-224	188	41	placing	place	VERB
chd-224	188	42	minority	minority	NOUN
chd-224	188	43	populations	population	NOUN
chd-224	188	44	at	at	ADP
chd-224	188	45	particular	particular	ADJ
chd-224	188	46	risk	risk	NOUN
chd-224	188	47	of	of	ADP
chd-224	188	48	thyroid	thyroid	NOUN
chd-224	188	49	cancer	cancer	NOUN
chd-224	188	50	.	.	PUNCT
chd-224	189	1	some	some	DET
chd-224	189	2	other	other	ADJ
chd-224	189	3	lifestyle	lifestyle	NOUN
chd-224	189	4	practices	practice	NOUN
chd-224	189	5	,	,	PUNCT
chd-224	189	6	such	such	ADJ
chd-224	189	7	as	as	ADP
chd-224	189	8	smoking	smoking	NOUN
chd-224	189	9	and	and	CCONJ
chd-224	189	10	alcohol	alcohol	NOUN
chd-224	189	11	consumption	consumption	NOUN
chd-224	189	12	,	,	PUNCT
chd-224	189	13	could	could	AUX
chd-224	189	14	affect	affect	VERB
chd-224	189	15	one	one	NUM
chd-224	189	16	’s	’s	PART
chd-224	189	17	risk	risk	NOUN
chd-224	189	18	of	of	ADP
chd-224	189	19	thyroid	thyroid	NOUN
chd-224	189	20	cancer	cancer	NOUN
chd-224	189	21	.	.	PUNCT
chd-224	190	1	in	in	ADP
chd-224	190	2	the	the	DET
chd-224	190	3	united	united	PROPN
chd-224	190	4	states	states	PROPN
chd-224	190	5	,	,	PUNCT
chd-224	190	6	one	one	NUM
chd-224	190	7	study	study	NOUN
chd-224	190	8	examining	examine	VERB
chd-224	190	9	smoking	smoking	NOUN
chd-224	190	10	found	find	VERB
chd-224	190	11	that	that	SCONJ
chd-224	190	12	e	e	NOUN
chd-224	190	13	-	-	NOUN
chd-224	190	14	cigarette	cigarette	ADJ
chd-224	190	15	users	user	NOUN
chd-224	190	16	had	have	VERB
chd-224	190	17	a	a	DET
chd-224	190	18	higher	high	ADJ
chd-224	190	19	prevalence	prevalence	NOUN
chd-224	190	20	of	of	ADP
chd-224	190	21	several	several	ADJ
chd-224	190	22	cancer	cancer	NOUN
chd-224	190	23	types	type	NOUN
chd-224	190	24	including	include	VERB
chd-224	190	25	thyroid	thyroid	NOUN
chd-224	190	26	cancer	cancer	NOUN
chd-224	190	27	compared	compare	VERB
chd-224	190	28	to	to	ADP
chd-224	190	29	traditional	traditional	ADJ
chd-224	190	30	smokers	smoker	NOUN
chd-224	190	31	(	(	PUNCT
chd-224	190	32	chidharla	chidharla	NOUN
chd-224	190	33	et	et	NOUN
chd-224	190	34	al	al	PROPN
chd-224	190	35	.	.	PROPN
chd-224	190	36	,	,	PUNCT
chd-224	190	37	2022	2022	NUM
chd-224	190	38	)	)	PUNCT
chd-224	190	39	.	.	PUNCT
chd-224	191	1	smoking	smoking	NOUN
chd-224	191	2	and	and	CCONJ
chd-224	191	3	alcohol	alcohol	NOUN
chd-224	191	4	consumption	consumption	NOUN
chd-224	191	5	habits	habit	NOUN
chd-224	191	6	vary	vary	VERB
chd-224	191	7	by	by	ADP
chd-224	191	8	racial	racial	ADJ
chd-224	191	9	/	/	SYM
chd-224	191	10	ethnic	ethnic	ADJ
chd-224	191	11	group	group	NOUN
chd-224	191	12	,	,	PUNCT
chd-224	191	13	as	as	ADV
chd-224	191	14	well	well	ADV
chd-224	191	15	,	,	PUNCT
chd-224	191	16	and	and	CCONJ
chd-224	191	17	could	could	AUX
chd-224	191	18	be	be	AUX
chd-224	191	19	due	due	ADJ
chd-224	191	20	to	to	ADP
chd-224	191	21	social	social	ADJ
chd-224	191	22	and	and	CCONJ
chd-224	191	23	cultural	cultural	ADJ
chd-224	191	24	factors	factor	NOUN
chd-224	191	25	.	.	PUNCT
chd-224	192	1	according	accord	VERB
chd-224	192	2	to	to	ADP
chd-224	192	3	the	the	DET
chd-224	192	4	cdc	cdc	PROPN
chd-224	192	5	,	,	PUNCT
chd-224	192	6	cigarette	cigarette	NOUN
chd-224	192	7	smoking	smoking	NOUN
chd-224	192	8	prevalence	prevalence	NOUN
chd-224	192	9	is	be	AUX
chd-224	192	10	the	the	DET
chd-224	192	11	highest	high	ADJ
chd-224	192	12	in	in	ADP
chd-224	192	13	native	native	ADJ
chd-224	192	14	americans	americans	PROPN
chd-224	192	15	and	and	CCONJ
chd-224	192	16	alaska	alaska	PROPN
chd-224	192	17	natives	native	NOUN
chd-224	192	18	and	and	CCONJ
chd-224	192	19	lowest	low	ADJ
chd-224	192	20	among	among	ADP
chd-224	192	21	asian	asian	ADJ
chd-224	192	22	americans	americans	PROPN
chd-224	192	23	although	although	SCONJ
chd-224	192	24	within	within	ADP
chd-224	192	25	asian	asian	ADJ
chd-224	192	26	subgroups	subgroup	NOUN
chd-224	192	27	,	,	PUNCT
chd-224	192	28	koreans	koreans	PROPN
chd-224	192	29	and	and	CCONJ
chd-224	192	30	vietnamese	vietnamese	NOUN
chd-224	192	31	have	have	VERB
chd-224	192	32	high	high	ADJ
chd-224	192	33	smoking	smoking	NOUN
chd-224	192	34	prevalence	prevalence	NOUN
chd-224	192	35	(	(	PUNCT
chd-224	192	36	chartier	chartier	NOUN
chd-224	192	37	and	and	CCONJ
chd-224	192	38	caetano	caetano	PROPN
chd-224	192	39	,	,	PUNCT
chd-224	192	40	2010	2010	NUM
chd-224	192	41	)	)	PUNCT
chd-224	192	42	.	.	PUNCT
chd-224	193	1	alcohol	alcohol	NOUN
chd-224	193	2	consumption	consumption	NOUN
chd-224	193	3	tends	tend	VERB
chd-224	193	4	to	to	PART
chd-224	193	5	be	be	AUX
chd-224	193	6	most	most	ADV
chd-224	193	7	common	common	ADJ
chd-224	193	8	in	in	ADP
chd-224	193	9	european	european	PROPN
chd-224	193	10	americans	americans	PROPN
chd-224	193	11	,	,	PUNCT
chd-224	193	12	lowest	low	ADJ
chd-224	193	13	in	in	ADP
chd-224	193	14	asian	asian	ADJ
chd-224	193	15	americans	americans	PROPN
chd-224	193	16	,	,	PUNCT
chd-224	193	17	and	and	CCONJ
chd-224	193	18	similar	similar	ADJ
chd-224	193	19	amongst	amongst	ADP
chd-224	193	20	native	native	ADJ
chd-224	193	21	americans	americans	PROPN
chd-224	193	22	,	,	PUNCT
chd-224	193	23	hispanics	hispanic	NOUN
chd-224	193	24	,	,	PUNCT
chd-224	193	25	and	and	CCONJ
chd-224	193	26	african	african	ADJ
chd-224	193	27	americans	americans	PROPN
chd-224	193	28	;	;	PUNCT
chd-224	193	29	however	however	ADV
chd-224	193	30	native	native	ADJ
chd-224	193	31	americans	americans	PROPN
chd-224	193	32	tend	tend	VERB
chd-224	193	33	to	to	PART
chd-224	193	34	have	have	VERB
chd-224	193	35	the	the	DET
chd-224	193	36	highest	high	ADJ
chd-224	193	37	prevalence	prevalence	NOUN
chd-224	193	38	of	of	ADP
chd-224	193	39	heavy	heavy	ADJ
chd-224	193	40	and	and	CCONJ
chd-224	193	41	binge	binge	ADJ
chd-224	193	42	drinking	drinking	NOUN
chd-224	193	43	(	(	PUNCT
chd-224	193	44	chartier	chartier	NOUN
chd-224	193	45	and	and	CCONJ
chd-224	193	46	caetano	caetano	PROPN
chd-224	193	47	,	,	PUNCT
chd-224	193	48	2010	2010	NUM
chd-224	193	49	)	)	PUNCT
chd-224	193	50	.	.	PUNCT
chd-224	194	1	these	these	DET
chd-224	194	2	variations	variation	NOUN
chd-224	194	3	in	in	ADP
chd-224	194	4	smoking	smoking	NOUN
chd-224	194	5	and	and	CCONJ
chd-224	194	6	alcohol	alcohol	NOUN
chd-224	194	7	consumption	consumption	NOUN
chd-224	194	8	habits	habit	NOUN
chd-224	194	9	could	could	AUX
chd-224	194	10	contribute	contribute	VERB
chd-224	194	11	to	to	ADP
chd-224	194	12	the	the	DET
chd-224	194	13	thyroid	thyroid	NOUN
chd-224	194	14	cancer	cancer	NOUN
chd-224	194	15	health	health	NOUN
chd-224	194	16	disparities	disparity	NOUN
chd-224	194	17	seen	see	VERB
chd-224	194	18	between	between	ADP
chd-224	194	19	racial	racial	ADJ
chd-224	194	20	/	/	SYM
chd-224	194	21	ethnic	ethnic	ADJ
chd-224	194	22	groups	group	NOUN
chd-224	194	23	in	in	ADP
chd-224	194	24	the	the	DET
chd-224	194	25	united	united	PROPN
chd-224	194	26	states	states	PROPN
chd-224	194	27	,	,	PUNCT
chd-224	194	28	however	however	ADV
chd-224	194	29	,	,	PUNCT
chd-224	194	30	further	further	ADJ
chd-224	194	31	research	research	NOUN
chd-224	194	32	is	be	AUX
chd-224	194	33	needed	need	VERB
chd-224	194	34	to	to	PART
chd-224	194	35	examine	examine	VERB
chd-224	194	36	these	these	DET
chd-224	194	37	relationships	relationship	NOUN
chd-224	194	38	.	.	PUNCT
chd-224	195	1	3.6	3.6	NUM
chd-224	195	2	.	.	PUNCT
chd-224	196	1	biological	biological	ADJ
chd-224	196	2	factors	factor	NOUN
chd-224	196	3	3.6.1	3.6.1	NUM
chd-224	196	4	.	.	PUNCT
chd-224	196	5	thyroid	thyroid	NOUN
chd-224	196	6	-	-	PUNCT
chd-224	196	7	stimulating	stimulate	VERB
chd-224	196	8	hormone	hormone	NOUN
chd-224	196	9	(	(	PUNCT
chd-224	196	10	tsh	tsh	NOUN
chd-224	196	11	)	)	PUNCT
chd-224	196	12	level	level	NOUN
chd-224	196	13	in	in	ADP
chd-224	196	14	tc	tc	NOUN
chd-224	196	15	health	health	NOUN
chd-224	196	16	disparities	disparity	NOUN
chd-224	196	17	research	research	NOUN
chd-224	196	18	suggests	suggest	VERB
chd-224	196	19	that	that	SCONJ
chd-224	196	20	thyroid	thyroid	NOUN
chd-224	196	21	stimulating	stimulate	VERB
chd-224	196	22	hormone	hormone	NOUN
chd-224	196	23	(	(	PUNCT
chd-224	196	24	tsh	tsh	NOUN
chd-224	196	25	)	)	PUNCT
chd-224	196	26	,	,	PUNCT
chd-224	196	27	also	also	ADV
chd-224	196	28	known	know	VERB
chd-224	196	29	as	as	ADP
chd-224	196	30	thyrotropin	thyrotropin	NOUN
chd-224	196	31	,	,	PUNCT
chd-224	196	32	mediates	mediate	NOUN
chd-224	196	33	thyroid	thyroid	VERB
chd-224	196	34	cell	cell	NOUN
chd-224	196	35	growth	growth	NOUN
chd-224	196	36	factors	factor	NOUN
chd-224	196	37	,	,	PUNCT
chd-224	196	38	such	such	ADJ
chd-224	196	39	as	as	ADP
chd-224	196	40	igf	igf	PROPN
chd-224	196	41	-	-	PROPN
chd-224	196	42	i	i	PROPN
chd-224	196	43	and	and	CCONJ
chd-224	196	44	insulin	insulin	NOUN
chd-224	196	45	(	(	PUNCT
chd-224	196	46	bogović	bogović	NOUN
chd-224	196	47	crnčić	crnčić	NOUN
chd-224	196	48	et	et	PROPN
chd-224	196	49	al	al	PROPN
chd-224	196	50	.	.	PROPN
chd-224	196	51	,	,	PUNCT
chd-224	196	52	2020	2020	NUM
chd-224	196	53	)	)	PUNCT
chd-224	196	54	.	.	PUNCT
chd-224	197	1	therefore	therefore	ADV
chd-224	197	2	,	,	PUNCT
chd-224	197	3	high	high	ADJ
chd-224	197	4	levels	level	NOUN
chd-224	197	5	of	of	ADP
chd-224	197	6	tsh	tsh	NOUN
chd-224	197	7	may	may	AUX
chd-224	197	8	lead	lead	VERB
chd-224	197	9	to	to	ADP
chd-224	197	10	an	an	DET
chd-224	197	11	enlarged	enlarge	VERB
chd-224	197	12	thyroid	thyroid	NOUN
chd-224	197	13	gland	gland	NOUN
chd-224	197	14	,	,	PUNCT
chd-224	197	15	or	or	CCONJ
chd-224	197	16	goiter	goiter	NOUN
chd-224	197	17	(	(	PUNCT
chd-224	197	18	bogović	bogović	NOUN
chd-224	197	19	crnčić	crnčić	PROPN
chd-224	197	20	et	et	PROPN
chd-224	197	21	al	al	PROPN
chd-224	197	22	.	.	PROPN
chd-224	197	23	,	,	PUNCT
chd-224	197	24	2020	2020	NUM
chd-224	197	25	;	;	PUNCT
chd-224	197	26	yildirim	yildirim	PROPN
chd-224	197	27	simsir	simsir	VERB
chd-224	197	28	et	et	PROPN
chd-224	197	29	al	al	PROPN
chd-224	197	30	.	.	PROPN
chd-224	197	31	,	,	PUNCT
chd-224	197	32	2020	2020	NUM
chd-224	197	33	)	)	PUNCT
chd-224	197	34	.	.	PUNCT
chd-224	198	1	one	one	NUM
chd-224	198	2	study	study	NOUN
chd-224	198	3	has	have	AUX
chd-224	198	4	found	find	VERB
chd-224	198	5	that	that	SCONJ
chd-224	198	6	higher	high	ADJ
chd-224	198	7	levels	level	NOUN
chd-224	198	8	of	of	ADP
chd-224	198	9	tsh	tsh	NOUN
chd-224	198	10	is	be	AUX
chd-224	198	11	associated	associate	VERB
chd-224	198	12	with	with	ADP
chd-224	198	13	a	a	DET
chd-224	198	14	fourfold	fourfold	ADJ
chd-224	198	15	increase	increase	NOUN
chd-224	198	16	of	of	ADP
chd-224	198	17	thyroid	thyroid	NOUN
chd-224	198	18	cancer	cancer	NOUN
chd-224	198	19	and	and	CCONJ
chd-224	198	20	a	a	DET
chd-224	198	21	higher	high	ADJ
chd-224	198	22	risk	risk	NOUN
chd-224	198	23	of	of	ADP
chd-224	198	24	advanced	advanced	ADJ
chd-224	198	25	stage	stage	NOUN
chd-224	198	26	differentiated	differentiate	VERB
chd-224	198	27	thyroid	thyroid	NOUN
chd-224	198	28	cancer	cancer	NOUN
chd-224	198	29	(	(	PUNCT
chd-224	198	30	bogović	bogović	NOUN
chd-224	198	31	crnčić	crnčić	NOUN
chd-224	198	32	et	et	PROPN
chd-224	198	33	al	al	PROPN
chd-224	198	34	.	.	PROPN
chd-224	198	35	,	,	PUNCT
chd-224	198	36	2020	2020	NUM
chd-224	198	37	)	)	PUNCT
chd-224	198	38	.	.	PUNCT
chd-224	199	1	another	another	DET
chd-224	199	2	study	study	NOUN
chd-224	199	3	has	have	AUX
chd-224	199	4	found	find	VERB
chd-224	199	5	that	that	SCONJ
chd-224	199	6	even	even	ADV
chd-224	199	7	minimal	minimal	ADJ
chd-224	199	8	elevations	elevation	NOUN
chd-224	199	9	of	of	ADP
chd-224	199	10	serum	serum	NOUN
chd-224	199	11	tsh	tsh	NOUN
chd-224	199	12	over	over	ADP
chd-224	199	13	time	time	NOUN
chd-224	199	14	could	could	AUX
chd-224	199	15	lead	lead	VERB
chd-224	199	16	to	to	ADP
chd-224	199	17	increased	increase	VERB
chd-224	199	18	thyroid	thyroid	NOUN
chd-224	199	19	volume	volume	NOUN
chd-224	199	20	and	and	CCONJ
chd-224	199	21	goiter	goiter	NOUN
chd-224	199	22	(	(	PUNCT
chd-224	199	23	yildirim	yildirim	PROPN
chd-224	199	24	simsir	simsir	VERB
chd-224	199	25	et	et	PROPN
chd-224	199	26	al	al	PROPN
chd-224	199	27	.	.	PROPN
chd-224	199	28	,	,	PUNCT
chd-224	199	29	2020	2020	NUM
chd-224	199	30	)	)	PUNCT
chd-224	199	31	.	.	PUNCT
chd-224	200	1	obese	obese	ADJ
chd-224	200	2	individuals	individual	NOUN
chd-224	200	3	are	be	AUX
chd-224	200	4	at	at	ADP
chd-224	200	5	a	a	DET
chd-224	200	6	higher	high	ADJ
chd-224	200	7	risk	risk	NOUN
chd-224	200	8	of	of	ADP
chd-224	200	9	increased	increase	VERB
chd-224	200	10	tsh	tsh	NOUN
chd-224	200	11	levels	level	NOUN
chd-224	200	12	and	and	CCONJ
chd-224	200	13	the	the	DET
chd-224	200	14	development	development	NOUN
chd-224	200	15	of	of	ADP
chd-224	200	16	goiter	goiter	NOUN
chd-224	200	17	and	and	CCONJ
chd-224	200	18	papillary	papillary	ADJ
chd-224	200	19	thyroid	thyroid	NOUN
chd-224	200	20	cancer	cancer	NOUN
chd-224	200	21	(	(	PUNCT
chd-224	200	22	yildirim	yildirim	PROPN
chd-224	200	23	simsir	simsir	VERB
chd-224	200	24	et	et	PROPN
chd-224	200	25	al	al	PROPN
chd-224	200	26	.	.	PROPN
chd-224	200	27	,	,	PUNCT
chd-224	200	28	2020	2020	NUM
chd-224	200	29	)	)	PUNCT
chd-224	200	30	.	.	PUNCT
chd-224	201	1	therefore	therefore	ADV
chd-224	201	2	,	,	PUNCT
chd-224	201	3	it	it	PRON
chd-224	201	4	is	be	AUX
chd-224	201	5	not	not	PART
chd-224	201	6	surprising	surprising	ADJ
chd-224	201	7	that	that	SCONJ
chd-224	201	8	tsh	tsh	NOUN
chd-224	201	9	suppression	suppression	NOUN
chd-224	201	10	therapy	therapy	NOUN
chd-224	201	11	following	follow	VERB
chd-224	201	12	radioiodine	radioiodine	NOUN
chd-224	201	13	treatment	treatment	NOUN
chd-224	201	14	can	can	AUX
chd-224	201	15	reduce	reduce	VERB
chd-224	201	16	the	the	DET
chd-224	201	17	recurrence	recurrence	NOUN
chd-224	201	18	rate	rate	NOUN
chd-224	201	19	of	of	ADP
chd-224	201	20	differentiated	differentiated	ADJ
chd-224	201	21	thyroid	thyroid	NOUN
chd-224	201	22	cancer	cancer	NOUN
chd-224	201	23	(	(	PUNCT
chd-224	201	24	bartenstein	bartenstein	PROPN
chd-224	201	25	et	et	PROPN
chd-224	201	26	al	al	PROPN
chd-224	201	27	.	.	PROPN
chd-224	201	28	,	,	PUNCT
chd-224	201	29	2014	2014	NUM
chd-224	201	30	;	;	PUNCT
chd-224	201	31	kim	kim	PROPN
chd-224	201	32	et	et	PROPN
chd-224	201	33	al	al	PROPN
chd-224	201	34	.	.	PROPN
chd-224	201	35	,	,	PUNCT
chd-224	201	36	2014	2014	NUM
chd-224	201	37	;	;	PUNCT
chd-224	201	38	wang	wang	PROPN
chd-224	201	39	et	et	PROPN
chd-224	201	40	al	al	PROPN
chd-224	201	41	.	.	PROPN
chd-224	201	42	,	,	PUNCT
chd-224	201	43	2022	2022	NUM
chd-224	201	44	)	)	PUNCT
chd-224	201	45	.	.	PUNCT
chd-224	202	1	however	however	ADV
chd-224	202	2	,	,	PUNCT
chd-224	202	3	further	further	ADJ
chd-224	202	4	research	research	NOUN
chd-224	202	5	is	be	AUX
chd-224	202	6	needed	need	VERB
chd-224	202	7	to	to	PART
chd-224	202	8	look	look	VERB
chd-224	202	9	at	at	ADP
chd-224	202	10	whether	whether	SCONJ
chd-224	202	11	levels	level	NOUN
chd-224	202	12	of	of	ADP
chd-224	202	13	tsh	tsh	NOUN
chd-224	202	14	vary	vary	NOUN
chd-224	202	15	by	by	ADP
chd-224	202	16	race	race	NOUN
chd-224	202	17	/	/	SYM
chd-224	202	18	ethnicity	ethnicity	NOUN
chd-224	202	19	in	in	ADP
chd-224	202	20	the	the	DET
chd-224	202	21	united	united	PROPN
chd-224	202	22	states	states	PROPN
chd-224	202	23	.	.	PUNCT
chd-224	203	1	3.6.2	3.6.2	X
chd-224	203	2	.	.	PUNCT
chd-224	203	3	sex	sex	NOUN
chd-224	203	4	in	in	ADP
chd-224	203	5	tc	tc	NOUN
chd-224	203	6	health	health	NOUN
chd-224	203	7	disparities	disparity	NOUN
chd-224	203	8	thyroid	thyroid	NOUN
chd-224	203	9	cancer	cancer	NOUN
chd-224	203	10	is	be	AUX
chd-224	203	11	one	one	NUM
chd-224	203	12	of	of	ADP
chd-224	203	13	the	the	DET
chd-224	203	14	most	most	ADV
chd-224	203	15	rapidly	rapidly	ADV
chd-224	203	16	increasing	increase	VERB
chd-224	203	17	types	type	NOUN
chd-224	203	18	of	of	ADP
chd-224	203	19	cancer	cancer	NOUN
chd-224	203	20	in	in	ADP
chd-224	203	21	both	both	DET
chd-224	203	22	women	woman	NOUN
chd-224	203	23	and	and	CCONJ
chd-224	203	24	men	man	NOUN
chd-224	203	25	(	(	PUNCT
chd-224	203	26	lim	lim	PROPN
chd-224	203	27	et	et	PROPN
chd-224	203	28	al	al	PROPN
chd-224	203	29	.	.	PROPN
chd-224	203	30	,	,	PUNCT
chd-224	203	31	2017	2017	NUM
chd-224	203	32	;	;	PUNCT
chd-224	204	1	rahbari	rahbari	PROPN
chd-224	204	2	et	et	PROPN
chd-224	204	3	al	al	PROPN
chd-224	204	4	.	.	PROPN
chd-224	204	5	,	,	PUNCT
chd-224	204	6	2010	2010	NUM
chd-224	204	7	;	;	PUNCT
chd-224	204	8	tortolero	tortolero	NUM
chd-224	204	9	-	-	PUNCT
chd-224	204	10	luna	luna	PROPN
chd-224	204	11	et	et	PROPN
chd-224	204	12	al	al	PROPN
chd-224	204	13	.	.	PROPN
chd-224	204	14	,	,	PUNCT
chd-224	204	15	2019	2019	NUM
chd-224	204	16	;	;	PUNCT
chd-224	204	17	weeks	week	NOUN
chd-224	204	18	et	et	PROPN
chd-224	204	19	al	al	PROPN
chd-224	204	20	.	.	PROPN
chd-224	204	21	,	,	PUNCT
chd-224	204	22	2018	2018	NUM
chd-224	204	23	)	)	PUNCT
chd-224	204	24	.	.	PUNCT
chd-224	205	1	it	it	PRON
chd-224	205	2	is	be	AUX
chd-224	205	3	known	know	VERB
chd-224	205	4	that	that	SCONJ
chd-224	205	5	women	woman	NOUN
chd-224	205	6	are	be	AUX
chd-224	205	7	about	about	ADV
chd-224	205	8	three	three	NUM
chd-224	205	9	times	time	NOUN
chd-224	205	10	more	more	ADV
chd-224	205	11	likely	likely	ADJ
chd-224	205	12	to	to	PART
chd-224	205	13	be	be	AUX
chd-224	205	14	diagnosed	diagnose	VERB
chd-224	205	15	with	with	ADP
chd-224	205	16	thyroid	thyroid	NOUN
chd-224	205	17	cancer	cancer	NOUN
chd-224	205	18	than	than	ADP
chd-224	205	19	men	man	NOUN
chd-224	205	20	,	,	PUNCT
chd-224	205	21	particularly	particularly	ADV
chd-224	205	22	through	through	ADP
chd-224	205	23	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-224	205	24	e11	e11	ADJ
chd-224	205	25	cancer	cancer	NOUN
chd-224	205	26	health	health	NOUN
chd-224	205	27	disparities	disparity	NOUN
chd-224	205	28	research	research	VERB
chd-224	205	29	the	the	DET
chd-224	205	30	finding	finding	NOUN
chd-224	205	31	of	of	ADP
chd-224	205	32	small	small	ADJ
chd-224	205	33	tumors	tumor	NOUN
chd-224	205	34	(	(	PUNCT
chd-224	205	35	<	<	X
chd-224	205	36	40	40	NUM
chd-224	205	37	mm	mm	NOUN
chd-224	205	38	)	)	PUNCT
chd-224	205	39	(	(	PUNCT
chd-224	205	40	rahbari	rahbari	NOUN
chd-224	205	41	et	et	PROPN
chd-224	205	42	al	al	PROPN
chd-224	205	43	.	.	PROPN
chd-224	205	44	,	,	PUNCT
chd-224	205	45	2010	2010	NUM
chd-224	205	46	;	;	PUNCT
chd-224	205	47	weeks	week	NOUN
chd-224	205	48	et	et	PROPN
chd-224	205	49	al	al	PROPN
chd-224	205	50	.	.	PROPN
chd-224	205	51	,	,	PUNCT
chd-224	205	52	2018	2018	NUM
chd-224	205	53	)	)	PUNCT
chd-224	205	54	.	.	PUNCT
chd-224	206	1	this	this	DET
chd-224	206	2	places	place	NOUN
chd-224	206	3	thyroid	thyroid	VERB
chd-224	206	4	cancer	cancer	NOUN
chd-224	206	5	as	as	ADP
chd-224	206	6	one	one	NUM
chd-224	206	7	of	of	ADP
chd-224	206	8	the	the	DET
chd-224	206	9	top	top	ADJ
chd-224	206	10	ten	ten	NUM
chd-224	206	11	most	most	ADV
chd-224	206	12	diagnosed	diagnose	VERB
chd-224	206	13	cancers	cancer	NOUN
chd-224	206	14	in	in	ADP
chd-224	206	15	women	woman	NOUN
chd-224	206	16	as	as	ADP
chd-224	206	17	of	of	ADP
chd-224	206	18	2018	2018	NUM
chd-224	206	19	(	(	PUNCT
chd-224	206	20	rahbari	rahbari	PROPN
chd-224	206	21	et	et	PROPN
chd-224	206	22	al	al	PROPN
chd-224	206	23	.	.	PROPN
chd-224	206	24	,	,	PUNCT
chd-224	206	25	2010	2010	NUM
chd-224	206	26	;	;	PUNCT
chd-224	206	27	weeks	week	NOUN
chd-224	206	28	et	et	PROPN
chd-224	206	29	al	al	PROPN
chd-224	206	30	.	.	PROPN
chd-224	206	31	,	,	PUNCT
chd-224	206	32	2018	2018	NUM
chd-224	206	33	)	)	PUNCT
chd-224	206	34	.	.	PUNCT
chd-224	207	1	furthermore	furthermore	ADV
chd-224	207	2	,	,	PUNCT
chd-224	207	3	follicular	follicular	ADJ
chd-224	207	4	and	and	CCONJ
chd-224	207	5	papillary	papillary	ADJ
chd-224	207	6	thyroid	thyroid	NOUN
chd-224	207	7	cancers	cancer	NOUN
chd-224	207	8	make	make	VERB
chd-224	207	9	up	up	ADP
chd-224	207	10	approximately	approximately	ADV
chd-224	207	11	80	80	NUM
chd-224	207	12	%	%	NOUN
chd-224	207	13	of	of	ADP
chd-224	207	14	thyroid	thyroid	NOUN
chd-224	207	15	cancer	cancer	NOUN
chd-224	207	16	cases	case	NOUN
chd-224	207	17	in	in	ADP
chd-224	207	18	women	woman	NOUN
chd-224	207	19	,	,	PUNCT
chd-224	207	20	and	and	CCONJ
chd-224	207	21	papillary	papillary	ADJ
chd-224	207	22	thyroid	thyroid	NOUN
chd-224	207	23	cancer	cancer	NOUN
chd-224	207	24	is	be	AUX
chd-224	207	25	three	three	NUM
chd-224	207	26	times	time	NOUN
chd-224	207	27	more	more	ADV
chd-224	207	28	common	common	ADJ
chd-224	207	29	in	in	ADP
chd-224	207	30	women	woman	NOUN
chd-224	207	31	than	than	ADP
chd-224	207	32	in	in	ADP
chd-224	207	33	men	man	NOUN
chd-224	207	34	(	(	PUNCT
chd-224	207	35	horn	horn	NOUN
chd-224	207	36	-	-	PUNCT
chd-224	207	37	ross	ross	PROPN
chd-224	207	38	et	et	PROPN
chd-224	207	39	al	al	PROPN
chd-224	207	40	.	.	PROPN
chd-224	207	41	,	,	PUNCT
chd-224	207	42	2011	2011	NUM
chd-224	207	43	;	;	PUNCT
chd-224	208	1	rahbari	rahbari	PROPN
chd-224	208	2	et	et	PROPN
chd-224	208	3	al	al	PROPN
chd-224	208	4	.	.	PROPN
chd-224	208	5	,	,	PUNCT
chd-224	208	6	2010	2010	NUM
chd-224	208	7	)	)	PUNCT
chd-224	208	8	.	.	PUNCT
chd-224	209	1	however	however	ADV
chd-224	209	2	,	,	PUNCT
chd-224	209	3	it	it	PRON
chd-224	209	4	is	be	AUX
chd-224	209	5	also	also	ADV
chd-224	209	6	known	know	VERB
chd-224	209	7	that	that	SCONJ
chd-224	209	8	men	man	NOUN
chd-224	209	9	have	have	VERB
chd-224	209	10	a	a	DET
chd-224	209	11	higher	high	ADJ
chd-224	209	12	mortality	mortality	NOUN
chd-224	209	13	rate	rate	NOUN
chd-224	209	14	compared	compare	VERB
chd-224	209	15	to	to	ADP
chd-224	209	16	women	woman	NOUN
chd-224	209	17	(	(	PUNCT
chd-224	209	18	keegan	keegan	PROPN
chd-224	209	19	et	et	PROPN
chd-224	209	20	al	al	PROPN
chd-224	209	21	.	.	PROPN
chd-224	209	22	,	,	PUNCT
chd-224	209	23	2015	2015	NUM
chd-224	209	24	;	;	PUNCT
chd-224	209	25	rahbari	rahbari	PROPN
chd-224	209	26	et	et	PROPN
chd-224	209	27	al	al	PROPN
chd-224	209	28	.	.	PROPN
chd-224	209	29	,	,	PUNCT
chd-224	209	30	2010	2010	NUM
chd-224	209	31	;	;	PUNCT
chd-224	209	32	tortolero	tortolero	NUM
chd-224	209	33	-	-	PUNCT
chd-224	209	34	luna	luna	PROPN
chd-224	209	35	et	et	PROPN
chd-224	209	36	al	al	PROPN
chd-224	209	37	.	.	PROPN
chd-224	209	38	,	,	PUNCT
chd-224	209	39	2019	2019	NUM
chd-224	209	40	)	)	PUNCT
chd-224	209	41	.	.	PUNCT
chd-224	210	1	additionally	additionally	ADV
chd-224	210	2	,	,	PUNCT
chd-224	210	3	men	man	NOUN
chd-224	210	4	are	be	AUX
chd-224	210	5	more	more	ADV
chd-224	210	6	likely	likely	ADJ
chd-224	210	7	to	to	PART
chd-224	210	8	have	have	VERB
chd-224	210	9	regional	regional	ADJ
chd-224	210	10	/	/	SYM
chd-224	210	11	distant	distant	ADJ
chd-224	210	12	stages	stage	NOUN
chd-224	210	13	of	of	ADP
chd-224	210	14	disease	disease	NOUN
chd-224	210	15	upon	upon	SCONJ
chd-224	210	16	diagnosis	diagnosis	NOUN
chd-224	210	17	,	,	PUNCT
chd-224	210	18	unfavorable	unfavorable	ADJ
chd-224	210	19	clinicopathological	clinicopathological	ADJ
chd-224	210	20	characteristics	characteristic	NOUN
chd-224	210	21	such	such	ADJ
chd-224	210	22	as	as	ADP
chd-224	210	23	angioinvasion	angioinvasion	NOUN
chd-224	210	24	,	,	PUNCT
chd-224	210	25	and	and	CCONJ
chd-224	210	26	a	a	DET
chd-224	210	27	higher	high	ADJ
chd-224	210	28	risk	risk	NOUN
chd-224	210	29	for	for	ADP
chd-224	210	30	recurrence	recurrence	NOUN
chd-224	210	31	of	of	ADP
chd-224	210	32	well	well	ADV
chd-224	210	33	-	-	PUNCT
chd-224	210	34	differentiated	differentiate	VERB
chd-224	210	35	thyroid	thyroid	NOUN
chd-224	210	36	cancer	cancer	NOUN
chd-224	210	37	(	(	PUNCT
chd-224	210	38	gajowiec	gajowiec	PROPN
chd-224	210	39	et	et	PROPN
chd-224	210	40	al	al	PROPN
chd-224	210	41	.	.	PROPN
chd-224	210	42	,	,	PUNCT
chd-224	210	43	2021	2021	NUM
chd-224	210	44	;	;	PUNCT
chd-224	211	1	keegan	keegan	PROPN
chd-224	211	2	et	et	PROPN
chd-224	211	3	al	al	PROPN
chd-224	211	4	.	.	PROPN
chd-224	211	5	,	,	PUNCT
chd-224	211	6	2015	2015	NUM
chd-224	211	7	;	;	PUNCT
chd-224	211	8	zahedi	zahedi	PROPN
chd-224	211	9	et	et	PROPN
chd-224	211	10	al	al	PROPN
chd-224	211	11	.	.	PROPN
chd-224	211	12	,	,	PUNCT
chd-224	211	13	2020	2020	NUM
chd-224	211	14	)	)	PUNCT
chd-224	211	15	.	.	PUNCT
chd-224	212	1	while	while	SCONJ
chd-224	212	2	some	some	DET
chd-224	212	3	studies	study	NOUN
chd-224	212	4	have	have	AUX
chd-224	212	5	been	be	AUX
chd-224	212	6	looking	look	VERB
chd-224	212	7	at	at	ADP
chd-224	212	8	differences	difference	NOUN
chd-224	212	9	between	between	ADP
chd-224	212	10	men	man	NOUN
chd-224	212	11	and	and	CCONJ
chd-224	212	12	women	woman	NOUN
chd-224	212	13	in	in	ADP
chd-224	212	14	hormonal	hormonal	ADJ
chd-224	212	15	regulation	regulation	NOUN
chd-224	212	16	,	,	PUNCT
chd-224	212	17	androgen	androgen	NOUN
chd-224	212	18	receptor	receptor	NOUN
chd-224	212	19	gene	gene	NOUN
chd-224	212	20	expression	expression	NOUN
chd-224	212	21	,	,	PUNCT
chd-224	212	22	and	and	CCONJ
chd-224	212	23	certain	certain	ADJ
chd-224	212	24	somatic	somatic	ADJ
chd-224	212	25	mutations	mutation	NOUN
chd-224	212	26	,	,	PUNCT
chd-224	212	27	further	further	ADJ
chd-224	212	28	research	research	NOUN
chd-224	212	29	is	be	AUX
chd-224	212	30	needed	need	VERB
chd-224	212	31	to	to	PART
chd-224	212	32	find	find	VERB
chd-224	212	33	if	if	SCONJ
chd-224	212	34	there	there	PRON
chd-224	212	35	are	be	VERB
chd-224	212	36	any	any	DET
chd-224	212	37	strong	strong	ADJ
chd-224	212	38	associations	association	NOUN
chd-224	212	39	with	with	ADP
chd-224	212	40	thyroid	thyroid	NOUN
chd-224	212	41	cancer	cancer	NOUN
chd-224	212	42	(	(	PUNCT
chd-224	212	43	asban	asban	NOUN
chd-224	212	44	et	et	PROPN
chd-224	212	45	al	al	PROPN
chd-224	212	46	.	.	PROPN
chd-224	212	47	,	,	PUNCT
chd-224	212	48	2019	2019	NUM
chd-224	212	49	;	;	PUNCT
chd-224	213	1	chou	chou	PROPN
chd-224	213	2	et	et	PROPN
chd-224	213	3	al	al	PROPN
chd-224	213	4	.	.	PROPN
chd-224	213	5	,	,	PUNCT
chd-224	213	6	2020	2020	NUM
chd-224	213	7	;	;	PUNCT
chd-224	213	8	megwalu	megwalu	PROPN
chd-224	213	9	et	et	PROPN
chd-224	213	10	al	al	PROPN
chd-224	213	11	.	.	PROPN
chd-224	213	12	,	,	PUNCT
chd-224	213	13	2021	2021	NUM
chd-224	213	14	;	;	PUNCT
chd-224	213	15	o'connell	o'connell	PROPN
chd-224	213	16	et	et	PROPN
chd-224	213	17	al	al	PROPN
chd-224	213	18	.	.	PROPN
chd-224	213	19	,	,	PUNCT
chd-224	213	20	2021	2021	NUM
chd-224	213	21	;	;	PUNCT
chd-224	213	22	rahbari	rahbari	PROPN
chd-224	213	23	et	et	PROPN
chd-224	213	24	al	al	PROPN
chd-224	213	25	.	.	PROPN
chd-224	213	26	,	,	PUNCT
chd-224	213	27	2010	2010	NUM
chd-224	213	28	)	)	PUNCT
chd-224	213	29	.	.	PUNCT
chd-224	214	1	when	when	SCONJ
chd-224	214	2	looking	look	VERB
chd-224	214	3	at	at	ADP
chd-224	214	4	whether	whether	SCONJ
chd-224	214	5	sex	sex	NOUN
chd-224	214	6	as	as	ADP
chd-224	214	7	a	a	DET
chd-224	214	8	risk	risk	NOUN
chd-224	214	9	factor	factor	NOUN
chd-224	214	10	for	for	ADP
chd-224	214	11	thyroid	thyroid	NOUN
chd-224	214	12	cancer	cancer	NOUN
chd-224	214	13	varies	vary	VERB
chd-224	214	14	by	by	ADP
chd-224	214	15	race	race	NOUN
chd-224	214	16	/	/	SYM
chd-224	214	17	ethnicity	ethnicity	NOUN
chd-224	214	18	,	,	PUNCT
chd-224	214	19	one	one	NUM
chd-224	214	20	study	study	NOUN
chd-224	214	21	found	find	VERB
chd-224	214	22	a	a	DET
chd-224	214	23	ratio	ratio	NOUN
chd-224	214	24	of	of	ADP
chd-224	214	25	female	female	ADJ
chd-224	214	26	to	to	ADP
chd-224	214	27	male	male	ADJ
chd-224	214	28	incidence	incidence	NOUN
chd-224	214	29	rates	rate	NOUN
chd-224	214	30	of	of	ADP
chd-224	214	31	3:1	3:1	NUM
chd-224	214	32	to	to	PART
chd-224	214	33	4:1	4:1	NUM
chd-224	214	34	across	across	ADP
chd-224	214	35	racial	racial	ADJ
chd-224	214	36	/	/	SYM
chd-224	214	37	ethnic	ethnic	ADJ
chd-224	214	38	groups	group	NOUN
chd-224	214	39	,	,	PUNCT
chd-224	214	40	including	include	VERB
chd-224	214	41	european	european	PROPN
chd-224	214	42	americans	americans	PROPN
chd-224	214	43	,	,	PUNCT
chd-224	214	44	hispanics	hispanic	NOUN
chd-224	214	45	,	,	PUNCT
chd-224	214	46	asians	asian	NOUN
chd-224	214	47	,	,	PUNCT
chd-224	214	48	african	african	ADJ
chd-224	214	49	americans	americans	PROPN
chd-224	214	50	,	,	PUNCT
chd-224	214	51	and	and	CCONJ
chd-224	214	52	native	native	ADJ
chd-224	214	53	americans	americans	PROPN
chd-224	214	54	(	(	PUNCT
chd-224	214	55	weeks	week	NOUN
chd-224	214	56	et	et	PROPN
chd-224	214	57	al	al	PROPN
chd-224	214	58	.	.	PROPN
chd-224	214	59	,	,	PUNCT
chd-224	214	60	2018	2018	NUM
chd-224	214	61	)	)	PUNCT
chd-224	214	62	.	.	PUNCT
chd-224	215	1	it	it	PRON
chd-224	215	2	is	be	AUX
chd-224	215	3	likely	likely	ADJ
chd-224	215	4	that	that	SCONJ
chd-224	215	5	this	this	DET
chd-224	215	6	higher	high	ADJ
chd-224	215	7	incidence	incidence	NOUN
chd-224	215	8	among	among	ADP
chd-224	215	9	women	woman	NOUN
chd-224	215	10	and	and	CCONJ
chd-224	215	11	the	the	DET
chd-224	215	12	size	size	NOUN
chd-224	215	13	of	of	ADP
chd-224	215	14	tumors	tumor	NOUN
chd-224	215	15	upon	upon	SCONJ
chd-224	215	16	diagnosis	diagnosis	NOUN
chd-224	215	17	could	could	AUX
chd-224	215	18	be	be	AUX
chd-224	215	19	due	due	ADJ
chd-224	215	20	to	to	ADP
chd-224	215	21	differences	difference	NOUN
chd-224	215	22	in	in	ADP
chd-224	215	23	access	access	NOUN
chd-224	215	24	to	to	ADP
chd-224	215	25	medical	medical	ADJ
chd-224	215	26	care	care	NOUN
chd-224	215	27	and	and	CCONJ
chd-224	215	28	women	woman	NOUN
chd-224	215	29	receiving	receive	VERB
chd-224	215	30	more	more	ADV
chd-224	215	31	regular	regular	ADJ
chd-224	215	32	check	check	NOUN
chd-224	215	33	-	-	PUNCT
chd-224	215	34	ups	up	NOUN
chd-224	215	35	than	than	ADP
chd-224	215	36	men	man	NOUN
chd-224	215	37	(	(	PUNCT
chd-224	215	38	rahbari	rahbari	NOUN
chd-224	215	39	et	et	PROPN
chd-224	215	40	al	al	PROPN
chd-224	215	41	.	.	PROPN
chd-224	215	42	,	,	PUNCT
chd-224	215	43	2010	2010	NUM
chd-224	215	44	;	;	PUNCT
chd-224	215	45	weeks	week	NOUN
chd-224	215	46	et	et	PROPN
chd-224	215	47	al	al	PROPN
chd-224	215	48	.	.	PROPN
chd-224	215	49	,	,	PUNCT
chd-224	215	50	2018	2018	NUM
chd-224	215	51	)	)	PUNCT
chd-224	215	52	.	.	PUNCT
chd-224	216	1	generally	generally	ADV
chd-224	216	2	,	,	PUNCT
chd-224	216	3	however	however	ADV
chd-224	216	4	,	,	PUNCT
chd-224	216	5	there	there	PRON
chd-224	216	6	is	be	VERB
chd-224	216	7	a	a	DET
chd-224	216	8	uniform	uniform	ADJ
chd-224	216	9	3:1	3:1	NUM
chd-224	216	10	ratio	ratio	NOUN
chd-224	216	11	of	of	ADP
chd-224	216	12	sex	sex	NOUN
chd-224	216	13	disparities	disparity	NOUN
chd-224	216	14	across	across	ADP
chd-224	216	15	all	all	DET
chd-224	216	16	ethnicities	ethnicity	NOUN
chd-224	216	17	,	,	PUNCT
chd-224	216	18	suggesting	suggest	VERB
chd-224	216	19	that	that	SCONJ
chd-224	216	20	sex	sex	NOUN
chd-224	216	21	is	be	AUX
chd-224	216	22	a	a	DET
chd-224	216	23	risk	risk	NOUN
chd-224	216	24	factor	factor	NOUN
chd-224	216	25	for	for	ADP
chd-224	216	26	thyroid	thyroid	NOUN
chd-224	216	27	cancer	cancer	NOUN
chd-224	216	28	that	that	PRON
chd-224	216	29	does	do	AUX
chd-224	216	30	not	not	PART
chd-224	216	31	differentially	differentially	ADV
chd-224	216	32	impact	impact	VERB
chd-224	216	33	certain	certain	ADJ
chd-224	216	34	racial	racial	ADJ
chd-224	216	35	/	/	SYM
chd-224	216	36	ethnic	ethnic	ADJ
chd-224	216	37	groups	group	NOUN
chd-224	216	38	.	.	PUNCT
chd-224	217	1	based	base	VERB
chd-224	217	2	on	on	ADP
chd-224	217	3	these	these	DET
chd-224	217	4	findings	finding	NOUN
chd-224	217	5	,	,	PUNCT
chd-224	217	6	it	it	PRON
chd-224	217	7	is	be	AUX
chd-224	217	8	of	of	ADP
chd-224	217	9	interest	interest	NOUN
chd-224	217	10	to	to	PART
chd-224	217	11	investigate	investigate	VERB
chd-224	217	12	differences	difference	NOUN
chd-224	217	13	in	in	ADP
chd-224	217	14	sex	sex	NOUN
chd-224	217	15	hormone	hormone	NOUN
chd-224	217	16	levels	level	NOUN
chd-224	217	17	among	among	ADP
chd-224	217	18	racial	racial	ADJ
chd-224	217	19	/	/	SYM
chd-224	217	20	ethnic	ethnic	ADJ
chd-224	217	21	groups	group	NOUN
chd-224	217	22	.	.	PUNCT
chd-224	218	1	for	for	ADP
chd-224	218	2	example	example	NOUN
chd-224	218	3	,	,	PUNCT
chd-224	218	4	a	a	DET
chd-224	218	5	study	study	NOUN
chd-224	218	6	found	find	VERB
chd-224	218	7	that	that	SCONJ
chd-224	218	8	african	african	ADJ
chd-224	218	9	american	american	ADJ
chd-224	218	10	men	man	NOUN
chd-224	218	11	had	have	VERB
chd-224	218	12	higher	high	ADJ
chd-224	218	13	sex	sex	NOUN
chd-224	218	14	hormone	hormone	NOUN
chd-224	218	15	binding	bind	VERB
chd-224	218	16	globulin	globulin	NOUN
chd-224	218	17	(	(	PUNCT
chd-224	218	18	shbg	shbg	NOUN
chd-224	218	19	)	)	PUNCT
chd-224	218	20	concentration	concentration	NOUN
chd-224	218	21	and	and	CCONJ
chd-224	218	22	serum	serum	PROPN
chd-224	218	23	estradiol	estradiol	PROPN
chd-224	218	24	levels	level	NOUN
chd-224	218	25	than	than	ADP
chd-224	218	26	hispanic	hispanic	ADJ
chd-224	218	27	american	american	ADJ
chd-224	218	28	and	and	CCONJ
chd-224	218	29	european	european	ADJ
chd-224	218	30	american	american	ADJ
chd-224	218	31	men	man	NOUN
chd-224	218	32	(	(	PUNCT
chd-224	218	33	rohrmann	rohrmann	PROPN
chd-224	218	34	et	et	PROPN
chd-224	218	35	al	al	PROPN
chd-224	218	36	.	.	PROPN
chd-224	218	37	,	,	PUNCT
chd-224	218	38	2007	2007	NUM
chd-224	218	39	)	)	PUNCT
chd-224	218	40	.	.	PUNCT
chd-224	219	1	serum	serum	PROPN
chd-224	219	2	testosterone	testosterone	NOUN
chd-224	219	3	levels	level	NOUN
chd-224	219	4	did	do	AUX
chd-224	219	5	not	not	PART
chd-224	219	6	differ	differ	VERB
chd-224	219	7	between	between	ADP
chd-224	219	8	african	african	ADJ
chd-224	219	9	american	american	ADJ
chd-224	219	10	men	man	NOUN
chd-224	219	11	and	and	CCONJ
chd-224	219	12	european	european	ADJ
chd-224	219	13	american	american	ADJ
chd-224	219	14	men	man	NOUN
chd-224	219	15	,	,	PUNCT
chd-224	219	16	however	however	ADV
chd-224	219	17	hispanic	hispanic	ADJ
chd-224	219	18	american	american	ADJ
chd-224	219	19	men	man	NOUN
chd-224	219	20	had	have	VERB
chd-224	219	21	higher	high	ADJ
chd-224	219	22	serum	serum	NOUN
chd-224	219	23	testosterone	testosterone	NOUN
chd-224	219	24	levels	level	NOUN
chd-224	219	25	than	than	ADP
chd-224	219	26	the	the	DET
chd-224	219	27	other	other	ADJ
chd-224	219	28	racial	racial	ADJ
chd-224	219	29	/	/	SYM
chd-224	219	30	ethnic	ethnic	ADJ
chd-224	219	31	groups	group	NOUN
chd-224	219	32	(	(	PUNCT
chd-224	219	33	rohrmann	rohrmann	PROPN
chd-224	219	34	et	et	PROPN
chd-224	219	35	al	al	PROPN
chd-224	219	36	.	.	PROPN
chd-224	219	37	,	,	PUNCT
chd-224	219	38	2007	2007	NUM
chd-224	219	39	)	)	PUNCT
chd-224	219	40	.	.	PUNCT
chd-224	220	1	another	another	DET
chd-224	220	2	study	study	NOUN
chd-224	220	3	looked	look	VERB
chd-224	220	4	at	at	ADP
chd-224	220	5	variations	variation	NOUN
chd-224	220	6	in	in	ADP
chd-224	220	7	hormone	hormone	NOUN
chd-224	220	8	levels	level	NOUN
chd-224	220	9	among	among	ADP
chd-224	220	10	overweight	overweight	ADJ
chd-224	220	11	,	,	PUNCT
chd-224	220	12	glucose	glucose	NOUN
chd-224	220	13	-	-	PUNCT
chd-224	220	14	intolerant	intolerant	ADJ
chd-224	220	15	,	,	PUNCT
chd-224	220	16	postmenopausal	postmenopausal	ADJ
chd-224	220	17	women	woman	NOUN
chd-224	220	18	(	(	PUNCT
chd-224	220	19	kim	kim	PROPN
chd-224	220	20	et	et	PROPN
chd-224	220	21	al	al	PROPN
chd-224	220	22	.	.	PROPN
chd-224	220	23	,	,	PUNCT
chd-224	220	24	2012	2012	NUM
chd-224	220	25	)	)	PUNCT
chd-224	220	26	.	.	PUNCT
chd-224	221	1	this	this	DET
chd-224	221	2	study	study	NOUN
chd-224	221	3	found	find	VERB
chd-224	221	4	that	that	SCONJ
chd-224	221	5	,	,	PUNCT
chd-224	221	6	among	among	ADP
chd-224	221	7	women	woman	NOUN
chd-224	221	8	not	not	PART
chd-224	221	9	using	use	VERB
chd-224	221	10	estrogen	estrogen	NOUN
chd-224	221	11	,	,	PUNCT
chd-224	221	12	non	non	ADJ
chd-224	221	13	-	-	ADJ
chd-224	221	14	hispanic	hispanic	ADJ
chd-224	221	15	european	european	ADJ
chd-224	221	16	americans	americans	PROPN
chd-224	221	17	had	have	VERB
chd-224	221	18	higher	high	ADJ
chd-224	221	19	baseline	baseline	NOUN
chd-224	221	20	total	total	ADJ
chd-224	221	21	and	and	CCONJ
chd-224	221	22	bioavailable	bioavailable	ADJ
chd-224	221	23	estradiol	estradiol	NOUN
chd-224	221	24	and	and	CCONJ
chd-224	221	25	testosterone	testosterone	NOUN
chd-224	221	26	levels	level	NOUN
chd-224	221	27	than	than	ADP
chd-224	221	28	hispanics	hispanic	NOUN
chd-224	221	29	,	,	PUNCT
chd-224	221	30	as	as	ADV
chd-224	221	31	well	well	ADV
chd-224	221	32	as	as	ADP
chd-224	221	33	higher	high	ADJ
chd-224	221	34	baseline	baseline	ADJ
chd-224	221	35	bioavailable	bioavailable	ADJ
chd-224	221	36	estradiol	estradiol	NOUN
chd-224	221	37	and	and	CCONJ
chd-224	221	38	lower	low	ADJ
chd-224	221	39	levels	level	NOUN
chd-224	221	40	of	of	ADP
chd-224	221	41	shbg	shbg	NOUN
chd-224	221	42	than	than	ADP
chd-224	221	43	african	african	ADJ
chd-224	221	44	americans	americans	PROPN
chd-224	221	45	(	(	PUNCT
chd-224	221	46	kim	kim	PROPN
chd-224	221	47	et	et	PROPN
chd-224	221	48	al	al	PROPN
chd-224	221	49	.	.	PROPN
chd-224	221	50	,	,	PUNCT
chd-224	221	51	2012	2012	NUM
chd-224	221	52	)	)	PUNCT
chd-224	221	53	.	.	PUNCT
chd-224	222	1	therefore	therefore	ADV
chd-224	222	2	,	,	PUNCT
chd-224	222	3	while	while	SCONJ
chd-224	222	4	sex	sex	NOUN
chd-224	222	5	differences	difference	NOUN
chd-224	222	6	exist	exist	VERB
chd-224	222	7	across	across	ADP
chd-224	222	8	all	all	DET
chd-224	222	9	racial	racial	ADJ
chd-224	222	10	/	/	SYM
chd-224	222	11	ethnic	ethnic	ADJ
chd-224	222	12	groups	group	NOUN
chd-224	222	13	,	,	PUNCT
chd-224	222	14	it	it	PRON
chd-224	222	15	is	be	AUX
chd-224	222	16	still	still	ADV
chd-224	222	17	possible	possible	ADJ
chd-224	222	18	that	that	SCONJ
chd-224	222	19	variations	variation	NOUN
chd-224	222	20	in	in	ADP
chd-224	222	21	androgen	androgen	NOUN
chd-224	222	22	and	and	CCONJ
chd-224	222	23	androgen	androgen	NOUN
chd-224	222	24	receptor	receptor	NOUN
chd-224	222	25	levels	level	NOUN
chd-224	222	26	between	between	ADP
chd-224	222	27	racial	racial	ADJ
chd-224	222	28	/	/	SYM
chd-224	222	29	ethnic	ethnic	ADJ
chd-224	222	30	groups	group	NOUN
chd-224	222	31	could	could	AUX
chd-224	222	32	contribute	contribute	VERB
chd-224	222	33	to	to	ADP
chd-224	222	34	the	the	DET
chd-224	222	35	racial	racial	ADJ
chd-224	222	36	/	/	SYM
chd-224	222	37	ethnic	ethnic	ADJ
chd-224	222	38	disparity	disparity	NOUN
chd-224	222	39	in	in	ADP
chd-224	222	40	thyroid	thyroid	NOUN
chd-224	222	41	cancer	cancer	NOUN
chd-224	222	42	.	.	PUNCT
chd-224	223	1	future	future	ADJ
chd-224	223	2	studies	study	NOUN
chd-224	223	3	are	be	AUX
chd-224	223	4	required	require	VERB
chd-224	223	5	to	to	PART
chd-224	223	6	investigate	investigate	VERB
chd-224	223	7	the	the	DET
chd-224	223	8	correlation	correlation	NOUN
chd-224	223	9	between	between	ADP
chd-224	223	10	androgen	androgen	NOUN
chd-224	223	11	and	and	CCONJ
chd-224	223	12	thyroid	thyroid	NOUN
chd-224	223	13	cancer	cancer	NOUN
chd-224	223	14	health	health	NOUN
chd-224	223	15	disparities	disparity	NOUN
chd-224	223	16	.	.	PUNCT
chd-224	224	1	3.6.3	3.6.3	X
chd-224	224	2	.	.	PUNCT
chd-224	225	1	autoimmunity	autoimmunity	NOUN
chd-224	225	2	in	in	ADP
chd-224	225	3	tc	tc	NOUN
chd-224	225	4	health	health	NOUN
chd-224	225	5	disparities	disparity	NOUN
chd-224	225	6	autoimmune	autoimmune	NOUN
chd-224	225	7	diseases	disease	NOUN
chd-224	225	8	(	(	PUNCT
chd-224	225	9	ad	ad	NOUN
chd-224	225	10	)	)	PUNCT
chd-224	225	11	are	be	AUX
chd-224	225	12	caused	cause	VERB
chd-224	225	13	by	by	ADP
chd-224	225	14	inflammation	inflammation	NOUN
chd-224	225	15	of	of	ADP
chd-224	225	16	organs	organ	NOUN
chd-224	225	17	due	due	ADJ
chd-224	225	18	to	to	ADP
chd-224	225	19	production	production	NOUN
chd-224	225	20	of	of	ADP
chd-224	225	21	antibodies	antibody	NOUN
chd-224	225	22	against	against	ADP
chd-224	225	23	self	self	NOUN
chd-224	225	24	-	-	PUNCT
chd-224	225	25	structures	structure	NOUN
chd-224	225	26	and	and	CCONJ
chd-224	225	27	cytotoxic	cytotoxic	ADJ
chd-224	225	28	action	action	NOUN
chd-224	225	29	of	of	ADP
chd-224	225	30	t	t	PROPN
chd-224	225	31	cells	cell	NOUN
chd-224	225	32	(	(	PUNCT
chd-224	225	33	fröhlich	fröhlich	PROPN
chd-224	225	34	and	and	CCONJ
chd-224	225	35	wahl	wahl	PROPN
chd-224	225	36	,	,	PUNCT
chd-224	225	37	2017	2017	NUM
chd-224	225	38	)	)	PUNCT
chd-224	225	39	.	.	PUNCT
chd-224	226	1	ad	ad	NOUN
chd-224	226	2	is	be	AUX
chd-224	226	3	prevalent	prevalent	ADJ
chd-224	226	4	in	in	ADP
chd-224	226	5	the	the	DET
chd-224	226	6	population	population	NOUN
chd-224	226	7	and	and	CCONJ
chd-224	226	8	is	be	AUX
chd-224	226	9	more	more	ADV
chd-224	226	10	common	common	ADJ
chd-224	226	11	in	in	ADP
chd-224	226	12	women	woman	NOUN
chd-224	226	13	(	(	PUNCT
chd-224	226	14	≥85	≥85	NOUN
chd-224	226	15	%	%	NOUN
chd-224	226	16	)	)	PUNCT
chd-224	226	17	than	than	ADP
chd-224	226	18	in	in	ADP
chd-224	226	19	men	man	NOUN
chd-224	226	20	.	.	PUNCT
chd-224	227	1	additionally	additionally	ADV
chd-224	227	2	,	,	PUNCT
chd-224	227	3	autoimmune	autoimmune	ADJ
chd-224	227	4	thyroid	thyroid	NOUN
chd-224	227	5	disease	disease	NOUN
chd-224	227	6	(	(	PUNCT
chd-224	227	7	aitd	aitd	ADJ
chd-224	227	8	)	)	PUNCT
chd-224	227	9	is	be	AUX
chd-224	227	10	one	one	NUM
chd-224	227	11	of	of	ADP
chd-224	227	12	the	the	DET
chd-224	227	13	most	most	ADV
chd-224	227	14	common	common	ADJ
chd-224	227	15	types	type	NOUN
chd-224	227	16	(	(	PUNCT
chd-224	227	17	fröhlich	fröhlich	PROPN
chd-224	227	18	and	and	CCONJ
chd-224	227	19	wahl	wahl	PROPN
chd-224	227	20	,	,	PUNCT
chd-224	227	21	2017	2017	NUM
chd-224	227	22	)	)	PUNCT
chd-224	227	23	.	.	PUNCT
chd-224	228	1	graves	grave	NOUN
chd-224	228	2	’	’	PART
chd-224	228	3	disease	disease	NOUN
chd-224	228	4	and	and	CCONJ
chd-224	228	5	hashimoto	hashimoto	NOUN
chd-224	228	6	’s	’s	PART
chd-224	228	7	thyroiditis	thyroiditis	NOUN
chd-224	228	8	(	(	PUNCT
chd-224	228	9	ht	ht	NOUN
chd-224	228	10	)	)	PUNCT
chd-224	228	11	are	be	AUX
chd-224	228	12	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-224	228	13	e12	e12	NOUN
chd-224	228	14	cancer	cancer	NOUN
chd-224	228	15	health	health	NOUN
chd-224	228	16	disparities	disparity	NOUN
chd-224	228	17	research	research	VERB
chd-224	228	18	examples	example	NOUN
chd-224	228	19	of	of	ADP
chd-224	228	20	thyroid	thyroid	NOUN
chd-224	228	21	autoimmune	autoimmune	NOUN
chd-224	228	22	diseases	disease	NOUN
chd-224	228	23	(	(	PUNCT
chd-224	228	24	umar	umar	PROPN
chd-224	228	25	et	et	PROPN
chd-224	228	26	al	al	PROPN
chd-224	228	27	.	.	PROPN
chd-224	228	28	,	,	PUNCT
chd-224	228	29	2010	2010	NUM
chd-224	228	30	)	)	PUNCT
chd-224	228	31	.	.	PUNCT
chd-224	229	1	in	in	ADP
chd-224	229	2	graves	grave	NOUN
chd-224	229	3	’	’	PART
chd-224	229	4	disease	disease	NOUN
chd-224	229	5	,	,	PUNCT
chd-224	229	6	hyperthyroidism	hyperthyroidism	NOUN
chd-224	229	7	(	(	PUNCT
chd-224	229	8	low	low	ADJ
chd-224	229	9	tsh	tsh	NOUN
chd-224	229	10	and	and	CCONJ
chd-224	229	11	elevated	elevated	ADJ
chd-224	229	12	free	free	ADJ
chd-224	229	13	t4	t4	PROPN
chd-224	229	14	concentrations	concentration	NOUN
chd-224	229	15	)	)	PUNCT
chd-224	229	16	is	be	AUX
chd-224	229	17	caused	cause	VERB
chd-224	229	18	by	by	ADP
chd-224	229	19	thyroid	thyroid	NOUN
chd-224	229	20	-	-	PUNCT
chd-224	229	21	stimulating	stimulate	VERB
chd-224	229	22	autoantibodies	autoantibody	NOUN
chd-224	229	23	to	to	ADP
chd-224	229	24	the	the	DET
chd-224	229	25	tsh	tsh	NOUN
chd-224	229	26	receptor	receptor	NOUN
chd-224	229	27	(	(	PUNCT
chd-224	229	28	tshr	tshr	NOUN
chd-224	229	29	)	)	PUNCT
chd-224	229	30	,	,	PUNCT
chd-224	229	31	which	which	PRON
chd-224	229	32	may	may	AUX
chd-224	229	33	lead	lead	VERB
chd-224	229	34	to	to	ADP
chd-224	229	35	hyperfunction	hyperfunction	NOUN
chd-224	229	36	of	of	ADP
chd-224	229	37	the	the	DET
chd-224	229	38	thyroid	thyroid	NOUN
chd-224	229	39	gland	gland	NOUN
chd-224	229	40	(	(	PUNCT
chd-224	229	41	umar	umar	PROPN
chd-224	229	42	et	et	PROPN
chd-224	229	43	al	al	PROPN
chd-224	229	44	.	.	PROPN
chd-224	229	45	,	,	PUNCT
chd-224	229	46	2010	2010	NUM
chd-224	229	47	)	)	PUNCT
chd-224	229	48	.	.	PUNCT
chd-224	230	1	after	after	ADP
chd-224	230	2	delivering	deliver	VERB
chd-224	230	3	a	a	DET
chd-224	230	4	baby	baby	NOUN
chd-224	230	5	,	,	PUNCT
chd-224	230	6	some	some	DET
chd-224	230	7	patients	patient	NOUN
chd-224	230	8	may	may	AUX
chd-224	230	9	develop	develop	VERB
chd-224	230	10	forms	form	NOUN
chd-224	230	11	of	of	ADP
chd-224	230	12	autoimmune	autoimmune	ADJ
chd-224	230	13	thyroid	thyroid	NOUN
chd-224	230	14	dysfunction	dysfunction	NOUN
chd-224	230	15	,	,	PUNCT
chd-224	230	16	such	such	ADJ
chd-224	230	17	as	as	ADP
chd-224	230	18	graves	grave	NOUN
chd-224	230	19	’	'	PUNCT
chd-224	230	20	disease	disease	NOUN
chd-224	230	21	(	(	PUNCT
chd-224	230	22	inaba	inaba	PROPN
chd-224	230	23	and	and	CCONJ
chd-224	230	24	akamizu	akamizu	PROPN
chd-224	230	25	,	,	PUNCT
chd-224	230	26	2000	2000	NUM
chd-224	230	27	)	)	PUNCT
chd-224	230	28	.	.	PUNCT
chd-224	231	1	another	another	PRON
chd-224	231	2	is	be	AUX
chd-224	231	3	postpartum	postpartum	ADJ
chd-224	231	4	thyroiditis	thyroiditis	NOUN
chd-224	231	5	,	,	PUNCT
chd-224	231	6	which	which	PRON
chd-224	231	7	is	be	AUX
chd-224	231	8	also	also	ADV
chd-224	231	9	believed	believe	VERB
chd-224	231	10	to	to	PART
chd-224	231	11	be	be	AUX
chd-224	231	12	an	an	DET
chd-224	231	13	autoimmune	autoimmune	ADJ
chd-224	231	14	disorder	disorder	NOUN
chd-224	231	15	,	,	PUNCT
chd-224	231	16	and	and	CCONJ
chd-224	231	17	its	its	PRON
chd-224	231	18	prevalence	prevalence	NOUN
chd-224	231	19	ranges	range	VERB
chd-224	231	20	from	from	ADP
chd-224	231	21	3	3	NUM
chd-224	231	22	to	to	PART
chd-224	231	23	8	8	NUM
chd-224	231	24	percent	percent	NOUN
chd-224	231	25	of	of	ADP
chd-224	231	26	all	all	DET
chd-224	231	27	pregnancies	pregnancy	NOUN
chd-224	231	28	(	(	PUNCT
chd-224	231	29	inaba	inaba	PROPN
chd-224	231	30	and	and	CCONJ
chd-224	231	31	akamizu	akamizu	PROPN
chd-224	231	32	,	,	PUNCT
chd-224	231	33	2000	2000	NUM
chd-224	231	34	)	)	PUNCT
chd-224	231	35	.	.	PUNCT
chd-224	232	1	it	it	PRON
chd-224	232	2	is	be	AUX
chd-224	232	3	painless	painless	ADJ
chd-224	232	4	and	and	CCONJ
chd-224	232	5	occurs	occur	VERB
chd-224	232	6	within	within	ADP
chd-224	232	7	6	6	NUM
chd-224	232	8	months	month	NOUN
chd-224	232	9	after	after	ADP
chd-224	232	10	pregnancy	pregnancy	NOUN
chd-224	232	11	,	,	PUNCT
chd-224	232	12	with	with	ADP
chd-224	232	13	a	a	DET
chd-224	232	14	return	return	NOUN
chd-224	232	15	to	to	ADP
chd-224	232	16	normal	normal	ADJ
chd-224	232	17	thyroid	thyroid	NOUN
chd-224	232	18	function	function	NOUN
chd-224	232	19	typically	typically	ADV
chd-224	232	20	within	within	ADP
chd-224	232	21	a	a	DET
chd-224	232	22	year	year	NOUN
chd-224	232	23	,	,	PUNCT
chd-224	232	24	although	although	SCONJ
chd-224	232	25	some	some	DET
chd-224	232	26	patients	patient	NOUN
chd-224	232	27	develop	develop	VERB
chd-224	232	28	permanent	permanent	ADJ
chd-224	232	29	hypothyroidism	hypothyroidism	NOUN
chd-224	232	30	as	as	ADP
chd-224	232	31	a	a	DET
chd-224	232	32	result	result	NOUN
chd-224	232	33	(	(	PUNCT
chd-224	232	34	inaba	inaba	PROPN
chd-224	232	35	and	and	CCONJ
chd-224	232	36	akamizu	akamizu	PROPN
chd-224	232	37	,	,	PUNCT
chd-224	232	38	2000	2000	NUM
chd-224	232	39	)	)	PUNCT
chd-224	232	40	.	.	PUNCT
chd-224	233	1	it	it	PRON
chd-224	233	2	is	be	AUX
chd-224	233	3	characterized	characterize	VERB
chd-224	233	4	by	by	ADP
chd-224	233	5	transient	transient	ADJ
chd-224	233	6	thyrotoxicosis	thyrotoxicosis	NOUN
chd-224	233	7	followed	follow	VERB
chd-224	233	8	by	by	ADP
chd-224	233	9	hypothyroidism	hypothyroidism	NOUN
chd-224	233	10	or	or	CCONJ
chd-224	233	11	by	by	ADP
chd-224	233	12	one	one	NUM
chd-224	233	13	or	or	CCONJ
chd-224	233	14	the	the	DET
chd-224	233	15	other	other	ADJ
chd-224	233	16	occurring	occur	VERB
chd-224	233	17	in	in	ADP
chd-224	233	18	the	the	DET
chd-224	233	19	first	first	ADJ
chd-224	233	20	year	year	NOUN
chd-224	233	21	after	after	ADP
chd-224	233	22	parturition	parturition	NOUN
chd-224	233	23	(	(	PUNCT
chd-224	233	24	inaba	inaba	PROPN
chd-224	233	25	and	and	CCONJ
chd-224	233	26	akamizu	akamizu	PROPN
chd-224	233	27	,	,	PUNCT
chd-224	233	28	2000	2000	NUM
chd-224	233	29	)	)	PUNCT
chd-224	233	30	.	.	PUNCT
chd-224	234	1	diagnostic	diagnostic	ADJ
chd-224	234	2	tests	test	NOUN
chd-224	234	3	reveal	reveal	VERB
chd-224	234	4	that	that	SCONJ
chd-224	234	5	serum	serum	NOUN
chd-224	234	6	tsh	tsh	NOUN
chd-224	234	7	is	be	AUX
chd-224	234	8	suppressed	suppress	VERB
chd-224	234	9	,	,	PUNCT
chd-224	234	10	associated	associate	VERB
chd-224	234	11	with	with	ADP
chd-224	234	12	an	an	DET
chd-224	234	13	increase	increase	NOUN
chd-224	234	14	in	in	ADP
chd-224	234	15	serum	serum	NOUN
chd-224	234	16	ft3	ft3	PROPN
chd-224	234	17	and	and	CCONJ
chd-224	234	18	ft4	ft4	PROPN
chd-224	234	19	levels	level	NOUN
chd-224	234	20	(	(	PUNCT
chd-224	234	21	inaba	inaba	PROPN
chd-224	234	22	and	and	CCONJ
chd-224	234	23	akamizu	akamizu	PROPN
chd-224	234	24	,	,	PUNCT
chd-224	234	25	2000	2000	NUM
chd-224	234	26	)	)	PUNCT
chd-224	234	27	.	.	PUNCT
chd-224	235	1	in	in	ADP
chd-224	235	2	ht	ht	PROPN
chd-224	235	3	,	,	PUNCT
chd-224	235	4	hypothyroidism	hypothyroidism	NOUN
chd-224	235	5	(	(	PUNCT
chd-224	235	6	elevated	elevated	ADJ
chd-224	235	7	tsh	tsh	NOUN
chd-224	235	8	and	and	CCONJ
chd-224	235	9	low	low	ADJ
chd-224	235	10	free	free	ADJ
chd-224	235	11	t4	t4	PROPN
chd-224	235	12	concentrations	concentration	NOUN
chd-224	235	13	)	)	PUNCT
chd-224	235	14	is	be	AUX
chd-224	235	15	associated	associate	VERB
chd-224	235	16	with	with	ADP
chd-224	235	17	thyroid	thyroid	NOUN
chd-224	235	18	peroxidase	peroxidase	NOUN
chd-224	235	19	and	and	CCONJ
chd-224	235	20	thyroglobulin	thyroglobulin	PROPN
chd-224	235	21	autoantibodies	autoantibody	NOUN
chd-224	235	22	(	(	PUNCT
chd-224	235	23	mclachlan	mclachlan	PROPN
chd-224	235	24	et	et	PROPN
chd-224	235	25	al	al	PROPN
chd-224	235	26	.	.	PROPN
chd-224	235	27	,	,	PUNCT
chd-224	235	28	2007	2007	NUM
chd-224	235	29	)	)	PUNCT
chd-224	235	30	,	,	PUNCT
chd-224	235	31	and	and	CCONJ
chd-224	235	32	is	be	AUX
chd-224	235	33	thought	think	VERB
chd-224	235	34	to	to	PART
chd-224	235	35	be	be	AUX
chd-224	235	36	caused	cause	VERB
chd-224	235	37	by	by	ADP
chd-224	235	38	a	a	DET
chd-224	235	39	tsh	tsh	NOUN
chd-224	235	40	stimulation	stimulation	NOUN
chd-224	235	41	-	-	PUNCT
chd-224	235	42	blocking	block	VERB
chd-224	235	43	antibody	antibody	NOUN
chd-224	235	44	(	(	PUNCT
chd-224	235	45	tsbab	tsbab	PROPN
chd-224	235	46	)	)	PUNCT
chd-224	235	47	which	which	PRON
chd-224	235	48	blocks	block	VERB
chd-224	235	49	the	the	DET
chd-224	235	50	action	action	NOUN
chd-224	235	51	of	of	ADP
chd-224	235	52	the	the	DET
chd-224	235	53	tsh	tsh	NOUN
chd-224	235	54	hormone	hormone	NOUN
chd-224	235	55	causing	cause	VERB
chd-224	235	56	damage	damage	NOUN
chd-224	235	57	to	to	ADP
chd-224	235	58	the	the	DET
chd-224	235	59	thyroid	thyroid	NOUN
chd-224	235	60	gland	gland	NOUN
chd-224	235	61	(	(	PUNCT
chd-224	235	62	umar	umar	PROPN
chd-224	235	63	et	et	PROPN
chd-224	235	64	al	al	PROPN
chd-224	235	65	.	.	PROPN
chd-224	235	66	,	,	PUNCT
chd-224	235	67	2010	2010	NUM
chd-224	235	68	)	)	PUNCT
chd-224	235	69	.	.	PUNCT
chd-224	236	1	retrospective	retrospective	ADJ
chd-224	236	2	pathological	pathological	ADJ
chd-224	236	3	studies	study	NOUN
chd-224	236	4	and	and	CCONJ
chd-224	236	5	fna	fna	NOUN
chd-224	236	6	cytological	cytological	ADJ
chd-224	236	7	studies	study	NOUN
chd-224	236	8	have	have	AUX
chd-224	236	9	shown	show	VERB
chd-224	236	10	an	an	DET
chd-224	236	11	association	association	NOUN
chd-224	236	12	between	between	ADP
chd-224	236	13	ht	ht	PROPN
chd-224	236	14	and	and	CCONJ
chd-224	236	15	papillary	papillary	ADJ
chd-224	236	16	thyroid	thyroid	NOUN
chd-224	236	17	carcinoma	carcinoma	NOUN
chd-224	236	18	(	(	PUNCT
chd-224	236	19	ptc	ptc	PROPN
chd-224	236	20	)	)	PUNCT
chd-224	236	21	(	(	PUNCT
chd-224	236	22	boi	boi	NOUN
chd-224	236	23	et	et	PROPN
chd-224	236	24	al	al	PROPN
chd-224	236	25	.	.	PROPN
chd-224	236	26	,	,	PUNCT
chd-224	236	27	2017	2017	NUM
chd-224	236	28	)	)	PUNCT
chd-224	236	29	.	.	PUNCT
chd-224	237	1	most	most	ADJ
chd-224	237	2	pathological	pathological	ADJ
chd-224	237	3	studies	study	NOUN
chd-224	237	4	showed	show	VERB
chd-224	237	5	high	high	ADJ
chd-224	237	6	prevalence	prevalence	NOUN
chd-224	237	7	of	of	ADP
chd-224	237	8	ptc	ptc	PROPN
chd-224	237	9	in	in	ADP
chd-224	237	10	ht	ht	PROPN
chd-224	237	11	(	(	PUNCT
chd-224	237	12	boi	boi	NOUN
chd-224	237	13	et	et	PROPN
chd-224	237	14	al	al	PROPN
chd-224	237	15	.	.	PROPN
chd-224	237	16	,	,	PUNCT
chd-224	237	17	2017	2017	NUM
chd-224	237	18	)	)	PUNCT
chd-224	237	19	.	.	PUNCT
chd-224	238	1	in	in	ADP
chd-224	238	2	most	most	ADJ
chd-224	238	3	fnac	fnac	PROPN
chd-224	238	4	studies	study	NOUN
chd-224	238	5	,	,	PUNCT
chd-224	238	6	increased	increase	VERB
chd-224	238	7	thyroid	thyroid	NOUN
chd-224	238	8	-	-	PUNCT
chd-224	238	9	stimulating	stimulate	VERB
chd-224	238	10	hormone	hormone	NOUN
chd-224	238	11	(	(	PUNCT
chd-224	238	12	tsh	tsh	NOUN
chd-224	238	13	)	)	PUNCT
chd-224	238	14	levels	level	NOUN
chd-224	238	15	were	be	AUX
chd-224	238	16	the	the	DET
chd-224	238	17	main	main	ADJ
chd-224	238	18	risk	risk	NOUN
chd-224	238	19	factor	factor	NOUN
chd-224	238	20	for	for	ADP
chd-224	238	21	malignancy	malignancy	NOUN
chd-224	238	22	(	(	PUNCT
chd-224	238	23	boi	boi	NOUN
chd-224	238	24	et	et	PROPN
chd-224	238	25	al	al	PROPN
chd-224	238	26	.	.	PROPN
chd-224	238	27	,	,	PUNCT
chd-224	238	28	2017	2017	NUM
chd-224	238	29	)	)	PUNCT
chd-224	238	30	.	.	PUNCT
chd-224	239	1	additionally	additionally	ADV
chd-224	239	2	,	,	PUNCT
chd-224	239	3	several	several	ADJ
chd-224	239	4	studies	study	NOUN
chd-224	239	5	have	have	AUX
chd-224	239	6	shown	show	VERB
chd-224	239	7	an	an	DET
chd-224	239	8	association	association	NOUN
chd-224	239	9	between	between	ADP
chd-224	239	10	chronic	chronic	ADJ
chd-224	239	11	inflammation	inflammation	NOUN
chd-224	239	12	and	and	CCONJ
chd-224	239	13	increased	increase	VERB
chd-224	239	14	risk	risk	NOUN
chd-224	239	15	of	of	ADP
chd-224	239	16	developing	develop	VERB
chd-224	239	17	differentiated	differentiated	ADJ
chd-224	239	18	thyroid	thyroid	NOUN
chd-224	239	19	cancers	cancer	NOUN
chd-224	239	20	(	(	PUNCT
chd-224	239	21	dtcs	dtcs	NOUN
chd-224	239	22	)	)	PUNCT
chd-224	239	23	(	(	PUNCT
chd-224	239	24	pagano	pagano	NOUN
chd-224	239	25	et	et	PROPN
chd-224	239	26	al	al	PROPN
chd-224	239	27	.	.	PROPN
chd-224	239	28	,	,	PUNCT
chd-224	239	29	2018	2018	NUM
chd-224	239	30	)	)	PUNCT
chd-224	239	31	.	.	PUNCT
chd-224	240	1	this	this	PRON
chd-224	240	2	suggests	suggest	VERB
chd-224	240	3	that	that	SCONJ
chd-224	240	4	the	the	DET
chd-224	240	5	inflammatory	inflammatory	ADJ
chd-224	240	6	microenvironment	microenvironment	NOUN
chd-224	240	7	is	be	AUX
chd-224	240	8	essential	essential	ADJ
chd-224	240	9	in	in	ADP
chd-224	240	10	cellular	cellular	ADJ
chd-224	240	11	transformation	transformation	NOUN
chd-224	240	12	and	and	CCONJ
chd-224	240	13	tumor	tumor	NOUN
chd-224	240	14	progression	progression	NOUN
chd-224	240	15	(	(	PUNCT
chd-224	240	16	pagano	pagano	NOUN
chd-224	240	17	et	et	PROPN
chd-224	240	18	al	al	PROPN
chd-224	240	19	.	.	PROPN
chd-224	240	20	,	,	PUNCT
chd-224	240	21	2018	2018	NUM
chd-224	240	22	)	)	PUNCT
chd-224	240	23	.	.	PUNCT
chd-224	241	1	it	it	PRON
chd-224	241	2	has	have	AUX
chd-224	241	3	been	be	AUX
chd-224	241	4	demonstrated	demonstrate	VERB
chd-224	241	5	that	that	SCONJ
chd-224	241	6	inflammatory	inflammatory	ADJ
chd-224	241	7	cells	cell	NOUN
chd-224	241	8	within	within	ADP
chd-224	241	9	the	the	DET
chd-224	241	10	cancer	cancer	NOUN
chd-224	241	11	site	site	NOUN
chd-224	241	12	and	and	CCONJ
chd-224	241	13	activation	activation	NOUN
chd-224	241	14	of	of	ADP
chd-224	241	15	oncoprotein	oncoprotein	ADJ
chd-224	241	16	-	-	PUNCT
chd-224	241	17	mediated	mediate	VERB
chd-224	241	18	signaling	signal	VERB
chd-224	241	19	in	in	ADP
chd-224	241	20	epithelial	epithelial	ADJ
chd-224	241	21	cancer	cancer	NOUN
chd-224	241	22	cells	cell	NOUN
chd-224	241	23	influence	influence	NOUN
chd-224	241	24	thyroid	thyroid	VERB
chd-224	241	25	cancer	cancer	NOUN
chd-224	241	26	progression	progression	NOUN
chd-224	241	27	(	(	PUNCT
chd-224	241	28	pagano	pagano	NOUN
chd-224	241	29	et	et	PROPN
chd-224	241	30	al	al	PROPN
chd-224	241	31	.	.	PROPN
chd-224	241	32	,	,	PUNCT
chd-224	241	33	2018	2018	NUM
chd-224	241	34	)	)	PUNCT
chd-224	241	35	.	.	PUNCT
chd-224	242	1	racial	racial	ADJ
chd-224	242	2	disparities	disparity	NOUN
chd-224	242	3	have	have	AUX
chd-224	242	4	been	be	AUX
chd-224	242	5	noted	note	VERB
chd-224	242	6	in	in	ADP
chd-224	242	7	autoimmune	autoimmune	ADJ
chd-224	242	8	thyroid	thyroid	NOUN
chd-224	242	9	conditions	condition	NOUN
chd-224	242	10	(	(	PUNCT
chd-224	242	11	table	table	NOUN
chd-224	242	12	2	2	NUM
chd-224	242	13	)	)	PUNCT
chd-224	242	14	.	.	PUNCT
chd-224	243	1	a	a	DET
chd-224	243	2	study	study	NOUN
chd-224	243	3	has	have	AUX
chd-224	243	4	shown	show	VERB
chd-224	243	5	that	that	SCONJ
chd-224	243	6	african	african	ADJ
chd-224	243	7	americans	americans	PROPN
chd-224	243	8	and	and	CCONJ
chd-224	243	9	asians	asians	PROPN
chd-224	243	10	are	be	AUX
chd-224	243	11	much	much	ADV
chd-224	243	12	more	more	ADV
chd-224	243	13	likely	likely	ADJ
chd-224	243	14	to	to	PART
chd-224	243	15	develop	develop	VERB
chd-224	243	16	graves	grave	NOUN
chd-224	243	17	’	'	PUNCT
chd-224	243	18	disease	disease	NOUN
chd-224	243	19	than	than	ADP
chd-224	243	20	european	european	PROPN
chd-224	243	21	americans	americans	PROPN
chd-224	243	22	(	(	PUNCT
chd-224	243	23	mcleod	mcleod	PROPN
chd-224	243	24	et	et	PROPN
chd-224	243	25	al	al	PROPN
chd-224	243	26	.	.	PROPN
chd-224	243	27	,	,	PUNCT
chd-224	243	28	2014	2014	NUM
chd-224	243	29	)	)	PUNCT
chd-224	243	30	.	.	PUNCT
chd-224	244	1	on	on	ADP
chd-224	244	2	the	the	DET
chd-224	244	3	other	other	ADJ
chd-224	244	4	hand	hand	NOUN
chd-224	244	5	,	,	PUNCT
chd-224	244	6	european	european	PROPN
chd-224	244	7	americans	americans	PROPN
chd-224	244	8	have	have	VERB
chd-224	244	9	a	a	DET
chd-224	244	10	greater	great	ADJ
chd-224	244	11	risk	risk	NOUN
chd-224	244	12	of	of	ADP
chd-224	244	13	developing	develop	VERB
chd-224	244	14	ht	ht	PROPN
chd-224	244	15	compared	compare	VERB
chd-224	244	16	to	to	ADP
chd-224	244	17	other	other	ADJ
chd-224	244	18	ethnic	ethnic	ADJ
chd-224	244	19	groups	group	NOUN
chd-224	244	20	(	(	PUNCT
chd-224	244	21	mcleod	mcleod	PROPN
chd-224	244	22	et	et	PROPN
chd-224	244	23	al	al	PROPN
chd-224	244	24	.	.	PROPN
chd-224	244	25	,	,	PUNCT
chd-224	244	26	2014	2014	NUM
chd-224	244	27	)	)	PUNCT
chd-224	244	28	.	.	PUNCT
chd-224	245	1	when	when	SCONJ
chd-224	245	2	evaluating	evaluate	VERB
chd-224	245	3	thyroid	thyroid	NOUN
chd-224	245	4	function	function	NOUN
chd-224	245	5	and	and	CCONJ
chd-224	245	6	autoimmunity	autoimmunity	NOUN
chd-224	245	7	in	in	ADP
chd-224	245	8	african	african	ADJ
chd-224	245	9	american	american	ADJ
chd-224	245	10	and	and	CCONJ
chd-224	245	11	european	european	ADJ
chd-224	245	12	american	american	ADJ
chd-224	245	13	women	woman	NOUN
chd-224	245	14	during	during	ADP
chd-224	245	15	pregnancy	pregnancy	NOUN
chd-224	245	16	and	and	CCONJ
chd-224	245	17	the	the	DET
chd-224	245	18	postpartum	postpartum	NOUN
chd-224	245	19	period	period	NOUN
chd-224	245	20	,	,	PUNCT
chd-224	245	21	another	another	DET
chd-224	245	22	study	study	NOUN
chd-224	245	23	found	find	VERB
chd-224	245	24	that	that	SCONJ
chd-224	245	25	african	african	ADJ
chd-224	245	26	american	american	ADJ
chd-224	245	27	women	woman	NOUN
chd-224	245	28	always	always	ADV
chd-224	245	29	had	have	VERB
chd-224	245	30	lower	low	ADJ
chd-224	245	31	tsh	tsh	NOUN
chd-224	245	32	values	value	NOUN
chd-224	245	33	than	than	ADP
chd-224	245	34	european	european	ADJ
chd-224	245	35	american	american	ADJ
chd-224	245	36	women	woman	NOUN
chd-224	245	37	(	(	PUNCT
chd-224	245	38	walker	walker	PROPN
chd-224	245	39	et	et	PROPN
chd-224	245	40	al	al	PROPN
chd-224	245	41	.	.	PROPN
chd-224	245	42	,	,	PUNCT
chd-224	245	43	2005	2005	NUM
chd-224	245	44	)	)	PUNCT
chd-224	245	45	.	.	PUNCT
chd-224	246	1	these	these	DET
chd-224	246	2	findings	finding	NOUN
chd-224	246	3	provide	provide	VERB
chd-224	246	4	awareness	awareness	NOUN
chd-224	246	5	of	of	ADP
chd-224	246	6	racial	racial	ADJ
chd-224	246	7	disparities	disparity	NOUN
chd-224	246	8	in	in	ADP
chd-224	246	9	thyroid	thyroid	NOUN
chd-224	246	10	autoimmune	autoimmune	ADJ
chd-224	246	11	disorders	disorder	NOUN
chd-224	246	12	.	.	PUNCT
chd-224	247	1	table	table	NOUN
chd-224	247	2	2	2	NUM
chd-224	247	3	.	.	PUNCT
chd-224	248	1	racial	racial	ADJ
chd-224	248	2	disparities	disparity	NOUN
chd-224	248	3	in	in	ADP
chd-224	248	4	autoimmune	autoimmune	ADJ
chd-224	248	5	thyroiditis	thyroiditis	NOUN
chd-224	248	6	.	.	PUNCT
chd-224	249	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-224	249	2	e13	e13	PROPN
chd-224	249	3	cancer	cancer	NOUN
chd-224	249	4	health	health	NOUN
chd-224	249	5	disparities	disparity	NOUN
chd-224	249	6	research	research	VERB
chd-224	249	7	european	european	PROPN
chd-224	249	8	americans	americans	PROPN
chd-224	249	9	(	(	PUNCT
chd-224	249	10	ea	ea	NOUN
chd-224	249	11	)	)	PUNCT
chd-224	249	12	african	african	ADJ
chd-224	249	13	americans	americans	PROPN
chd-224	249	14	(	(	PUNCT
chd-224	249	15	aa	aa	NOUN
chd-224	249	16	)	)	PUNCT
chd-224	249	17	asian	asian	PROPN
chd-224	249	18	americans	americans	PROPN
chd-224	249	19	graves	grave	VERB
chd-224	249	20	’	'	PUNCT
chd-224	249	21	disease	disease	NOUN
chd-224	249	22	(	(	PUNCT
chd-224	249	23	mcleod	mcleod	PROPN
chd-224	249	24	et	et	PROPN
chd-224	249	25	al	al	PROPN
chd-224	249	26	.	.	PROPN
chd-224	249	27	,	,	PUNCT
chd-224	249	28	2014	2014	NUM
chd-224	249	29	)	)	PUNCT
chd-224	249	30	less	less	ADV
chd-224	249	31	susceptible	susceptible	ADJ
chd-224	249	32	more	more	ADV
chd-224	249	33	susceptible	susceptible	ADJ
chd-224	249	34	more	more	ADV
chd-224	249	35	susceptible	susceptible	ADJ
chd-224	249	36	hashimoto	hashimoto	NOUN
chd-224	249	37	thyroiditis	thyroiditis	NOUN
chd-224	249	38	(	(	PUNCT
chd-224	249	39	mcleod	mcleod	PROPN
chd-224	249	40	et	et	PROPN
chd-224	249	41	al	al	PROPN
chd-224	249	42	.	.	PROPN
chd-224	249	43	,	,	PUNCT
chd-224	249	44	2014	2014	NUM
chd-224	249	45	)	)	PUNCT
chd-224	249	46	more	more	ADV
chd-224	249	47	susceptible	susceptible	ADJ
chd-224	249	48	less	less	ADV
chd-224	249	49	susceptible	susceptible	ADJ
chd-224	249	50	less	less	ADV
chd-224	249	51	susceptible	susceptible	ADJ
chd-224	249	52	pregnancy	pregnancy	NOUN
chd-224	249	53	/	/	SYM
chd-224	249	54	postpartum	postpartum	NOUN
chd-224	249	55	(	(	PUNCT
chd-224	249	56	walker	walker	PROPN
chd-224	249	57	et	et	PROPN
chd-224	249	58	al	al	PROPN
chd-224	249	59	.	.	PROPN
chd-224	249	60	,	,	PUNCT
chd-224	249	61	2005	2005	NUM
chd-224	249	62	)	)	PUNCT
chd-224	249	63	higher	high	ADJ
chd-224	249	64	tsh	tsh	NOUN
chd-224	249	65	values	value	NOUN
chd-224	249	66	compared	compare	VERB
chd-224	249	67	to	to	ADP
chd-224	249	68	aas	aas	VERB
chd-224	249	69	lower	low	ADJ
chd-224	249	70	tsh	tsh	NOUN
chd-224	249	71	values	value	NOUN
chd-224	249	72	compared	compare	VERB
chd-224	249	73	to	to	ADP
chd-224	249	74	eas	eas	PROPN
chd-224	249	75	3.6.4	3.6.4	NUM
chd-224	249	76	.	.	PUNCT
chd-224	250	1	thyroid	thyroid	PROPN
chd-224	250	2	nodule	nodule	NOUN
chd-224	250	3	size	size	NOUN
chd-224	250	4	in	in	ADP
chd-224	250	5	tc	tc	NOUN
chd-224	250	6	health	health	NOUN
chd-224	250	7	disparities	disparity	NOUN
chd-224	250	8	it	it	PRON
chd-224	250	9	is	be	AUX
chd-224	250	10	proposed	propose	VERB
chd-224	250	11	that	that	SCONJ
chd-224	250	12	the	the	DET
chd-224	250	13	dramatic	dramatic	ADJ
chd-224	250	14	increase	increase	NOUN
chd-224	250	15	in	in	ADP
chd-224	250	16	thyroid	thyroid	NOUN
chd-224	250	17	cancer	cancer	NOUN
chd-224	250	18	incidence	incidence	NOUN
chd-224	250	19	rates	rate	NOUN
chd-224	250	20	within	within	ADP
chd-224	250	21	the	the	DET
chd-224	250	22	last	last	ADJ
chd-224	250	23	few	few	ADJ
chd-224	250	24	decades	decade	NOUN
chd-224	250	25	could	could	AUX
chd-224	250	26	be	be	AUX
chd-224	250	27	due	due	ADJ
chd-224	250	28	to	to	ADP
chd-224	250	29	improved	improve	VERB
chd-224	250	30	diagnostic	diagnostic	ADJ
chd-224	250	31	techniques	technique	NOUN
chd-224	250	32	and	and	CCONJ
chd-224	250	33	the	the	DET
chd-224	250	34	introduction	introduction	NOUN
chd-224	250	35	of	of	ADP
chd-224	250	36	ultrasound	ultrasound	NOUN
chd-224	250	37	-	-	PUNCT
chd-224	250	38	guided	guide	VERB
chd-224	250	39	fineneedle	fineneedle	NOUN
chd-224	250	40	aspiration	aspiration	NOUN
chd-224	250	41	(	(	PUNCT
chd-224	250	42	us	us	NOUN
chd-224	250	43	-	-	PUNCT
chd-224	250	44	guided	guide	VERB
chd-224	250	45	fna	fna	NOUN
chd-224	250	46	)	)	PUNCT
chd-224	250	47	into	into	ADP
chd-224	250	48	the	the	DET
chd-224	250	49	united	united	PROPN
chd-224	250	50	states	states	PROPN
chd-224	250	51	healthcare	healthcare	NOUN
chd-224	250	52	system	system	NOUN
chd-224	250	53	in	in	ADP
chd-224	250	54	the	the	DET
chd-224	250	55	1990s	1990	NOUN
chd-224	250	56	,	,	PUNCT
chd-224	250	57	which	which	PRON
chd-224	250	58	aids	aid	VERB
chd-224	250	59	in	in	ADP
chd-224	250	60	detecting	detect	VERB
chd-224	250	61	tumors	tumor	NOUN
chd-224	250	62	that	that	PRON
chd-224	250	63	are	be	AUX
chd-224	250	64	not	not	PART
chd-224	250	65	easily	easily	ADV
chd-224	250	66	discovered	discover	VERB
chd-224	250	67	by	by	ADP
chd-224	250	68	palpation	palpation	NOUN
chd-224	250	69	(	(	PUNCT
chd-224	250	70	la	la	X
chd-224	250	71	vecchia	vecchia	PROPN
chd-224	250	72	et	et	PROPN
chd-224	250	73	al	al	PROPN
chd-224	250	74	.	.	PROPN
chd-224	250	75	,	,	PUNCT
chd-224	250	76	2015	2015	NUM
chd-224	250	77	;	;	PUNCT
chd-224	250	78	lim	lim	PROPN
chd-224	250	79	et	et	PROPN
chd-224	250	80	al	al	PROPN
chd-224	250	81	.	.	PROPN
chd-224	250	82	,	,	PUNCT
chd-224	250	83	2017	2017	NUM
chd-224	250	84	;	;	PUNCT
chd-224	250	85	tortolero	tortolero	NUM
chd-224	250	86	-	-	PUNCT
chd-224	250	87	luna	luna	PROPN
chd-224	250	88	et	et	PROPN
chd-224	250	89	al	al	PROPN
chd-224	250	90	.	.	PROPN
chd-224	250	91	,	,	PUNCT
chd-224	250	92	2019	2019	NUM
chd-224	250	93	;	;	PUNCT
chd-224	250	94	weeks	week	NOUN
chd-224	250	95	et	et	PROPN
chd-224	250	96	al	al	PROPN
chd-224	250	97	.	.	PROPN
chd-224	250	98	,	,	PUNCT
chd-224	250	99	2018	2018	NUM
chd-224	250	100	;	;	PUNCT
chd-224	250	101	zevallos	zevallos	X
chd-224	250	102	et	et	PROPN
chd-224	250	103	al	al	PROPN
chd-224	250	104	.	.	PROPN
chd-224	250	105	,	,	PUNCT
chd-224	250	106	2015	2015	NUM
chd-224	250	107	)	)	PUNCT
chd-224	250	108	.	.	PUNCT
chd-224	251	1	more	more	ADV
chd-224	251	2	sensitive	sensitive	ADJ
chd-224	251	3	diagnostic	diagnostic	ADJ
chd-224	251	4	procedures	procedure	NOUN
chd-224	251	5	,	,	PUNCT
chd-224	251	6	such	such	ADJ
chd-224	251	7	as	as	ADP
chd-224	251	8	ct	ct	NUM
chd-224	251	9	or	or	CCONJ
chd-224	251	10	mri	mri	NOUN
chd-224	251	11	scans	scan	NOUN
chd-224	251	12	(	(	PUNCT
chd-224	251	13	done	do	VERB
chd-224	251	14	for	for	ADP
chd-224	251	15	other	other	ADJ
chd-224	251	16	medical	medical	ADJ
chd-224	251	17	problems	problem	NOUN
chd-224	251	18	)	)	PUNCT
chd-224	251	19	,	,	PUNCT
chd-224	251	20	can	can	AUX
chd-224	251	21	detect	detect	VERB
chd-224	251	22	nonpalpable	nonpalpable	ADJ
chd-224	251	23	,	,	PUNCT
chd-224	251	24	incidental	incidental	ADJ
chd-224	251	25	thyroid	thyroid	NOUN
chd-224	251	26	nodules	nodule	NOUN
chd-224	251	27	(	(	PUNCT
chd-224	251	28	itns	itns	NOUN
chd-224	251	29	)	)	PUNCT
chd-224	251	30	that	that	PRON
chd-224	251	31	might	might	AUX
chd-224	251	32	not	not	PART
chd-224	251	33	otherwise	otherwise	ADV
chd-224	251	34	have	have	AUX
chd-224	251	35	been	be	AUX
chd-224	251	36	found	find	VERB
chd-224	251	37	in	in	ADP
chd-224	251	38	the	the	DET
chd-224	251	39	past	past	NOUN
chd-224	251	40	(	(	PUNCT
chd-224	251	41	fisher	fisher	PROPN
chd-224	251	42	and	and	CCONJ
chd-224	251	43	perrier	perrier	NOUN
chd-224	251	44	,	,	PUNCT
chd-224	251	45	2018	2018	NUM
chd-224	251	46	)	)	PUNCT
chd-224	251	47	.	.	PUNCT
chd-224	252	1	imaging	imaging	NOUN
chd-224	252	2	studies	study	NOUN
chd-224	252	3	can	can	AUX
chd-224	252	4	detect	detect	VERB
chd-224	252	5	up	up	ADP
chd-224	252	6	to	to	PART
chd-224	252	7	10	10	NUM
chd-224	252	8	times	time	NOUN
chd-224	252	9	more	more	ADJ
chd-224	252	10	nodules	nodule	NOUN
chd-224	252	11	than	than	ADP
chd-224	252	12	by	by	ADP
chd-224	252	13	palpation	palpation	NOUN
chd-224	252	14	,	,	PUNCT
chd-224	252	15	most	most	ADJ
chd-224	252	16	of	of	ADP
chd-224	252	17	which	which	PRON
chd-224	252	18	are	be	AUX
chd-224	252	19	benign	benign	ADJ
chd-224	252	20	(	(	PUNCT
chd-224	252	21	fisher	fisher	NOUN
chd-224	252	22	and	and	CCONJ
chd-224	252	23	perrier	perrier	NOUN
chd-224	252	24	,	,	PUNCT
chd-224	252	25	2018	2018	NUM
chd-224	252	26	)	)	PUNCT
chd-224	252	27	.	.	PUNCT
chd-224	253	1	approximately	approximately	ADV
chd-224	253	2	5	5	NUM
chd-224	253	3	to	to	PART
chd-224	253	4	15	15	NUM
chd-224	253	5	%	%	NOUN
chd-224	253	6	of	of	ADP
chd-224	253	7	nodules	nodule	NOUN
chd-224	253	8	are	be	AUX
chd-224	253	9	found	find	VERB
chd-224	253	10	to	to	PART
chd-224	253	11	be	be	AUX
chd-224	253	12	malignant	malignant	ADJ
chd-224	253	13	(	(	PUNCT
chd-224	253	14	alexander	alexander	PROPN
chd-224	253	15	et	et	PROPN
chd-224	253	16	al	al	PROPN
chd-224	253	17	.	.	PROPN
chd-224	253	18	,	,	PUNCT
chd-224	253	19	2012	2012	NUM
chd-224	253	20	)	)	PUNCT
chd-224	253	21	.	.	PUNCT
chd-224	254	1	for	for	ADP
chd-224	254	2	diagnostic	diagnostic	ADJ
chd-224	254	3	purposes	purpose	NOUN
chd-224	254	4	,	,	PUNCT
chd-224	254	5	nodules	nodule	NOUN
chd-224	254	6	1	1	NUM
chd-224	254	7	cm	cm	NOUN
chd-224	254	8	or	or	CCONJ
chd-224	254	9	larger	large	ADJ
chd-224	254	10	in	in	ADP
chd-224	254	11	diameter	diameter	NOUN
chd-224	254	12	prompt	prompt	PROPN
chd-224	254	13	diagnostic	diagnostic	ADJ
chd-224	254	14	us	us	PROPN
chd-224	254	15	-	-	PUNCT
chd-224	254	16	guided	guide	VERB
chd-224	254	17	fna	fna	NOUN
chd-224	254	18	,	,	PUNCT
chd-224	254	19	which	which	PRON
chd-224	254	20	is	be	AUX
chd-224	254	21	the	the	DET
chd-224	254	22	only	only	ADJ
chd-224	254	23	method	method	NOUN
chd-224	254	24	routinely	routinely	ADV
chd-224	254	25	used	use	VERB
chd-224	254	26	for	for	ADP
chd-224	254	27	thyroid	thyroid	NOUN
chd-224	254	28	nodule	nodule	NOUN
chd-224	254	29	evaluation	evaluation	NOUN
chd-224	254	30	(	(	PUNCT
chd-224	254	31	alexander	alexander	PROPN
chd-224	254	32	et	et	PROPN
chd-224	254	33	al	al	PROPN
chd-224	254	34	.	.	PROPN
chd-224	254	35	,	,	PUNCT
chd-224	254	36	2012	2012	NUM
chd-224	254	37	;	;	PUNCT
chd-224	254	38	yoon	yoon	PROPN
chd-224	254	39	et	et	PROPN
chd-224	254	40	al	al	PROPN
chd-224	254	41	.	.	PROPN
chd-224	254	42	,	,	PUNCT
chd-224	254	43	2014	2014	NUM
chd-224	254	44	)	)	PUNCT
chd-224	254	45	.	.	PUNCT
chd-224	255	1	however	however	ADV
chd-224	255	2	,	,	PUNCT
chd-224	255	3	about	about	ADV
chd-224	255	4	15	15	NUM
chd-224	255	5	to	to	PART
chd-224	255	6	30	30	NUM
chd-224	255	7	%	%	NOUN
chd-224	255	8	of	of	ADP
chd-224	255	9	thyroid	thyroid	NOUN
chd-224	255	10	nodules	nodule	NOUN
chd-224	255	11	evaluated	evaluate	VERB
chd-224	255	12	by	by	ADP
chd-224	255	13	fna	fna	NOUN
chd-224	255	14	are	be	AUX
chd-224	255	15	indeterminate	indeterminate	ADJ
chd-224	255	16	,	,	PUNCT
chd-224	255	17	so	so	CCONJ
chd-224	255	18	it	it	PRON
chd-224	255	19	is	be	AUX
chd-224	255	20	unclear	unclear	ADJ
chd-224	255	21	whether	whether	SCONJ
chd-224	255	22	they	they	PRON
chd-224	255	23	are	be	AUX
chd-224	255	24	benign	benign	ADJ
chd-224	255	25	or	or	CCONJ
chd-224	255	26	malignant	malignant	ADJ
chd-224	255	27	(	(	PUNCT
chd-224	255	28	alexander	alexander	PROPN
chd-224	255	29	et	et	PROPN
chd-224	255	30	al	al	PROPN
chd-224	255	31	.	.	PROPN
chd-224	255	32	,	,	PUNCT
chd-224	255	33	2012	2012	NUM
chd-224	255	34	)	)	PUNCT
chd-224	255	35	.	.	PUNCT
chd-224	256	1	indeterminate	indeterminate	ADJ
chd-224	256	2	nodules	nodule	NOUN
chd-224	256	3	are	be	AUX
chd-224	256	4	often	often	ADV
chd-224	256	5	referred	refer	VERB
chd-224	256	6	for	for	ADP
chd-224	256	7	diagnostic	diagnostic	ADJ
chd-224	256	8	surgery	surgery	NOUN
chd-224	256	9	,	,	PUNCT
chd-224	256	10	though	though	SCONJ
chd-224	256	11	most	most	ADJ
chd-224	256	12	of	of	ADP
chd-224	256	13	these	these	DET
chd-224	256	14	nodules	nodule	NOUN
chd-224	256	15	are	be	AUX
chd-224	256	16	shown	show	VERB
chd-224	256	17	to	to	PART
chd-224	256	18	be	be	AUX
chd-224	256	19	benign	benign	ADJ
chd-224	256	20	(	(	PUNCT
chd-224	256	21	alexander	alexander	PROPN
chd-224	256	22	et	et	PROPN
chd-224	256	23	al	al	PROPN
chd-224	256	24	.	.	PROPN
chd-224	256	25	,	,	PUNCT
chd-224	256	26	2012	2012	NUM
chd-224	256	27	)	)	PUNCT
chd-224	256	28	.	.	PUNCT
chd-224	257	1	this	this	PRON
chd-224	257	2	exposes	expose	VERB
chd-224	257	3	these	these	DET
chd-224	257	4	patients	patient	NOUN
chd-224	257	5	to	to	ADP
chd-224	257	6	a	a	DET
chd-224	257	7	2	2	NUM
chd-224	257	8	to	to	PART
chd-224	257	9	10	10	NUM
chd-224	257	10	%	%	NOUN
chd-224	257	11	risk	risk	NOUN
chd-224	257	12	of	of	ADP
chd-224	257	13	serious	serious	ADJ
chd-224	257	14	surgical	surgical	ADJ
chd-224	257	15	complications	complication	NOUN
chd-224	257	16	,	,	PUNCT
chd-224	257	17	and	and	CCONJ
chd-224	257	18	they	they	PRON
chd-224	257	19	could	could	AUX
chd-224	257	20	require	require	VERB
chd-224	257	21	thyroid	thyroid	NOUN
chd-224	257	22	hormone	hormone	NOUN
chd-224	257	23	replacement	replacement	NOUN
chd-224	257	24	therapy	therapy	NOUN
chd-224	257	25	for	for	ADP
chd-224	257	26	life	life	NOUN
chd-224	257	27	to	to	PART
chd-224	257	28	overcome	overcome	VERB
chd-224	257	29	hypothyroidism	hypothyroidism	NOUN
chd-224	257	30	(	(	PUNCT
chd-224	257	31	alexander	alexander	PROPN
chd-224	257	32	et	et	PROPN
chd-224	257	33	al	al	PROPN
chd-224	257	34	.	.	PROPN
chd-224	257	35	,	,	PUNCT
chd-224	257	36	2012	2012	NUM
chd-224	257	37	)	)	PUNCT
chd-224	257	38	.	.	PUNCT
chd-224	258	1	future	future	ADJ
chd-224	258	2	work	work	NOUN
chd-224	258	3	is	be	AUX
chd-224	258	4	needed	need	VERB
chd-224	258	5	for	for	ADP
chd-224	258	6	better	well	ADJ
chd-224	258	7	diagnostic	diagnostic	ADJ
chd-224	258	8	tools	tool	NOUN
chd-224	258	9	in	in	ADP
chd-224	258	10	preoperative	preoperative	ADJ
chd-224	258	11	diagnosis	diagnosis	NOUN
chd-224	258	12	of	of	ADP
chd-224	258	13	thyroid	thyroid	NOUN
chd-224	258	14	cancer	cancer	NOUN
chd-224	258	15	.	.	PUNCT
chd-224	259	1	autopsy	autopsy	ADJ
chd-224	259	2	studies	study	NOUN
chd-224	259	3	estimate	estimate	VERB
chd-224	259	4	that	that	SCONJ
chd-224	259	5	thyroid	thyroid	NOUN
chd-224	259	6	nodules	nodule	NOUN
chd-224	259	7	may	may	AUX
chd-224	259	8	be	be	AUX
chd-224	259	9	present	present	ADJ
chd-224	259	10	in	in	ADP
chd-224	259	11	up	up	ADP
chd-224	259	12	to	to	PART
chd-224	259	13	50	50	NUM
chd-224	259	14	%	%	NOUN
chd-224	259	15	to	to	PART
chd-224	259	16	60	60	NUM
chd-224	259	17	%	%	NOUN
chd-224	259	18	of	of	ADP
chd-224	259	19	all	all	DET
chd-224	259	20	adults	adult	NOUN
chd-224	259	21	(	(	PUNCT
chd-224	259	22	fisher	fisher	NOUN
chd-224	259	23	and	and	CCONJ
chd-224	259	24	perrier	perrier	NOUN
chd-224	259	25	,	,	PUNCT
chd-224	259	26	2018	2018	NUM
chd-224	259	27	)	)	PUNCT
chd-224	259	28	.	.	PUNCT
chd-224	260	1	women	woman	NOUN
chd-224	260	2	are	be	AUX
chd-224	260	3	more	more	ADV
chd-224	260	4	frequently	frequently	ADV
chd-224	260	5	affected	affect	VERB
chd-224	260	6	than	than	ADP
chd-224	260	7	men	man	NOUN
chd-224	260	8	(	(	PUNCT
chd-224	260	9	4:1	4:1	NUM
chd-224	260	10	)	)	PUNCT
chd-224	260	11	,	,	PUNCT
chd-224	260	12	and	and	CCONJ
chd-224	260	13	the	the	DET
chd-224	260	14	prevalence	prevalence	NOUN
chd-224	260	15	of	of	ADP
chd-224	260	16	thyroid	thyroid	NOUN
chd-224	260	17	nodules	nodule	NOUN
chd-224	260	18	in	in	ADP
chd-224	260	19	women	woman	NOUN
chd-224	260	20	increases	increase	VERB
chd-224	260	21	with	with	ADP
chd-224	260	22	age	age	NOUN
chd-224	260	23	(	(	PUNCT
chd-224	260	24	fisher	fisher	PROPN
chd-224	260	25	and	and	CCONJ
chd-224	260	26	perrier	perrier	NOUN
chd-224	260	27	,	,	PUNCT
chd-224	260	28	2018	2018	NUM
chd-224	260	29	)	)	PUNCT
chd-224	260	30	.	.	PUNCT
chd-224	261	1	studies	study	NOUN
chd-224	261	2	have	have	AUX
chd-224	261	3	been	be	AUX
chd-224	261	4	done	do	VERB
chd-224	261	5	exploring	explore	VERB
chd-224	261	6	ethnicities	ethnicity	NOUN
chd-224	261	7	affected	affect	VERB
chd-224	261	8	.	.	PUNCT
chd-224	262	1	zheng	zheng	PROPN
chd-224	262	2	et	et	PROPN
chd-224	262	3	al	al	PROPN
chd-224	262	4	.	.	PROPN
chd-224	262	5	showed	show	VERB
chd-224	262	6	that	that	SCONJ
chd-224	262	7	thyroid	thyroid	NOUN
chd-224	262	8	nodules	nodule	NOUN
chd-224	262	9	in	in	ADP
chd-224	262	10	african	african	ADJ
chd-224	262	11	americans	americans	PROPN
chd-224	262	12	had	have	VERB
chd-224	262	13	consistently	consistently	ADV
chd-224	262	14	lower	low	ADJ
chd-224	262	15	rates	rate	NOUN
chd-224	262	16	of	of	ADP
chd-224	262	17	harboring	harbor	VERB
chd-224	262	18	malignancy	malignancy	NOUN
chd-224	262	19	compared	compare	VERB
chd-224	262	20	to	to	ADP
chd-224	262	21	other	other	ADJ
chd-224	262	22	groups	group	NOUN
chd-224	262	23	(	(	PUNCT
chd-224	262	24	zheng	zheng	X
chd-224	262	25	et	et	PROPN
chd-224	262	26	al	al	PROPN
chd-224	262	27	.	.	PROPN
chd-224	262	28	,	,	PUNCT
chd-224	262	29	2022	2022	NUM
chd-224	262	30	)	)	PUNCT
chd-224	262	31	.	.	PUNCT
chd-224	263	1	among	among	ADP
chd-224	263	2	different	different	ADJ
chd-224	263	3	ethnic	ethnic	ADJ
chd-224	263	4	groups	group	NOUN
chd-224	263	5	represented	represent	VERB
chd-224	263	6	in	in	ADP
chd-224	263	7	the	the	DET
chd-224	263	8	study	study	NOUN
chd-224	263	9	,	,	PUNCT
chd-224	263	10	the	the	DET
chd-224	263	11	prevalence	prevalence	NOUN
chd-224	263	12	of	of	ADP
chd-224	263	13	thyroid	thyroid	NOUN
chd-224	263	14	malignancy	malignancy	NOUN
chd-224	263	15	was	be	AUX
chd-224	263	16	24.0	24.0	NUM
chd-224	263	17	%	%	NOUN
chd-224	263	18	of	of	ADP
chd-224	263	19	african	african	PROPN
chd-224	263	20	americans	americans	PROPN
chd-224	263	21	,	,	PUNCT
chd-224	263	22	52.1	52.1	NUM
chd-224	263	23	%	%	NOUN
chd-224	263	24	of	of	ADP
chd-224	263	25	caucasian	caucasian	PROPN
chd-224	263	26	americans	americans	PROPN
chd-224	263	27	,	,	PUNCT
chd-224	263	28	58.7	58.7	NUM
chd-224	263	29	%	%	NOUN
chd-224	263	30	of	of	ADP
chd-224	263	31	hispanic	hispanic	ADJ
chd-224	263	32	americans	americans	PROPN
chd-224	263	33	,	,	PUNCT
chd-224	263	34	and	and	CCONJ
chd-224	263	35	71.7	71.7	NUM
chd-224	263	36	%	%	NOUN
chd-224	263	37	of	of	ADP
chd-224	263	38	asian	asian	ADJ
chd-224	263	39	americans	americans	PROPN
chd-224	263	40	(	(	PUNCT
chd-224	263	41	zheng	zheng	X
chd-224	263	42	et	et	PROPN
chd-224	263	43	al	al	PROPN
chd-224	263	44	.	.	PROPN
chd-224	263	45	,	,	PUNCT
chd-224	263	46	2022	2022	NUM
chd-224	263	47	)	)	PUNCT
chd-224	263	48	.	.	PUNCT
chd-224	264	1	iwata	iwata	PROPN
chd-224	264	2	et	et	PROPN
chd-224	264	3	al	al	PROPN
chd-224	264	4	.	.	PROPN
chd-224	264	5	noted	note	VERB
chd-224	264	6	that	that	SCONJ
chd-224	264	7	african	african	ADJ
chd-224	264	8	americans	americans	PROPN
chd-224	264	9	have	have	VERB
chd-224	264	10	a	a	DET
chd-224	264	11	much	much	ADV
chd-224	264	12	lower	low	ADJ
chd-224	264	13	incidence	incidence	NOUN
chd-224	264	14	of	of	ADP
chd-224	264	15	thyroid	thyroid	NOUN
chd-224	264	16	cancer	cancer	NOUN
chd-224	264	17	than	than	ADP
chd-224	264	18	other	other	ADJ
chd-224	264	19	ethnic	ethnic	ADJ
chd-224	264	20	groups	group	NOUN
chd-224	264	21	despite	despite	SCONJ
chd-224	264	22	presenting	present	VERB
chd-224	264	23	with	with	ADP
chd-224	264	24	larger	large	ADJ
chd-224	264	25	nodules	nodule	NOUN
chd-224	264	26	,	,	PUNCT
chd-224	264	27	and	and	CCONJ
chd-224	264	28	european	european	PROPN
chd-224	264	29	americans	americans	PROPN
chd-224	264	30	have	have	VERB
chd-224	264	31	a	a	DET
chd-224	264	32	greater	great	ADJ
chd-224	264	33	risk	risk	NOUN
chd-224	264	34	(	(	PUNCT
chd-224	264	35	iwata	iwata	PROPN
chd-224	264	36	et	et	PROPN
chd-224	264	37	al	al	PROPN
chd-224	264	38	.	.	PROPN
chd-224	264	39	,	,	PUNCT
chd-224	264	40	2018	2018	NUM
chd-224	264	41	)	)	PUNCT
chd-224	264	42	.	.	PUNCT
chd-224	265	1	this	this	DET
chd-224	265	2	study	study	NOUN
chd-224	265	3	aimed	aim	VERB
chd-224	265	4	to	to	PART
chd-224	265	5	see	see	VERB
chd-224	265	6	if	if	SCONJ
chd-224	265	7	there	there	PRON
chd-224	265	8	was	be	VERB
chd-224	265	9	a	a	DET
chd-224	265	10	true	true	ADJ
chd-224	265	11	difference	difference	NOUN
chd-224	265	12	in	in	ADP
chd-224	265	13	the	the	DET
chd-224	265	14	thyroid	thyroid	NOUN
chd-224	265	15	cancer	cancer	NOUN
chd-224	265	16	rates	rate	NOUN
chd-224	265	17	between	between	ADP
chd-224	265	18	these	these	DET
chd-224	265	19	ethnicities	ethnicity	NOUN
chd-224	265	20	,	,	PUNCT
chd-224	265	21	or	or	CCONJ
chd-224	265	22	if	if	SCONJ
chd-224	265	23	socioeconomic	socioeconomic	ADJ
chd-224	265	24	status	status	NOUN
chd-224	265	25	perhaps	perhaps	ADV
chd-224	265	26	played	play	VERB
chd-224	265	27	a	a	DET
chd-224	265	28	role	role	NOUN
chd-224	265	29	(	(	PUNCT
chd-224	265	30	iwata	iwata	PROPN
chd-224	265	31	et	et	PROPN
chd-224	265	32	al	al	PROPN
chd-224	265	33	.	.	PROPN
chd-224	265	34	,	,	PUNCT
chd-224	265	35	2018	2018	NUM
chd-224	265	36	)	)	PUNCT
chd-224	265	37	.	.	PUNCT
chd-224	266	1	they	they	PRON
chd-224	266	2	found	find	VERB
chd-224	266	3	that	that	SCONJ
chd-224	266	4	european	european	PROPN
chd-224	266	5	americans	americans	PROPN
chd-224	266	6	have	have	VERB
chd-224	266	7	a	a	DET
chd-224	266	8	higher	high	ADJ
chd-224	266	9	incidence	incidence	NOUN
chd-224	266	10	not	not	PART
chd-224	266	11	only	only	ADV
chd-224	266	12	due	due	ADJ
chd-224	266	13	to	to	ADP
chd-224	266	14	diagnostic	diagnostic	ADJ
chd-224	266	15	bias	bias	NOUN
chd-224	266	16	,	,	PUNCT
chd-224	266	17	but	but	CCONJ
chd-224	266	18	also	also	ADV
chd-224	266	19	due	due	ADP
chd-224	266	20	to	to	ADP
chd-224	266	21	a	a	DET
chd-224	266	22	true	true	ADJ
chd-224	266	23	difference	difference	NOUN
chd-224	266	24	in	in	ADP
chd-224	266	25	cancer	cancer	NOUN
chd-224	266	26	prevalence	prevalence	NOUN
chd-224	266	27	(	(	PUNCT
chd-224	266	28	iwata	iwata	PROPN
chd-224	266	29	et	et	PROPN
chd-224	266	30	al	al	PROPN
chd-224	266	31	.	.	PROPN
chd-224	266	32	,	,	PUNCT
chd-224	266	33	2018	2018	NUM
chd-224	266	34	)	)	PUNCT
chd-224	266	35	.	.	PUNCT
chd-224	267	1	another	another	DET
chd-224	267	2	study	study	NOUN
chd-224	267	3	aimed	aim	VERB
chd-224	267	4	to	to	PART
chd-224	267	5	determine	determine	VERB
chd-224	267	6	whether	whether	SCONJ
chd-224	267	7	patients	patient	NOUN
chd-224	267	8	of	of	ADP
chd-224	267	9	filipino	filipino	ADJ
chd-224	267	10	descent	descent	NOUN
chd-224	267	11	are	be	AUX
chd-224	267	12	at	at	ADP
chd-224	267	13	increased	increase	VERB
chd-224	267	14	risk	risk	NOUN
chd-224	267	15	of	of	ADP
chd-224	267	16	thyroid	thyroid	NOUN
chd-224	267	17	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PART
chd-224	267	18	e14	e14	PROPN
chd-224	267	19	cancer	cancer	NOUN
chd-224	267	20	health	health	NOUN
chd-224	267	21	disparities	disparity	NOUN
chd-224	267	22	research	research	NOUN
chd-224	267	23	cancer	cancer	NOUN
chd-224	267	24	compared	compare	VERB
chd-224	267	25	to	to	ADP
chd-224	267	26	matched	match	VERB
chd-224	267	27	controls	control	NOUN
chd-224	267	28	(	(	PUNCT
chd-224	267	29	clark	clark	PROPN
chd-224	267	30	et	et	PROPN
chd-224	267	31	al	al	PROPN
chd-224	267	32	.	.	PROPN
chd-224	267	33	,	,	PUNCT
chd-224	267	34	2006	2006	NUM
chd-224	267	35	)	)	PUNCT
chd-224	267	36	.	.	PUNCT
chd-224	268	1	this	this	DET
chd-224	268	2	group	group	NOUN
chd-224	268	3	found	find	VERB
chd-224	268	4	that	that	SCONJ
chd-224	268	5	filipino	filipino	ADJ
chd-224	268	6	patients	patient	NOUN
chd-224	268	7	with	with	ADP
chd-224	268	8	thyroid	thyroid	NOUN
chd-224	268	9	nodules	nodule	NOUN
chd-224	268	10	are	be	AUX
chd-224	268	11	at	at	ADP
chd-224	268	12	significantly	significantly	ADV
chd-224	268	13	increased	increase	VERB
chd-224	268	14	risk	risk	NOUN
chd-224	268	15	.	.	PUNCT
chd-224	269	1	thus	thus	ADV
chd-224	269	2	,	,	PUNCT
chd-224	269	3	suspicion	suspicion	NOUN
chd-224	269	4	for	for	ADP
chd-224	269	5	malignancy	malignancy	NOUN
chd-224	269	6	should	should	AUX
chd-224	269	7	be	be	AUX
chd-224	269	8	high	high	ADJ
chd-224	269	9	when	when	SCONJ
chd-224	269	10	evaluating	evaluate	VERB
chd-224	269	11	these	these	DET
chd-224	269	12	patients	patient	NOUN
chd-224	269	13	.	.	PUNCT
chd-224	270	1	recently	recently	ADV
chd-224	270	2	,	,	PUNCT
chd-224	270	3	we	we	PRON
chd-224	270	4	showed	show	VERB
chd-224	270	5	a	a	DET
chd-224	270	6	differential	differential	ADJ
chd-224	270	7	expression	expression	NOUN
chd-224	270	8	of	of	ADP
chd-224	270	9	vitamin	vitamin	NOUN
chd-224	270	10	d	d	NOUN
chd-224	270	11	binding	bind	VERB
chd-224	270	12	protein	protein	NOUN
chd-224	270	13	(	(	PUNCT
chd-224	270	14	dbp	dbp	PROPN
chd-224	270	15	)	)	PUNCT
chd-224	270	16	in	in	ADP
chd-224	270	17	two	two	NUM
chd-224	270	18	different	different	ADJ
chd-224	270	19	ethnic	ethnic	ADJ
chd-224	270	20	groups	group	NOUN
chd-224	270	21	,	,	PUNCT
chd-224	270	22	which	which	PRON
chd-224	270	23	was	be	AUX
chd-224	270	24	related	relate	VERB
chd-224	270	25	to	to	ADP
chd-224	270	26	advanced	advanced	ADJ
chd-224	270	27	stage	stage	NOUN
chd-224	270	28	thyroid	thyroid	NOUN
chd-224	270	29	cancer	cancer	NOUN
chd-224	270	30	in	in	ADP
chd-224	270	31	filipino	filipino	PROPN
chd-224	270	32	americans	americans	PROPN
chd-224	270	33	compared	compare	VERB
chd-224	270	34	to	to	ADP
chd-224	270	35	european	european	PROPN
chd-224	270	36	americans	americans	PROPN
chd-224	270	37	(	(	PUNCT
chd-224	270	38	mull	mull	NOUN
chd-224	270	39	et	et	PROPN
chd-224	270	40	al	al	PROPN
chd-224	270	41	.	.	PROPN
chd-224	270	42	,	,	PUNCT
chd-224	270	43	2021	2021	NUM
chd-224	270	44	)	)	PUNCT
chd-224	270	45	;	;	PUNCT
chd-224	270	46	higher	high	ADJ
chd-224	270	47	dbp	dbp	PROPN
chd-224	270	48	expression	expression	NOUN
chd-224	270	49	in	in	ADP
chd-224	270	50	european	european	PROPN
chd-224	270	51	americans	americans	PROPN
chd-224	270	52	correlated	correlate	VERB
chd-224	270	53	to	to	ADP
chd-224	270	54	better	well	ADJ
chd-224	270	55	prognosis	prognosis	NOUN
chd-224	270	56	.	.	PUNCT
chd-224	271	1	we	we	PRON
chd-224	271	2	further	far	ADV
chd-224	271	3	demonstrated	demonstrate	VERB
chd-224	271	4	that	that	SCONJ
chd-224	271	5	differential	differential	ADJ
chd-224	271	6	small	small	ADJ
chd-224	271	7	non	non	ADJ
chd-224	271	8	-	-	ADJ
chd-224	271	9	coding	coding	ADJ
chd-224	271	10	rnas	rna	NOUN
chd-224	271	11	may	may	AUX
chd-224	271	12	potentially	potentially	ADV
chd-224	271	13	influence	influence	VERB
chd-224	271	14	the	the	DET
chd-224	271	15	poor	poor	ADJ
chd-224	271	16	prognosis	prognosis	NOUN
chd-224	271	17	in	in	ADP
chd-224	271	18	filipino	filipino	PROPN
chd-224	271	19	americans	americans	PROPN
chd-224	271	20	versus	versus	ADP
chd-224	271	21	european	european	PROPN
chd-224	271	22	americans	americans	PROPN
chd-224	271	23	(	(	PUNCT
chd-224	271	24	rood	rood	PROPN
chd-224	271	25	et	et	PROPN
chd-224	271	26	al	al	PROPN
chd-224	271	27	.	.	PROPN
chd-224	271	28	,	,	PUNCT
chd-224	271	29	2021	2021	NUM
chd-224	271	30	)	)	PUNCT
chd-224	271	31	.	.	PUNCT
chd-224	272	1	3.6.5	3.6.5	X
chd-224	272	2	.	.	PUNCT
chd-224	272	3	chromosomal	chromosomal	ADJ
chd-224	272	4	alterations	alteration	NOUN
chd-224	272	5	/	/	SYM
chd-224	272	6	non	non	ADJ
chd-224	272	7	-	-	ADJ
chd-224	272	8	hereditary	hereditary	ADJ
chd-224	272	9	conditions	condition	NOUN
chd-224	272	10	influencing	influence	VERB
chd-224	272	11	tc	tc	NUM
chd-224	272	12	health	health	NOUN
chd-224	272	13	disparities	disparity	NOUN
chd-224	272	14	although	although	SCONJ
chd-224	272	15	germline	germline	NOUN
chd-224	272	16	mutations	mutation	NOUN
chd-224	272	17	are	be	AUX
chd-224	272	18	very	very	ADV
chd-224	272	19	rare	rare	ADJ
chd-224	272	20	,	,	PUNCT
chd-224	272	21	somatic	somatic	ADJ
chd-224	272	22	mutations	mutation	NOUN
chd-224	272	23	play	play	VERB
chd-224	272	24	an	an	DET
chd-224	272	25	important	important	ADJ
chd-224	272	26	role	role	NOUN
chd-224	272	27	in	in	ADP
chd-224	272	28	thyroid	thyroid	NOUN
chd-224	272	29	cancer	cancer	NOUN
chd-224	272	30	oncogenesis	oncogenesis	NOUN
chd-224	272	31	.	.	PUNCT
chd-224	273	1	several	several	ADJ
chd-224	273	2	genetic	genetic	ADJ
chd-224	273	3	alterations	alteration	NOUN
chd-224	273	4	have	have	AUX
chd-224	273	5	been	be	AUX
chd-224	273	6	implicated	implicate	VERB
chd-224	273	7	in	in	ADP
chd-224	273	8	the	the	DET
chd-224	273	9	development	development	NOUN
chd-224	273	10	of	of	ADP
chd-224	273	11	thyroid	thyroid	NOUN
chd-224	273	12	cancer	cancer	NOUN
chd-224	273	13	,	,	PUNCT
chd-224	273	14	including	include	VERB
chd-224	273	15	activation	activation	NOUN
chd-224	273	16	of	of	ADP
chd-224	273	17	signaling	signal	VERB
chd-224	273	18	pathways	pathway	NOUN
chd-224	273	19	by	by	ADP
chd-224	273	20	either	either	CCONJ
chd-224	273	21	recombination	recombination	NOUN
chd-224	273	22	events	event	NOUN
chd-224	273	23	or	or	CCONJ
chd-224	273	24	point	point	NOUN
chd-224	273	25	mutations	mutation	NOUN
chd-224	273	26	,	,	PUNCT
chd-224	273	27	with	with	ADP
chd-224	273	28	some	some	DET
chd-224	273	29	mutations	mutation	NOUN
chd-224	273	30	associated	associate	VERB
chd-224	273	31	with	with	ADP
chd-224	273	32	more	more	ADV
chd-224	273	33	aggressive	aggressive	ADJ
chd-224	273	34	forms	form	NOUN
chd-224	273	35	(	(	PUNCT
chd-224	273	36	bogović	bogović	NOUN
chd-224	273	37	crnčić	crnčić	NOUN
chd-224	273	38	et	et	PROPN
chd-224	273	39	al	al	PROPN
chd-224	273	40	.	.	PROPN
chd-224	273	41	,	,	PUNCT
chd-224	273	42	2020	2020	NUM
chd-224	273	43	;	;	PUNCT
chd-224	273	44	yildirim	yildirim	PROPN
chd-224	273	45	simsir	simsir	VERB
chd-224	273	46	et	et	PROPN
chd-224	273	47	al	al	PROPN
chd-224	273	48	.	.	PROPN
chd-224	273	49	,	,	PUNCT
chd-224	273	50	2020	2020	NUM
chd-224	273	51	)	)	PUNCT
chd-224	273	52	.	.	PUNCT
chd-224	274	1	somatic	somatic	ADJ
chd-224	274	2	mutations	mutation	NOUN
chd-224	274	3	can	can	AUX
chd-224	274	4	cause	cause	VERB
chd-224	274	5	dysregulation	dysregulation	NOUN
chd-224	274	6	of	of	ADP
chd-224	274	7	mitogen	mitogen	NOUN
chd-224	274	8	-	-	PUNCT
chd-224	274	9	activated	activate	VERB
chd-224	274	10	protein	protein	NOUN
chd-224	274	11	kinases	kinase	NOUN
chd-224	274	12	(	(	PUNCT
chd-224	274	13	mapk	mapk	NOUN
chd-224	274	14	)	)	PUNCT
chd-224	274	15	,	,	PUNCT
chd-224	274	16	phosphoinositide	phosphoinositide	NOUN
chd-224	274	17	2	2	NUM
chd-224	274	18	kinase	kinase	PROPN
chd-224	274	19	-	-	PUNCT
chd-224	274	20	akt	akt	PROPN
chd-224	274	21	(	(	PUNCT
chd-224	274	22	pi3k	pi3k	PROPN
chd-224	274	23	-	-	PUNCT
chd-224	274	24	akt	akt	PROPN
chd-224	274	25	)	)	PUNCT
chd-224	274	26	,	,	PUNCT
chd-224	274	27	and	and	CCONJ
chd-224	274	28	wingless	wingless	NOUN
chd-224	274	29	-	-	PUNCT
chd-224	274	30	related	relate	VERB
chd-224	274	31	integration	integration	NOUN
chd-224	274	32	site	site	NOUN
chd-224	274	33	(	(	PUNCT
chd-224	274	34	wnt	wnt	PROPN
chd-224	274	35	)	)	PUNCT
chd-224	274	36	cell	cell	NOUN
chd-224	274	37	signaling	signal	VERB
chd-224	274	38	pathways	pathway	NOUN
chd-224	274	39	(	(	PUNCT
chd-224	274	40	singh	singh	PROPN
chd-224	274	41	et	et	PROPN
chd-224	274	42	al	al	PROPN
chd-224	274	43	.	.	PROPN
chd-224	274	44	,	,	PUNCT
chd-224	274	45	2021	2021	NUM
chd-224	274	46	)	)	PUNCT
chd-224	274	47	.	.	PUNCT
chd-224	275	1	they	they	PRON
chd-224	275	2	are	be	AUX
chd-224	275	3	some	some	PRON
chd-224	275	4	of	of	ADP
chd-224	275	5	the	the	DET
chd-224	275	6	most	most	ADV
chd-224	275	7	common	common	ADJ
chd-224	275	8	pathways	pathway	NOUN
chd-224	275	9	associated	associate	VERB
chd-224	275	10	with	with	ADP
chd-224	275	11	thyroid	thyroid	NOUN
chd-224	275	12	cancer	cancer	NOUN
chd-224	275	13	(	(	PUNCT
chd-224	275	14	singh	singh	PROPN
chd-224	275	15	et	et	PROPN
chd-224	275	16	al	al	PROPN
chd-224	275	17	.	.	PROPN
chd-224	275	18	,	,	PUNCT
chd-224	275	19	2021	2021	NUM
chd-224	275	20	)	)	PUNCT
chd-224	275	21	.	.	PUNCT
chd-224	276	1	both	both	PRON
chd-224	276	2	mapk	mapk	NOUN
chd-224	276	3	and	and	CCONJ
chd-224	276	4	pi3k	pi3k	PROPN
chd-224	276	5	-	-	PUNCT
chd-224	276	6	akt	akt	PROPN
chd-224	276	7	pathways	pathway	NOUN
chd-224	276	8	are	be	AUX
chd-224	276	9	coupled	couple	VERB
chd-224	276	10	to	to	ADP
chd-224	276	11	the	the	DET
chd-224	276	12	cell	cell	NOUN
chd-224	276	13	membrane	membrane	NOUN
chd-224	276	14	receptor	receptor	NOUN
chd-224	276	15	tyrosine	tyrosine	PROPN
chd-224	276	16	kinase	kinase	PROPN
chd-224	276	17	(	(	PUNCT
chd-224	276	18	rtk	rtk	PROPN
chd-224	276	19	)	)	PUNCT
chd-224	276	20	,	,	PUNCT
chd-224	276	21	which	which	PRON
chd-224	276	22	leads	lead	VERB
chd-224	276	23	to	to	ADP
chd-224	276	24	downstream	downstream	VERB
chd-224	276	25	intracellular	intracellular	ADJ
chd-224	276	26	signaling	signal	VERB
chd-224	276	27	and	and	CCONJ
chd-224	276	28	ultimately	ultimately	ADV
chd-224	276	29	activation	activation	NOUN
chd-224	276	30	and	and	CCONJ
chd-224	276	31	deactivation	deactivation	NOUN
chd-224	276	32	of	of	ADP
chd-224	276	33	genes	gene	NOUN
chd-224	276	34	related	relate	VERB
chd-224	276	35	to	to	ADP
chd-224	276	36	cell	cell	NOUN
chd-224	276	37	growth	growth	NOUN
chd-224	276	38	,	,	PUNCT
chd-224	276	39	proliferation	proliferation	NOUN
chd-224	276	40	,	,	PUNCT
chd-224	276	41	and	and	CCONJ
chd-224	276	42	survival	survival	NOUN
chd-224	276	43	(	(	PUNCT
chd-224	276	44	xing	xing	PROPN
chd-224	276	45	et	et	PROPN
chd-224	276	46	al	al	PROPN
chd-224	276	47	.	.	PROPN
chd-224	276	48	,	,	PUNCT
chd-224	276	49	2013	2013	NUM
chd-224	276	50	)	)	PUNCT
chd-224	276	51	.	.	PUNCT
chd-224	277	1	the	the	DET
chd-224	277	2	wnt	wnt	PROPN
chd-224	277	3	pathway	pathway	NOUN
chd-224	277	4	similarly	similarly	ADV
chd-224	277	5	leads	lead	VERB
chd-224	277	6	to	to	ADP
chd-224	277	7	disordered	disordered	ADJ
chd-224	277	8	cellular	cellular	ADJ
chd-224	277	9	growth	growth	NOUN
chd-224	277	10	by	by	ADP
chd-224	277	11	preventing	prevent	VERB
chd-224	277	12	degradation	degradation	NOUN
chd-224	277	13	of	of	ADP
chd-224	277	14	β	β	NOUN
chd-224	277	15	-	-	NOUN
chd-224	277	16	catenin	catenin	ADJ
chd-224	277	17	,	,	PUNCT
chd-224	277	18	thus	thus	ADV
chd-224	277	19	allowing	allow	VERB
chd-224	277	20	its	its	PRON
chd-224	277	21	localization	localization	NOUN
chd-224	277	22	into	into	ADP
chd-224	277	23	the	the	DET
chd-224	277	24	nucleus	nucleus	NOUN
chd-224	277	25	and	and	CCONJ
chd-224	277	26	subsequent	subsequent	ADJ
chd-224	277	27	activation	activation	NOUN
chd-224	277	28	of	of	ADP
chd-224	277	29	transcription	transcription	NOUN
chd-224	277	30	factors	factor	NOUN
chd-224	277	31	involved	involve	VERB
chd-224	277	32	in	in	ADP
chd-224	277	33	cellular	cellular	ADJ
chd-224	277	34	proliferation	proliferation	NOUN
chd-224	277	35	and	and	CCONJ
chd-224	277	36	cell	cell	NOUN
chd-224	277	37	-	-	PUNCT
chd-224	277	38	cell	cell	NOUN
chd-224	277	39	adhesion	adhesion	NOUN
chd-224	277	40	(	(	PUNCT
chd-224	277	41	pai	pai	NOUN
chd-224	277	42	et	et	NOUN
chd-224	277	43	al	al	PROPN
chd-224	277	44	.	.	PROPN
chd-224	277	45	,	,	PUNCT
chd-224	277	46	2017	2017	NUM
chd-224	277	47	)	)	PUNCT
chd-224	277	48	.	.	PUNCT
chd-224	278	1	activating	activate	VERB
chd-224	278	2	point	point	NOUN
chd-224	278	3	mutations	mutation	NOUN
chd-224	278	4	of	of	ADP
chd-224	278	5	ras	ra	NOUN
chd-224	278	6	and	and	CCONJ
chd-224	278	7	braf	braf	NOUN
chd-224	278	8	and	and	CCONJ
chd-224	278	9	rearrangements	rearrangement	NOUN
chd-224	278	10	of	of	ADP
chd-224	278	11	ret	ret	PROPN
chd-224	278	12	/	/	SYM
chd-224	278	13	ptc	ptc	PROPN
chd-224	278	14	and	and	CCONJ
chd-224	278	15	ntrk	ntrk	NOUN
chd-224	278	16	genes	gene	NOUN
chd-224	278	17	within	within	ADP
chd-224	278	18	the	the	DET
chd-224	278	19	mapk	mapk	NOUN
chd-224	278	20	pathway	pathway	NOUN
chd-224	278	21	,	,	PUNCT
chd-224	278	22	are	be	AUX
chd-224	278	23	common	common	ADJ
chd-224	278	24	drivers	driver	NOUN
chd-224	278	25	of	of	ADP
chd-224	278	26	papillary	papillary	ADJ
chd-224	278	27	thyroid	thyroid	NOUN
chd-224	278	28	cancer	cancer	NOUN
chd-224	278	29	(	(	PUNCT
chd-224	278	30	ptc	ptc	PROPN
chd-224	278	31	)	)	PUNCT
chd-224	278	32	.	.	PUNCT
chd-224	279	1	in	in	ADP
chd-224	279	2	contrast	contrast	NOUN
chd-224	279	3	,	,	PUNCT
chd-224	279	4	follicular	follicular	ADJ
chd-224	279	5	thyroid	thyroid	NOUN
chd-224	279	6	cancer	cancer	NOUN
chd-224	279	7	(	(	PUNCT
chd-224	279	8	ftc	ftc	PROPN
chd-224	279	9	)	)	PUNCT
chd-224	279	10	frequently	frequently	ADV
chd-224	279	11	has	have	VERB
chd-224	279	12	alterations	alteration	NOUN
chd-224	279	13	of	of	ADP
chd-224	279	14	the	the	DET
chd-224	279	15	pi3kakt	pi3kakt	PROPN
chd-224	279	16	pathway	pathway	NOUN
chd-224	279	17	such	such	ADJ
chd-224	279	18	as	as	ADP
chd-224	279	19	activating	activate	VERB
chd-224	279	20	mutations	mutation	NOUN
chd-224	279	21	of	of	ADP
chd-224	279	22	pik3ca	pik3ca	NOUN
chd-224	279	23	,	,	PUNCT
chd-224	279	24	ras	ras	NOUN
chd-224	279	25	,	,	PUNCT
chd-224	279	26	and	and	CCONJ
chd-224	279	27	akt1	akt1	PROPN
chd-224	279	28	,	,	PUNCT
chd-224	279	29	and	and	CCONJ
chd-224	279	30	deactivating	deactivate	VERB
chd-224	279	31	mutations	mutation	NOUN
chd-224	279	32	of	of	ADP
chd-224	279	33	pten	pten	NOUN
chd-224	279	34	.	.	PUNCT
chd-224	280	1	other	other	ADJ
chd-224	280	2	mutations	mutation	NOUN
chd-224	280	3	such	such	ADJ
chd-224	280	4	as	as	ADP
chd-224	280	5	p53	p53	NOUN
chd-224	280	6	and	and	CCONJ
chd-224	280	7	tert	tert	NOUN
chd-224	280	8	promoter	promoter	NOUN
chd-224	280	9	mutations	mutation	NOUN
chd-224	280	10	,	,	PUNCT
chd-224	280	11	and	and	CCONJ
chd-224	280	12	wnt	wnt	PROPN
chd-224	280	13	/	/	SYM
chd-224	280	14	β	β	NOUN
chd-224	280	15	-	-	ADJ
chd-224	280	16	catenin	catenin	ADJ
chd-224	280	17	pathway	pathway	NOUN
chd-224	280	18	alterations	alteration	NOUN
chd-224	280	19	have	have	AUX
chd-224	280	20	been	be	AUX
chd-224	280	21	implicated	implicate	VERB
chd-224	280	22	in	in	ADP
chd-224	280	23	thyroid	thyroid	NOUN
chd-224	280	24	cancer	cancer	NOUN
chd-224	280	25	disease	disease	NOUN
chd-224	280	26	progression	progression	NOUN
chd-224	280	27	and	and	CCONJ
chd-224	280	28	dedifferentiation	dedifferentiation	NOUN
chd-224	280	29	(	(	PUNCT
chd-224	280	30	prete	prete	NOUN
chd-224	280	31	et	et	PROPN
chd-224	280	32	al	al	PROPN
chd-224	280	33	.	.	PROPN
chd-224	280	34	,	,	PUNCT
chd-224	280	35	2020	2020	NUM
chd-224	280	36	)	)	PUNCT
chd-224	280	37	.	.	PUNCT
chd-224	281	1	there	there	PRON
chd-224	281	2	are	be	VERB
chd-224	281	3	few	few	ADJ
chd-224	281	4	studies	study	NOUN
chd-224	281	5	comparing	compare	VERB
chd-224	281	6	the	the	DET
chd-224	281	7	prevalence	prevalence	NOUN
chd-224	281	8	of	of	ADP
chd-224	281	9	these	these	DET
chd-224	281	10	mutations	mutation	NOUN
chd-224	281	11	across	across	ADP
chd-224	281	12	different	different	ADJ
chd-224	281	13	racial	racial	ADJ
chd-224	281	14	/	/	SYM
chd-224	281	15	ethnic	ethnic	ADJ
chd-224	281	16	groups	group	NOUN
chd-224	281	17	.	.	PUNCT
chd-224	282	1	one	one	NUM
chd-224	282	2	study	study	NOUN
chd-224	282	3	evaluated	evaluate	VERB
chd-224	282	4	radioiodine	radioiodine	NOUN
chd-224	282	5	refractory	refractory	NOUN
chd-224	282	6	thyroid	thyroid	NOUN
chd-224	282	7	(	(	PUNCT
chd-224	282	8	rair	rair	NOUN
chd-224	282	9	)	)	PUNCT
chd-224	282	10	cancers	cancer	NOUN
chd-224	282	11	and	and	CCONJ
chd-224	282	12	found	find	VERB
chd-224	282	13	that	that	SCONJ
chd-224	282	14	european	european	ADJ
chd-224	282	15	race	race	NOUN
chd-224	282	16	/	/	SYM
chd-224	282	17	ethnicity	ethnicity	NOUN
chd-224	282	18	was	be	AUX
chd-224	282	19	associated	associate	VERB
chd-224	282	20	with	with	ADP
chd-224	282	21	a	a	DET
chd-224	282	22	reduced	reduce	VERB
chd-224	282	23	odds	odd	NOUN
chd-224	282	24	ratio	ratio	NOUN
chd-224	282	25	of	of	ADP
chd-224	282	26	radioiodine	radioiodine	NOUN
chd-224	282	27	refractoriness	refractoriness	NOUN
chd-224	282	28	(	(	PUNCT
chd-224	282	29	shobab	shobab	PROPN
chd-224	282	30	et	et	PROPN
chd-224	282	31	al	al	PROPN
chd-224	282	32	.	.	PROPN
chd-224	282	33	,	,	PUNCT
chd-224	282	34	2019	2019	NUM
chd-224	282	35	)	)	PUNCT
chd-224	282	36	.	.	PUNCT
chd-224	283	1	additionally	additionally	ADV
chd-224	283	2	,	,	PUNCT
chd-224	283	3	50	50	NUM
chd-224	283	4	%	%	NOUN
chd-224	283	5	of	of	ADP
chd-224	283	6	patients	patient	NOUN
chd-224	283	7	with	with	ADP
chd-224	283	8	rair	rair	NOUN
chd-224	283	9	had	have	VERB
chd-224	283	10	mutations	mutation	NOUN
chd-224	283	11	in	in	ADP
chd-224	283	12	the	the	DET
chd-224	283	13	ras	ras	PROPN
chd-224	283	14	/	/	SYM
chd-224	283	15	raf	raf	PROPN
chd-224	283	16	pathway	pathway	NOUN
chd-224	283	17	;	;	PUNCT
chd-224	283	18	however	however	ADV
chd-224	283	19	,	,	PUNCT
chd-224	283	20	the	the	DET
chd-224	283	21	prevalence	prevalence	NOUN
chd-224	283	22	of	of	ADP
chd-224	283	23	ras	ras	PROPN
chd-224	283	24	/	/	SYM
chd-224	283	25	raf	raf	PROPN
chd-224	283	26	mutation	mutation	NOUN
chd-224	283	27	within	within	ADP
chd-224	283	28	europeans	europeans	PROPN
chd-224	283	29	was	be	AUX
chd-224	283	30	not	not	PART
chd-224	283	31	directly	directly	ADV
chd-224	283	32	measured	measure	VERB
chd-224	283	33	(	(	PUNCT
chd-224	283	34	shobab	shobab	PROPN
chd-224	283	35	et	et	PROPN
chd-224	283	36	al	al	PROPN
chd-224	283	37	.	.	PROPN
chd-224	283	38	,	,	PUNCT
chd-224	283	39	2019	2019	NUM
chd-224	283	40	)	)	PUNCT
chd-224	283	41	.	.	PUNCT
chd-224	284	1	another	another	DET
chd-224	284	2	study	study	NOUN
chd-224	284	3	performed	perform	VERB
chd-224	284	4	whole	whole	ADJ
chd-224	284	5	-	-	PUNCT
chd-224	284	6	genome	genome	NOUN
chd-224	284	7	genotyping	genotyping	NOUN
chd-224	284	8	on	on	ADP
chd-224	284	9	european	european	ADJ
chd-224	284	10	and	and	CCONJ
chd-224	284	11	african	african	ADJ
chd-224	284	12	american	american	ADJ
chd-224	284	13	patients	patient	NOUN
chd-224	284	14	with	with	ADP
chd-224	284	15	rair	rair	NOUN
chd-224	284	16	and	and	CCONJ
chd-224	284	17	found	find	VERB
chd-224	284	18	that	that	SCONJ
chd-224	284	19	the	the	DET
chd-224	284	20	thyroglobulin	thyroglobulin	PROPN
chd-224	284	21	,	,	PUNCT
chd-224	284	22	brca1	brca1	PROPN
chd-224	284	23	,	,	PUNCT
chd-224	284	24	and	and	CCONJ
chd-224	284	25	the	the	DET
chd-224	284	26	nsmce2	nsmce2	NOUN
chd-224	284	27	haplotypes	haplotype	NOUN
chd-224	284	28	were	be	AUX
chd-224	284	29	uniquely	uniquely	ADV
chd-224	284	30	associated	associate	VERB
chd-224	284	31	with	with	ADP
chd-224	284	32	african	african	ADJ
chd-224	284	33	americans	americans	PROPN
chd-224	284	34	(	(	PUNCT
chd-224	284	35	hurst	hurst	PROPN
chd-224	284	36	et	et	PROPN
chd-224	284	37	al	al	PROPN
chd-224	284	38	.	.	PROPN
chd-224	284	39	,	,	PUNCT
chd-224	284	40	2019	2019	NUM
chd-224	284	41	)	)	PUNCT
chd-224	284	42	.	.	PUNCT
chd-224	285	1	differences	difference	NOUN
chd-224	285	2	in	in	ADP
chd-224	285	3	mutation	mutation	NOUN
chd-224	285	4	can	can	AUX
chd-224	285	5	explain	explain	VERB
chd-224	285	6	the	the	DET
chd-224	285	7	established	establish	VERB
chd-224	285	8	differences	difference	NOUN
chd-224	285	9	in	in	ADP
chd-224	285	10	the	the	DET
chd-224	285	11	incidence	incidence	NOUN
chd-224	285	12	of	of	ADP
chd-224	285	13	thyroid	thyroid	NOUN
chd-224	285	14	cancer	cancer	NOUN
chd-224	285	15	among	among	ADP
chd-224	285	16	racial	racial	ADJ
chd-224	285	17	/	/	SYM
chd-224	285	18	ethnic	ethnic	ADJ
chd-224	285	19	groups	group	NOUN
chd-224	285	20	.	.	PUNCT
chd-224	286	1	different	different	ADJ
chd-224	286	2	mutations	mutation	NOUN
chd-224	286	3	also	also	ADV
chd-224	286	4	carry	carry	VERB
chd-224	286	5	varying	vary	VERB
chd-224	286	6	prognoses	prognosis	NOUN
chd-224	286	7	.	.	PUNCT
chd-224	287	1	therefore	therefore	ADV
chd-224	287	2	,	,	PUNCT
chd-224	287	3	differences	difference	NOUN
chd-224	287	4	in	in	ADP
chd-224	287	5	chromosomal	chromosomal	ADJ
chd-224	287	6	alterations	alteration	NOUN
chd-224	287	7	between	between	ADP
chd-224	287	8	races	race	NOUN
chd-224	287	9	/	/	SYM
chd-224	287	10	ethnicities	ethnicity	NOUN
chd-224	287	11	can	can	AUX
chd-224	287	12	potentially	potentially	ADV
chd-224	287	13	contribute	contribute	VERB
chd-224	287	14	to	to	ADP
chd-224	287	15	the	the	DET
chd-224	287	16	varying	vary	VERB
chd-224	287	17	disease	disease	NOUN
chd-224	287	18	outcomes	outcome	NOUN
chd-224	287	19	seen	see	VERB
chd-224	287	20	across	across	ADP
chd-224	287	21	racial	racial	ADJ
chd-224	287	22	/	/	SYM
chd-224	287	23	ethnic	ethnic	ADJ
chd-224	287	24	groups	group	NOUN
chd-224	287	25	.	.	PUNCT
chd-224	288	1	additional	additional	ADJ
chd-224	288	2	studies	study	NOUN
chd-224	288	3	are	be	AUX
chd-224	288	4	indicated	indicate	VERB
chd-224	288	5	to	to	PART
chd-224	288	6	further	far	ADV
chd-224	288	7	explore	explore	VERB
chd-224	288	8	the	the	DET
chd-224	288	9	demographics	demographic	NOUN
chd-224	288	10	and	and	CCONJ
chd-224	288	11	other	other	ADJ
chd-224	288	12	racial	racial	ADJ
chd-224	288	13	/	/	SYM
chd-224	288	14	ethnic	ethnic	ADJ
chd-224	288	15	groups	group	NOUN
chd-224	288	16	with	with	ADP
chd-224	288	17	common	common	ADJ
chd-224	288	18	thyroid	thyroid	NOUN
chd-224	288	19	cancer	cancer	NOUN
chd-224	288	20	mutations	mutation	NOUN
chd-224	288	21	.	.	PUNCT
chd-224	289	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-224	289	2	e15	e15	PROPN
chd-224	289	3	cancer	cancer	NOUN
chd-224	289	4	health	health	NOUN
chd-224	289	5	disparities	disparity	NOUN
chd-224	289	6	research	research	VERB
chd-224	289	7	4	4	NUM
chd-224	289	8	.	.	PUNCT
chd-224	289	9	conclusions	conclusion	NOUN
chd-224	289	10	through	through	ADP
chd-224	289	11	this	this	DET
chd-224	289	12	literature	literature	NOUN
chd-224	289	13	review	review	NOUN
chd-224	289	14	,	,	PUNCT
chd-224	289	15	several	several	ADJ
chd-224	289	16	risk	risk	NOUN
chd-224	289	17	factors	factor	NOUN
chd-224	289	18	are	be	AUX
chd-224	289	19	found	find	VERB
chd-224	289	20	to	to	PART
chd-224	289	21	potentially	potentially	ADV
chd-224	289	22	impact	impact	VERB
chd-224	289	23	thyroid	thyroid	NOUN
chd-224	289	24	cancer	cancer	NOUN
chd-224	289	25	incidence	incidence	NOUN
chd-224	289	26	and	and	CCONJ
chd-224	289	27	aggressiveness	aggressiveness	NOUN
chd-224	289	28	differently	differently	ADV
chd-224	289	29	by	by	ADP
chd-224	289	30	racial	racial	ADJ
chd-224	289	31	/	/	SYM
chd-224	289	32	ethnic	ethnic	ADJ
chd-224	289	33	groups	group	NOUN
chd-224	289	34	.	.	PUNCT
chd-224	290	1	chromosomal	chromosomal	ADJ
chd-224	290	2	alterations	alteration	NOUN
chd-224	290	3	/	/	SYM
chd-224	290	4	non	non	ADJ
chd-224	290	5	-	-	ADJ
chd-224	290	6	hereditary	hereditary	ADJ
chd-224	290	7	conditions	condition	NOUN
chd-224	290	8	,	,	PUNCT
chd-224	290	9	autoimmunity	autoimmunity	NOUN
chd-224	290	10	,	,	PUNCT
chd-224	290	11	thyroid	thyroid	NOUN
chd-224	290	12	nodules	nodule	NOUN
chd-224	290	13	,	,	PUNCT
chd-224	290	14	and	and	CCONJ
chd-224	290	15	socioeconomic	socioeconomic	ADJ
chd-224	290	16	differences	difference	NOUN
chd-224	290	17	are	be	AUX
chd-224	290	18	identified	identify	VERB
chd-224	290	19	as	as	ADP
chd-224	290	20	factors	factor	NOUN
chd-224	290	21	that	that	PRON
chd-224	290	22	vary	vary	VERB
chd-224	290	23	by	by	ADP
chd-224	290	24	racial	racial	ADJ
chd-224	290	25	/	/	SYM
chd-224	290	26	ethnic	ethnic	ADJ
chd-224	290	27	group	group	NOUN
chd-224	290	28	and	and	CCONJ
chd-224	290	29	influence	influence	NOUN
chd-224	290	30	thyroid	thyroid	NOUN
chd-224	290	31	cancer	cancer	NOUN
chd-224	290	32	incidence	incidence	NOUN
chd-224	290	33	and	and	CCONJ
chd-224	290	34	outcomes	outcome	NOUN
chd-224	290	35	.	.	PUNCT
chd-224	291	1	some	some	PRON
chd-224	291	2	of	of	ADP
chd-224	291	3	these	these	DET
chd-224	291	4	potential	potential	ADJ
chd-224	291	5	risk	risk	NOUN
chd-224	291	6	factors	factor	NOUN
chd-224	291	7	require	require	VERB
chd-224	291	8	further	further	ADJ
chd-224	291	9	research	research	NOUN
chd-224	291	10	to	to	PART
chd-224	291	11	incorporate	incorporate	VERB
chd-224	291	12	more	more	ADV
chd-224	291	13	racial	racial	ADJ
chd-224	291	14	/	/	SYM
chd-224	291	15	ethnic	ethnic	ADJ
chd-224	291	16	groups	group	NOUN
chd-224	291	17	.	.	PUNCT
chd-224	292	1	the	the	DET
chd-224	292	2	only	only	ADJ
chd-224	292	3	risk	risk	NOUN
chd-224	292	4	factor	factor	NOUN
chd-224	292	5	that	that	PRON
chd-224	292	6	does	do	AUX
chd-224	292	7	not	not	PART
chd-224	292	8	vary	vary	VERB
chd-224	292	9	by	by	ADP
chd-224	292	10	racial	racial	ADJ
chd-224	292	11	/	/	SYM
chd-224	292	12	ethnic	ethnic	ADJ
chd-224	292	13	group	group	NOUN
chd-224	292	14	is	be	AUX
chd-224	292	15	sex	sex	NOUN
chd-224	292	16	disparities	disparity	NOUN
chd-224	292	17	.	.	PUNCT
chd-224	293	1	however	however	ADV
chd-224	293	2	,	,	PUNCT
chd-224	293	3	differences	difference	NOUN
chd-224	293	4	found	find	VERB
chd-224	293	5	in	in	ADP
chd-224	293	6	sex	sex	NOUN
chd-224	293	7	hormone	hormone	NOUN
chd-224	293	8	levels	level	NOUN
chd-224	293	9	between	between	ADP
chd-224	293	10	racial	racial	ADJ
chd-224	293	11	/	/	SYM
chd-224	293	12	ethnic	ethnic	ADJ
chd-224	293	13	groups	group	NOUN
chd-224	293	14	may	may	AUX
chd-224	293	15	suggest	suggest	VERB
chd-224	293	16	their	their	PRON
chd-224	293	17	possible	possible	ADJ
chd-224	293	18	influence	influence	NOUN
chd-224	293	19	on	on	ADP
chd-224	293	20	thyroid	thyroid	NOUN
chd-224	293	21	cancer	cancer	NOUN
chd-224	293	22	health	health	NOUN
chd-224	293	23	disparities	disparity	NOUN
chd-224	293	24	and	and	CCONJ
chd-224	293	25	necessitates	necessitate	VERB
chd-224	293	26	further	further	ADJ
chd-224	293	27	research	research	NOUN
chd-224	293	28	.	.	PUNCT
chd-224	294	1	some	some	DET
chd-224	294	2	studies	study	NOUN
chd-224	294	3	on	on	ADP
chd-224	294	4	iodine	iodine	NOUN
chd-224	294	5	deficiency	deficiency	NOUN
chd-224	294	6	,	,	PUNCT
chd-224	294	7	environmental	environmental	ADJ
chd-224	294	8	pollutants	pollutant	NOUN
chd-224	294	9	,	,	PUNCT
chd-224	294	10	obesity	obesity	NOUN
chd-224	294	11	/	/	SYM
chd-224	294	12	metabolic	metabolic	NOUN
chd-224	294	13	syndrome	syndrome	NOUN
chd-224	294	14	/	/	SYM
chd-224	294	15	insulin	insulin	NOUN
chd-224	294	16	resistance	resistance	NOUN
chd-224	294	17	,	,	PUNCT
chd-224	294	18	and	and	CCONJ
chd-224	294	19	lifestyle	lifestyle	NOUN
chd-224	294	20	/	/	SYM
chd-224	294	21	diet	diet	NOUN
chd-224	294	22	as	as	ADP
chd-224	294	23	risk	risk	NOUN
chd-224	294	24	factors	factor	NOUN
chd-224	294	25	for	for	ADP
chd-224	294	26	thyroid	thyroid	NOUN
chd-224	294	27	cancer	cancer	NOUN
chd-224	294	28	suggest	suggest	VERB
chd-224	294	29	that	that	SCONJ
chd-224	294	30	certain	certain	ADJ
chd-224	294	31	racial	racial	ADJ
chd-224	294	32	/	/	SYM
chd-224	294	33	ethnic	ethnic	ADJ
chd-224	294	34	groups	group	NOUN
chd-224	294	35	could	could	AUX
chd-224	294	36	be	be	AUX
chd-224	294	37	differentially	differentially	ADV
chd-224	294	38	impacted	impact	VERB
chd-224	294	39	.	.	PUNCT
chd-224	295	1	further	further	ADJ
chd-224	295	2	research	research	NOUN
chd-224	295	3	,	,	PUNCT
chd-224	295	4	however	however	ADV
chd-224	295	5	,	,	PUNCT
chd-224	295	6	is	be	AUX
chd-224	295	7	needed	need	VERB
chd-224	295	8	to	to	PART
chd-224	295	9	specifically	specifically	ADV
chd-224	295	10	examine	examine	VERB
chd-224	295	11	their	their	PRON
chd-224	295	12	relation	relation	NOUN
chd-224	295	13	to	to	PART
chd-224	295	14	thyroid	thyroid	VERB
chd-224	295	15	cancer	cancer	NOUN
chd-224	295	16	or	or	CCONJ
chd-224	295	17	to	to	PART
chd-224	295	18	clarify	clarify	VERB
chd-224	295	19	whether	whether	SCONJ
chd-224	295	20	certain	certain	ADJ
chd-224	295	21	racial	racial	ADJ
chd-224	295	22	/	/	SYM
chd-224	295	23	ethnic	ethnic	ADJ
chd-224	295	24	groups	group	NOUN
chd-224	295	25	are	be	AUX
chd-224	295	26	differentially	differentially	ADV
chd-224	295	27	impacted	impact	VERB
chd-224	295	28	in	in	ADP
chd-224	295	29	the	the	DET
chd-224	295	30	united	united	PROPN
chd-224	295	31	states	states	PROPN
chd-224	295	32	.	.	PUNCT
chd-224	296	1	additionally	additionally	ADV
chd-224	296	2	,	,	PUNCT
chd-224	296	3	while	while	SCONJ
chd-224	296	4	some	some	DET
chd-224	296	5	racial	racial	ADJ
chd-224	296	6	/	/	SYM
chd-224	296	7	ethnic	ethnic	ADJ
chd-224	296	8	disparities	disparity	NOUN
chd-224	296	9	exist	exist	VERB
chd-224	296	10	in	in	ADP
chd-224	296	11	regards	regard	NOUN
chd-224	296	12	to	to	ADP
chd-224	296	13	the	the	DET
chd-224	296	14	use	use	NOUN
chd-224	296	15	of	of	ADP
chd-224	296	16	rai	rai	PROPN
chd-224	296	17	treatment	treatment	NOUN
chd-224	296	18	,	,	PUNCT
chd-224	296	19	recent	recent	ADJ
chd-224	296	20	research	research	NOUN
chd-224	296	21	suggests	suggest	VERB
chd-224	296	22	that	that	SCONJ
chd-224	296	23	this	this	PRON
chd-224	296	24	is	be	AUX
chd-224	296	25	not	not	PART
chd-224	296	26	a	a	DET
chd-224	296	27	risk	risk	NOUN
chd-224	296	28	factor	factor	NOUN
chd-224	296	29	for	for	ADP
chd-224	296	30	secondary	secondary	ADJ
chd-224	296	31	thyroid	thyroid	NOUN
chd-224	296	32	cancer	cancer	NOUN
chd-224	296	33	.	.	PUNCT
chd-224	297	1	other	other	ADJ
chd-224	297	2	potential	potential	ADJ
chd-224	297	3	risk	risk	NOUN
chd-224	297	4	factors	factor	NOUN
chd-224	297	5	including	include	VERB
chd-224	297	6	radiation	radiation	NOUN
chd-224	297	7	exposure	exposure	NOUN
chd-224	297	8	,	,	PUNCT
chd-224	297	9	hereditary	hereditary	ADJ
chd-224	297	10	conditions	condition	NOUN
chd-224	297	11	,	,	PUNCT
chd-224	297	12	and	and	CCONJ
chd-224	297	13	tsh	tsh	NOUN
chd-224	297	14	level	level	NOUN
chd-224	297	15	have	have	AUX
chd-224	297	16	not	not	PART
chd-224	297	17	yet	yet	ADV
chd-224	297	18	been	be	AUX
chd-224	297	19	studied	study	VERB
chd-224	297	20	regarding	regard	VERB
chd-224	297	21	their	their	PRON
chd-224	297	22	potential	potential	ADJ
chd-224	297	23	influence	influence	NOUN
chd-224	297	24	on	on	ADP
chd-224	297	25	thyroid	thyroid	NOUN
chd-224	297	26	cancer	cancer	NOUN
chd-224	297	27	incidence	incidence	NOUN
chd-224	297	28	and	and	CCONJ
chd-224	297	29	outcomes	outcome	NOUN
chd-224	297	30	for	for	ADP
chd-224	297	31	different	different	ADJ
chd-224	297	32	racial	racial	ADJ
chd-224	297	33	/	/	SYM
chd-224	297	34	ethnic	ethnic	ADJ
chd-224	297	35	groups	group	NOUN
chd-224	297	36	in	in	ADP
chd-224	297	37	the	the	DET
chd-224	297	38	united	united	PROPN
chd-224	297	39	states	states	PROPN
chd-224	297	40	.	.	PUNCT
chd-224	298	1	these	these	PRON
chd-224	298	2	should	should	AUX
chd-224	298	3	be	be	AUX
chd-224	298	4	given	give	VERB
chd-224	298	5	priority	priority	NOUN
chd-224	298	6	in	in	ADP
chd-224	298	7	future	future	ADJ
chd-224	298	8	research	research	NOUN
chd-224	298	9	work	work	NOUN
chd-224	298	10	.	.	PUNCT
chd-224	299	1	5	5	X
chd-224	299	2	.	.	X
chd-224	299	3	limitations	limitation	NOUN
chd-224	299	4	a	a	DET
chd-224	299	5	limitation	limitation	NOUN
chd-224	299	6	of	of	ADP
chd-224	299	7	our	our	PRON
chd-224	299	8	literature	literature	NOUN
chd-224	299	9	review	review	NOUN
chd-224	299	10	is	be	AUX
chd-224	299	11	that	that	SCONJ
chd-224	299	12	we	we	PRON
chd-224	299	13	did	do	AUX
chd-224	299	14	not	not	PART
chd-224	299	15	perform	perform	VERB
chd-224	299	16	a	a	DET
chd-224	299	17	meta	meta	ADJ
chd-224	299	18	-	-	PUNCT
chd-224	299	19	analysis	analysis	NOUN
chd-224	299	20	of	of	ADP
chd-224	299	21	potential	potential	ADJ
chd-224	299	22	factors	factor	NOUN
chd-224	299	23	contributing	contribute	VERB
chd-224	299	24	to	to	PART
chd-224	299	25	thyroid	thyroid	VERB
chd-224	299	26	cancer	cancer	NOUN
chd-224	299	27	health	health	NOUN
chd-224	299	28	disparities	disparity	NOUN
chd-224	299	29	.	.	PUNCT
chd-224	300	1	however	however	ADV
chd-224	300	2	,	,	PUNCT
chd-224	300	3	we	we	PRON
chd-224	300	4	are	be	AUX
chd-224	300	5	currently	currently	ADV
chd-224	300	6	gathering	gather	VERB
chd-224	300	7	insight	insight	NOUN
chd-224	300	8	into	into	ADP
chd-224	300	9	the	the	DET
chd-224	300	10	factors	factor	NOUN
chd-224	300	11	that	that	PRON
chd-224	300	12	may	may	AUX
chd-224	300	13	contribute	contribute	VERB
chd-224	300	14	to	to	ADP
chd-224	300	15	the	the	DET
chd-224	300	16	differences	difference	NOUN
chd-224	300	17	in	in	ADP
chd-224	300	18	the	the	DET
chd-224	300	19	genetic	genetic	ADJ
chd-224	300	20	and	and	CCONJ
chd-224	300	21	epigenetic	epigenetic	ADJ
chd-224	300	22	pathways	pathway	NOUN
chd-224	300	23	of	of	ADP
chd-224	300	24	health	health	NOUN
chd-224	300	25	disparities	disparity	NOUN
chd-224	300	26	.	.	PUNCT
chd-224	301	1	additionally	additionally	ADV
chd-224	301	2	,	,	PUNCT
chd-224	301	3	the	the	DET
chd-224	301	4	findings	finding	NOUN
chd-224	301	5	of	of	ADP
chd-224	301	6	our	our	PRON
chd-224	301	7	literature	literature	NOUN
chd-224	301	8	review	review	NOUN
chd-224	301	9	are	be	AUX
chd-224	301	10	limited	limit	VERB
chd-224	301	11	by	by	ADP
chd-224	301	12	the	the	DET
chd-224	301	13	racial	racial	ADJ
chd-224	301	14	/	/	SYM
chd-224	301	15	ethnic	ethnic	ADJ
chd-224	301	16	groups	group	NOUN
chd-224	301	17	that	that	PRON
chd-224	301	18	have	have	AUX
chd-224	301	19	been	be	AUX
chd-224	301	20	studied	study	VERB
chd-224	301	21	by	by	ADP
chd-224	301	22	the	the	DET
chd-224	301	23	articles	article	NOUN
chd-224	301	24	reviewed	review	VERB
chd-224	301	25	.	.	PUNCT
chd-224	302	1	in	in	ADP
chd-224	302	2	particular	particular	ADJ
chd-224	302	3	,	,	PUNCT
chd-224	302	4	some	some	DET
chd-224	302	5	studies	study	NOUN
chd-224	302	6	focused	focus	VERB
chd-224	302	7	on	on	ADP
chd-224	302	8	two	two	NUM
chd-224	302	9	racial	racial	ADJ
chd-224	302	10	/	/	SYM
chd-224	302	11	ethnic	ethnic	ADJ
chd-224	302	12	populations	population	NOUN
chd-224	302	13	only	only	ADV
chd-224	302	14	or	or	CCONJ
chd-224	302	15	may	may	AUX
chd-224	302	16	have	have	AUX
chd-224	302	17	grouped	group	VERB
chd-224	302	18	some	some	DET
chd-224	302	19	racial	racial	ADJ
chd-224	302	20	/	/	SYM
chd-224	302	21	ethnic	ethnic	ADJ
chd-224	302	22	populations	population	NOUN
chd-224	302	23	together	together	ADV
chd-224	302	24	.	.	PUNCT
chd-224	303	1	therefore	therefore	ADV
chd-224	303	2	,	,	PUNCT
chd-224	303	3	it	it	PRON
chd-224	303	4	is	be	AUX
chd-224	303	5	possible	possible	ADJ
chd-224	303	6	that	that	SCONJ
chd-224	303	7	variations	variation	NOUN
chd-224	303	8	in	in	ADP
chd-224	303	9	the	the	DET
chd-224	303	10	potential	potential	ADJ
chd-224	303	11	thyroid	thyroid	NOUN
chd-224	303	12	cancer	cancer	NOUN
chd-224	303	13	risk	risk	NOUN
chd-224	303	14	factors	factor	NOUN
chd-224	303	15	between	between	ADP
chd-224	303	16	racial	racial	ADJ
chd-224	303	17	/	/	SYM
chd-224	303	18	ethnic	ethnic	ADJ
chd-224	303	19	groups	group	NOUN
chd-224	303	20	may	may	AUX
chd-224	303	21	have	have	AUX
chd-224	303	22	been	be	AUX
chd-224	303	23	limited	limit	VERB
chd-224	303	24	by	by	ADP
chd-224	303	25	the	the	DET
chd-224	303	26	lack	lack	NOUN
chd-224	303	27	of	of	ADP
chd-224	303	28	diversity	diversity	NOUN
chd-224	303	29	in	in	ADP
chd-224	303	30	some	some	PRON
chd-224	303	31	of	of	ADP
chd-224	303	32	these	these	DET
chd-224	303	33	studies	study	NOUN
chd-224	303	34	.	.	PUNCT
chd-224	304	1	6	6	X
chd-224	304	2	.	.	X
chd-224	304	3	future	future	ADJ
chd-224	304	4	directions	direction	NOUN
chd-224	304	5	there	there	PRON
chd-224	304	6	are	be	VERB
chd-224	304	7	several	several	ADJ
chd-224	304	8	areas	area	NOUN
chd-224	304	9	of	of	ADP
chd-224	304	10	research	research	NOUN
chd-224	304	11	which	which	PRON
chd-224	304	12	need	need	VERB
chd-224	304	13	to	to	PART
chd-224	304	14	be	be	AUX
chd-224	304	15	addressed	address	VERB
chd-224	304	16	regarding	regard	VERB
chd-224	304	17	thyroid	thyroid	NOUN
chd-224	304	18	cancer	cancer	NOUN
chd-224	304	19	health	health	NOUN
chd-224	304	20	disparities	disparity	NOUN
chd-224	304	21	,	,	PUNCT
chd-224	304	22	as	as	SCONJ
chd-224	304	23	highlighted	highlight	VERB
chd-224	304	24	by	by	ADP
chd-224	304	25	this	this	DET
chd-224	304	26	literature	literature	NOUN
chd-224	304	27	review	review	NOUN
chd-224	304	28	.	.	PUNCT
chd-224	305	1	one	one	NUM
chd-224	305	2	such	such	ADJ
chd-224	305	3	area	area	NOUN
chd-224	305	4	of	of	ADP
chd-224	305	5	interest	interest	NOUN
chd-224	305	6	for	for	ADP
chd-224	305	7	our	our	PRON
chd-224	305	8	lab	lab	NOUN
chd-224	305	9	is	be	AUX
chd-224	305	10	the	the	DET
chd-224	305	11	sex	sex	NOUN
chd-224	305	12	hormone	hormone	NOUN
chd-224	305	13	-	-	PUNCT
chd-224	305	14	induced	induce	VERB
chd-224	305	15	immune	immune	ADJ
chd-224	305	16	pathway	pathway	NOUN
chd-224	305	17	in	in	ADP
chd-224	305	18	cancer	cancer	NOUN
chd-224	305	19	cells	cell	NOUN
chd-224	305	20	.	.	PUNCT
chd-224	306	1	in	in	ADP
chd-224	306	2	future	future	ADJ
chd-224	306	3	work	work	NOUN
chd-224	306	4	,	,	PUNCT
chd-224	306	5	we	we	PRON
chd-224	306	6	will	will	AUX
chd-224	306	7	examine	examine	VERB
chd-224	306	8	this	this	DET
chd-224	306	9	pathway	pathway	NOUN
chd-224	306	10	in	in	ADP
chd-224	306	11	relation	relation	NOUN
chd-224	306	12	to	to	ADP
chd-224	306	13	racial	racial	ADJ
chd-224	306	14	/	/	SYM
chd-224	306	15	ethnic	ethnic	ADJ
chd-224	306	16	groups	group	NOUN
chd-224	306	17	in	in	ADP
chd-224	306	18	the	the	DET
chd-224	306	19	united	united	PROPN
chd-224	306	20	states	states	PROPN
chd-224	306	21	to	to	PART
chd-224	306	22	understand	understand	VERB
chd-224	306	23	why	why	SCONJ
chd-224	306	24	filipino	filipino	ADJ
chd-224	306	25	americans	americans	PROPN
chd-224	306	26	have	have	VERB
chd-224	306	27	higher	high	ADJ
chd-224	306	28	tc	tc	NOUN
chd-224	306	29	incidence	incidence	NOUN
chd-224	306	30	rates	rate	NOUN
chd-224	306	31	.	.	PUNCT
chd-224	307	1	additionally	additionally	ADV
chd-224	307	2	,	,	PUNCT
chd-224	307	3	although	although	SCONJ
chd-224	307	4	biologic	biologic	NOUN
chd-224	307	5	differences	difference	NOUN
chd-224	307	6	were	be	AUX
chd-224	307	7	thought	think	VERB
chd-224	307	8	to	to	PART
chd-224	307	9	be	be	AUX
chd-224	307	10	responsible	responsible	ADJ
chd-224	307	11	for	for	ADP
chd-224	307	12	the	the	DET
chd-224	307	13	difference	difference	NOUN
chd-224	307	14	in	in	ADP
chd-224	307	15	the	the	DET
chd-224	307	16	severity	severity	NOUN
chd-224	307	17	and	and	CCONJ
chd-224	307	18	progression	progression	NOUN
chd-224	307	19	of	of	ADP
chd-224	307	20	thyroid	thyroid	NOUN
chd-224	307	21	cancer	cancer	NOUN
chd-224	307	22	,	,	PUNCT
chd-224	307	23	no	no	DET
chd-224	307	24	genetic	genetic	ADJ
chd-224	307	25	or	or	CCONJ
chd-224	307	26	molecular	molecular	ADJ
chd-224	307	27	level	level	NOUN
chd-224	307	28	differences	difference	NOUN
chd-224	307	29	were	be	AUX
chd-224	307	30	reported	report	VERB
chd-224	307	31	so	so	ADV
chd-224	307	32	far	far	ADV
chd-224	307	33	.	.	PUNCT
chd-224	308	1	this	this	DET
chd-224	308	2	literature	literature	NOUN
chd-224	308	3	review	review	NOUN
chd-224	308	4	contributes	contribute	VERB
chd-224	308	5	to	to	ADP
chd-224	308	6	our	our	PRON
chd-224	308	7	knowledge	knowledge	NOUN
chd-224	308	8	of	of	ADP
chd-224	308	9	the	the	DET
chd-224	308	10	several	several	ADJ
chd-224	308	11	factors	factor	NOUN
chd-224	308	12	that	that	PRON
chd-224	308	13	may	may	AUX
chd-224	308	14	be	be	AUX
chd-224	308	15	correlated	correlate	VERB
chd-224	308	16	to	to	ADP
chd-224	308	17	the	the	DET
chd-224	308	18	differential	differential	ADJ
chd-224	308	19	mirna	mirna	NOUN
chd-224	308	20	expression	expression	NOUN
chd-224	308	21	we	we	PRON
chd-224	308	22	observe	observe	VERB
chd-224	308	23	within	within	ADP
chd-224	308	24	ethnic	ethnic	ADJ
chd-224	308	25	groups	group	NOUN
chd-224	308	26	.	.	PUNCT
chd-224	309	1	future	future	ADJ
chd-224	309	2	work	work	NOUN
chd-224	309	3	may	may	AUX
chd-224	309	4	include	include	VERB
chd-224	309	5	taking	take	VERB
chd-224	309	6	these	these	DET
chd-224	309	7	factors	factor	NOUN
chd-224	309	8	into	into	ADP
chd-224	309	9	account	account	NOUN
chd-224	309	10	in	in	ADP
chd-224	309	11	our	our	PRON
chd-224	309	12	statistical	statistical	ADJ
chd-224	309	13	analysis	analysis	NOUN
chd-224	309	14	in	in	ADP
chd-224	309	15	a	a	DET
chd-224	309	16	larger	large	ADJ
chd-224	309	17	cohort	cohort	NOUN
chd-224	309	18	of	of	ADP
chd-224	309	19	patients	patient	NOUN
chd-224	309	20	.	.	PUNCT
chd-224	310	1	acknowledgements	acknowledgement	NOUN
chd-224	310	2	the	the	DET
chd-224	310	3	authors	author	NOUN
chd-224	310	4	would	would	AUX
chd-224	310	5	like	like	VERB
chd-224	310	6	to	to	PART
chd-224	310	7	thank	thank	VERB
chd-224	310	8	dr	dr	PROPN
chd-224	310	9	.	.	PROPN
chd-224	310	10	reinhard	reinhard	PROPN
chd-224	310	11	schulte	schulte	PROPN
chd-224	310	12	,	,	PUNCT
chd-224	310	13	md	md	PROPN
chd-224	310	14	;	;	PUNCT
chd-224	310	15	dr	dr	PROPN
chd-224	310	16	.	.	PROPN
chd-224	310	17	mia	mia	PROPN
chd-224	310	18	perez	perez	PROPN
chd-224	310	19	,	,	PUNCT
chd-224	310	20	md	md	PROPN
chd-224	310	21	;	;	PUNCT
chd-224	310	22	celina	celina	PROPN
chd-224	310	23	r.	r.	PROPN
chd-224	310	24	yamauchi	yamauchi	PROPN
chd-224	310	25	,	,	PUNCT
chd-224	310	26	bs	bs	X
chd-224	310	27	;	;	PUNCT
chd-224	310	28	and	and	CCONJ
chd-224	310	29	dr	dr	PROPN
chd-224	310	30	.	.	PROPN
chd-224	310	31	qudus	qudus	PROPN
chd-224	310	32	lawal	lawal	PROPN
chd-224	310	33	,	,	PUNCT
chd-224	310	34	md	md	PROPN
chd-224	310	35	for	for	ADP
chd-224	310	36	contributing	contribute	VERB
chd-224	310	37	through	through	ADP
chd-224	310	38	conceptualization	conceptualization	NOUN
chd-224	310	39	,	,	PUNCT
chd-224	310	40	reviewing	reviewing	NOUN
chd-224	310	41	,	,	PUNCT
chd-224	310	42	and	and	CCONJ
chd-224	310	43	editing	editing	NOUN
chd-224	310	44	of	of	ADP
chd-224	310	45	the	the	DET
chd-224	310	46	manuscript	manuscript	NOUN
chd-224	310	47	.	.	PUNCT
chd-224	311	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-224	311	2	e16	e16	PROPN
chd-224	311	3	cancer	cancer	NOUN
chd-224	311	4	health	health	NOUN
chd-224	311	5	disparities	disparity	NOUN
chd-224	311	6	research	research	NOUN
chd-224	311	7	funding	fund	VERB
chd-224	311	8	this	this	DET
chd-224	311	9	research	research	NOUN
chd-224	311	10	was	be	AUX
chd-224	311	11	supported	support	VERB
chd-224	311	12	by	by	ADP
chd-224	311	13	the	the	DET
chd-224	311	14	department	department	PROPN
chd-224	311	15	of	of	ADP
chd-224	311	16	otolaryngology	otolaryngology	NOUN
chd-224	311	17	and	and	CCONJ
chd-224	311	18	the	the	DET
chd-224	311	19	national	national	PROPN
chd-224	311	20	institute	institute	PROPN
chd-224	311	21	on	on	ADP
chd-224	311	22	minority	minority	NOUN
chd-224	311	23	health	health	PROPN
chd-224	311	24	and	and	CCONJ
chd-224	311	25	health	health	NOUN
chd-224	311	26	disparities	disparity	NOUN
chd-224	311	27	(	(	PUNCT
chd-224	311	28	nimhd	nimhd	NOUN
chd-224	311	29	)	)	PUNCT
chd-224	312	1	[	[	X
chd-224	312	2	grant	grant	NOUN
chd-224	312	3	number	number	NOUN
chd-224	312	4	p20md001632	p20md001632	NOUN
chd-224	312	5	]	]	PUNCT
chd-224	312	6	(	(	PUNCT
chd-224	312	7	pi	pi	NOUN
chd-224	312	8	:	:	PUNCT
chd-224	312	9	deleon	deleon	PROPN
chd-224	312	10	)	)	PUNCT
chd-224	312	11	from	from	ADP
chd-224	312	12	center	center	PROPN
chd-224	312	13	for	for	ADP
chd-224	312	14	health	health	NOUN
chd-224	312	15	disparities	disparity	NOUN
chd-224	312	16	&	&	CCONJ
chd-224	312	17	molecular	molecular	ADJ
chd-224	312	18	medicine	medicine	NOUN
chd-224	312	19	,	,	PUNCT
chd-224	312	20	loma	loma	PROPN
chd-224	312	21	linda	linda	PROPN
chd-224	312	22	university	university	PROPN
chd-224	312	23	school	school	NOUN
chd-224	312	24	of	of	ADP
chd-224	312	25	medicine	medicine	NOUN
chd-224	312	26	.	.	PUNCT
chd-224	313	1	this	this	DET
chd-224	313	2	work	work	NOUN
chd-224	313	3	was	be	AUX
chd-224	313	4	also	also	ADV
chd-224	313	5	supported	support	VERB
chd-224	313	6	by	by	ADP
chd-224	313	7	nimhd	nimhd	NOUN
chd-224	313	8	grant	grant	NOUN
chd-224	313	9	[	[	AUX
chd-224	313	10	grant	grant	VERB
chd-224	313	11	number	number	NOUN
chd-224	313	12	5u54md007592	5u54md007592	NUM
chd-224	313	13	]	]	PUNCT
chd-224	313	14	.	.	PUNCT
chd-224	314	1	author	author	NOUN
chd-224	314	2	’s	’s	PART
chd-224	314	3	contribution	contribution	NOUN
chd-224	314	4	conceptualization	conceptualization	NOUN
chd-224	314	5	,	,	PUNCT
chd-224	314	6	kr	kr	PROPN
chd-224	314	7	,	,	PUNCT
chd-224	314	8	rl	rl	PROPN
chd-224	314	9	,	,	PUNCT
chd-224	314	10	sk	sk	INTJ
chd-224	314	11	;	;	PUNCT
chd-224	314	12	writing	writing	NOUN
chd-224	314	13	—	—	PUNCT
chd-224	314	14	original	original	ADJ
chd-224	314	15	draft	draft	NOUN
chd-224	314	16	preparation	preparation	NOUN
chd-224	314	17	,	,	PUNCT
chd-224	314	18	rl	rl	X
chd-224	314	19	,	,	PUNCT
chd-224	314	20	kr	kr	PROPN
chd-224	314	21	,	,	PUNCT
chd-224	314	22	as	as	ADP
chd-224	314	23	,	,	PUNCT
chd-224	314	24	hsk	hsk	NOUN
chd-224	314	25	,	,	PUNCT
chd-224	314	26	sk	sk	INTJ
chd-224	314	27	;	;	PUNCT
chd-224	314	28	writing	writing	NOUN
chd-224	314	29	—	—	PUNCT
chd-224	314	30	review	review	NOUN
chd-224	314	31	and	and	CCONJ
chd-224	314	32	editing	editing	NOUN
chd-224	314	33	,	,	PUNCT
chd-224	314	34	rl	rl	X
chd-224	314	35	,	,	PUNCT
chd-224	314	36	kr	kr	PROPN
chd-224	314	37	,	,	PUNCT
chd-224	314	38	as	as	ADP
chd-224	314	39	,	,	PUNCT
chd-224	314	40	hsk	hsk	NOUN
chd-224	314	41	,	,	PUNCT
chd-224	314	42	sk	sk	INTJ
chd-224	314	43	;	;	PUNCT
chd-224	314	44	supervision	supervision	NOUN
chd-224	314	45	,	,	PUNCT
chd-224	314	46	sk	sk	INTJ
chd-224	314	47	;	;	PUNCT
chd-224	314	48	funding	funding	NOUN
chd-224	314	49	acquisition	acquisition	NOUN
chd-224	314	50	,	,	PUNCT
chd-224	314	51	sk	sk	INTJ
chd-224	314	52	.	.	PUNCT
chd-224	315	1	all	all	DET
chd-224	315	2	authors	author	NOUN
chd-224	315	3	have	have	AUX
chd-224	315	4	read	read	VERB
chd-224	315	5	and	and	CCONJ
chd-224	315	6	agreed	agree	VERB
chd-224	315	7	to	to	ADP
chd-224	315	8	the	the	DET
chd-224	315	9	published	publish	VERB
chd-224	315	10	version	version	NOUN
chd-224	315	11	of	of	ADP
chd-224	315	12	the	the	DET
chd-224	315	13	manuscript	manuscript	NOUN
chd-224	315	14	.	.	PUNCT
chd-224	316	1	conflicts	conflict	NOUN
chd-224	316	2	of	of	ADP
chd-224	316	3	interest	interest	NOUN
chd-224	316	4	the	the	DET
chd-224	316	5	authors	author	NOUN
chd-224	316	6	declare	declare	VERB
chd-224	316	7	that	that	SCONJ
chd-224	316	8	there	there	PRON
chd-224	316	9	is	be	VERB
chd-224	316	10	no	no	DET
chd-224	316	11	conflict	conflict	NOUN
chd-224	316	12	of	of	ADP
chd-224	316	13	interest	interest	NOUN
chd-224	316	14	regarding	regard	VERB
chd-224	316	15	the	the	DET
chd-224	316	16	publication	publication	NOUN
chd-224	316	17	of	of	ADP
chd-224	316	18	this	this	DET
chd-224	316	19	article	article	NOUN
chd-224	316	20	.	.	PUNCT
chd-224	317	1	consent	consent	VERB
chd-224	317	2	all	all	DET
chd-224	317	3	co	co	NOUN
chd-224	317	4	-	-	NOUN
chd-224	317	5	authors	author	NOUN
chd-224	317	6	approve	approve	VERB
chd-224	317	7	the	the	DET
chd-224	317	8	submission	submission	NOUN
chd-224	317	9	of	of	ADP
chd-224	317	10	this	this	DET
chd-224	317	11	manuscript	manuscript	NOUN
chd-224	317	12	.	.	PUNCT
chd-224	318	1	confirmation	confirmation	NOUN
chd-224	318	2	content	content	NOUN
chd-224	318	3	of	of	ADP
chd-224	318	4	this	this	DET
chd-224	318	5	manuscript	manuscript	NOUN
chd-224	318	6	has	have	AUX
chd-224	318	7	not	not	PART
chd-224	318	8	been	be	AUX
chd-224	318	9	submitted	submit	VERB
chd-224	318	10	for	for	ADP
chd-224	318	11	publication	publication	NOUN
chd-224	318	12	elsewhere	elsewhere	ADV
chd-224	318	13	,	,	PUNCT
chd-224	318	14	and	and	CCONJ
chd-224	318	15	is	be	AUX
chd-224	318	16	not	not	PART
chd-224	318	17	under	under	ADP
chd-224	318	18	consideration	consideration	NOUN
chd-224	318	19	for	for	ADP
chd-224	318	20	publication	publication	NOUN
chd-224	318	21	by	by	ADP
chd-224	318	22	any	any	DET
chd-224	318	23	other	other	ADJ
chd-224	318	24	journal	journal	NOUN
chd-224	318	25	.	.	PUNCT
chd-224	319	1	references	reference	NOUN
chd-224	319	2	autoimmune	autoimmune	ADJ
chd-224	319	3	thyroiditis	thyroiditis	NOUN
chd-224	319	4	.	.	PUNCT
chd-224	320	1	arup	arup	PROPN
chd-224	320	2	consult	consult	PROPN
chd-224	320	3	®	®	PROPN
chd-224	320	4	.	.	PUNCT
chd-224	321	1	alexander	alexander	PROPN
chd-224	321	2	,	,	PUNCT
chd-224	321	3	e.k	e.k	PROPN
chd-224	321	4	.	.	PROPN
chd-224	321	5	,	,	PUNCT
chd-224	321	6	kennedy	kennedy	PROPN
chd-224	321	7	,	,	PUNCT
chd-224	321	8	g.c	g.c	PROPN
chd-224	321	9	.	.	PROPN
chd-224	321	10	,	,	PUNCT
chd-224	321	11	baloch	baloch	PROPN
chd-224	321	12	,	,	PUNCT
chd-224	321	13	z.w	z.w	PROPN
chd-224	321	14	.	.	PROPN
chd-224	321	15	,	,	PUNCT
chd-224	321	16	cibas	cibas	PROPN
chd-224	321	17	,	,	PUNCT
chd-224	321	18	e.s	e.s	PROPN
chd-224	321	19	.	.	PROPN
chd-224	321	20	,	,	PUNCT
chd-224	321	21	chudova	chudova	PROPN
chd-224	321	22	,	,	PUNCT
chd-224	321	23	d.	d.	PROPN
chd-224	321	24	,	,	PUNCT
chd-224	321	25	diggans	diggans	PROPN
chd-224	321	26	,	,	PUNCT
chd-224	321	27	j.	j.	PROPN
chd-224	321	28	,	,	PUNCT
chd-224	321	29	friedman	friedman	PROPN
chd-224	321	30	,	,	PUNCT
chd-224	321	31	l.	l.	PROPN
chd-224	321	32	,	,	PUNCT
chd-224	321	33	kloos	kloos	PROPN
chd-224	321	34	,	,	PUNCT
chd-224	321	35	r.t	r.t	PROPN
chd-224	321	36	.	.	PROPN
chd-224	321	37	,	,	PUNCT
chd-224	321	38	livolsi	livolsi	PROPN
chd-224	321	39	,	,	PUNCT
chd-224	321	40	v.a	v.a	PROPN
chd-224	321	41	.	.	PROPN
chd-224	321	42	,	,	PUNCT
chd-224	321	43	mandel	mandel	PROPN
chd-224	321	44	,	,	PUNCT
chd-224	321	45	s.j	s.j	PROPN
chd-224	321	46	.	.	PROPN
chd-224	321	47	,	,	PUNCT
chd-224	321	48	et	et	PROPN
chd-224	321	49	al	al	PROPN
chd-224	321	50	.	.	PUNCT
chd-224	322	1	(	(	PUNCT
chd-224	322	2	2012	2012	NUM
chd-224	322	3	)	)	PUNCT
chd-224	322	4	.	.	PUNCT
chd-224	323	1	preoperative	preoperative	ADJ
chd-224	323	2	diagnosis	diagnosis	NOUN
chd-224	323	3	of	of	ADP
chd-224	323	4	benign	benign	ADJ
chd-224	323	5	thyroid	thyroid	NOUN
chd-224	323	6	nodules	nodule	NOUN
chd-224	323	7	with	with	ADP
chd-224	323	8	indeterminate	indeterminate	ADJ
chd-224	323	9	cytology	cytology	NOUN
chd-224	323	10	.	.	PUNCT
chd-224	324	1	367	367	NUM
chd-224	324	2	,	,	PUNCT
chd-224	324	3	705	705	NUM
chd-224	324	4	-	-	SYM
chd-224	324	5	715	715	NUM
chd-224	324	6	.	.	PUNCT
chd-224	325	1	artiga	artiga	PROPN
chd-224	325	2	s	s	PROPN
chd-224	325	3	,	,	PUNCT
chd-224	325	4	h.l	h.l	PROPN
chd-224	325	5	.	.	PROPN
chd-224	325	6	,	,	PUNCT
chd-224	325	7	orgera	orgera	PROPN
chd-224	325	8	k	k	PROPN
chd-224	325	9	,	,	PUNCT
chd-224	325	10	damico	damico	VERB
chd-224	325	11	a	a	DET
chd-224	325	12	(	(	PUNCT
chd-224	325	13	2021	2021	NUM
chd-224	325	14	)	)	PUNCT
chd-224	325	15	.	.	PUNCT
chd-224	326	1	health	health	NOUN
chd-224	326	2	coverage	coverage	NOUN
chd-224	326	3	by	by	ADP
chd-224	326	4	race	race	NOUN
chd-224	326	5	and	and	CCONJ
chd-224	326	6	ethnicity	ethnicity	NOUN
chd-224	326	7	,	,	PUNCT
chd-224	326	8	2010	2010	NUM
chd-224	326	9	-	-	SYM
chd-224	326	10	2019	2019	NUM
chd-224	326	11	.	.	PUNCT
chd-224	327	1	kff	kff	PROPN
chd-224	327	2	.	.	PROPN
chd-224	327	3	asban	asban	PROPN
chd-224	327	4	,	,	PUNCT
chd-224	327	5	a.	a.	NOUN
chd-224	327	6	,	,	PUNCT
chd-224	327	7	chung	chung	PROPN
chd-224	327	8	,	,	PUNCT
chd-224	327	9	s.k	s.k	PROPN
chd-224	327	10	.	.	PROPN
chd-224	327	11	,	,	PUNCT
chd-224	327	12	xie	xie	PROPN
chd-224	327	13	,	,	PUNCT
chd-224	327	14	r.	r.	PROPN
chd-224	327	15	,	,	PUNCT
chd-224	327	16	lindeman	lindeman	NOUN
chd-224	327	17	,	,	PUNCT
chd-224	327	18	b.m	b.m	PROPN
chd-224	327	19	.	.	PROPN
chd-224	327	20	,	,	PUNCT
chd-224	327	21	balentine	balentine	PROPN
chd-224	327	22	,	,	PUNCT
chd-224	327	23	c.j	c.j	PROPN
chd-224	327	24	.	.	PROPN
chd-224	327	25	,	,	PUNCT
chd-224	327	26	kirklin	kirklin	PROPN
chd-224	327	27	,	,	PUNCT
chd-224	327	28	j.k	j.k	PROPN
chd-224	327	29	.	.	PROPN
chd-224	327	30	,	,	PUNCT
chd-224	327	31	and	and	CCONJ
chd-224	327	32	chen	chen	PROPN
chd-224	327	33	,	,	PUNCT
chd-224	327	34	h.	h.	PROPN
chd-224	327	35	(	(	PUNCT
chd-224	327	36	2019	2019	NUM
chd-224	327	37	)	)	PUNCT
chd-224	327	38	.	.	PUNCT
chd-224	328	1	gender	gender	NOUN
chd-224	328	2	and	and	CCONJ
chd-224	328	3	racial	racial	ADJ
chd-224	328	4	disparities	disparity	NOUN
chd-224	328	5	in	in	ADP
chd-224	328	6	survival	survival	NOUN
chd-224	328	7	after	after	ADP
chd-224	328	8	surgery	surgery	NOUN
chd-224	328	9	among	among	ADP
chd-224	328	10	papillary	papillary	NOUN
chd-224	328	11	and	and	CCONJ
chd-224	328	12	patients	patient	NOUN
chd-224	328	13	with	with	ADP
chd-224	328	14	follicular	follicular	ADJ
chd-224	328	15	thyroid	thyroid	NOUN
chd-224	328	16	cancer	cancer	NOUN
chd-224	328	17	:	:	PUNCT
chd-224	328	18	a	a	DET
chd-224	328	19	45	45	NUM
chd-224	328	20	-	-	PUNCT
chd-224	328	21	year	year	NOUN
chd-224	328	22	experience	experience	NOUN
chd-224	328	23	.	.	PUNCT
chd-224	329	1	clin	clin	PROPN
chd-224	329	2	med	med	PROPN
chd-224	329	3	insights	insight	NOUN
chd-224	329	4	endocrinol	endocrinol	VERB
chd-224	329	5	diabetes	diabetes	NOUN
chd-224	329	6	12	12	NUM
chd-224	329	7	,	,	PUNCT
chd-224	329	8	1179551419866196	1179551419866196	NUM
chd-224	329	9	.	.	PUNCT
chd-224	330	1	bartenstein	bartenstein	PROPN
chd-224	330	2	,	,	PUNCT
chd-224	330	3	p.	p.	NOUN
chd-224	330	4	,	,	PUNCT
chd-224	330	5	calabuig	calabuig	NOUN
chd-224	330	6	,	,	PUNCT
chd-224	330	7	e.c	e.c	PROPN
chd-224	330	8	.	.	PROPN
chd-224	330	9	,	,	PUNCT
chd-224	330	10	maini	maini	PROPN
chd-224	330	11	,	,	PUNCT
chd-224	330	12	c.l	c.l	PROPN
chd-224	330	13	.	.	PROPN
chd-224	330	14	,	,	PUNCT
chd-224	330	15	mazzarotto	mazzarotto	PROPN
chd-224	330	16	,	,	PUNCT
chd-224	330	17	r.	r.	PROPN
chd-224	330	18	,	,	PUNCT
chd-224	330	19	muros	muros	PROPN
chd-224	330	20	de	de	X
chd-224	330	21	fuentes	fuentes	PROPN
chd-224	330	22	,	,	PUNCT
chd-224	330	23	m.a	m.a	PROPN
chd-224	330	24	.	.	PROPN
chd-224	330	25	,	,	PUNCT
chd-224	330	26	petrich	petrich	PROPN
chd-224	330	27	,	,	PUNCT
chd-224	330	28	t.	t.	PROPN
chd-224	330	29	,	,	PUNCT
chd-224	330	30	rodrigues	rodrigues	PROPN
chd-224	330	31	,	,	PUNCT
chd-224	330	32	f.j	f.j	PROPN
chd-224	330	33	.	.	PROPN
chd-224	330	34	,	,	PUNCT
chd-224	330	35	vallejo	vallejo	PROPN
chd-224	330	36	casas	casas	PROPN
chd-224	330	37	,	,	PUNCT
chd-224	330	38	j.a	j.a	PROPN
chd-224	330	39	.	.	PROPN
chd-224	330	40	,	,	PUNCT
chd-224	330	41	vianello	vianello	PROPN
chd-224	330	42	,	,	PUNCT
chd-224	330	43	f.	f.	PROPN
chd-224	330	44	,	,	PUNCT
chd-224	330	45	basso	basso	NOUN
chd-224	330	46	,	,	PUNCT
chd-224	330	47	m.	m.	NOUN
chd-224	330	48	,	,	PUNCT
chd-224	330	49	et	et	PROPN
chd-224	330	50	al	al	PROPN
chd-224	330	51	.	.	PUNCT
chd-224	331	1	(	(	PUNCT
chd-224	331	2	2014	2014	NUM
chd-224	331	3	)	)	PUNCT
chd-224	331	4	.	.	PUNCT
chd-224	332	1	high	high	ADJ
chd-224	332	2	-	-	PUNCT
chd-224	332	3	risk	risk	NOUN
chd-224	332	4	patients	patient	NOUN
chd-224	332	5	with	with	ADP
chd-224	332	6	differentiated	differentiated	ADJ
chd-224	332	7	thyroid	thyroid	NOUN
chd-224	332	8	cancer	cancer	NOUN
chd-224	332	9	t4	t4	PROPN
chd-224	332	10	primary	primary	ADJ
chd-224	332	11	tumors	tumor	NOUN
chd-224	332	12	achieve	achieve	VERB
chd-224	332	13	remnant	remnant	ADJ
chd-224	332	14	ablation	ablation	NOUN
chd-224	332	15	equally	equally	ADV
chd-224	332	16	well	well	ADV
chd-224	332	17	using	use	VERB
chd-224	332	18	rhtsh	rhtsh	NOUN
chd-224	332	19	or	or	CCONJ
chd-224	332	20	thyroid	thyroid	VERB
chd-224	332	21	hormone	hormone	NOUN
chd-224	332	22	withdrawal	withdrawal	NOUN
chd-224	332	23	.	.	PUNCT
chd-224	333	1	thyroid	thyroid	NOUN
chd-224	333	2	24	24	NUM
chd-224	333	3	,	,	PUNCT
chd-224	333	4	480	480	NUM
chd-224	333	5	-	-	SYM
chd-224	333	6	487	487	NUM
chd-224	333	7	.	.	PUNCT
chd-224	334	1	bogović	bogović	NOUN
chd-224	334	2	crnčić	crnčić	NOUN
chd-224	334	3	,	,	PUNCT
chd-224	334	4	t.	t.	PROPN
chd-224	334	5	,	,	PUNCT
chd-224	334	6	ilić	ilić	ADJ
chd-224	334	7	tomaš	tomaš	NOUN
chd-224	334	8	,	,	PUNCT
chd-224	334	9	m.	m.	NOUN
chd-224	334	10	,	,	PUNCT
chd-224	334	11	girotto	girotto	NOUN
chd-224	334	12	,	,	PUNCT
chd-224	334	13	n.	n.	NOUN
chd-224	334	14	,	,	PUNCT
chd-224	334	15	and	and	CCONJ
chd-224	334	16	grbac	grbac	PROPN
chd-224	334	17	ivanković	ivanković	PROPN
chd-224	334	18	,	,	PUNCT
chd-224	334	19	s.	s.	PROPN
chd-224	334	20	(	(	PUNCT
chd-224	334	21	2020	2020	NUM
chd-224	334	22	)	)	PUNCT
chd-224	334	23	.	.	PUNCT
chd-224	335	1	risk	risk	NOUN
chd-224	335	2	factors	factor	NOUN
chd-224	335	3	for	for	ADP
chd-224	335	4	thyroid	thyroid	NOUN
chd-224	335	5	cancer	cancer	NOUN
chd-224	335	6	:	:	PUNCT
chd-224	335	7	what	what	PRON
chd-224	335	8	do	do	AUX
chd-224	335	9	we	we	PRON
chd-224	335	10	know	know	VERB
chd-224	335	11	so	so	ADV
chd-224	335	12	far	far	ADV
chd-224	335	13	?	?	PUNCT
chd-224	336	1	acta	acta	PROPN
chd-224	336	2	clin	clin	PROPN
chd-224	336	3	croat	croat	PROPN
chd-224	336	4	59	59	NUM
chd-224	336	5	,	,	PUNCT
chd-224	336	6	66	66	NUM
chd-224	336	7	-	-	SYM
chd-224	336	8	72	72	NUM
chd-224	336	9	.	.	PUNCT
chd-224	337	1	boi	boi	PROPN
chd-224	337	2	,	,	PUNCT
chd-224	337	3	f.	f.	PROPN
chd-224	337	4	,	,	PUNCT
chd-224	337	5	pani	pani	PROPN
chd-224	337	6	,	,	PUNCT
chd-224	337	7	f.	f.	PROPN
chd-224	337	8	,	,	PUNCT
chd-224	337	9	and	and	CCONJ
chd-224	337	10	mariotti	mariotti	PROPN
chd-224	337	11	,	,	PUNCT
chd-224	337	12	s.	s.	PROPN
chd-224	337	13	(	(	PUNCT
chd-224	337	14	2017	2017	NUM
chd-224	337	15	)	)	PUNCT
chd-224	337	16	.	.	PUNCT
chd-224	338	1	thyroid	thyroid	NOUN
chd-224	338	2	autoimmunity	autoimmunity	NOUN
chd-224	338	3	and	and	CCONJ
chd-224	338	4	thyroid	thyroid	NOUN
chd-224	338	5	cancer	cancer	NOUN
chd-224	338	6	:	:	PUNCT
chd-224	338	7	review	review	NOUN
chd-224	338	8	focused	focus	VERB
chd-224	338	9	on	on	ADP
chd-224	338	10	cytological	cytological	ADJ
chd-224	338	11	studies	study	NOUN
chd-224	338	12	.	.	PUNCT
chd-224	339	1	eur	eur	PROPN
chd-224	339	2	thyroid	thyroid	PROPN
chd-224	339	3	j	j	PROPN
chd-224	339	4	6	6	NUM
chd-224	339	5	,	,	PUNCT
chd-224	339	6	178	178	NUM
chd-224	339	7	-	-	SYM
chd-224	339	8	186	186	NUM
chd-224	339	9	.	.	PUNCT
chd-224	340	1	brown	brown	PROPN
chd-224	340	2	,	,	PUNCT
chd-224	340	3	s.r	s.r	PROPN
chd-224	340	4	.	.	PROPN
chd-224	340	5	,	,	PUNCT
chd-224	340	6	lee	lee	PROPN
chd-224	340	7	,	,	PUNCT
chd-224	340	8	s.	s.	PROPN
chd-224	340	9	,	,	PUNCT
chd-224	340	10	brown	brown	PROPN
chd-224	340	11	,	,	PUNCT
chd-224	340	12	t.a	t.a	PROPN
chd-224	340	13	.	.	PROPN
chd-224	340	14	,	,	PUNCT
chd-224	340	15	and	and	CCONJ
chd-224	340	16	waddell	waddell	PROPN
chd-224	340	17	,	,	PUNCT
chd-224	340	18	b.e	b.e	PROPN
chd-224	340	19	.	.	PROPN
chd-224	340	20	(	(	PUNCT
chd-224	340	21	2010	2010	NUM
chd-224	340	22	)	)	PUNCT
chd-224	340	23	.	.	PUNCT
chd-224	341	1	effect	effect	NOUN
chd-224	341	2	of	of	ADP
chd-224	341	3	race	race	NOUN
chd-224	341	4	on	on	ADP
chd-224	341	5	thyroid	thyroid	NOUN
chd-224	341	6	cancer	cancer	NOUN
chd-224	341	7	care	care	NOUN
chd-224	341	8	in	in	ADP
chd-224	341	9	an	an	DET
chd-224	341	10	equal	equal	ADJ
chd-224	341	11	access	access	NOUN
chd-224	341	12	healthcare	healthcare	NOUN
chd-224	341	13	system	system	NOUN
chd-224	341	14	.	.	PUNCT
chd-224	342	1	am	be	AUX
chd-224	342	2	j	j	PROPN
chd-224	342	3	surg	surg	PROPN
chd-224	342	4	199	199	NUM
chd-224	342	5	,	,	PUNCT
chd-224	342	6	685	685	NUM
chd-224	342	7	-	-	SYM
chd-224	342	8	689	689	NUM
chd-224	342	9	.	.	PUNCT
chd-224	343	1	chartier	chartier	NOUN
chd-224	343	2	,	,	PUNCT
chd-224	343	3	k.	k.	PROPN
chd-224	343	4	,	,	PUNCT
chd-224	343	5	and	and	CCONJ
chd-224	343	6	caetano	caetano	PROPN
chd-224	343	7	,	,	PUNCT
chd-224	343	8	r.	r.	PROPN
chd-224	343	9	(	(	PUNCT
chd-224	343	10	2010	2010	NUM
chd-224	343	11	)	)	PUNCT
chd-224	343	12	.	.	PUNCT
chd-224	344	1	ethnicity	ethnicity	NOUN
chd-224	344	2	and	and	CCONJ
chd-224	344	3	health	health	NOUN
chd-224	344	4	disparities	disparity	NOUN
chd-224	344	5	in	in	ADP
chd-224	344	6	alcohol	alcohol	NOUN
chd-224	344	7	research	research	NOUN
chd-224	344	8	.	.	PUNCT
chd-224	345	1	alcohol	alcohol	NOUN
chd-224	345	2	res	res	PROPN
chd-224	345	3	health	health	NOUN
chd-224	345	4	33	33	NUM
chd-224	345	5	,	,	PUNCT
chd-224	345	6	152160	152160	NUM
chd-224	345	7	.	.	PUNCT
chd-224	346	1	chidharla	chidharla	NOUN
chd-224	346	2	,	,	PUNCT
chd-224	346	3	a.	a.	NOUN
chd-224	346	4	,	,	PUNCT
chd-224	346	5	agarwal	agarwal	PROPN
chd-224	346	6	,	,	PUNCT
chd-224	346	7	k.	k.	PROPN
chd-224	346	8	,	,	PUNCT
chd-224	346	9	abdelwahed	abdelwahe	VERB
chd-224	346	10	,	,	PUNCT
chd-224	346	11	s.	s.	PROPN
chd-224	346	12	,	,	PUNCT
chd-224	346	13	bhandari	bhandari	PROPN
chd-224	346	14	,	,	PUNCT
chd-224	346	15	r.	r.	PROPN
chd-224	346	16	,	,	PUNCT
chd-224	346	17	singh	singh	PROPN
chd-224	346	18	,	,	PUNCT
chd-224	346	19	a.	a.	NOUN
chd-224	346	20	,	,	PUNCT
chd-224	346	21	rabbani	rabbani	PROPN
chd-224	346	22	,	,	PUNCT
chd-224	346	23	r.	r.	PROPN
chd-224	346	24	,	,	PUNCT
chd-224	346	25	patel	patel	PROPN
chd-224	346	26	,	,	PUNCT
chd-224	346	27	k.	k.	PROPN
chd-224	346	28	,	,	PUNCT
chd-224	346	29	singh	singh	PROPN
chd-224	346	30	,	,	PUNCT
chd-224	346	31	p.	p.	PROPN
chd-224	346	32	,	,	PUNCT
chd-224	346	33	mehta	mehta	PROPN
chd-224	346	34	,	,	PUNCT
chd-224	346	35	d.	d.	PROPN
chd-224	346	36	,	,	PUNCT
chd-224	346	37	manaktala	manaktala	PROPN
chd-224	346	38	,	,	PUNCT
chd-224	346	39	p.s	p.s	PROPN
chd-224	346	40	.	.	PROPN
chd-224	346	41	,	,	PUNCT
chd-224	346	42	et	et	PROPN
chd-224	346	43	al	al	PROPN
chd-224	346	44	.	.	PROPN
chd-224	347	1	(	(	PUNCT
chd-224	347	2	2022	2022	NUM
chd-224	347	3	)	)	PUNCT
chd-224	347	4	.	.	PUNCT
chd-224	348	1	cancer	cancer	NOUN
chd-224	348	2	prevalence	prevalence	NOUN
chd-224	348	3	in	in	ADP
chd-224	348	4	e	e	NOUN
chd-224	348	5	-	-	NOUN
chd-224	348	6	cigarette	cigarette	ADJ
chd-224	348	7	users	user	NOUN
chd-224	348	8	:	:	PUNCT
chd-224	348	9	a	a	DET
chd-224	348	10	retrospective	retrospective	ADJ
chd-224	348	11	cross	cross	ADJ
chd-224	348	12	-	-	ADJ
chd-224	348	13	sectional	sectional	ADJ
chd-224	348	14	nhanes	nhane	NOUN
chd-224	348	15	study	study	VERB
chd-224	348	16	.	.	PUNCT
chd-224	349	1	world	world	PROPN
chd-224	349	2	j	j	PROPN
chd-224	349	3	oncol	oncol	ADJ
chd-224	349	4	13	13	NUM
chd-224	349	5	,	,	PUNCT
chd-224	349	6	20	20	NUM
chd-224	349	7	-	-	SYM
chd-224	349	8	26	26	NUM
chd-224	349	9	.	.	PUNCT
chd-224	350	1	chou	chou	NOUN
chd-224	350	2	,	,	PUNCT
chd-224	350	3	c.k	c.k	PROPN
chd-224	350	4	.	.	PROPN
chd-224	350	5	,	,	PUNCT
chd-224	350	6	chi	chi	PROPN
chd-224	350	7	,	,	PUNCT
chd-224	350	8	s.y	s.y	PROPN
chd-224	350	9	.	.	PROPN
chd-224	350	10	,	,	PUNCT
chd-224	350	11	chou	chou	PROPN
chd-224	350	12	,	,	PUNCT
chd-224	350	13	f.f	f.f	PROPN
chd-224	350	14	.	.	PROPN
chd-224	350	15	,	,	PUNCT
chd-224	350	16	huang	huang	PROPN
chd-224	350	17	,	,	PUNCT
chd-224	350	18	s.c	s.c	PROPN
chd-224	350	19	.	.	PROPN
chd-224	350	20	,	,	PUNCT
chd-224	350	21	wang	wang	PROPN
chd-224	350	22	,	,	PUNCT
chd-224	350	23	j.h	j.h	PROPN
chd-224	350	24	.	.	PROPN
chd-224	350	25	,	,	PUNCT
chd-224	350	26	chen	chen	PROPN
chd-224	350	27	,	,	PUNCT
chd-224	350	28	c.c	c.c	PROPN
chd-224	350	29	.	.	PROPN
chd-224	350	30	,	,	PUNCT
chd-224	350	31	and	and	CCONJ
chd-224	350	32	kang	kang	PROPN
chd-224	350	33	,	,	PUNCT
chd-224	350	34	h.y	h.y	PROPN
chd-224	350	35	.	.	PROPN
chd-224	350	36	(	(	PUNCT
chd-224	350	37	2020	2020	NUM
chd-224	350	38	)	)	PUNCT
chd-224	350	39	.	.	PUNCT
chd-224	351	1	aberrant	aberrant	ADJ
chd-224	351	2	expression	expression	NOUN
chd-224	351	3	of	of	ADP
chd-224	351	4	androgen	androgen	NOUN
chd-224	351	5	receptor	receptor	NOUN
chd-224	351	6	associated	associate	VERB
chd-224	351	7	with	with	ADP
chd-224	351	8	high	high	ADJ
chd-224	351	9	cancer	cancer	NOUN
chd-224	351	10	risk	risk	NOUN
chd-224	351	11	and	and	CCONJ
chd-224	351	12	extrathyroidal	extrathyroidal	ADJ
chd-224	351	13	extension	extension	NOUN
chd-224	351	14	in	in	ADP
chd-224	351	15	papillary	papillary	ADJ
chd-224	351	16	thyroid	thyroid	NOUN
chd-224	351	17	carcinoma	carcinoma	NOUN
chd-224	351	18	.	.	PUNCT
chd-224	352	1	cancers	cancer	NOUN
chd-224	352	2	(	(	PUNCT
chd-224	352	3	basel	basel	PROPN
chd-224	352	4	)	)	PUNCT
chd-224	352	5	12	12	NUM
chd-224	352	6	.	.	PUNCT
chd-224	353	1	clark	clark	PROPN
chd-224	353	2	,	,	PUNCT
chd-224	353	3	j.r	j.r	PROPN
chd-224	353	4	.	.	PROPN
chd-224	353	5	,	,	PUNCT
chd-224	353	6	eski	eski	PROPN
chd-224	353	7	,	,	PUNCT
chd-224	353	8	s.j	s.j	PROPN
chd-224	353	9	.	.	PROPN
chd-224	353	10	,	,	PUNCT
chd-224	353	11	and	and	CCONJ
chd-224	353	12	freeman	freeman	PROPN
chd-224	353	13	,	,	PUNCT
chd-224	353	14	j.l	j.l	PROPN
chd-224	353	15	.	.	PROPN
chd-224	353	16	(	(	PUNCT
chd-224	353	17	2006	2006	NUM
chd-224	353	18	)	)	PUNCT
chd-224	353	19	.	.	PUNCT
chd-224	354	1	risk	risk	NOUN
chd-224	354	2	of	of	ADP
chd-224	354	3	malignancy	malignancy	NOUN
chd-224	354	4	in	in	ADP
chd-224	354	5	filipinos	filipino	NOUN
chd-224	354	6	with	with	ADP
chd-224	354	7	thyroid	thyroid	NOUN
chd-224	354	8	nodules	nodule	NOUN
chd-224	354	9	--	--	PUNCT
chd-224	354	10	a	a	DET
chd-224	354	11	matched	match	VERB
chd-224	354	12	pair	pair	NOUN
chd-224	354	13	analysis	analysis	NOUN
chd-224	354	14	.	.	PUNCT
chd-224	355	1	head	head	NOUN
chd-224	355	2	neck	neck	NOUN
chd-224	355	3	28	28	NUM
chd-224	355	4	,	,	PUNCT
chd-224	355	5	427	427	NUM
chd-224	355	6	-	-	SYM
chd-224	355	7	431	431	NUM
chd-224	355	8	.	.	PUNCT
chd-224	356	1	clinckspoor	clinckspoor	PROPN
chd-224	356	2	,	,	PUNCT
chd-224	356	3	i.	i.	NOUN
chd-224	356	4	,	,	PUNCT
chd-224	356	5	verlinden	verlinden	PROPN
chd-224	356	6	,	,	PUNCT
chd-224	356	7	l.	l.	PROPN
chd-224	356	8	,	,	PUNCT
chd-224	356	9	overbergh	overbergh	PROPN
chd-224	356	10	,	,	PUNCT
chd-224	356	11	l.	l.	PROPN
chd-224	356	12	,	,	PUNCT
chd-224	356	13	korch	korch	PROPN
chd-224	356	14	,	,	PUNCT
chd-224	356	15	c.	c.	NOUN
chd-224	356	16	,	,	PUNCT
chd-224	356	17	bouillon	bouillon	NOUN
chd-224	356	18	,	,	PUNCT
chd-224	356	19	r.	r.	PROPN
chd-224	356	20	,	,	PUNCT
chd-224	356	21	mathieu	mathieu	PROPN
chd-224	356	22	,	,	PUNCT
chd-224	356	23	c.	c.	PROPN
chd-224	356	24	,	,	PUNCT
chd-224	356	25	verstuyf	verstuyf	NOUN
chd-224	356	26	,	,	PUNCT
chd-224	356	27	a.	a.	NOUN
chd-224	356	28	,	,	PUNCT
chd-224	356	29	and	and	CCONJ
chd-224	356	30	decallonne	decallonne	NOUN
chd-224	356	31	,	,	PUNCT
chd-224	356	32	b.	b.	PROPN
chd-224	356	33	(	(	PUNCT
chd-224	356	34	2011	2011	NUM
chd-224	356	35	)	)	PUNCT
chd-224	356	36	.	.	PUNCT
chd-224	357	1	1,25	1,25	NUM
chd-224	357	2	-	-	PUNCT
chd-224	357	3	dihydroxyvitamin	dihydroxyvitamin	ADJ
chd-224	357	4	d3	d3	PROPN
chd-224	357	5	and	and	CCONJ
chd-224	357	6	a	a	DET
chd-224	357	7	superagonistic	superagonistic	ADJ
chd-224	357	8	analog	analog	NOUN
chd-224	357	9	in	in	ADP
chd-224	357	10	combination	combination	NOUN
chd-224	357	11	with	with	ADP
chd-224	357	12	paclitaxel	paclitaxel	PROPN
chd-224	357	13	or	or	CCONJ
chd-224	357	14	suberoylanilide	suberoylanilide	VERB
chd-224	357	15	hydroxamic	hydroxamic	PROPN
chd-224	357	16	acid	acid	PROPN
chd-224	357	17	have	have	AUX
chd-224	357	18	potent	potent	ADJ
chd-224	357	19	antiproliferative	antiproliferative	ADJ
chd-224	357	20	effects	effect	NOUN
chd-224	357	21	on	on	ADP
chd-224	357	22	anaplastic	anaplastic	ADJ
chd-224	357	23	thyroid	thyroid	NOUN
chd-224	357	24	cancer	cancer	NOUN
chd-224	357	25	.	.	PUNCT
chd-224	358	1	j	j	PROPN
chd-224	358	2	steroid	steroid	PROPN
chd-224	358	3	biochem	biochem	PROPN
chd-224	358	4	mol	mol	ADP
chd-224	358	5	biol	biol	PROPN
chd-224	358	6	124	124	NUM
chd-224	358	7	,	,	PUNCT
chd-224	358	8	1	1	NUM
chd-224	358	9	-	-	SYM
chd-224	358	10	9	9	NUM
chd-224	358	11	.	.	PUNCT
chd-224	359	1	correa	correa	PROPN
chd-224	359	2	,	,	PUNCT
chd-224	359	3	r.	r.	PROPN
chd-224	359	4	,	,	PUNCT
chd-224	359	5	salpea	salpea	NOUN
chd-224	359	6	,	,	PUNCT
chd-224	359	7	p.	p.	NOUN
chd-224	359	8	,	,	PUNCT
chd-224	359	9	and	and	CCONJ
chd-224	359	10	stratakis	stratakis	PROPN
chd-224	359	11	,	,	PUNCT
chd-224	359	12	c.a	c.a	PROPN
chd-224	359	13	.	.	PROPN
chd-224	359	14	(	(	PUNCT
chd-224	359	15	2015	2015	NUM
chd-224	359	16	)	)	PUNCT
chd-224	359	17	.	.	PUNCT
chd-224	360	1	carney	carney	PROPN
chd-224	360	2	complex	complex	PROPN
chd-224	360	3	:	:	PUNCT
chd-224	360	4	an	an	DET
chd-224	360	5	update	update	NOUN
chd-224	360	6	.	.	PUNCT
chd-224	361	1	eur	eur	PROPN
chd-224	361	2	j	j	PROPN
chd-224	361	3	endocrinol	endocrinol	PROPN
chd-224	361	4	173	173	NUM
chd-224	361	5	,	,	PUNCT
chd-224	361	6	m85	m85	NOUN
chd-224	361	7	-	-	PUNCT
chd-224	361	8	97	97	NUM
chd-224	361	9	.	.	PUNCT
chd-224	362	1	fisher	fisher	PROPN
chd-224	362	2	,	,	PUNCT
chd-224	362	3	s.b	s.b	PROPN
chd-224	362	4	.	.	PROPN
chd-224	362	5	,	,	PUNCT
chd-224	362	6	and	and	CCONJ
chd-224	362	7	perrier	perrier	PROPN
chd-224	362	8	,	,	PUNCT
chd-224	362	9	n.d	n.d	PROPN
chd-224	362	10	.	.	PROPN
chd-224	362	11	(	(	PUNCT
chd-224	362	12	2018	2018	NUM
chd-224	362	13	)	)	PUNCT
chd-224	362	14	.	.	PUNCT
chd-224	363	1	the	the	DET
chd-224	363	2	incidental	incidental	ADJ
chd-224	363	3	thyroid	thyroid	NOUN
chd-224	363	4	nodule	nodule	NOUN
chd-224	363	5	.	.	PUNCT
chd-224	364	1	ca	can	AUX
chd-224	364	2	cancer	cancer	PROPN
chd-224	364	3	j	j	PROPN
chd-224	364	4	clin	clin	PROPN
chd-224	364	5	68	68	NUM
chd-224	364	6	,	,	PUNCT
chd-224	364	7	97	97	NUM
chd-224	364	8	-	-	SYM
chd-224	364	9	105	105	NUM
chd-224	364	10	.	.	PUNCT
chd-224	364	11	franchini	franchini	PROPN
chd-224	364	12	,	,	PUNCT
chd-224	364	13	f.	f.	PROPN
chd-224	364	14	,	,	PUNCT
chd-224	364	15	palatucci	palatucci	PROPN
chd-224	364	16	,	,	PUNCT
chd-224	364	17	g.	g.	PROPN
chd-224	364	18	,	,	PUNCT
chd-224	364	19	colao	colao	PROPN
chd-224	364	20	,	,	PUNCT
chd-224	364	21	a.	a.	NOUN
chd-224	364	22	,	,	PUNCT
chd-224	364	23	ungaro	ungaro	NOUN
chd-224	364	24	,	,	PUNCT
chd-224	364	25	p.	p.	PROPN
chd-224	364	26	,	,	PUNCT
chd-224	364	27	macchia	macchia	PROPN
chd-224	364	28	,	,	PUNCT
chd-224	364	29	p.e	p.e	PROPN
chd-224	364	30	.	.	PROPN
chd-224	364	31	,	,	PUNCT
chd-224	364	32	and	and	CCONJ
chd-224	364	33	nettore	nettore	ADV
chd-224	364	34	,	,	PUNCT
chd-224	364	35	i.c	i.c	PROPN
chd-224	364	36	.	.	PROPN
chd-224	364	37	(	(	PUNCT
chd-224	364	38	2022	2022	NUM
chd-224	364	39	)	)	PUNCT
chd-224	364	40	.	.	PUNCT
chd-224	365	1	obesity	obesity	NOUN
chd-224	365	2	and	and	CCONJ
chd-224	365	3	thyroid	thyroid	NOUN
chd-224	365	4	cancer	cancer	NOUN
chd-224	365	5	risk	risk	NOUN
chd-224	365	6	:	:	PUNCT
chd-224	365	7	an	an	DET
chd-224	365	8	update	update	NOUN
chd-224	365	9	.	.	PUNCT
chd-224	366	1	int	int	PROPN
chd-224	367	1	j	j	PROPN
chd-224	367	2	environ	environ	PROPN
chd-224	367	3	res	res	PROPN
chd-224	367	4	public	public	ADJ
chd-224	367	5	health	health	PROPN
chd-224	367	6	19	19	NUM
chd-224	367	7	.	.	PUNCT
chd-224	368	1	friedenreich	friedenreich	PROPN
chd-224	368	2	,	,	PUNCT
chd-224	368	3	c.m	c.m	PROPN
chd-224	368	4	.	.	PROPN
chd-224	368	5	,	,	PUNCT
chd-224	368	6	ryder	ryder	NOUN
chd-224	368	7	-	-	PUNCT
chd-224	368	8	burbidge	burbidge	NOUN
chd-224	368	9	,	,	PUNCT
chd-224	368	10	c.	c.	NOUN
chd-224	368	11	,	,	PUNCT
chd-224	368	12	and	and	CCONJ
chd-224	368	13	mcneil	mcneil	PROPN
chd-224	368	14	,	,	PUNCT
chd-224	368	15	j.	j.	PROPN
chd-224	368	16	(	(	PUNCT
chd-224	368	17	2021	2021	NUM
chd-224	368	18	)	)	PUNCT
chd-224	368	19	.	.	PUNCT
chd-224	369	1	physical	physical	ADJ
chd-224	369	2	activity	activity	NOUN
chd-224	369	3	,	,	PUNCT
chd-224	369	4	obesity	obesity	NOUN
chd-224	369	5	and	and	CCONJ
chd-224	369	6	sedentary	sedentary	ADJ
chd-224	369	7	behavior	behavior	NOUN
chd-224	369	8	in	in	ADP
chd-224	369	9	cancer	cancer	NOUN
chd-224	369	10	etiology	etiology	NOUN
chd-224	369	11	:	:	PUNCT
chd-224	369	12	epidemiologic	epidemiologic	ADJ
chd-224	369	13	evidence	evidence	NOUN
chd-224	369	14	and	and	CCONJ
chd-224	369	15	biologic	biologic	NOUN
chd-224	369	16	mechanisms	mechanism	NOUN
chd-224	369	17	.	.	PUNCT
chd-224	370	1	mol	mol	ADP
chd-224	370	2	oncol	oncol	ADJ
chd-224	370	3	15	15	NUM
chd-224	370	4	,	,	PUNCT
chd-224	370	5	790	790	NUM
chd-224	370	6	-	-	SYM
chd-224	370	7	800	800	NUM
chd-224	370	8	.	.	PUNCT
chd-224	370	9	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-224	370	10	e17	e17	NOUN
chd-224	370	11	cancer	cancer	NOUN
chd-224	370	12	health	health	NOUN
chd-224	370	13	disparities	disparity	NOUN
chd-224	370	14	research	research	VERB
chd-224	370	15	fröhlich	fröhlich	PROPN
chd-224	370	16	,	,	PUNCT
chd-224	370	17	e.	e.	PROPN
chd-224	370	18	,	,	PUNCT
chd-224	370	19	and	and	CCONJ
chd-224	370	20	wahl	wahl	PROPN
chd-224	370	21	,	,	PUNCT
chd-224	370	22	r.	r.	PROPN
chd-224	370	23	(	(	PUNCT
chd-224	370	24	2017	2017	NUM
chd-224	370	25	)	)	PUNCT
chd-224	370	26	.	.	PUNCT
chd-224	371	1	thyroid	thyroid	NOUN
chd-224	371	2	autoimmunity	autoimmunity	NOUN
chd-224	371	3	:	:	PUNCT
chd-224	371	4	role	role	NOUN
chd-224	371	5	of	of	ADP
chd-224	371	6	anti	anti	ADJ
chd-224	371	7	-	-	ADJ
chd-224	371	8	thyroid	thyroid	ADJ
chd-224	371	9	antibodies	antibodie	VERB
chd-224	371	10	in	in	ADP
chd-224	371	11	thyroid	thyroid	NOUN
chd-224	371	12	and	and	CCONJ
chd-224	371	13	extra	extra	ADJ
chd-224	371	14	-	-	ADJ
chd-224	371	15	thyroidal	thyroidal	ADJ
chd-224	371	16	diseases	disease	NOUN
chd-224	371	17	.	.	PUNCT
chd-224	372	1	front	front	ADJ
chd-224	372	2	immunol	immunol	NOUN
chd-224	372	3	8	8	NUM
chd-224	372	4	,	,	PUNCT
chd-224	372	5	521	521	NUM
chd-224	372	6	.	.	PUNCT
chd-224	373	1	furukawa	furukawa	PROPN
chd-224	373	2	,	,	PUNCT
chd-224	373	3	k.	k.	PROPN
chd-224	373	4	,	,	PUNCT
chd-224	373	5	preston	preston	PROPN
chd-224	373	6	,	,	PUNCT
chd-224	373	7	d.	d.	PROPN
chd-224	373	8	,	,	PUNCT
chd-224	373	9	funamoto	funamoto	ADJ
chd-224	373	10	,	,	PUNCT
chd-224	373	11	s.	s.	PROPN
chd-224	373	12	,	,	PUNCT
chd-224	373	13	yonehara	yonehara	PROPN
chd-224	373	14	,	,	PUNCT
chd-224	373	15	s.	s.	PROPN
chd-224	373	16	,	,	PUNCT
chd-224	373	17	ito	ito	PROPN
chd-224	373	18	,	,	PUNCT
chd-224	373	19	m.	m.	NOUN
chd-224	373	20	,	,	PUNCT
chd-224	373	21	tokuoka	tokuoka	PROPN
chd-224	373	22	,	,	PUNCT
chd-224	373	23	s.	s.	PROPN
chd-224	373	24	,	,	PUNCT
chd-224	373	25	sugiyama	sugiyama	PROPN
chd-224	373	26	,	,	PUNCT
chd-224	373	27	h.	h.	PROPN
chd-224	373	28	,	,	PUNCT
chd-224	373	29	soda	soda	NOUN
chd-224	373	30	,	,	PUNCT
chd-224	373	31	m.	m.	NOUN
chd-224	373	32	,	,	PUNCT
chd-224	373	33	ozasa	ozasa	PROPN
chd-224	373	34	,	,	PUNCT
chd-224	373	35	k.	k.	PROPN
chd-224	373	36	,	,	PUNCT
chd-224	373	37	and	and	CCONJ
chd-224	373	38	mabuchi	mabuchi	PROPN
chd-224	373	39	,	,	PUNCT
chd-224	373	40	k.	k.	PROPN
chd-224	373	41	(	(	PUNCT
chd-224	373	42	2013	2013	NUM
chd-224	373	43	)	)	PUNCT
chd-224	373	44	.	.	PUNCT
chd-224	374	1	long	long	ADJ
chd-224	374	2	-	-	PUNCT
chd-224	374	3	term	term	NOUN
chd-224	374	4	trend	trend	NOUN
chd-224	374	5	of	of	ADP
chd-224	374	6	thyroid	thyroid	NOUN
chd-224	374	7	cancer	cancer	NOUN
chd-224	374	8	risk	risk	NOUN
chd-224	374	9	among	among	ADP
chd-224	374	10	japanese	japanese	ADJ
chd-224	374	11	atomic	atomic	ADJ
chd-224	374	12	-	-	PUNCT
chd-224	374	13	bomb	bomb	NOUN
chd-224	374	14	survivors	survivor	NOUN
chd-224	374	15	:	:	PUNCT
chd-224	374	16	60	60	NUM
chd-224	374	17	years	year	NOUN
chd-224	374	18	after	after	ADP
chd-224	374	19	exposure	exposure	NOUN
chd-224	374	20	.	.	PUNCT
chd-224	375	1	int	int	NOUN
chd-224	375	2	j	j	PROPN
chd-224	375	3	cancer	cancer	NOUN
chd-224	375	4	132	132	NUM
chd-224	375	5	,	,	PUNCT
chd-224	375	6	1222	1222	NUM
chd-224	375	7	-	-	SYM
chd-224	375	8	1226	1226	NUM
chd-224	375	9	.	.	PUNCT
chd-224	376	1	gajowiec	gajowiec	PROPN
chd-224	376	2	,	,	PUNCT
chd-224	376	3	a.	a.	NOUN
chd-224	376	4	,	,	PUNCT
chd-224	376	5	chromik	chromik	NOUN
chd-224	376	6	,	,	PUNCT
chd-224	376	7	a.	a.	NOUN
chd-224	376	8	,	,	PUNCT
chd-224	376	9	furga	furga	NOUN
chd-224	376	10	,	,	PUNCT
chd-224	376	11	k.	k.	PROPN
chd-224	376	12	,	,	PUNCT
chd-224	376	13	skuza	skuza	PROPN
chd-224	376	14	,	,	PUNCT
chd-224	376	15	a.	a.	NOUN
chd-224	376	16	,	,	PUNCT
chd-224	376	17	gąsior	gąsior	NOUN
chd-224	376	18	-	-	PUNCT
chd-224	376	19	perczak	perczak	NOUN
chd-224	376	20	,	,	PUNCT
chd-224	376	21	d.	d.	PROPN
chd-224	376	22	,	,	PUNCT
chd-224	376	23	walczyk	walczyk	VERB
chd-224	376	24	,	,	PUNCT
chd-224	376	25	a.	a.	NOUN
chd-224	376	26	,	,	PUNCT
chd-224	376	27	pałyga	pałyga	NOUN
chd-224	376	28	,	,	PUNCT
chd-224	376	29	i.	i.	NOUN
chd-224	376	30	,	,	PUNCT
chd-224	376	31	trybek	trybek	ADJ
chd-224	376	32	,	,	PUNCT
chd-224	376	33	t.	t.	PROPN
chd-224	376	34	,	,	PUNCT
chd-224	376	35	mikina	mikina	PROPN
chd-224	376	36	,	,	PUNCT
chd-224	376	37	e.	e.	PROPN
chd-224	376	38	,	,	PUNCT
chd-224	376	39	szymonek	szymonek	NOUN
chd-224	376	40	,	,	PUNCT
chd-224	376	41	m.	m.	NOUN
chd-224	376	42	,	,	PUNCT
chd-224	376	43	et	et	PROPN
chd-224	376	44	al	al	PROPN
chd-224	376	45	.	.	PROPN
chd-224	376	46	(	(	PUNCT
chd-224	376	47	2021	2021	NUM
chd-224	376	48	)	)	PUNCT
chd-224	376	49	.	.	PUNCT
chd-224	376	50	is	be	AUX
chd-224	376	51	male	male	ADJ
chd-224	376	52	sex	sex	NOUN
chd-224	376	53	a	a	DET
chd-224	376	54	prognostic	prognostic	ADJ
chd-224	376	55	factor	factor	NOUN
chd-224	376	56	in	in	ADP
chd-224	376	57	papillary	papillary	ADJ
chd-224	376	58	thyroid	thyroid	NOUN
chd-224	376	59	cancer	cancer	NOUN
chd-224	376	60	?	?	PUNCT
chd-224	377	1	j	j	PROPN
chd-224	377	2	clin	clin	PROPN
chd-224	377	3	med	me	VERB
chd-224	377	4	10	10	PROPN
chd-224	377	5	.	.	PUNCT
chd-224	378	1	garofola	garofola	PROPN
chd-224	378	2	,	,	PUNCT
chd-224	378	3	c.	c.	PROPN
chd-224	378	4	,	,	PUNCT
chd-224	378	5	jamal	jamal	PROPN
chd-224	378	6	,	,	PUNCT
chd-224	378	7	z.	z.	PROPN
chd-224	378	8	,	,	PUNCT
chd-224	378	9	and	and	CCONJ
chd-224	378	10	gross	gross	ADJ
chd-224	378	11	,	,	PUNCT
chd-224	378	12	g.p	g.p	PROPN
chd-224	378	13	.	.	PROPN
chd-224	378	14	(	(	PUNCT
chd-224	378	15	2022	2022	NUM
chd-224	378	16	)	)	PUNCT
chd-224	378	17	.	.	PUNCT
chd-224	379	1	cowden	cowden	PROPN
chd-224	379	2	disease	disease	PROPN
chd-224	379	3	.	.	PUNCT
chd-224	380	1	in	in	ADP
chd-224	380	2	statpearls	statpearl	NOUN
chd-224	380	3	(	(	PUNCT
chd-224	380	4	treasure	treasure	NOUN
chd-224	380	5	island	island	NOUN
chd-224	380	6	(	(	PUNCT
chd-224	380	7	fl	fl	PROPN
chd-224	380	8	):	):	PUNCT
chd-224	380	9	statpearls	statpearl	NOUN
chd-224	380	10	publishing	publish	VERB
chd-224	380	11	copyright	copyright	NOUN
chd-224	380	12	©	©	PROPN
chd-224	380	13	2022	2022	NUM
chd-224	380	14	,	,	PUNCT
chd-224	380	15	statpearls	statpearls	PROPN
chd-224	380	16	publishing	publishing	PROPN
chd-224	380	17	llc	llc	PROPN
chd-224	380	18	.	.	PUNCT
chd-224	380	19	)	)	PUNCT
chd-224	380	20	.	.	PUNCT
chd-224	381	1	gomez	gomez	PROPN
chd-224	381	2	,	,	PUNCT
chd-224	381	3	s.l	s.l	PROPN
chd-224	381	4	.	.	PROPN
chd-224	381	5	,	,	PUNCT
chd-224	381	6	noone	noone	PROPN
chd-224	381	7	,	,	PUNCT
chd-224	381	8	a.m.	a.m.	ADV
chd-224	381	9	,	,	PUNCT
chd-224	381	10	lichtensztajn	lichtensztajn	PROPN
chd-224	381	11	,	,	PUNCT
chd-224	381	12	d.y	d.y	PROPN
chd-224	381	13	.	.	PROPN
chd-224	381	14	,	,	PUNCT
chd-224	381	15	scoppa	scoppa	PROPN
chd-224	381	16	,	,	PUNCT
chd-224	381	17	s.	s.	PROPN
chd-224	381	18	,	,	PUNCT
chd-224	381	19	gibson	gibson	PROPN
chd-224	381	20	,	,	PUNCT
chd-224	381	21	j.t	j.t	PROPN
chd-224	381	22	.	.	PROPN
chd-224	381	23	,	,	PUNCT
chd-224	381	24	liu	liu	PROPN
chd-224	381	25	,	,	PUNCT
chd-224	381	26	l.	l.	PROPN
chd-224	381	27	,	,	PUNCT
chd-224	381	28	morris	morris	PROPN
chd-224	381	29	,	,	PUNCT
chd-224	381	30	c.	c.	PROPN
chd-224	381	31	,	,	PUNCT
chd-224	381	32	kwong	kwong	PROPN
chd-224	381	33	,	,	PUNCT
chd-224	381	34	s.	s.	PROPN
chd-224	381	35	,	,	PUNCT
chd-224	381	36	fish	fish	NOUN
chd-224	381	37	,	,	PUNCT
chd-224	381	38	k.	k.	PROPN
chd-224	381	39	,	,	PUNCT
chd-224	381	40	wilkens	wilkens	PROPN
chd-224	381	41	,	,	PUNCT
chd-224	381	42	l.r	l.r	PROPN
chd-224	381	43	.	.	PROPN
chd-224	381	44	,	,	PUNCT
chd-224	381	45	et	et	PROPN
chd-224	381	46	al	al	PROPN
chd-224	381	47	.	.	PROPN
chd-224	381	48	(	(	PUNCT
chd-224	381	49	2013	2013	NUM
chd-224	381	50	)	)	PUNCT
chd-224	381	51	.	.	PUNCT
chd-224	382	1	cancer	cancer	NOUN
chd-224	382	2	incidence	incidence	NOUN
chd-224	382	3	trends	trend	NOUN
chd-224	382	4	among	among	ADP
chd-224	382	5	asian	asian	ADJ
chd-224	382	6	american	american	ADJ
chd-224	382	7	populations	population	NOUN
chd-224	382	8	in	in	ADP
chd-224	382	9	the	the	DET
chd-224	382	10	united	united	PROPN
chd-224	382	11	states	states	PROPN
chd-224	382	12	,	,	PUNCT
chd-224	382	13	1990	1990	NUM
chd-224	382	14	-	-	SYM
chd-224	382	15	2008	2008	NUM
chd-224	382	16	.	.	PUNCT
chd-224	383	1	journal	journal	NOUN
chd-224	383	2	of	of	ADP
chd-224	383	3	the	the	DET
chd-224	383	4	national	national	PROPN
chd-224	383	5	cancer	cancer	PROPN
chd-224	383	6	institute	institute	PROPN
chd-224	383	7	105	105	NUM
chd-224	383	8	,	,	PUNCT
chd-224	383	9	1096	1096	NUM
chd-224	383	10	-	-	SYM
chd-224	383	11	1110	1110	NUM
chd-224	383	12	.	.	PUNCT
chd-224	384	1	gudenkauf	gudenkauf	PROPN
chd-224	384	2	,	,	PUNCT
chd-224	384	3	f.j	f.j	PROPN
chd-224	384	4	.	.	PROPN
chd-224	384	5	,	,	PUNCT
chd-224	384	6	and	and	CCONJ
chd-224	384	7	thrift	thrift	NOUN
chd-224	384	8	,	,	PUNCT
chd-224	384	9	a.p	a.p	PROPN
chd-224	384	10	.	.	PROPN
chd-224	384	11	(	(	PUNCT
chd-224	384	12	2021	2021	NUM
chd-224	384	13	)	)	PUNCT
chd-224	384	14	.	.	PUNCT
chd-224	385	1	preventable	preventable	ADJ
chd-224	385	2	causes	cause	NOUN
chd-224	385	3	of	of	ADP
chd-224	385	4	cancer	cancer	NOUN
chd-224	385	5	in	in	ADP
chd-224	385	6	texas	texas	PROPN
chd-224	385	7	by	by	ADP
chd-224	385	8	race	race	NOUN
chd-224	385	9	/	/	SYM
chd-224	385	10	ethnicity	ethnicity	NOUN
chd-224	385	11	:	:	PUNCT
chd-224	385	12	inadequate	inadequate	ADJ
chd-224	385	13	diet	diet	PROPN
chd-224	385	14	prev	prev	PROPN
chd-224	385	15	med	med	PROPN
chd-224	385	16	rep	rep	PROPN
chd-224	385	17	24	24	NUM
chd-224	385	18	,	,	PUNCT
chd-224	385	19	101637	101637	NUM
chd-224	385	20	.	.	PUNCT
chd-224	386	1	guilmette	guilmette	NOUN
chd-224	386	2	,	,	PUNCT
chd-224	386	3	j.	j.	PROPN
chd-224	386	4	,	,	PUNCT
chd-224	386	5	and	and	CCONJ
chd-224	386	6	nosé	nosé	PROPN
chd-224	386	7	,	,	PUNCT
chd-224	386	8	v.	v.	PROPN
chd-224	386	9	(	(	PUNCT
chd-224	386	10	2018	2018	NUM
chd-224	386	11	)	)	PUNCT
chd-224	386	12	.	.	PUNCT
chd-224	387	1	hereditary	hereditary	ADJ
chd-224	387	2	and	and	CCONJ
chd-224	387	3	familial	familial	ADJ
chd-224	387	4	thyroid	thyroid	NOUN
chd-224	387	5	tumours	tumours	NOUN
chd-224	387	6	.	.	PUNCT
chd-224	388	1	histopathology	histopathology	NOUN
chd-224	388	2	72	72	NUM
chd-224	388	3	,	,	PUNCT
chd-224	388	4	70	70	NUM
chd-224	388	5	-	-	SYM
chd-224	388	6	81	81	NUM
chd-224	388	7	.	.	PUNCT
chd-224	389	1	hales	hales	PROPN
chd-224	389	2	,	,	PUNCT
chd-224	389	3	c.m	c.m	PROPN
chd-224	389	4	.	.	PROPN
chd-224	389	5	,	,	PUNCT
chd-224	389	6	carroll	carroll	PROPN
chd-224	389	7	,	,	PUNCT
chd-224	389	8	m.d	m.d	PROPN
chd-224	389	9	.	.	PROPN
chd-224	389	10	,	,	PUNCT
chd-224	389	11	fryar	fryar	PROPN
chd-224	389	12	,	,	PUNCT
chd-224	389	13	c.d	c.d	PROPN
chd-224	389	14	.	.	PROPN
chd-224	389	15	,	,	PUNCT
chd-224	389	16	and	and	CCONJ
chd-224	389	17	ogden	ogden	PROPN
chd-224	389	18	,	,	PUNCT
chd-224	389	19	c.l	c.l	PROPN
chd-224	389	20	.	.	PROPN
chd-224	389	21	(	(	PUNCT
chd-224	389	22	2020	2020	NUM
chd-224	389	23	)	)	PUNCT
chd-224	389	24	.	.	PUNCT
chd-224	390	1	prevalence	prevalence	NOUN
chd-224	390	2	of	of	ADP
chd-224	390	3	obesity	obesity	NOUN
chd-224	390	4	and	and	CCONJ
chd-224	390	5	severe	severe	ADJ
chd-224	390	6	obesity	obesity	NOUN
chd-224	390	7	among	among	ADP
chd-224	390	8	adults	adult	NOUN
chd-224	390	9	:	:	PUNCT
chd-224	390	10	united	united	PROPN
chd-224	390	11	states	states	PROPN
chd-224	390	12	,	,	PUNCT
chd-224	390	13	2017	2017	NUM
chd-224	390	14	-	-	SYM
chd-224	390	15	2018	2018	NUM
chd-224	390	16	.	.	PUNCT
chd-224	391	1	nchs	nchs	PROPN
chd-224	391	2	data	data	PROPN
chd-224	391	3	brief	brief	NOUN
chd-224	391	4	,	,	PUNCT
chd-224	391	5	1	1	NUM
chd-224	391	6	-	-	SYM
chd-224	391	7	8	8	NUM
chd-224	391	8	.	.	PUNCT
chd-224	392	1	hanley	hanley	PROPN
chd-224	392	2	,	,	PUNCT
chd-224	392	3	j.p	j.p	PROPN
chd-224	392	4	.	.	PROPN
chd-224	392	5	,	,	PUNCT
chd-224	392	6	jackson	jackson	PROPN
chd-224	392	7	,	,	PUNCT
chd-224	392	8	e.	e.	PROPN
chd-224	392	9	,	,	PUNCT
chd-224	392	10	morrissey	morrissey	PROPN
chd-224	392	11	,	,	PUNCT
chd-224	392	12	l.a	l.a	PROPN
chd-224	392	13	.	.	PROPN
chd-224	392	14	,	,	PUNCT
chd-224	392	15	rizzo	rizzo	PROPN
chd-224	392	16	,	,	PUNCT
chd-224	392	17	d.m	d.m	PROPN
chd-224	392	18	.	.	PROPN
chd-224	392	19	,	,	PUNCT
chd-224	392	20	sprague	sprague	PROPN
chd-224	392	21	,	,	PUNCT
chd-224	392	22	b.l	b.l	PROPN
chd-224	392	23	.	.	PROPN
chd-224	392	24	,	,	PUNCT
chd-224	392	25	sarkar	sarkar	PROPN
chd-224	392	26	,	,	PUNCT
chd-224	392	27	i.n	i.n	PROPN
chd-224	392	28	.	.	PROPN
chd-224	392	29	,	,	PUNCT
chd-224	392	30	and	and	CCONJ
chd-224	392	31	carr	carr	PROPN
chd-224	392	32	,	,	PUNCT
chd-224	392	33	f.e	f.e	PROPN
chd-224	392	34	.	.	PROPN
chd-224	392	35	(	(	PUNCT
chd-224	392	36	2015	2015	NUM
chd-224	392	37	)	)	PUNCT
chd-224	392	38	.	.	PUNCT
chd-224	393	1	geospatial	geospatial	PROPN
chd-224	393	2	and	and	CCONJ
chd-224	393	3	temporal	temporal	ADJ
chd-224	393	4	analysis	analysis	NOUN
chd-224	393	5	of	of	ADP
chd-224	393	6	thyroid	thyroid	NOUN
chd-224	393	7	cancer	cancer	NOUN
chd-224	393	8	incidence	incidence	NOUN
chd-224	393	9	in	in	ADP
chd-224	393	10	a	a	DET
chd-224	393	11	rural	rural	ADJ
chd-224	393	12	population	population	NOUN
chd-224	393	13	.	.	PUNCT
chd-224	394	1	thyroid	thyroid	PROPN
chd-224	394	2	25	25	NUM
chd-224	394	3	,	,	PUNCT
chd-224	394	4	812	812	NUM
chd-224	394	5	-	-	SYM
chd-224	394	6	822	822	NUM
chd-224	394	7	.	.	PUNCT
chd-224	395	1	herrick	herrick	PROPN
chd-224	395	2	,	,	PUNCT
chd-224	395	3	k.a	k.a	PROPN
chd-224	395	4	.	.	PROPN
chd-224	395	5	,	,	PUNCT
chd-224	395	6	perrine	perrine	PROPN
chd-224	395	7	,	,	PUNCT
chd-224	395	8	c.g	c.g	PROPN
chd-224	395	9	.	.	PROPN
chd-224	395	10	,	,	PUNCT
chd-224	395	11	aoki	aoki	PROPN
chd-224	395	12	,	,	PUNCT
chd-224	395	13	y.	y.	PROPN
chd-224	395	14	,	,	PUNCT
chd-224	395	15	and	and	CCONJ
chd-224	395	16	caldwell	caldwell	PROPN
chd-224	395	17	,	,	PUNCT
chd-224	395	18	k.l	k.l	PROPN
chd-224	395	19	.	.	PROPN
chd-224	395	20	(	(	PUNCT
chd-224	395	21	2018	2018	NUM
chd-224	395	22	)	)	PUNCT
chd-224	395	23	.	.	PUNCT
chd-224	396	1	iodine	iodine	NOUN
chd-224	396	2	status	status	NOUN
chd-224	396	3	and	and	CCONJ
chd-224	396	4	consumption	consumption	NOUN
chd-224	396	5	of	of	ADP
chd-224	396	6	key	key	ADJ
chd-224	396	7	iodine	iodine	NOUN
chd-224	396	8	sources	source	NOUN
chd-224	396	9	in	in	ADP
chd-224	396	10	the	the	DET
chd-224	396	11	u.s	u.s	PROPN
chd-224	396	12	.	.	PROPN
chd-224	396	13	population	population	NOUN
chd-224	396	14	with	with	ADP
chd-224	396	15	special	special	ADJ
chd-224	396	16	attention	attention	NOUN
chd-224	396	17	to	to	ADP
chd-224	396	18	reproductive	reproductive	ADJ
chd-224	396	19	age	age	NOUN
chd-224	396	20	women	woman	NOUN
chd-224	396	21	.	.	PUNCT
chd-224	397	1	nutrients	nutrient	NOUN
chd-224	397	2	10	10	NUM
chd-224	397	3	.	.	PUNCT
chd-224	398	1	horn	horn	NOUN
chd-224	398	2	-	-	PUNCT
chd-224	398	3	ross	ross	PROPN
chd-224	398	4	,	,	PUNCT
chd-224	398	5	p.l	p.l	PROPN
chd-224	398	6	.	.	PROPN
chd-224	398	7	,	,	PUNCT
chd-224	398	8	mcclure	mcclure	PROPN
chd-224	398	9	,	,	PUNCT
chd-224	398	10	l.a	l.a	PROPN
chd-224	398	11	.	.	PROPN
chd-224	398	12	,	,	PUNCT
chd-224	398	13	chang	chang	PROPN
chd-224	398	14	,	,	PUNCT
chd-224	398	15	e.t	e.t	PROPN
chd-224	398	16	.	.	PROPN
chd-224	398	17	,	,	PUNCT
chd-224	398	18	clarke	clarke	PROPN
chd-224	398	19	,	,	PUNCT
chd-224	398	20	c.a	c.a	PROPN
chd-224	398	21	.	.	PROPN
chd-224	398	22	,	,	PUNCT
chd-224	398	23	keegan	keegan	PROPN
chd-224	398	24	,	,	PUNCT
chd-224	398	25	t.h	t.h	PROPN
chd-224	398	26	.	.	PROPN
chd-224	398	27	,	,	PUNCT
chd-224	398	28	rull	rull	PROPN
chd-224	398	29	,	,	PUNCT
chd-224	398	30	r.p	r.p	PROPN
chd-224	398	31	.	.	PROPN
chd-224	398	32	,	,	PUNCT
chd-224	398	33	quach	quach	NOUN
chd-224	398	34	,	,	PUNCT
chd-224	398	35	t.	t.	PROPN
chd-224	398	36	,	,	PUNCT
chd-224	398	37	and	and	CCONJ
chd-224	398	38	gomez	gomez	PROPN
chd-224	398	39	,	,	PUNCT
chd-224	398	40	s.l	s.l	PROPN
chd-224	398	41	.	.	PROPN
chd-224	398	42	(	(	PUNCT
chd-224	398	43	2011	2011	NUM
chd-224	398	44	)	)	PUNCT
chd-224	398	45	.	.	PUNCT
chd-224	399	1	papillary	papillary	PROPN
chd-224	399	2	thyroid	thyroid	NOUN
chd-224	399	3	cancer	cancer	NOUN
chd-224	399	4	incidence	incidence	NOUN
chd-224	399	5	rates	rate	NOUN
chd-224	399	6	vary	vary	VERB
chd-224	399	7	significantly	significantly	ADV
chd-224	399	8	by	by	ADP
chd-224	399	9	birthplace	birthplace	NOUN
chd-224	399	10	in	in	ADP
chd-224	399	11	asian	asian	ADJ
chd-224	399	12	american	american	ADJ
chd-224	399	13	women	woman	NOUN
chd-224	399	14	.	.	PUNCT
chd-224	400	1	cancer	cancer	NOUN
chd-224	400	2	causes	cause	VERB
chd-224	400	3	control	control	NOUN
chd-224	400	4	22	22	NUM
chd-224	400	5	,	,	PUNCT
chd-224	400	6	479	479	NUM
chd-224	400	7	-	-	SYM
chd-224	400	8	485	485	NUM
chd-224	400	9	.	.	PUNCT
chd-224	401	1	hurst	hurst	PROPN
chd-224	401	2	,	,	PUNCT
chd-224	401	3	z.	z.	PROPN
chd-224	401	4	,	,	PUNCT
chd-224	401	5	liyanarachchi	liyanarachchi	PROPN
chd-224	401	6	,	,	PUNCT
chd-224	401	7	s.	s.	PROPN
chd-224	401	8	,	,	PUNCT
chd-224	401	9	he	he	PRON
chd-224	401	10	,	,	PUNCT
chd-224	401	11	h.	h.	PROPN
chd-224	401	12	,	,	PUNCT
chd-224	401	13	brock	brock	PROPN
chd-224	401	14	,	,	PUNCT
chd-224	401	15	p.	p.	NOUN
chd-224	401	16	,	,	PUNCT
chd-224	401	17	sipos	sipos	PROPN
chd-224	401	18	,	,	PUNCT
chd-224	401	19	j.	j.	PROPN
chd-224	401	20	,	,	PUNCT
chd-224	401	21	nabhan	nabhan	ADP
chd-224	401	22	,	,	PUNCT
chd-224	401	23	f.	f.	PROPN
chd-224	401	24	,	,	PUNCT
chd-224	401	25	kebebew	kebebew	PROPN
chd-224	401	26	,	,	PUNCT
chd-224	401	27	e.	e.	PROPN
chd-224	401	28	,	,	PUNCT
chd-224	401	29	green	green	ADJ
chd-224	401	30	,	,	PUNCT
chd-224	401	31	p.	p.	NOUN
chd-224	401	32	,	,	PUNCT
chd-224	401	33	cote	cote	PROPN
chd-224	401	34	,	,	PUNCT
chd-224	401	35	g.j	g.j	PROPN
chd-224	401	36	.	.	PROPN
chd-224	401	37	,	,	PUNCT
chd-224	401	38	sherman	sherman	PROPN
chd-224	401	39	,	,	PUNCT
chd-224	401	40	s.	s.	PROPN
chd-224	401	41	,	,	PUNCT
chd-224	401	42	et	et	PROPN
chd-224	401	43	al	al	PROPN
chd-224	401	44	.	.	PROPN
chd-224	401	45	(	(	PUNCT
chd-224	401	46	2019	2019	NUM
chd-224	401	47	)	)	PUNCT
chd-224	401	48	.	.	PUNCT
chd-224	402	1	risk	risk	NOUN
chd-224	402	2	haplotypes	haplotype	NOUN
chd-224	402	3	uniquely	uniquely	ADV
chd-224	402	4	associated	associate	VERB
chd-224	402	5	with	with	ADP
chd-224	402	6	radioiodine	radioiodine	NOUN
chd-224	402	7	-	-	PUNCT
chd-224	402	8	refractory	refractory	NOUN
chd-224	402	9	thyroid	thyroid	NOUN
chd-224	402	10	cancer	cancer	NOUN
chd-224	402	11	patients	patient	NOUN
chd-224	402	12	of	of	ADP
chd-224	402	13	high	high	ADJ
chd-224	402	14	african	african	ADJ
chd-224	402	15	ancestry	ancestry	NOUN
chd-224	402	16	.	.	PUNCT
chd-224	403	1	thyroid	thyroid	PROPN
chd-224	403	2	29	29	NUM
chd-224	403	3	,	,	PUNCT
chd-224	403	4	530	530	NUM
chd-224	403	5	-	-	SYM
chd-224	403	6	539	539	NUM
chd-224	403	7	.	.	PUNCT
chd-224	404	1	inaba	inaba	PROPN
chd-224	404	2	,	,	PUNCT
chd-224	404	3	h.	h.	PROPN
chd-224	404	4	,	,	PUNCT
chd-224	404	5	and	and	CCONJ
chd-224	404	6	akamizu	akamizu	PROPN
chd-224	404	7	,	,	PUNCT
chd-224	404	8	t.	t.	PROPN
chd-224	404	9	(	(	PUNCT
chd-224	404	10	2000	2000	NUM
chd-224	404	11	)	)	PUNCT
chd-224	404	12	.	.	PUNCT
chd-224	405	1	postpartum	postpartum	PROPN
chd-224	405	2	thyroiditis	thyroiditis	NOUN
chd-224	405	3	.	.	PUNCT
chd-224	406	1	in	in	ADP
chd-224	406	2	endotext	endotext	NOUN
chd-224	406	3	,	,	PUNCT
chd-224	406	4	k.r	k.r	PROPN
chd-224	406	5	.	.	PROPN
chd-224	406	6	feingold	feingold	PROPN
chd-224	406	7	,	,	PUNCT
chd-224	406	8	b.	b.	PROPN
chd-224	406	9	anawalt	anawalt	PROPN
chd-224	406	10	,	,	PUNCT
chd-224	406	11	a.	a.	PROPN
chd-224	406	12	boyce	boyce	PROPN
chd-224	406	13	,	,	PUNCT
chd-224	406	14	g.	g.	PROPN
chd-224	406	15	chrousos	chrousos	PROPN
chd-224	406	16	,	,	PUNCT
chd-224	406	17	w.w	w.w	PROPN
chd-224	406	18	.	.	PROPN
chd-224	406	19	de	de	PROPN
chd-224	406	20	herder	herder	PROPN
chd-224	406	21	,	,	PUNCT
chd-224	406	22	k.	k.	PROPN
chd-224	406	23	dhatariya	dhatariya	PROPN
chd-224	406	24	,	,	PUNCT
chd-224	406	25	k.	k.	PROPN
chd-224	406	26	dungan	dungan	PROPN
chd-224	406	27	,	,	PUNCT
chd-224	406	28	j.m	j.m	PROPN
chd-224	406	29	.	.	PROPN
chd-224	406	30	hershman	hershman	PROPN
chd-224	406	31	,	,	PUNCT
chd-224	406	32	j.	j.	PROPN
chd-224	406	33	hofland	hofland	PROPN
chd-224	406	34	,	,	PUNCT
chd-224	406	35	s.	s.	PROPN
chd-224	406	36	kalra	kalra	PROPN
chd-224	406	37	,	,	PUNCT
chd-224	406	38	et	et	PROPN
chd-224	406	39	al	al	PROPN
chd-224	406	40	.	.	PROPN
chd-224	406	41	,	,	PUNCT
chd-224	406	42	eds	eds	PROPN
chd-224	406	43	.	.	PUNCT
chd-224	407	1	(	(	PUNCT
chd-224	407	2	south	south	NOUN
chd-224	407	3	dartmouth	dartmouth	PROPN
chd-224	407	4	(	(	PUNCT
chd-224	407	5	ma	ma	PROPN
chd-224	407	6	):	):	PUNCT
chd-224	407	7	mdtext.com	mdtext.com	PROPN
chd-224	407	8	,	,	PUNCT
chd-224	407	9	inc	inc	PROPN
chd-224	407	10	.	.	PROPN
chd-224	407	11	copyright	copyright	NOUN
chd-224	407	12	©	©	ADP
chd-224	407	13	2000	2000	NUM
chd-224	407	14	-	-	SYM
chd-224	407	15	2022	2022	NUM
chd-224	407	16	,	,	PUNCT
chd-224	407	17	mdtext.com	mdtext.com	X
chd-224	407	18	,	,	PUNCT
chd-224	407	19	inc	inc	PROPN
chd-224	407	20	.	.	PROPN
chd-224	407	21	)	)	PUNCT
chd-224	407	22	.	.	PUNCT
chd-224	408	1	inra	inra	NOUN
chd-224	408	2	,	,	PUNCT
chd-224	408	3	j.a	j.a	PROPN
chd-224	408	4	.	.	PROPN
chd-224	408	5	,	,	PUNCT
chd-224	408	6	steyerberg	steyerberg	PROPN
chd-224	408	7	,	,	PUNCT
chd-224	408	8	e.w	e.w	PROPN
chd-224	408	9	.	.	PROPN
chd-224	408	10	,	,	PUNCT
chd-224	408	11	grover	grover	PROPN
chd-224	408	12	,	,	PUNCT
chd-224	408	13	s.	s.	PROPN
chd-224	408	14	,	,	PUNCT
chd-224	408	15	mcfarland	mcfarland	PROPN
chd-224	408	16	,	,	PUNCT
chd-224	408	17	a.	a.	PROPN
chd-224	408	18	,	,	PUNCT
chd-224	408	19	syngal	syngal	PROPN
chd-224	408	20	,	,	PUNCT
chd-224	408	21	s.	s.	PROPN
chd-224	408	22	,	,	PUNCT
chd-224	408	23	and	and	CCONJ
chd-224	408	24	kastrinos	kastrinos	PROPN
chd-224	408	25	,	,	PUNCT
chd-224	408	26	f.	f.	PROPN
chd-224	408	27	(	(	PUNCT
chd-224	408	28	2015	2015	NUM
chd-224	408	29	)	)	PUNCT
chd-224	408	30	.	.	PUNCT
chd-224	409	1	racial	racial	ADJ
chd-224	409	2	variation	variation	NOUN
chd-224	409	3	in	in	ADP
chd-224	409	4	frequency	frequency	NOUN
chd-224	409	5	and	and	CCONJ
chd-224	409	6	phenotypes	phenotype	NOUN
chd-224	409	7	of	of	ADP
chd-224	409	8	apc	apc	PROPN
chd-224	409	9	and	and	CCONJ
chd-224	409	10	mutyh	mutyh	PROPN
chd-224	409	11	mutations	mutation	NOUN
chd-224	409	12	in	in	ADP
chd-224	409	13	6,169	6,169	NUM
chd-224	409	14	individuals	individual	NOUN
chd-224	409	15	undergoing	undergo	VERB
chd-224	409	16	genetic	genetic	ADJ
chd-224	409	17	testing	testing	NOUN
chd-224	409	18	.	.	PUNCT
chd-224	410	1	genet	genet	PROPN
chd-224	410	2	med	me	VERB
chd-224	410	3	17	17	NUM
chd-224	410	4	,	,	PUNCT
chd-224	410	5	815	815	NUM
chd-224	410	6	-	-	SYM
chd-224	410	7	821	821	NUM
chd-224	410	8	.	.	PUNCT
chd-224	411	1	iwata	iwata	PROPN
chd-224	411	2	,	,	PUNCT
chd-224	411	3	a.j	a.j	PROPN
chd-224	411	4	.	.	PROPN
chd-224	411	5	,	,	PUNCT
chd-224	411	6	bhan	bhan	PROPN
chd-224	411	7	,	,	PUNCT
chd-224	411	8	a.	a.	PROPN
chd-224	411	9	,	,	PUNCT
chd-224	411	10	lahiri	lahiri	PROPN
chd-224	411	11	,	,	PUNCT
chd-224	411	12	s.	s.	PROPN
chd-224	411	13	,	,	PUNCT
chd-224	411	14	williams	williams	PROPN
chd-224	411	15	,	,	PUNCT
chd-224	411	16	a.m.	a.m.	ADV
chd-224	411	17	,	,	PUNCT
chd-224	411	18	burmeister	burmeister	NOUN
chd-224	411	19	,	,	PUNCT
chd-224	411	20	c.	c.	PROPN
chd-224	411	21	,	,	PUNCT
chd-224	411	22	chang	chang	PROPN
chd-224	411	23	,	,	PUNCT
chd-224	411	24	s.s	s.s	PROPN
chd-224	411	25	.	.	PROPN
chd-224	411	26	,	,	PUNCT
chd-224	411	27	and	and	CCONJ
chd-224	411	28	singer	singer	NOUN
chd-224	411	29	,	,	PUNCT
chd-224	411	30	m.c	m.c	PROPN
chd-224	411	31	.	.	PROPN
chd-224	411	32	(	(	PUNCT
chd-224	411	33	2018	2018	NUM
chd-224	411	34	)	)	PUNCT
chd-224	411	35	.	.	PUNCT
chd-224	412	1	incidental	incidental	ADJ
chd-224	412	2	thyroid	thyroid	NOUN
chd-224	412	3	nodules	nodule	NOUN
chd-224	412	4	:	:	PUNCT
chd-224	412	5	race	race	NOUN
chd-224	412	6	/	/	SYM
chd-224	412	7	ethnicity	ethnicity	NOUN
chd-224	412	8	disparities	disparity	NOUN
chd-224	412	9	and	and	CCONJ
chd-224	412	10	outcomes	outcome	NOUN
chd-224	412	11	.	.	PUNCT
chd-224	413	1	endocr	endocr	PROPN
chd-224	413	2	pract	pract	PROPN
chd-224	413	3	24	24	NUM
chd-224	413	4	,	,	PUNCT
chd-224	413	5	941	941	NUM
chd-224	413	6	-	-	SYM
chd-224	413	7	947	947	NUM
chd-224	413	8	.	.	PUNCT
chd-224	414	1	jin	jin	PROPN
chd-224	414	2	,	,	PUNCT
chd-224	414	3	h.	h.	PROPN
chd-224	414	4	,	,	PUNCT
chd-224	414	5	pinheiro	pinheiro	PROPN
chd-224	414	6	,	,	PUNCT
chd-224	414	7	p.s	p.s	PROPN
chd-224	414	8	.	.	PROPN
chd-224	414	9	,	,	PUNCT
chd-224	414	10	xu	xu	PROPN
chd-224	414	11	,	,	PUNCT
chd-224	414	12	j.	j.	PROPN
chd-224	414	13	,	,	PUNCT
chd-224	414	14	and	and	CCONJ
chd-224	414	15	amei	amei	PROPN
chd-224	414	16	,	,	PUNCT
chd-224	414	17	a.	a.	NOUN
chd-224	414	18	(	(	PUNCT
chd-224	414	19	2016	2016	NUM
chd-224	414	20	)	)	PUNCT
chd-224	414	21	.	.	PUNCT
chd-224	415	1	cancer	cancer	NOUN
chd-224	415	2	incidence	incidence	NOUN
chd-224	415	3	among	among	ADP
chd-224	415	4	asian	asian	ADJ
chd-224	415	5	american	american	ADJ
chd-224	415	6	populations	population	NOUN
chd-224	415	7	in	in	ADP
chd-224	415	8	the	the	DET
chd-224	415	9	united	united	PROPN
chd-224	415	10	states	states	PROPN
chd-224	415	11	,	,	PUNCT
chd-224	415	12	2009	2009	NUM
chd-224	415	13	-	-	SYM
chd-224	415	14	2011	2011	NUM
chd-224	415	15	.	.	PUNCT
chd-224	416	1	int	int	NOUN
chd-224	416	2	j	j	PROPN
chd-224	416	3	cancer	cancer	NOUN
chd-224	416	4	138	138	NUM
chd-224	416	5	,	,	PUNCT
chd-224	416	6	2136	2136	NUM
chd-224	416	7	-	-	SYM
chd-224	416	8	2145	2145	NUM
chd-224	416	9	.	.	PUNCT
chd-224	417	1	keegan	keegan	PROPN
chd-224	417	2	,	,	PUNCT
chd-224	417	3	t.h	t.h	PROPN
chd-224	417	4	.	.	PROPN
chd-224	417	5	,	,	PUNCT
chd-224	417	6	grogan	grogan	PROPN
chd-224	417	7	,	,	PUNCT
chd-224	417	8	r.h	r.h	PROPN
chd-224	417	9	.	.	PROPN
chd-224	417	10	,	,	PUNCT
chd-224	417	11	parsons	parsons	PROPN
chd-224	417	12	,	,	PUNCT
chd-224	417	13	h.m	h.m	PROPN
chd-224	417	14	.	.	PROPN
chd-224	417	15	,	,	PUNCT
chd-224	417	16	tao	tao	PROPN
chd-224	417	17	,	,	PUNCT
chd-224	417	18	l.	l.	PROPN
chd-224	417	19	,	,	PUNCT
chd-224	417	20	white	white	PROPN
chd-224	417	21	,	,	PUNCT
chd-224	417	22	m.g	m.g	PROPN
chd-224	417	23	.	.	PROPN
chd-224	417	24	,	,	PUNCT
chd-224	417	25	onel	onel	PROPN
chd-224	417	26	,	,	PUNCT
chd-224	417	27	k.	k.	PROPN
chd-224	417	28	,	,	PUNCT
chd-224	417	29	and	and	CCONJ
chd-224	417	30	horn	horn	PROPN
chd-224	417	31	-	-	PUNCT
chd-224	417	32	ross	ross	PROPN
chd-224	417	33	,	,	PUNCT
chd-224	417	34	p.l	p.l	PROPN
chd-224	417	35	.	.	PROPN
chd-224	417	36	(	(	PUNCT
chd-224	417	37	2015	2015	NUM
chd-224	417	38	)	)	PUNCT
chd-224	417	39	.	.	PUNCT
chd-224	418	1	sociodemographic	sociodemographic	ADJ
chd-224	418	2	disparities	disparity	NOUN
chd-224	418	3	in	in	ADP
chd-224	418	4	differentiated	differentiated	ADJ
chd-224	418	5	thyroid	thyroid	NOUN
chd-224	418	6	cancer	cancer	NOUN
chd-224	418	7	survival	survival	NOUN
chd-224	418	8	among	among	ADP
chd-224	418	9	adolescents	adolescent	NOUN
chd-224	418	10	and	and	CCONJ
chd-224	418	11	young	young	ADJ
chd-224	418	12	adults	adult	NOUN
chd-224	418	13	in	in	ADP
chd-224	418	14	california	california	PROPN
chd-224	418	15	.	.	PUNCT
chd-224	418	16	thyroid	thyroid	PROPN
chd-224	418	17	25	25	NUM
chd-224	418	18	,	,	PUNCT
chd-224	418	19	635	635	NUM
chd-224	418	20	-	-	SYM
chd-224	418	21	648	648	NUM
chd-224	418	22	.	.	PUNCT
chd-224	419	1	kim	kim	PROPN
chd-224	419	2	,	,	PUNCT
chd-224	419	3	c.	c.	PROPN
chd-224	419	4	,	,	PUNCT
chd-224	419	5	golden	golden	ADJ
chd-224	419	6	,	,	PUNCT
chd-224	419	7	s.h	s.h	PROPN
chd-224	419	8	.	.	PROPN
chd-224	419	9	,	,	PUNCT
chd-224	419	10	mather	mather	PROPN
chd-224	419	11	,	,	PUNCT
chd-224	419	12	k.j	k.j	PROPN
chd-224	419	13	.	.	PROPN
chd-224	419	14	,	,	PUNCT
chd-224	419	15	laughlin	laughlin	PROPN
chd-224	419	16	,	,	PUNCT
chd-224	419	17	g.a	g.a	PROPN
chd-224	419	18	.	.	PROPN
chd-224	419	19	,	,	PUNCT
chd-224	419	20	kong	kong	PROPN
chd-224	419	21	,	,	PUNCT
chd-224	419	22	s.	s.	PROPN
chd-224	419	23	,	,	PUNCT
chd-224	419	24	nan	nan	PROPN
chd-224	419	25	,	,	PUNCT
chd-224	419	26	b.	b.	PROPN
chd-224	419	27	,	,	PUNCT
chd-224	419	28	barrett	barrett	PROPN
chd-224	419	29	-	-	PUNCT
chd-224	419	30	connor	connor	PROPN
chd-224	419	31	,	,	PUNCT
chd-224	419	32	e.	e.	PROPN
chd-224	419	33	,	,	PUNCT
chd-224	419	34	and	and	CCONJ
chd-224	419	35	randolph	randolph	PROPN
chd-224	419	36	,	,	PUNCT
chd-224	419	37	j.f	j.f	PROPN
chd-224	419	38	.	.	PROPN
chd-224	419	39	,	,	PUNCT
chd-224	419	40	jr	jr	PROPN
chd-224	419	41	.	.	PROPN
chd-224	419	42	(	(	PUNCT
chd-224	419	43	2012	2012	NUM
chd-224	419	44	)	)	PUNCT
chd-224	419	45	.	.	PUNCT
chd-224	420	1	racial	racial	ADJ
chd-224	420	2	/	/	SYM
chd-224	420	3	ethnic	ethnic	ADJ
chd-224	420	4	differences	difference	NOUN
chd-224	420	5	in	in	ADP
chd-224	420	6	sex	sex	NOUN
chd-224	420	7	hormone	hormone	NOUN
chd-224	420	8	levels	level	NOUN
chd-224	420	9	among	among	ADP
chd-224	420	10	postmenopausal	postmenopausal	ADJ
chd-224	420	11	women	woman	NOUN
chd-224	420	12	in	in	ADP
chd-224	420	13	the	the	DET
chd-224	420	14	diabetes	diabetes	NOUN
chd-224	420	15	prevention	prevention	NOUN
chd-224	420	16	program	program	NOUN
chd-224	420	17	.	.	PUNCT
chd-224	421	1	j	j	PROPN
chd-224	421	2	clin	clin	PROPN
chd-224	421	3	endocrinol	endocrinol	PROPN
chd-224	421	4	metab	metab	PROPN
chd-224	421	5	97	97	NUM
chd-224	421	6	,	,	PUNCT
chd-224	421	7	4051	4051	NUM
chd-224	421	8	-	-	SYM
chd-224	421	9	4060	4060	NUM
chd-224	421	10	.	.	PUNCT
chd-224	422	1	kim	kim	PROPN
chd-224	422	2	,	,	PUNCT
chd-224	422	3	k.h	k.h	PROPN
chd-224	422	4	.	.	PROPN
chd-224	422	5	,	,	PUNCT
chd-224	422	6	and	and	CCONJ
chd-224	422	7	woo	woo	PROPN
chd-224	422	8	,	,	PUNCT
chd-224	422	9	s.h	s.h	PROPN
chd-224	422	10	.	.	PROPN
chd-224	422	11	(	(	PUNCT
chd-224	422	12	2016	2016	NUM
chd-224	422	13	)	)	PUNCT
chd-224	422	14	.	.	PUNCT
chd-224	423	1	an	an	DET
chd-224	423	2	occupational	occupational	ADJ
chd-224	423	3	study	study	NOUN
chd-224	423	4	in	in	ADP
chd-224	423	5	nurses	nurse	NOUN
chd-224	423	6	:	:	PUNCT
chd-224	423	7	prevalence	prevalence	NOUN
chd-224	423	8	of	of	ADP
chd-224	423	9	thyroid	thyroid	NOUN
chd-224	423	10	nodules	nodule	NOUN
chd-224	423	11	and	and	CCONJ
chd-224	423	12	cancer	cancer	NOUN
chd-224	423	13	in	in	ADP
chd-224	423	14	comparison	comparison	NOUN
chd-224	423	15	to	to	ADP
chd-224	423	16	health	health	NOUN
chd-224	423	17	check	check	VERB
chd-224	423	18	-	-	PUNCT
chd-224	423	19	up	up	ADP
chd-224	423	20	female	female	NOUN
chd-224	423	21	.	.	PUNCT
chd-224	424	1	clin	clin	PROPN
chd-224	424	2	exp	exp	NOUN
chd-224	424	3	otorhinolaryngol	otorhinolaryngol	PROPN
chd-224	424	4	9	9	NUM
chd-224	424	5	,	,	PUNCT
chd-224	424	6	252	252	NUM
chd-224	424	7	-	-	SYM
chd-224	424	8	256	256	NUM
chd-224	424	9	.	.	PUNCT
chd-224	425	1	kim	kim	PROPN
chd-224	425	2	,	,	PUNCT
chd-224	425	3	s.y	s.y	PROPN
chd-224	425	4	.	.	PROPN
chd-224	425	5	,	,	PUNCT
chd-224	425	6	yoo	yoo	PROPN
chd-224	425	7	,	,	PUNCT
chd-224	425	8	d.m	d.m	PROPN
chd-224	425	9	.	.	PROPN
chd-224	425	10	,	,	PUNCT
chd-224	425	11	min	min	PROPN
chd-224	425	12	,	,	PUNCT
chd-224	425	13	c.	c.	NOUN
chd-224	425	14	,	,	PUNCT
chd-224	425	15	and	and	CCONJ
chd-224	425	16	choi	choi	NOUN
chd-224	425	17	,	,	PUNCT
chd-224	425	18	h.g	h.g	X
chd-224	425	19	.	.	PUNCT
chd-224	425	20	(	(	PUNCT
chd-224	425	21	2021	2021	NUM
chd-224	425	22	)	)	PUNCT
chd-224	425	23	.	.	PUNCT
chd-224	426	1	association	association	NOUN
chd-224	426	2	between	between	ADP
chd-224	426	3	coffee	coffee	NOUN
chd-224	426	4	consumption	consumption	NOUN
chd-224	426	5	/	/	SYM
chd-224	426	6	physical	physical	ADJ
chd-224	426	7	exercise	exercise	NOUN
chd-224	426	8	and	and	CCONJ
chd-224	426	9	gastric	gastric	ADJ
chd-224	426	10	,	,	PUNCT
chd-224	426	11	hepatic	hepatic	NOUN
chd-224	426	12	,	,	PUNCT
chd-224	426	13	colon	colon	NOUN
chd-224	426	14	,	,	PUNCT
chd-224	426	15	breast	breast	NOUN
chd-224	426	16	,	,	PUNCT
chd-224	426	17	uterine	uterine	ADJ
chd-224	426	18	cervix	cervix	NOUN
chd-224	426	19	,	,	PUNCT
chd-224	426	20	lung	lung	NOUN
chd-224	426	21	,	,	PUNCT
chd-224	426	22	thyroid	thyroid	NOUN
chd-224	426	23	,	,	PUNCT
chd-224	426	24	prostate	prostate	NOUN
chd-224	426	25	,	,	PUNCT
chd-224	426	26	and	and	CCONJ
chd-224	426	27	bladder	bladder	NOUN
chd-224	426	28	cancer	cancer	NOUN
chd-224	426	29	.	.	PUNCT
chd-224	427	1	nutrients	nutrient	NOUN
chd-224	427	2	13	13	NUM
chd-224	427	3	.	.	PUNCT
chd-224	428	1	kim	kim	PROPN
chd-224	428	2	,	,	PUNCT
chd-224	428	3	t.y	t.y	PROPN
chd-224	428	4	.	.	PROPN
chd-224	428	5	,	,	PUNCT
chd-224	428	6	kim	kim	PROPN
chd-224	428	7	,	,	PUNCT
chd-224	428	8	w.g	w.g	PROPN
chd-224	428	9	.	.	PROPN
chd-224	428	10	,	,	PUNCT
chd-224	428	11	kim	kim	PROPN
chd-224	428	12	,	,	PUNCT
chd-224	428	13	w.b	w.b	PROPN
chd-224	428	14	.	.	PROPN
chd-224	428	15	,	,	PUNCT
chd-224	428	16	and	and	CCONJ
chd-224	428	17	shong	shong	PROPN
chd-224	428	18	,	,	PUNCT
chd-224	428	19	y.k	y.k	PROPN
chd-224	428	20	.	.	PROPN
chd-224	428	21	(	(	PUNCT
chd-224	428	22	2014	2014	NUM
chd-224	428	23	)	)	PUNCT
chd-224	428	24	.	.	PUNCT
chd-224	429	1	current	current	ADJ
chd-224	429	2	status	status	NOUN
chd-224	429	3	and	and	CCONJ
chd-224	429	4	future	future	ADJ
chd-224	429	5	perspectives	perspective	NOUN
chd-224	429	6	in	in	ADP
chd-224	429	7	differentiated	differentiated	ADJ
chd-224	429	8	thyroid	thyroid	NOUN
chd-224	429	9	cancer	cancer	NOUN
chd-224	429	10	.	.	PUNCT
chd-224	430	1	endocrinology	endocrinology	NOUN
chd-224	430	2	and	and	CCONJ
chd-224	430	3	metabolism	metabolism	NOUN
chd-224	430	4	(	(	PUNCT
chd-224	430	5	seoul	seoul	PROPN
chd-224	430	6	,	,	PUNCT
chd-224	430	7	korea	korea	PROPN
chd-224	430	8	)	)	PUNCT
chd-224	430	9	29	29	NUM
chd-224	430	10	,	,	PUNCT
chd-224	430	11	217	217	NUM
chd-224	430	12	-	-	SYM
chd-224	430	13	225	225	NUM
chd-224	430	14	.	.	PUNCT
chd-224	431	1	kitahara	kitahara	PROPN
chd-224	431	2	,	,	PUNCT
chd-224	431	3	c.m	c.m	PROPN
chd-224	431	4	.	.	PROPN
chd-224	431	5	,	,	PUNCT
chd-224	431	6	mccullough	mccullough	PROPN
chd-224	431	7	,	,	PUNCT
chd-224	431	8	m.l	m.l	PROPN
chd-224	431	9	.	.	PROPN
chd-224	431	10	,	,	PUNCT
chd-224	431	11	franceschi	franceschi	PROPN
chd-224	431	12	,	,	PUNCT
chd-224	431	13	s.	s.	PROPN
chd-224	431	14	,	,	PUNCT
chd-224	431	15	rinaldi	rinaldi	PROPN
chd-224	431	16	,	,	PUNCT
chd-224	431	17	s.	s.	PROPN
chd-224	431	18	,	,	PUNCT
chd-224	431	19	wolk	wolk	NOUN
chd-224	431	20	,	,	PUNCT
chd-224	431	21	a.	a.	NOUN
chd-224	431	22	,	,	PUNCT
chd-224	431	23	neta	neta	PROPN
chd-224	431	24	,	,	PUNCT
chd-224	431	25	g.	g.	PROPN
chd-224	431	26	,	,	PUNCT
chd-224	431	27	olov	olov	NOUN
chd-224	431	28	adami	adami	PROPN
chd-224	431	29	,	,	PUNCT
chd-224	431	30	h.	h.	PROPN
chd-224	431	31	,	,	PUNCT
chd-224	431	32	anderson	anderson	PROPN
chd-224	431	33	,	,	PUNCT
chd-224	431	34	k.	k.	PROPN
chd-224	431	35	,	,	PUNCT
chd-224	431	36	andreotti	andreotti	PROPN
chd-224	431	37	,	,	PUNCT
chd-224	431	38	g.	g.	PROPN
chd-224	431	39	,	,	PUNCT
chd-224	431	40	beane	beane	PROPN
chd-224	431	41	freeman	freeman	PROPN
chd-224	431	42	,	,	PUNCT
chd-224	431	43	l.e	l.e	PROPN
chd-224	431	44	.	.	PROPN
chd-224	431	45	,	,	PUNCT
chd-224	431	46	et	et	PROPN
chd-224	431	47	al	al	PROPN
chd-224	431	48	.	.	PUNCT
chd-224	431	49	(	(	PUNCT
chd-224	431	50	2016	2016	NUM
chd-224	431	51	)	)	PUNCT
chd-224	431	52	.	.	PUNCT
chd-224	432	1	anthropometric	anthropometric	ADJ
chd-224	432	2	factors	factor	NOUN
chd-224	432	3	and	and	CCONJ
chd-224	432	4	thyroid	thyroid	NOUN
chd-224	432	5	cancer	cancer	NOUN
chd-224	432	6	risk	risk	NOUN
chd-224	432	7	by	by	ADP
chd-224	432	8	histological	histological	ADJ
chd-224	432	9	subtype	subtype	NOUN
chd-224	432	10	:	:	PUNCT
chd-224	432	11	pooled	pool	VERB
chd-224	432	12	analysis	analysis	NOUN
chd-224	432	13	of	of	ADP
chd-224	432	14	22	22	NUM
chd-224	432	15	prospective	prospective	ADJ
chd-224	432	16	studies	study	NOUN
chd-224	432	17	.	.	PUNCT
chd-224	433	1	thyroid	thyroid	PROPN
chd-224	433	2	26	26	NUM
chd-224	433	3	,	,	PUNCT
chd-224	433	4	306	306	NUM
chd-224	433	5	-	-	SYM
chd-224	433	6	318	318	NUM
chd-224	433	7	.	.	PUNCT
chd-224	434	1	konturek	konturek	PROPN
chd-224	434	2	,	,	PUNCT
chd-224	434	3	a.	a.	NOUN
chd-224	434	4	,	,	PUNCT
chd-224	434	5	barczyński	barczyński	NOUN
chd-224	434	6	,	,	PUNCT
chd-224	434	7	m.	m.	NOUN
chd-224	434	8	,	,	PUNCT
chd-224	434	9	stopa	stopa	PROPN
chd-224	434	10	,	,	PUNCT
chd-224	434	11	m.	m.	NOUN
chd-224	434	12	,	,	PUNCT
chd-224	434	13	and	and	CCONJ
chd-224	434	14	nowak	nowak	PROPN
chd-224	434	15	,	,	PUNCT
chd-224	434	16	w.	w.	PROPN
chd-224	434	17	(	(	PUNCT
chd-224	434	18	2016	2016	NUM
chd-224	434	19	)	)	PUNCT
chd-224	434	20	.	.	PUNCT
chd-224	435	1	trends	trend	NOUN
chd-224	435	2	in	in	ADP
chd-224	435	3	prevalence	prevalence	NOUN
chd-224	435	4	of	of	ADP
chd-224	435	5	thyroid	thyroid	NOUN
chd-224	435	6	cancer	cancer	NOUN
chd-224	435	7	over	over	ADP
chd-224	435	8	three	three	NUM
chd-224	435	9	decades	decade	NOUN
chd-224	435	10	:	:	PUNCT
chd-224	435	11	a	a	DET
chd-224	435	12	retrospective	retrospective	ADJ
chd-224	435	13	cohort	cohort	NOUN
chd-224	435	14	study	study	NOUN
chd-224	435	15	of	of	ADP
chd-224	435	16	17,526	17,526	NUM
chd-224	435	17	surgical	surgical	ADJ
chd-224	435	18	patients	patient	NOUN
chd-224	435	19	.	.	PUNCT
chd-224	436	1	world	world	PROPN
chd-224	436	2	journal	journal	PROPN
chd-224	436	3	of	of	ADP
chd-224	436	4	surgery	surgery	NOUN
chd-224	436	5	40	40	NUM
chd-224	436	6	,	,	PUNCT
chd-224	436	7	538	538	NUM
chd-224	436	8	-	-	SYM
chd-224	436	9	544	544	NUM
chd-224	436	10	.	.	PUNCT
chd-224	437	1	korycinski	korycinski	PROPN
chd-224	437	2	,	,	PUNCT
chd-224	437	3	r.w	r.w	PROPN
chd-224	437	4	.	.	PROPN
chd-224	437	5	,	,	PUNCT
chd-224	437	6	tennant	tennant	PROPN
chd-224	437	7	,	,	PUNCT
chd-224	437	8	b.l	b.l	PROPN
chd-224	437	9	.	.	PROPN
chd-224	437	10	,	,	PUNCT
chd-224	437	11	cawley	cawley	NOUN
chd-224	437	12	,	,	PUNCT
chd-224	437	13	m.a	m.a	PROPN
chd-224	437	14	.	.	PROPN
chd-224	437	15	,	,	PUNCT
chd-224	437	16	bloodgood	bloodgood	PROPN
chd-224	437	17	,	,	PUNCT
chd-224	437	18	b.	b.	PROPN
chd-224	437	19	,	,	PUNCT
chd-224	437	20	oh	oh	INTJ
chd-224	437	21	,	,	PUNCT
chd-224	437	22	a.y	a.y	PROPN
chd-224	437	23	.	.	PROPN
chd-224	437	24	,	,	PUNCT
chd-224	437	25	and	and	CCONJ
chd-224	437	26	berrigan	berrigan	VERB
chd-224	437	27	,	,	PUNCT
chd-224	437	28	d.	d.	PROPN
chd-224	437	29	(	(	PUNCT
chd-224	437	30	2018	2018	NUM
chd-224	437	31	)	)	PUNCT
chd-224	437	32	.	.	PUNCT
chd-224	438	1	geospatial	geospatial	ADJ
chd-224	438	2	approaches	approach	NOUN
chd-224	438	3	to	to	ADP
chd-224	438	4	cancer	cancer	NOUN
chd-224	438	5	control	control	NOUN
chd-224	438	6	and	and	CCONJ
chd-224	438	7	population	population	NOUN
chd-224	438	8	sciences	science	NOUN
chd-224	438	9	at	at	ADP
chd-224	438	10	the	the	DET
chd-224	438	11	united	united	PROPN
chd-224	438	12	states	states	PROPN
chd-224	438	13	cancer	cancer	NOUN
chd-224	438	14	centers	center	NOUN
chd-224	438	15	.	.	PUNCT
chd-224	439	1	cancer	cancer	NOUN
chd-224	439	2	causes	cause	VERB
chd-224	439	3	control	control	NOUN
chd-224	439	4	29	29	NUM
chd-224	439	5	,	,	PUNCT
chd-224	439	6	371	371	NUM
chd-224	439	7	-	-	SYM
chd-224	439	8	377	377	NUM
chd-224	439	9	.	.	PUNCT
chd-224	440	1	krook	krook	PROPN
chd-224	440	2	,	,	PUNCT
chd-224	440	3	k.a	k.a	PROPN
chd-224	440	4	.	.	PROPN
chd-224	440	5	,	,	PUNCT
chd-224	440	6	fedewa	fedewa	PROPN
chd-224	440	7	,	,	PUNCT
chd-224	440	8	s.a	s.a	PROPN
chd-224	440	9	.	.	PROPN
chd-224	440	10	,	,	PUNCT
chd-224	440	11	and	and	CCONJ
chd-224	440	12	chen	chen	PROPN
chd-224	440	13	,	,	PUNCT
chd-224	440	14	a.y	a.y	PROPN
chd-224	440	15	.	.	PROPN
chd-224	440	16	(	(	PUNCT
chd-224	440	17	2015	2015	NUM
chd-224	440	18	)	)	PUNCT
chd-224	440	19	.	.	PUNCT
chd-224	441	1	prognostic	prognostic	ADJ
chd-224	441	2	indicators	indicator	NOUN
chd-224	441	3	in	in	ADP
chd-224	441	4	well	well	ADV
chd-224	441	5	-	-	PUNCT
chd-224	441	6	differentiated	differentiate	VERB
chd-224	441	7	thyroid	thyroid	NOUN
chd-224	441	8	carcinoma	carcinoma	NOUN
chd-224	441	9	when	when	SCONJ
chd-224	441	10	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-224	441	11	e18	e18	PROPN
chd-224	441	12	cancer	cancer	NOUN
chd-224	441	13	health	health	NOUN
chd-224	441	14	disparities	disparity	NOUN
chd-224	441	15	research	research	NOUN
chd-224	441	16	controlling	control	VERB
chd-224	441	17	for	for	ADP
chd-224	441	18	stage	stage	NOUN
chd-224	441	19	and	and	CCONJ
chd-224	441	20	treatment	treatment	NOUN
chd-224	441	21	.	.	PUNCT
chd-224	442	1	the	the	DET
chd-224	442	2	laryngoscope	laryngoscope	NOUN
chd-224	442	3	125	125	NUM
chd-224	442	4	,	,	PUNCT
chd-224	442	5	1021	1021	NUM
chd-224	442	6	-	-	SYM
chd-224	442	7	1027	1027	NUM
chd-224	442	8	.	.	PUNCT
chd-224	443	1	kushchayeva	kushchayeva	PROPN
chd-224	443	2	,	,	PUNCT
chd-224	443	3	y.	y.	PROPN
chd-224	443	4	,	,	PUNCT
chd-224	443	5	kushchayev	kushchayev	PROPN
chd-224	443	6	,	,	PUNCT
chd-224	443	7	s.	s.	PROPN
chd-224	443	8	,	,	PUNCT
chd-224	443	9	jensen	jensen	PROPN
chd-224	443	10	,	,	PUNCT
chd-224	443	11	k.	k.	PROPN
chd-224	443	12	,	,	PUNCT
chd-224	443	13	and	and	CCONJ
chd-224	443	14	brown	brown	ADJ
chd-224	443	15	,	,	PUNCT
chd-224	443	16	r.j	r.j	PROPN
chd-224	443	17	.	.	PROPN
chd-224	443	18	(	(	PUNCT
chd-224	443	19	2022	2022	NUM
chd-224	443	20	)	)	PUNCT
chd-224	443	21	.	.	PUNCT
chd-224	444	1	impaired	impair	VERB
chd-224	444	2	glucose	glucose	NOUN
chd-224	444	3	metabolism	metabolism	NOUN
chd-224	444	4	,	,	PUNCT
chd-224	444	5	anti	anti	ADJ
chd-224	444	6	-	-	ADJ
chd-224	444	7	diabetes	diabetes	ADJ
chd-224	444	8	medications	medication	NOUN
chd-224	444	9	,	,	PUNCT
chd-224	444	10	and	and	CCONJ
chd-224	444	11	risk	risk	NOUN
chd-224	444	12	of	of	ADP
chd-224	444	13	thyroid	thyroid	NOUN
chd-224	444	14	cancer	cancer	NOUN
chd-224	444	15	.	.	PUNCT
chd-224	445	1	cancers	cancer	NOUN
chd-224	445	2	(	(	PUNCT
chd-224	445	3	basel	basel	PROPN
chd-224	445	4	)	)	PUNCT
chd-224	445	5	14	14	NUM
chd-224	445	6	.	.	PUNCT
chd-224	445	7	la	la	PROPN
chd-224	445	8	vecchia	vecchia	PROPN
chd-224	445	9	,	,	PUNCT
chd-224	445	10	c.	c.	PROPN
chd-224	445	11	,	,	PUNCT
chd-224	445	12	malvezzi	malvezzi	PROPN
chd-224	445	13	,	,	PUNCT
chd-224	445	14	m.	m.	NOUN
chd-224	445	15	,	,	PUNCT
chd-224	445	16	bosetti	bosetti	PROPN
chd-224	445	17	,	,	PUNCT
chd-224	445	18	c.	c.	PROPN
chd-224	445	19	,	,	PUNCT
chd-224	445	20	garavello	garavello	PROPN
chd-224	445	21	,	,	PUNCT
chd-224	445	22	w.	w.	PROPN
chd-224	445	23	,	,	PUNCT
chd-224	445	24	bertuccio	bertuccio	PROPN
chd-224	445	25	,	,	PUNCT
chd-224	445	26	p.	p.	PROPN
chd-224	445	27	,	,	PUNCT
chd-224	445	28	levi	levi	PROPN
chd-224	445	29	,	,	PUNCT
chd-224	445	30	f.	f.	PROPN
chd-224	445	31	,	,	PUNCT
chd-224	445	32	and	and	CCONJ
chd-224	445	33	negri	negri	NOUN
chd-224	445	34	,	,	PUNCT
chd-224	445	35	e.	e.	PROPN
chd-224	445	36	(	(	PUNCT
chd-224	445	37	2015	2015	NUM
chd-224	445	38	)	)	PUNCT
chd-224	445	39	.	.	PUNCT
chd-224	446	1	thyroid	thyroid	NOUN
chd-224	446	2	cancer	cancer	NOUN
chd-224	446	3	mortality	mortality	NOUN
chd-224	446	4	and	and	CCONJ
chd-224	446	5	incidence	incidence	NOUN
chd-224	446	6	:	:	PUNCT
chd-224	446	7	a	a	DET
chd-224	446	8	global	global	ADJ
chd-224	446	9	overview	overview	NOUN
chd-224	446	10	.	.	PUNCT
chd-224	447	1	international	international	ADJ
chd-224	447	2	journal	journal	NOUN
chd-224	447	3	of	of	ADP
chd-224	447	4	cancer	cancer	NOUN
chd-224	447	5	136	136	NUM
chd-224	447	6	,	,	PUNCT
chd-224	447	7	2187	2187	NUM
chd-224	447	8	-	-	SYM
chd-224	447	9	2195	2195	NUM
chd-224	447	10	.	.	PUNCT
chd-224	448	1	lee	lee	PROPN
chd-224	448	2	,	,	PUNCT
chd-224	448	3	j.h	j.h	PROPN
chd-224	448	4	.	.	PROPN
chd-224	448	5	,	,	PUNCT
chd-224	448	6	youn	youn	PROPN
chd-224	448	7	,	,	PUNCT
chd-224	448	8	s.	s.	PROPN
chd-224	448	9	,	,	PUNCT
chd-224	448	10	jung	jung	PROPN
chd-224	448	11	,	,	PUNCT
chd-224	448	12	s.	s.	PROPN
chd-224	448	13	,	,	PUNCT
chd-224	448	14	kim	kim	PROPN
chd-224	448	15	,	,	PUNCT
chd-224	448	16	k.	k.	PROPN
chd-224	448	17	,	,	PUNCT
chd-224	448	18	chai	chai	NOUN
chd-224	448	19	,	,	PUNCT
chd-224	448	20	y.j	y.j	PROPN
chd-224	448	21	.	.	PROPN
chd-224	448	22	,	,	PUNCT
chd-224	448	23	chung	chung	PROPN
chd-224	448	24	,	,	PUNCT
chd-224	448	25	y.s	y.s	PROPN
chd-224	448	26	.	.	PROPN
chd-224	448	27	,	,	PUNCT
chd-224	448	28	park	park	PROPN
chd-224	448	29	,	,	PUNCT
chd-224	448	30	w.s	w.s	PROPN
chd-224	448	31	.	.	PROPN
chd-224	448	32	,	,	PUNCT
chd-224	448	33	lee	lee	PROPN
chd-224	448	34	,	,	PUNCT
chd-224	448	35	k.e	k.e	PROPN
chd-224	448	36	.	.	PROPN
chd-224	448	37	,	,	PUNCT
chd-224	448	38	and	and	CCONJ
chd-224	448	39	yi	yi	PROPN
chd-224	448	40	,	,	PUNCT
chd-224	448	41	k.h	k.h	PROPN
chd-224	448	42	.	.	PUNCT
chd-224	448	43	(	(	PUNCT
chd-224	448	44	2020	2020	NUM
chd-224	448	45	)	)	PUNCT
chd-224	448	46	.	.	PUNCT
chd-224	449	1	a	a	DET
chd-224	449	2	national	national	ADJ
chd-224	449	3	database	database	NOUN
chd-224	449	4	analysis	analysis	NOUN
chd-224	449	5	for	for	ADP
chd-224	449	6	factors	factor	NOUN
chd-224	449	7	associated	associate	VERB
chd-224	449	8	with	with	ADP
chd-224	449	9	thyroid	thyroid	NOUN
chd-224	449	10	cancer	cancer	NOUN
chd-224	449	11	occurrence	occurrence	NOUN
chd-224	449	12	.	.	PUNCT
chd-224	450	1	sci	sci	PROPN
chd-224	450	2	rep	rep	PROPN
chd-224	450	3	10	10	NUM
chd-224	450	4	,	,	PUNCT
chd-224	450	5	17791	17791	NUM
chd-224	450	6	.	.	PUNCT
chd-224	451	1	lee	lee	PROPN
chd-224	451	2	,	,	PUNCT
chd-224	451	3	w.j	w.j	PROPN
chd-224	451	4	.	.	PROPN
chd-224	451	5	,	,	PUNCT
chd-224	451	6	preston	preston	PROPN
chd-224	451	7	,	,	PUNCT
chd-224	451	8	d.l	d.l	PROPN
chd-224	451	9	.	.	PROPN
chd-224	451	10	,	,	PUNCT
chd-224	451	11	cha	cha	PROPN
chd-224	451	12	,	,	PUNCT
chd-224	451	13	e.s	e.s	PROPN
chd-224	451	14	.	.	PROPN
chd-224	451	15	,	,	PUNCT
chd-224	451	16	ko	ko	PROPN
chd-224	451	17	,	,	PUNCT
chd-224	451	18	s.	s.	PROPN
chd-224	451	19	,	,	PUNCT
chd-224	451	20	and	and	CCONJ
chd-224	451	21	lim	lim	PROPN
chd-224	451	22	,	,	PUNCT
chd-224	451	23	h.	h.	PROPN
chd-224	451	24	(	(	PUNCT
chd-224	451	25	2019	2019	NUM
chd-224	451	26	)	)	PUNCT
chd-224	451	27	.	.	PUNCT
chd-224	452	1	thyroid	thyroid	NOUN
chd-224	452	2	cancer	cancer	NOUN
chd-224	452	3	risks	risk	NOUN
chd-224	452	4	among	among	ADP
chd-224	452	5	medical	medical	ADJ
chd-224	452	6	radiation	radiation	NOUN
chd-224	452	7	workers	worker	NOUN
chd-224	452	8	in	in	ADP
chd-224	452	9	south	south	PROPN
chd-224	452	10	korea	korea	PROPN
chd-224	452	11	,	,	PUNCT
chd-224	452	12	1996	1996	NUM
chd-224	452	13	-	-	SYM
chd-224	452	14	2015	2015	NUM
chd-224	452	15	.	.	PUNCT
chd-224	453	1	environ	environ	PROPN
chd-224	453	2	health	health	PROPN
chd-224	453	3	18	18	NUM
chd-224	453	4	,	,	PUNCT
chd-224	453	5	19	19	NUM
chd-224	453	6	.	.	PUNCT
chd-224	454	1	li	li	PROPN
chd-224	454	2	,	,	PUNCT
chd-224	454	3	j.h	j.h	PROPN
chd-224	454	4	.	.	PROPN
chd-224	454	5	,	,	PUNCT
chd-224	454	6	he	he	PRON
chd-224	454	7	,	,	PUNCT
chd-224	454	8	z.h	z.h	PROPN
chd-224	454	9	.	.	PROPN
chd-224	454	10	,	,	PUNCT
chd-224	454	11	bansal	bansal	NOUN
chd-224	454	12	,	,	PUNCT
chd-224	454	13	v.	v.	ADV
chd-224	454	14	,	,	PUNCT
chd-224	454	15	and	and	CCONJ
chd-224	454	16	hennessey	hennessey	PROPN
chd-224	454	17	,	,	PUNCT
chd-224	454	18	j.v	j.v	PROPN
chd-224	454	19	.	.	PUNCT
chd-224	454	20	(	(	PUNCT
chd-224	454	21	2016	2016	NUM
chd-224	454	22	)	)	PUNCT
chd-224	454	23	.	.	PUNCT
chd-224	455	1	low	low	ADJ
chd-224	455	2	iodine	iodine	NOUN
chd-224	455	3	diet	diet	NOUN
chd-224	455	4	in	in	ADP
chd-224	455	5	differentiated	differentiated	ADJ
chd-224	455	6	thyroid	thyroid	NOUN
chd-224	455	7	cancer	cancer	NOUN
chd-224	455	8	:	:	PUNCT
chd-224	455	9	a	a	DET
chd-224	455	10	review	review	NOUN
chd-224	455	11	.	.	PUNCT
chd-224	456	1	clin	clin	PROPN
chd-224	456	2	endocrinol	endocrinol	PROPN
chd-224	456	3	(	(	PUNCT
chd-224	456	4	oxf	oxf	PROPN
chd-224	456	5	)	)	PUNCT
chd-224	456	6	84	84	NUM
chd-224	456	7	,	,	PUNCT
chd-224	456	8	3	3	NUM
chd-224	456	9	-	-	SYM
chd-224	456	10	12	12	NUM
chd-224	456	11	.	.	PUNCT
chd-224	457	1	lim	lim	PROPN
chd-224	457	2	,	,	PUNCT
chd-224	457	3	h.	h.	PROPN
chd-224	457	4	,	,	PUNCT
chd-224	457	5	devesa	devesa	PROPN
chd-224	457	6	,	,	PUNCT
chd-224	457	7	s.s	s.s	PROPN
chd-224	457	8	.	.	PROPN
chd-224	457	9	,	,	PUNCT
chd-224	457	10	sosa	sosa	PROPN
chd-224	457	11	,	,	PUNCT
chd-224	457	12	j.a	j.a	PROPN
chd-224	457	13	.	.	PROPN
chd-224	457	14	,	,	PUNCT
chd-224	457	15	check	check	PROPN
chd-224	457	16	,	,	PUNCT
chd-224	457	17	d.	d.	PROPN
chd-224	457	18	,	,	PUNCT
chd-224	457	19	and	and	CCONJ
chd-224	457	20	kitahara	kitahara	PROPN
chd-224	457	21	,	,	PUNCT
chd-224	457	22	c.m	c.m	PROPN
chd-224	457	23	.	.	PROPN
chd-224	457	24	(	(	PUNCT
chd-224	457	25	2017	2017	NUM
chd-224	457	26	)	)	PUNCT
chd-224	457	27	.	.	PUNCT
chd-224	458	1	trends	trend	NOUN
chd-224	458	2	in	in	ADP
chd-224	458	3	thyroid	thyroid	NOUN
chd-224	458	4	cancer	cancer	NOUN
chd-224	458	5	incidence	incidence	NOUN
chd-224	458	6	and	and	CCONJ
chd-224	458	7	mortality	mortality	NOUN
chd-224	458	8	in	in	ADP
chd-224	458	9	the	the	DET
chd-224	458	10	united	united	PROPN
chd-224	458	11	states	states	PROPN
chd-224	458	12	,	,	PUNCT
chd-224	458	13	1974	1974	NUM
chd-224	458	14	-	-	SYM
chd-224	458	15	2013	2013	NUM
chd-224	458	16	.	.	PUNCT
chd-224	459	1	jama	jama	PROPN
chd-224	459	2	317	317	NUM
chd-224	459	3	,	,	PUNCT
chd-224	459	4	1338	1338	NUM
chd-224	459	5	-	-	SYM
chd-224	459	6	1348	1348	NUM
chd-224	459	7	.	.	PUNCT
chd-224	460	1	lubin	lubin	PROPN
chd-224	460	2	,	,	PUNCT
chd-224	460	3	j.h	j.h	PROPN
chd-224	460	4	.	.	PROPN
chd-224	460	5	,	,	PUNCT
chd-224	460	6	adams	adams	PROPN
chd-224	460	7	,	,	PUNCT
chd-224	460	8	m.j	m.j	PROPN
chd-224	460	9	.	.	PROPN
chd-224	460	10	,	,	PUNCT
chd-224	460	11	shore	shore	PROPN
chd-224	460	12	,	,	PUNCT
chd-224	460	13	r.	r.	PROPN
chd-224	460	14	,	,	PUNCT
chd-224	460	15	holmberg	holmberg	PROPN
chd-224	460	16	,	,	PUNCT
chd-224	460	17	e.	e.	PROPN
chd-224	460	18	,	,	PUNCT
chd-224	460	19	schneider	schneider	PROPN
chd-224	460	20	,	,	PUNCT
chd-224	460	21	a.b	a.b	PROPN
chd-224	460	22	.	.	PROPN
chd-224	460	23	,	,	PUNCT
chd-224	460	24	hawkins	hawkins	PROPN
chd-224	460	25	,	,	PUNCT
chd-224	460	26	m.m	m.m	PROPN
chd-224	460	27	.	.	PROPN
chd-224	460	28	,	,	PUNCT
chd-224	460	29	robison	robison	PROPN
chd-224	460	30	,	,	PUNCT
chd-224	460	31	l.l	l.l	PROPN
chd-224	460	32	.	.	PROPN
chd-224	460	33	,	,	PUNCT
chd-224	460	34	inskip	inskip	ADJ
chd-224	460	35	,	,	PUNCT
chd-224	460	36	p.d	p.d	PROPN
chd-224	460	37	.	.	PROPN
chd-224	460	38	,	,	PUNCT
chd-224	460	39	lundell	lundell	NOUN
chd-224	460	40	,	,	PUNCT
chd-224	460	41	m.	m.	NOUN
chd-224	460	42	,	,	PUNCT
chd-224	460	43	johansson	johansson	PROPN
chd-224	460	44	,	,	PUNCT
chd-224	460	45	r.	r.	PROPN
chd-224	460	46	,	,	PUNCT
chd-224	460	47	et	et	PROPN
chd-224	460	48	al	al	PROPN
chd-224	460	49	.	.	PUNCT
chd-224	461	1	(	(	PUNCT
chd-224	461	2	2017	2017	NUM
chd-224	461	3	)	)	PUNCT
chd-224	461	4	.	.	PUNCT
chd-224	462	1	thyroid	thyroid	NOUN
chd-224	462	2	cancer	cancer	NOUN
chd-224	462	3	following	follow	VERB
chd-224	462	4	childhood	childhood	ADJ
chd-224	462	5	low	low	ADJ
chd-224	462	6	-	-	PUNCT
chd-224	462	7	dose	dose	NOUN
chd-224	462	8	radiation	radiation	NOUN
chd-224	462	9	exposure	exposure	NOUN
chd-224	462	10	:	:	PUNCT
chd-224	462	11	a	a	DET
chd-224	462	12	pooled	pooled	ADJ
chd-224	462	13	analysis	analysis	NOUN
chd-224	462	14	of	of	ADP
chd-224	462	15	nine	nine	NUM
chd-224	462	16	cohorts	cohort	NOUN
chd-224	462	17	.	.	PUNCT
chd-224	463	1	j	j	PROPN
chd-224	463	2	clin	clin	PROPN
chd-224	463	3	endocrinol	endocrinol	VERB
chd-224	463	4	metab	metab	PROPN
chd-224	463	5	102	102	NUM
chd-224	463	6	,	,	PUNCT
chd-224	463	7	2575	2575	NUM
chd-224	463	8	-	-	SYM
chd-224	463	9	2583	2583	NUM
chd-224	463	10	.	.	PUNCT
chd-224	464	1	ma	ma	PROPN
chd-224	464	2	,	,	PUNCT
chd-224	464	3	x.n	x.n	PROPN
chd-224	464	4	.	.	PROPN
chd-224	464	5	,	,	PUNCT
chd-224	464	6	ma	ma	PROPN
chd-224	464	7	,	,	PUNCT
chd-224	464	8	c.x	c.x	PROPN
chd-224	464	9	.	.	PROPN
chd-224	464	10	,	,	PUNCT
chd-224	464	11	hou	hou	PROPN
chd-224	464	12	,	,	PUNCT
chd-224	464	13	l.j	l.j	PROPN
chd-224	464	14	.	.	PROPN
chd-224	464	15	,	,	PUNCT
chd-224	464	16	and	and	CCONJ
chd-224	464	17	fu	fu	ADJ
chd-224	464	18	,	,	PUNCT
chd-224	464	19	s.b	s.b	PROPN
chd-224	464	20	.	.	PROPN
chd-224	464	21	(	(	PUNCT
chd-224	464	22	2022	2022	NUM
chd-224	464	23	)	)	PUNCT
chd-224	464	24	.	.	PUNCT
chd-224	465	1	the	the	DET
chd-224	465	2	association	association	NOUN
chd-224	465	3	of	of	ADP
chd-224	465	4	obesity	obesity	NOUN
chd-224	465	5	with	with	ADP
chd-224	465	6	thyroid	thyroid	NOUN
chd-224	465	7	carcinoma	carcinoma	NOUN
chd-224	465	8	risk	risk	NOUN
chd-224	465	9	.	.	PUNCT
chd-224	466	1	cancer	cancer	NOUN
chd-224	466	2	med	me	VERB
chd-224	466	3	11	11	NUM
chd-224	466	4	,	,	PUNCT
chd-224	466	5	1136	1136	NUM
chd-224	466	6	-	-	SYM
chd-224	466	7	1144	1144	NUM
chd-224	466	8	.	.	PUNCT
chd-224	467	1	magreni	magreni	NOUN
chd-224	467	2	,	,	PUNCT
chd-224	467	3	a.	a.	PROPN
chd-224	467	4	,	,	PUNCT
chd-224	467	5	bann	bann	PROPN
chd-224	467	6	,	,	PUNCT
chd-224	467	7	d.v	d.v	PROPN
chd-224	467	8	.	.	PROPN
chd-224	467	9	,	,	PUNCT
chd-224	467	10	schubart	schubart	PROPN
chd-224	467	11	,	,	PUNCT
chd-224	467	12	j.r	j.r	PROPN
chd-224	467	13	.	.	PROPN
chd-224	467	14	,	,	PUNCT
chd-224	467	15	and	and	CCONJ
chd-224	467	16	goldenberg	goldenberg	PROPN
chd-224	467	17	,	,	PUNCT
chd-224	467	18	d.	d.	PROPN
chd-224	467	19	(	(	PUNCT
chd-224	467	20	2015	2015	NUM
chd-224	467	21	)	)	PUNCT
chd-224	467	22	.	.	PUNCT
chd-224	468	1	the	the	DET
chd-224	468	2	effects	effect	NOUN
chd-224	468	3	of	of	ADP
chd-224	468	4	race	race	NOUN
chd-224	468	5	and	and	CCONJ
chd-224	468	6	ethnicity	ethnicity	NOUN
chd-224	468	7	on	on	ADP
chd-224	468	8	thyroid	thyroid	NOUN
chd-224	468	9	cancer	cancer	NOUN
chd-224	468	10	incidence	incidence	NOUN
chd-224	468	11	.	.	PUNCT
chd-224	469	1	jama	jama	PROPN
chd-224	469	2	otolaryngology	otolaryngology	NOUN
chd-224	469	3	-	-	PUNCT
chd-224	469	4	head	head	NOUN
chd-224	469	5	&	&	CCONJ
chd-224	469	6	neck	neck	PROPN
chd-224	469	7	surgery	surgery	NOUN
chd-224	469	8	141	141	NUM
chd-224	469	9	,	,	PUNCT
chd-224	469	10	319	319	NUM
chd-224	469	11	-	-	SYM
chd-224	469	12	323	323	NUM
chd-224	469	13	.	.	PUNCT
chd-224	470	1	marti	marti	PROPN
chd-224	470	2	,	,	PUNCT
chd-224	470	3	j.l	j.l	PROPN
chd-224	470	4	.	.	PROPN
chd-224	470	5	,	,	PUNCT
chd-224	470	6	davies	davy	NOUN
chd-224	470	7	,	,	PUNCT
chd-224	470	8	l.	l.	PROPN
chd-224	470	9	,	,	PUNCT
chd-224	470	10	haymart	haymart	PROPN
chd-224	470	11	,	,	PUNCT
chd-224	470	12	m.r	m.r	PROPN
chd-224	470	13	.	.	PROPN
chd-224	470	14	,	,	PUNCT
chd-224	470	15	roman	roman	PROPN
chd-224	470	16	,	,	PUNCT
chd-224	470	17	b.r	b.r	PROPN
chd-224	470	18	.	.	PROPN
chd-224	470	19	,	,	PUNCT
chd-224	470	20	tuttle	tuttle	PROPN
chd-224	470	21	,	,	PUNCT
chd-224	470	22	r.m	r.m	PROPN
chd-224	470	23	.	.	PROPN
chd-224	470	24	,	,	PUNCT
chd-224	470	25	and	and	CCONJ
chd-224	470	26	morris	morris	PROPN
chd-224	470	27	,	,	PUNCT
chd-224	470	28	l.g	l.g	PROPN
chd-224	470	29	.	.	PROPN
chd-224	470	30	(	(	PUNCT
chd-224	470	31	2015	2015	NUM
chd-224	470	32	)	)	PUNCT
chd-224	470	33	.	.	PUNCT
chd-224	471	1	inappropriate	inappropriate	ADJ
chd-224	471	2	use	use	NOUN
chd-224	471	3	of	of	ADP
chd-224	471	4	radioactive	radioactive	ADJ
chd-224	471	5	iodine	iodine	NOUN
chd-224	471	6	for	for	ADP
chd-224	471	7	low	low	ADJ
chd-224	471	8	-	-	PUNCT
chd-224	471	9	risk	risk	NOUN
chd-224	471	10	papillary	papillary	NOUN
chd-224	471	11	thyroid	thyroid	NOUN
chd-224	471	12	cancer	cancer	NOUN
chd-224	471	13	is	be	AUX
chd-224	471	14	most	most	ADV
chd-224	471	15	common	common	ADJ
chd-224	471	16	in	in	ADP
chd-224	471	17	regions	region	NOUN
chd-224	471	18	with	with	ADP
chd-224	471	19	poor	poor	ADJ
chd-224	471	20	access	access	NOUN
chd-224	471	21	to	to	ADP
chd-224	471	22	healthcare	healthcare	PROPN
chd-224	471	23	.	.	PUNCT
chd-224	472	1	thyroid	thyroid	PROPN
chd-224	472	2	25	25	NUM
chd-224	472	3	,	,	PUNCT
chd-224	472	4	865	865	NUM
chd-224	472	5	-	-	SYM
chd-224	472	6	866	866	NUM
chd-224	472	7	.	.	PUNCT
chd-224	473	1	matsuu	matsuu	PROPN
chd-224	473	2	-	-	PUNCT
chd-224	473	3	matsuyama	matsuyama	PROPN
chd-224	473	4	,	,	PUNCT
chd-224	473	5	m.	m.	NOUN
chd-224	473	6	,	,	PUNCT
chd-224	473	7	shichijo	shichijo	PROPN
chd-224	473	8	,	,	PUNCT
chd-224	473	9	k.	k.	PROPN
chd-224	473	10	,	,	PUNCT
chd-224	473	11	matsuda	matsuda	PROPN
chd-224	473	12	,	,	PUNCT
chd-224	473	13	k.	k.	PROPN
chd-224	473	14	,	,	PUNCT
chd-224	473	15	fujimoto	fujimoto	PROPN
chd-224	473	16	,	,	PUNCT
chd-224	473	17	n.	n.	PROPN
chd-224	473	18	,	,	PUNCT
chd-224	473	19	kondo	kondo	PROPN
chd-224	473	20	,	,	PUNCT
chd-224	473	21	h.	h.	PROPN
chd-224	473	22	,	,	PUNCT
chd-224	473	23	miura	miura	PROPN
chd-224	473	24	,	,	PUNCT
chd-224	473	25	s.	s.	PROPN
chd-224	473	26	,	,	PUNCT
chd-224	473	27	kurashige	kurashige	NOUN
chd-224	473	28	,	,	PUNCT
chd-224	473	29	t.	t.	PROPN
chd-224	473	30	,	,	PUNCT
chd-224	473	31	nagayama	nagayama	NOUN
chd-224	473	32	,	,	PUNCT
chd-224	473	33	y.	y.	PROPN
chd-224	473	34	,	,	PUNCT
chd-224	473	35	and	and	CCONJ
chd-224	473	36	nakashima	nakashima	PROPN
chd-224	473	37	,	,	PUNCT
chd-224	473	38	m.	m.	NOUN
chd-224	473	39	(	(	PUNCT
chd-224	473	40	2021	2021	NUM
chd-224	473	41	)	)	PUNCT
chd-224	473	42	.	.	PUNCT
chd-224	474	1	age	age	NOUN
chd-224	474	2	-	-	PUNCT
chd-224	474	3	dependent	dependent	ADJ
chd-224	474	4	effects	effect	NOUN
chd-224	474	5	on	on	ADP
chd-224	474	6	radiation	radiation	NOUN
chd-224	474	7	-	-	PUNCT
chd-224	474	8	induced	induce	VERB
chd-224	474	9	carcinogenesis	carcinogenesis	NOUN
chd-224	474	10	in	in	ADP
chd-224	474	11	the	the	DET
chd-224	474	12	rat	rat	NOUN
chd-224	474	13	thyroid	thyroid	NOUN
chd-224	474	14	.	.	PUNCT
chd-224	475	1	sci	sci	PROPN
chd-224	475	2	rep	rep	PROPN
chd-224	475	3	11	11	NUM
chd-224	475	4	,	,	PUNCT
chd-224	475	5	19096	19096	NUM
chd-224	475	6	.	.	PUNCT
chd-224	476	1	mclachlan	mclachlan	PROPN
chd-224	476	2	,	,	PUNCT
chd-224	476	3	s.m	s.m	PROPN
chd-224	476	4	.	.	PROPN
chd-224	476	5	,	,	PUNCT
chd-224	476	6	nagayama	nagayama	NOUN
chd-224	476	7	,	,	PUNCT
chd-224	476	8	y.	y.	NOUN
chd-224	476	9	,	,	PUNCT
chd-224	476	10	pichurin	pichurin	NOUN
chd-224	476	11	,	,	PUNCT
chd-224	476	12	p.n	p.n	PROPN
chd-224	476	13	.	.	PROPN
chd-224	476	14	,	,	PUNCT
chd-224	476	15	mizutori	mizutori	PROPN
chd-224	476	16	,	,	PUNCT
chd-224	476	17	y.	y.	PROPN
chd-224	476	18	,	,	PUNCT
chd-224	476	19	chen	chen	PROPN
chd-224	476	20	,	,	PUNCT
chd-224	476	21	c.-r	c.-r	PROPN
chd-224	476	22	.	.	PROPN
chd-224	476	23	,	,	PUNCT
chd-224	476	24	misharin	misharin	PROPN
chd-224	476	25	,	,	PUNCT
chd-224	476	26	a.	a.	NOUN
chd-224	476	27	,	,	PUNCT
chd-224	476	28	aliesky	aliesky	NOUN
chd-224	476	29	,	,	PUNCT
chd-224	476	30	h.a	h.a	PROPN
chd-224	476	31	.	.	PROPN
chd-224	476	32	,	,	PUNCT
chd-224	476	33	and	and	CCONJ
chd-224	476	34	rapoport	rapoport	NOUN
chd-224	476	35	,	,	PUNCT
chd-224	476	36	b.	b.	PROPN
chd-224	476	37	(	(	PUNCT
chd-224	476	38	2007	2007	NUM
chd-224	476	39	)	)	PUNCT
chd-224	476	40	.	.	PUNCT
chd-224	477	1	the	the	DET
chd-224	477	2	link	link	NOUN
chd-224	477	3	between	between	ADP
chd-224	477	4	graves	grave	NOUN
chd-224	477	5	’	’	PART
chd-224	477	6	disease	disease	NOUN
chd-224	477	7	and	and	CCONJ
chd-224	477	8	hashimoto	hashimoto	NOUN
chd-224	477	9	’s	’s	PART
chd-224	477	10	thyroiditis	thyroiditis	NOUN
chd-224	477	11	:	:	PUNCT
chd-224	477	12	a	a	DET
chd-224	477	13	role	role	NOUN
chd-224	477	14	for	for	ADP
chd-224	477	15	regulatory	regulatory	ADJ
chd-224	477	16	t	t	NOUN
chd-224	477	17	cells	cell	NOUN
chd-224	477	18	.	.	PUNCT
chd-224	478	1	endocrinology	endocrinology	NOUN
chd-224	478	2	148	148	NUM
chd-224	478	3	,	,	PUNCT
chd-224	478	4	5724	5724	NUM
chd-224	478	5	-	-	SYM
chd-224	478	6	5733	5733	NUM
chd-224	478	7	.	.	PUNCT
chd-224	479	1	mcleod	mcleod	PROPN
chd-224	479	2	,	,	PUNCT
chd-224	479	3	d.s	d.s	PROPN
chd-224	479	4	.	.	PROPN
chd-224	479	5	,	,	PUNCT
chd-224	479	6	caturegli	caturegli	PROPN
chd-224	479	7	,	,	PUNCT
chd-224	479	8	p.	p.	NOUN
chd-224	479	9	,	,	PUNCT
chd-224	479	10	cooper	cooper	PROPN
chd-224	479	11	,	,	PUNCT
chd-224	479	12	d.s	d.s	PROPN
chd-224	479	13	.	.	PROPN
chd-224	479	14	,	,	PUNCT
chd-224	479	15	matos	matos	PROPN
chd-224	479	16	,	,	PUNCT
chd-224	479	17	p.g	p.g	PROPN
chd-224	479	18	.	.	PROPN
chd-224	479	19	,	,	PUNCT
chd-224	479	20	and	and	CCONJ
chd-224	479	21	hutfless	hutfless	NOUN
chd-224	479	22	,	,	PUNCT
chd-224	479	23	s.	s.	PROPN
chd-224	479	24	(	(	PUNCT
chd-224	479	25	2014	2014	NUM
chd-224	479	26	)	)	PUNCT
chd-224	479	27	.	.	PUNCT
chd-224	480	1	variation	variation	NOUN
chd-224	480	2	in	in	ADP
chd-224	480	3	rates	rate	NOUN
chd-224	480	4	of	of	ADP
chd-224	480	5	autoimmune	autoimmune	ADJ
chd-224	480	6	thyroid	thyroid	NOUN
chd-224	480	7	disease	disease	NOUN
chd-224	480	8	by	by	ADP
chd-224	480	9	race	race	NOUN
chd-224	480	10	/	/	SYM
chd-224	480	11	ethnicity	ethnicity	NOUN
chd-224	480	12	in	in	ADP
chd-224	480	13	us	us	PROPN
chd-224	480	14	military	military	NOUN
chd-224	480	15	personnel	personnel	NOUN
chd-224	480	16	.	.	PUNCT
chd-224	481	1	jama	jama	PROPN
chd-224	481	2	311	311	NUM
chd-224	481	3	,	,	PUNCT
chd-224	481	4	1563	1563	NUM
chd-224	481	5	-	-	SYM
chd-224	481	6	1565	1565	NUM
chd-224	481	7	.	.	PUNCT
chd-224	482	1	megwalu	megwalu	PROPN
chd-224	482	2	,	,	PUNCT
chd-224	482	3	u.c	u.c	PROPN
chd-224	482	4	.	.	PROPN
chd-224	482	5	,	,	PUNCT
chd-224	482	6	ma	ma	PROPN
chd-224	482	7	,	,	PUNCT
chd-224	482	8	y.	y.	NOUN
chd-224	482	9	,	,	PUNCT
chd-224	482	10	osazuwa	osazuwa	ADJ
chd-224	482	11	-	-	PUNCT
chd-224	482	12	peters	peter	NOUN
chd-224	482	13	,	,	PUNCT
chd-224	482	14	n.	n.	NOUN
chd-224	482	15	,	,	PUNCT
chd-224	482	16	and	and	CCONJ
chd-224	482	17	orloff	orloff	PROPN
chd-224	482	18	,	,	PUNCT
chd-224	482	19	l.a	l.a	PROPN
chd-224	482	20	.	.	PROPN
chd-224	482	21	(	(	PUNCT
chd-224	482	22	2021	2021	NUM
chd-224	482	23	)	)	PUNCT
chd-224	482	24	.	.	PUNCT
chd-224	483	1	clinical	clinical	ADJ
chd-224	483	2	presentation	presentation	NOUN
chd-224	483	3	and	and	CCONJ
chd-224	483	4	survival	survival	NOUN
chd-224	483	5	outcomes	outcome	NOUN
chd-224	483	6	of	of	ADP
chd-224	483	7	welldifferentiated	welldifferentiate	VERB
chd-224	483	8	thyroid	thyroid	NOUN
chd-224	483	9	cancer	cancer	NOUN
chd-224	483	10	in	in	ADP
chd-224	483	11	filipinos	filipinos	PROPN
chd-224	483	12	.	.	PUNCT
chd-224	484	1	cancer	cancer	NOUN
chd-224	484	2	med	med	PROPN
chd-224	484	3	.	.	PROPN
chd-224	484	4	morris	morris	PROPN
chd-224	484	5	,	,	PUNCT
chd-224	484	6	l.g	l.g	PROPN
chd-224	484	7	.	.	PROPN
chd-224	484	8	,	,	PUNCT
chd-224	484	9	sikora	sikora	PROPN
chd-224	484	10	,	,	PUNCT
chd-224	484	11	a.g	a.g	PROPN
chd-224	484	12	.	.	PROPN
chd-224	484	13	,	,	PUNCT
chd-224	484	14	tosteson	tosteson	PROPN
chd-224	484	15	,	,	PUNCT
chd-224	484	16	t.d	t.d	PROPN
chd-224	484	17	.	.	PROPN
chd-224	484	18	,	,	PUNCT
chd-224	484	19	and	and	CCONJ
chd-224	484	20	davies	davy	NOUN
chd-224	484	21	,	,	PUNCT
chd-224	484	22	l.	l.	PROPN
chd-224	484	23	(	(	PUNCT
chd-224	484	24	2013	2013	NUM
chd-224	484	25	)	)	PUNCT
chd-224	484	26	.	.	PUNCT
chd-224	485	1	the	the	DET
chd-224	485	2	increasing	increase	VERB
chd-224	485	3	incidence	incidence	NOUN
chd-224	485	4	of	of	ADP
chd-224	485	5	thyroid	thyroid	NOUN
chd-224	485	6	cancer	cancer	NOUN
chd-224	485	7	:	:	PUNCT
chd-224	485	8	the	the	DET
chd-224	485	9	influence	influence	NOUN
chd-224	485	10	of	of	ADP
chd-224	485	11	access	access	NOUN
chd-224	485	12	to	to	ADP
chd-224	485	13	care	care	NOUN
chd-224	485	14	.	.	PUNCT
chd-224	486	1	thyroid	thyroid	PROPN
chd-224	486	2	23	23	NUM
chd-224	486	3	,	,	PUNCT
chd-224	486	4	885	885	NUM
chd-224	486	5	-	-	SYM
chd-224	486	6	891	891	NUM
chd-224	486	7	.	.	PUNCT
chd-224	487	1	mull	mull	NOUN
chd-224	487	2	,	,	PUNCT
chd-224	487	3	b.	b.	PROPN
chd-224	487	4	,	,	PUNCT
chd-224	487	5	davis	davis	PROPN
chd-224	487	6	,	,	PUNCT
chd-224	487	7	r.	r.	PROPN
chd-224	487	8	,	,	PUNCT
chd-224	487	9	munir	munir	PROPN
chd-224	487	10	,	,	PUNCT
chd-224	487	11	i.	i.	PROPN
chd-224	487	12	,	,	PUNCT
chd-224	487	13	perez	perez	PROPN
chd-224	487	14	,	,	PUNCT
chd-224	487	15	m.c	m.c	PROPN
chd-224	487	16	.	.	PROPN
chd-224	487	17	,	,	PUNCT
chd-224	487	18	simental	simental	PROPN
chd-224	487	19	,	,	PUNCT
chd-224	487	20	a.a	a.a	PROPN
chd-224	487	21	.	.	PROPN
chd-224	487	22	,	,	PUNCT
chd-224	487	23	and	and	CCONJ
chd-224	487	24	khan	khan	PROPN
chd-224	487	25	,	,	PUNCT
chd-224	487	26	s.	s.	PROPN
chd-224	487	27	(	(	PUNCT
chd-224	487	28	2021	2021	NUM
chd-224	487	29	)	)	PUNCT
chd-224	487	30	.	.	PUNCT
chd-224	488	1	differential	differential	ADJ
chd-224	488	2	expression	expression	NOUN
chd-224	488	3	of	of	ADP
chd-224	488	4	vitamin	vitamin	NOUN
chd-224	488	5	d	d	NOUN
chd-224	488	6	binding	bind	VERB
chd-224	488	7	protein	protein	NOUN
chd-224	488	8	in	in	ADP
chd-224	488	9	thyroid	thyroid	NOUN
chd-224	488	10	cancer	cancer	NOUN
chd-224	488	11	health	health	NOUN
chd-224	488	12	disparities	disparity	NOUN
chd-224	488	13	.	.	PUNCT
chd-224	489	1	oncotarget	oncotarget	NOUN
chd-224	489	2	12	12	NUM
chd-224	489	3	,	,	PUNCT
chd-224	489	4	596	596	NUM
chd-224	489	5	-	-	SYM
chd-224	489	6	607	607	NUM
chd-224	489	7	.	.	PUNCT
chd-224	490	1	national	national	PROPN
chd-224	490	2	research	research	PROPN
chd-224	490	3	council	council	PROPN
chd-224	490	4	panel	panel	NOUN
chd-224	490	5	on	on	ADP
chd-224	490	6	race	race	NOUN
chd-224	490	7	,	,	PUNCT
chd-224	490	8	e.	e.	PROPN
chd-224	490	9	,	,	PUNCT
chd-224	490	10	and	and	CCONJ
chd-224	490	11	health	health	NOUN
chd-224	490	12	in	in	ADP
chd-224	490	13	later	later	ADV
chd-224	490	14	,	,	PUNCT
chd-224	490	15	l.	l.	PROPN
chd-224	490	16	(	(	PUNCT
chd-224	490	17	2004	2004	NUM
chd-224	490	18	)	)	PUNCT
chd-224	490	19	.	.	PUNCT
chd-224	491	1	the	the	DET
chd-224	491	2	national	national	ADJ
chd-224	491	3	academies	academies	PROPN
chd-224	491	4	collection	collection	NOUN
chd-224	491	5	:	:	PUNCT
chd-224	491	6	reports	report	NOUN
chd-224	491	7	funded	fund	VERB
chd-224	491	8	by	by	ADP
chd-224	491	9	national	national	ADJ
chd-224	491	10	institutes	institutes	PROPN
chd-224	491	11	of	of	ADP
chd-224	491	12	health	health	NOUN
chd-224	491	13	.	.	PUNCT
chd-224	492	1	in	in	ADP
chd-224	492	2	critical	critical	ADJ
chd-224	492	3	perspectives	perspective	NOUN
chd-224	492	4	on	on	ADP
chd-224	492	5	racial	racial	ADJ
chd-224	492	6	and	and	CCONJ
chd-224	492	7	ethnic	ethnic	ADJ
chd-224	492	8	differences	difference	NOUN
chd-224	492	9	in	in	ADP
chd-224	492	10	health	health	NOUN
chd-224	492	11	in	in	ADP
chd-224	492	12	late	late	ADJ
chd-224	492	13	life	life	NOUN
chd-224	492	14	,	,	PUNCT
chd-224	492	15	n.b	n.b	PROPN
chd-224	492	16	.	.	PROPN
chd-224	492	17	anderson	anderson	PROPN
chd-224	492	18	,	,	PUNCT
chd-224	492	19	r.a	r.a	PROPN
chd-224	492	20	.	.	PROPN
chd-224	492	21	bulatao	bulatao	PROPN
chd-224	492	22	,	,	PUNCT
chd-224	492	23	and	and	CCONJ
chd-224	492	24	b.	b.	PROPN
chd-224	492	25	cohen	cohen	PROPN
chd-224	492	26	,	,	PUNCT
chd-224	492	27	eds	eds	PROPN
chd-224	492	28	.	.	PUNCT
chd-224	493	1	(	(	PUNCT
chd-224	493	2	washington	washington	PROPN
chd-224	493	3	(	(	PUNCT
chd-224	493	4	dc	dc	PROPN
chd-224	493	5	):	):	PUNCT
chd-224	493	6	national	national	PROPN
chd-224	493	7	academies	academies	PROPN
chd-224	493	8	press	press	PROPN
chd-224	493	9	(	(	PUNCT
chd-224	493	10	us	we	PRON
chd-224	493	11	)	)	PUNCT
chd-224	493	12	copyright	copyright	NOUN
chd-224	493	13	©	©	PROPN
chd-224	493	14	2004	2004	NUM
chd-224	493	15	,	,	PUNCT
chd-224	493	16	national	national	PROPN
chd-224	493	17	academy	academy	PROPN
chd-224	493	18	of	of	ADP
chd-224	493	19	sciences	sciences	PROPN
chd-224	493	20	.	.	PUNCT
chd-224	493	21	)	)	PUNCT
chd-224	493	22	.	.	PUNCT
chd-224	494	1	nguyen	nguyen	NOUN
chd-224	494	2	,	,	PUNCT
chd-224	494	3	m.t	m.t	PROPN
chd-224	494	4	.	.	PROPN
chd-224	494	5	,	,	PUNCT
chd-224	494	6	hu	hu	PROPN
chd-224	494	7	,	,	PUNCT
chd-224	494	8	j.	j.	PROPN
chd-224	494	9	,	,	PUNCT
chd-224	494	10	hastings	hastings	PROPN
chd-224	494	11	,	,	PUNCT
chd-224	494	12	k.g	k.g	PROPN
chd-224	494	13	.	.	PROPN
chd-224	494	14	,	,	PUNCT
chd-224	494	15	daza	daza	PROPN
chd-224	494	16	,	,	PUNCT
chd-224	494	17	e.j	e.j	PROPN
chd-224	494	18	.	.	PROPN
chd-224	494	19	,	,	PUNCT
chd-224	494	20	cullen	cullen	PROPN
chd-224	494	21	,	,	PUNCT
chd-224	494	22	m.r	m.r	PROPN
chd-224	494	23	.	.	PROPN
chd-224	494	24	,	,	PUNCT
chd-224	494	25	orloff	orloff	PROPN
chd-224	494	26	,	,	PUNCT
chd-224	494	27	l.a	l.a	PROPN
chd-224	494	28	.	.	PROPN
chd-224	494	29	,	,	PUNCT
chd-224	494	30	and	and	CCONJ
chd-224	494	31	palaniappan	palaniappan	NOUN
chd-224	494	32	,	,	PUNCT
chd-224	494	33	l.p	l.p	PROPN
chd-224	494	34	.	.	PROPN
chd-224	494	35	(	(	PUNCT
chd-224	494	36	2017	2017	NUM
chd-224	494	37	)	)	PUNCT
chd-224	494	38	.	.	PUNCT
chd-224	495	1	thyroid	thyroid	NOUN
chd-224	495	2	cancer	cancer	NOUN
chd-224	495	3	mortality	mortality	NOUN
chd-224	495	4	is	be	AUX
chd-224	495	5	higher	high	ADJ
chd-224	495	6	in	in	ADP
chd-224	495	7	filipinos	filipino	NOUN
chd-224	495	8	in	in	ADP
chd-224	495	9	the	the	DET
chd-224	495	10	united	united	PROPN
chd-224	495	11	states	states	PROPN
chd-224	495	12	:	:	PUNCT
chd-224	495	13	an	an	DET
chd-224	495	14	analysis	analysis	NOUN
chd-224	495	15	using	use	VERB
chd-224	495	16	national	national	ADJ
chd-224	495	17	mortality	mortality	NOUN
chd-224	495	18	records	record	NOUN
chd-224	495	19	from	from	ADP
chd-224	495	20	2003	2003	NUM
chd-224	495	21	through	through	ADP
chd-224	495	22	2012	2012	NUM
chd-224	495	23	.	.	PUNCT
chd-224	496	1	cancer	cancer	NOUN
chd-224	496	2	123	123	NUM
chd-224	496	3	,	,	PUNCT
chd-224	496	4	4860	4860	NUM
chd-224	496	5	-	-	SYM
chd-224	496	6	4867	4867	NUM
chd-224	496	7	.	.	PUNCT
chd-224	497	1	o'connell	o'connell	PROPN
chd-224	497	2	,	,	PUNCT
chd-224	497	3	t.j	t.j	PROPN
chd-224	497	4	.	.	PROPN
chd-224	497	5	,	,	PUNCT
chd-224	497	6	dadafarin	dadafarin	PROPN
chd-224	497	7	,	,	PUNCT
chd-224	497	8	s.	s.	PROPN
chd-224	497	9	,	,	PUNCT
chd-224	497	10	jones	jones	PROPN
chd-224	497	11	,	,	PUNCT
chd-224	497	12	m.	m.	NOUN
chd-224	497	13	,	,	PUNCT
chd-224	497	14	rodríguez	rodríguez	NOUN
chd-224	497	15	,	,	PUNCT
chd-224	497	16	t.	t.	PROPN
chd-224	497	17	,	,	PUNCT
chd-224	497	18	gupta	gupta	PROPN
chd-224	497	19	,	,	PUNCT
chd-224	497	20	a.	a.	NOUN
chd-224	497	21	,	,	PUNCT
chd-224	497	22	shin	shin	PROPN
chd-224	497	23	,	,	PUNCT
chd-224	497	24	e.	e.	PROPN
chd-224	497	25	,	,	PUNCT
chd-224	497	26	moscatello	moscatello	PROPN
chd-224	497	27	,	,	PUNCT
chd-224	497	28	a.	a.	NOUN
chd-224	497	29	,	,	PUNCT
chd-224	497	30	iacob	iacob	NOUN
chd-224	497	31	,	,	PUNCT
chd-224	497	32	c.	c.	PROPN
chd-224	497	33	,	,	PUNCT
chd-224	497	34	islam	islam	PROPN
chd-224	497	35	,	,	PUNCT
chd-224	497	36	h.	h.	PROPN
chd-224	497	37	,	,	PUNCT
chd-224	497	38	tiwari	tiwari	PROPN
chd-224	497	39	,	,	PUNCT
chd-224	497	40	r.k	r.k	PROPN
chd-224	497	41	.	.	PROPN
chd-224	497	42	,	,	PUNCT
chd-224	497	43	et	et	PROPN
chd-224	497	44	al	al	PROPN
chd-224	497	45	.	.	PROPN
chd-224	497	46	(	(	PUNCT
chd-224	497	47	2021	2021	NUM
chd-224	497	48	)	)	PUNCT
chd-224	497	49	.	.	PUNCT
chd-224	498	1	androgen	androgen	NOUN
chd-224	498	2	activity	activity	NOUN
chd-224	498	3	is	be	AUX
chd-224	498	4	associated	associate	VERB
chd-224	498	5	with	with	ADP
chd-224	498	6	pd	pd	PROPN
chd-224	498	7	-	-	PUNCT
chd-224	498	8	l1	l1	PROPN
chd-224	498	9	downregulation	downregulation	NOUN
chd-224	498	10	in	in	ADP
chd-224	498	11	thyroid	thyroid	NOUN
chd-224	498	12	cancer	cancer	NOUN
chd-224	498	13	.	.	PUNCT
chd-224	499	1	front	front	ADJ
chd-224	499	2	cell	cell	NOUN
chd-224	499	3	dev	dev	PROPN
chd-224	499	4	biol	biol	NOUN
chd-224	499	5	9	9	NUM
chd-224	499	6	,	,	PUNCT
chd-224	499	7	663130	663130	NUM
chd-224	499	8	.	.	PUNCT
chd-224	500	1	paes	paes	PROPN
chd-224	500	2	,	,	PUNCT
chd-224	500	3	j.e	j.e	PROPN
chd-224	500	4	.	.	PROPN
chd-224	500	5	,	,	PUNCT
chd-224	500	6	hua	hua	PROPN
chd-224	500	7	,	,	PUNCT
chd-224	500	8	k.	k.	PROPN
chd-224	500	9	,	,	PUNCT
chd-224	500	10	nagy	nagy	PROPN
chd-224	500	11	,	,	PUNCT
chd-224	500	12	r.	r.	PROPN
chd-224	500	13	,	,	PUNCT
chd-224	500	14	kloos	kloos	PROPN
chd-224	500	15	,	,	PUNCT
chd-224	500	16	r.t	r.t	PROPN
chd-224	500	17	.	.	PROPN
chd-224	500	18	,	,	PUNCT
chd-224	500	19	jarjoura	jarjoura	PROPN
chd-224	500	20	,	,	PUNCT
chd-224	500	21	d.	d.	PROPN
chd-224	500	22	,	,	PUNCT
chd-224	500	23	and	and	CCONJ
chd-224	500	24	ringel	ringel	NOUN
chd-224	500	25	,	,	PUNCT
chd-224	500	26	m.d	m.d	PROPN
chd-224	500	27	.	.	PROPN
chd-224	500	28	(	(	PUNCT
chd-224	500	29	2010	2010	NUM
chd-224	500	30	)	)	PUNCT
chd-224	500	31	.	.	PUNCT
chd-224	501	1	the	the	DET
chd-224	501	2	relationship	relationship	NOUN
chd-224	501	3	between	between	ADP
chd-224	501	4	body	body	NOUN
chd-224	501	5	mass	mass	NOUN
chd-224	501	6	index	index	NOUN
chd-224	501	7	and	and	CCONJ
chd-224	501	8	thyroid	thyroid	NOUN
chd-224	501	9	cancer	cancer	NOUN
chd-224	501	10	pathology	pathology	NOUN
chd-224	501	11	features	feature	VERB
chd-224	501	12	and	and	CCONJ
chd-224	501	13	outcomes	outcome	NOUN
chd-224	501	14	:	:	PUNCT
chd-224	501	15	a	a	DET
chd-224	501	16	clinicopathological	clinicopathological	ADJ
chd-224	501	17	cohort	cohort	NOUN
chd-224	501	18	study	study	NOUN
chd-224	501	19	.	.	PUNCT
chd-224	502	1	j	j	PROPN
chd-224	502	2	clin	clin	PROPN
chd-224	502	3	endocrinol	endocrinol	PROPN
chd-224	502	4	metab	metab	PROPN
chd-224	502	5	95	95	NUM
chd-224	502	6	,	,	PUNCT
chd-224	502	7	4244	4244	NUM
chd-224	502	8	-	-	SYM
chd-224	502	9	4250	4250	NUM
chd-224	502	10	.	.	PUNCT
chd-224	503	1	pagano	pagano	PROPN
chd-224	503	2	,	,	PUNCT
chd-224	503	3	l.	l.	PROPN
chd-224	503	4	,	,	PUNCT
chd-224	503	5	mele	mele	PROPN
chd-224	503	6	,	,	PUNCT
chd-224	503	7	c.	c.	PROPN
chd-224	503	8	,	,	PUNCT
chd-224	503	9	sama	sama	PROPN
chd-224	503	10	,	,	PUNCT
chd-224	503	11	m.t	m.t	PROPN
chd-224	503	12	.	.	PROPN
chd-224	503	13	,	,	PUNCT
chd-224	503	14	zavattaro	zavattaro	NOUN
chd-224	503	15	,	,	PUNCT
chd-224	503	16	m.	m.	NOUN
chd-224	503	17	,	,	PUNCT
chd-224	503	18	caputo	caputo	PROPN
chd-224	503	19	,	,	PUNCT
chd-224	503	20	m.	m.	NOUN
chd-224	503	21	,	,	PUNCT
chd-224	503	22	de	de	X
chd-224	503	23	marchi	marchi	PROPN
chd-224	503	24	,	,	PUNCT
chd-224	503	25	l.	l.	PROPN
chd-224	503	26	,	,	PUNCT
chd-224	503	27	paggi	paggi	PROPN
chd-224	503	28	,	,	PUNCT
chd-224	503	29	s.	s.	PROPN
chd-224	503	30	,	,	PUNCT
chd-224	503	31	prodam	prodam	PROPN
chd-224	503	32	,	,	PUNCT
chd-224	503	33	f.	f.	PROPN
chd-224	503	34	,	,	PUNCT
chd-224	503	35	aimaretti	aimaretti	PROPN
chd-224	503	36	,	,	PUNCT
chd-224	503	37	g.	g.	PROPN
chd-224	503	38	,	,	PUNCT
chd-224	503	39	and	and	CCONJ
chd-224	503	40	marzullo	marzullo	NOUN
chd-224	503	41	,	,	PUNCT
chd-224	503	42	p.	p.	NOUN
chd-224	503	43	(	(	PUNCT
chd-224	503	44	2018	2018	NUM
chd-224	503	45	)	)	PUNCT
chd-224	503	46	.	.	PUNCT
chd-224	504	1	thyroid	thyroid	NOUN
chd-224	504	2	cancer	cancer	NOUN
chd-224	504	3	phenotypes	phenotype	NOUN
chd-224	504	4	in	in	ADP
chd-224	504	5	relation	relation	NOUN
chd-224	504	6	to	to	ADP
chd-224	504	7	inflammation	inflammation	NOUN
chd-224	504	8	and	and	CCONJ
chd-224	504	9	autoimmunity	autoimmunity	NOUN
chd-224	504	10	.	.	PUNCT
chd-224	505	1	front	front	ADJ
chd-224	505	2	biosci	biosci	PROPN
chd-224	505	3	(	(	PUNCT
chd-224	505	4	landmark	landmark	PROPN
chd-224	505	5	ed	ed	NOUN
chd-224	505	6	)	)	PUNCT
chd-224	505	7	23	23	NUM
chd-224	505	8	,	,	PUNCT
chd-224	505	9	2267	2267	NUM
chd-224	505	10	-	-	SYM
chd-224	505	11	2282	2282	NUM
chd-224	505	12	.	.	PUNCT
chd-224	506	1	pai	pai	PROPN
chd-224	506	2	,	,	PUNCT
chd-224	506	3	s.g	s.g	PROPN
chd-224	506	4	.	.	PROPN
chd-224	506	5	,	,	PUNCT
chd-224	506	6	carneiro	carneiro	PROPN
chd-224	506	7	,	,	PUNCT
chd-224	506	8	b.a	b.a	PROPN
chd-224	506	9	.	.	PROPN
chd-224	506	10	,	,	PUNCT
chd-224	506	11	mota	mota	PROPN
chd-224	506	12	,	,	PUNCT
chd-224	506	13	j.m	j.m	PROPN
chd-224	506	14	.	.	PROPN
chd-224	506	15	,	,	PUNCT
chd-224	506	16	costa	costa	PROPN
chd-224	506	17	,	,	PUNCT
chd-224	506	18	r.	r.	PROPN
chd-224	506	19	,	,	PUNCT
chd-224	506	20	leite	leite	PROPN
chd-224	506	21	,	,	PUNCT
chd-224	506	22	c.a	c.a	PROPN
chd-224	506	23	.	.	PROPN
chd-224	506	24	,	,	PUNCT
chd-224	506	25	barroso	barroso	PROPN
chd-224	506	26	-	-	PUNCT
chd-224	506	27	sousa	sousa	PROPN
chd-224	506	28	,	,	PUNCT
chd-224	506	29	r.	r.	PROPN
chd-224	506	30	,	,	PUNCT
chd-224	506	31	kaplan	kaplan	PROPN
chd-224	506	32	,	,	PUNCT
chd-224	506	33	j.b	j.b	PROPN
chd-224	506	34	.	.	PROPN
chd-224	506	35	,	,	PUNCT
chd-224	506	36	chae	chae	PROPN
chd-224	506	37	,	,	PUNCT
chd-224	506	38	y.k	y.k	PROPN
chd-224	506	39	.	.	PROPN
chd-224	506	40	,	,	PUNCT
chd-224	506	41	and	and	CCONJ
chd-224	506	42	giles	gile	NOUN
chd-224	506	43	,	,	PUNCT
chd-224	506	44	f.j	f.j	PROPN
chd-224	506	45	.	.	PROPN
chd-224	506	46	(	(	PUNCT
chd-224	506	47	2017	2017	NUM
chd-224	506	48	)	)	PUNCT
chd-224	506	49	.	.	PUNCT
chd-224	507	1	wnt	wnt	PROPN
chd-224	507	2	/	/	SYM
chd-224	507	3	beta	beta	NOUN
chd-224	507	4	-	-	PUNCT
chd-224	507	5	catenin	catenin	NOUN
chd-224	507	6	pathway	pathway	NOUN
chd-224	507	7	:	:	PUNCT
chd-224	507	8	modulating	modulate	VERB
chd-224	507	9	anticancer	anticancer	NOUN
chd-224	507	10	immune	immune	ADJ
chd-224	507	11	response	response	NOUN
chd-224	507	12	.	.	PUNCT
chd-224	508	1	j	j	PROPN
chd-224	508	2	hematol	hematol	NOUN
chd-224	508	3	oncol	oncol	ADJ
chd-224	508	4	10	10	NUM
chd-224	508	5	,	,	PUNCT
chd-224	508	6	101	101	NUM
chd-224	508	7	.	.	PUNCT
chd-224	509	1	palaniappan	palaniappan	PROPN
chd-224	509	2	,	,	PUNCT
chd-224	509	3	l.p	l.p	PROPN
chd-224	509	4	.	.	PROPN
chd-224	509	5	,	,	PUNCT
chd-224	509	6	wong	wong	PROPN
chd-224	509	7	,	,	PUNCT
chd-224	509	8	e.c	e.c	PROPN
chd-224	509	9	.	.	PROPN
chd-224	509	10	,	,	PUNCT
chd-224	509	11	shin	shin	PROPN
chd-224	509	12	,	,	PUNCT
chd-224	509	13	j.j	j.j	PROPN
chd-224	509	14	.	.	PROPN
chd-224	509	15	,	,	PUNCT
chd-224	509	16	fortmann	fortmann	PROPN
chd-224	509	17	,	,	PUNCT
chd-224	509	18	s.p	s.p	PROPN
chd-224	509	19	.	.	PROPN
chd-224	509	20	,	,	PUNCT
chd-224	509	21	and	and	CCONJ
chd-224	509	22	lauderdale	lauderdale	PROPN
chd-224	509	23	,	,	PUNCT
chd-224	509	24	d.s	d.s	PROPN
chd-224	509	25	.	.	PROPN
chd-224	509	26	(	(	PUNCT
chd-224	509	27	2011	2011	NUM
chd-224	509	28	)	)	PUNCT
chd-224	509	29	.	.	PUNCT
chd-224	510	1	asian	asian	PROPN
chd-224	510	2	americans	americans	PROPN
chd-224	510	3	have	have	VERB
chd-224	510	4	greater	great	ADJ
chd-224	510	5	prevalence	prevalence	NOUN
chd-224	510	6	of	of	ADP
chd-224	510	7	metabolic	metabolic	NOUN
chd-224	510	8	syndrome	syndrome	NOUN
chd-224	510	9	despite	despite	SCONJ
chd-224	510	10	lower	low	ADJ
chd-224	510	11	body	body	NOUN
chd-224	510	12	mass	mass	NOUN
chd-224	510	13	index	index	NOUN
chd-224	510	14	.	.	PUNCT
chd-224	511	1	int	int	PROPN
chd-224	511	2	j	j	PROPN
chd-224	511	3	obes	obes	PROPN
chd-224	511	4	(	(	PUNCT
chd-224	511	5	lond	lond	ADJ
chd-224	511	6	)	)	PUNCT
chd-224	511	7	35	35	NUM
chd-224	511	8	,	,	PUNCT
chd-224	511	9	393	393	NUM
chd-224	511	10	-	-	SYM
chd-224	511	11	400	400	NUM
chd-224	511	12	.	.	PUNCT
chd-224	512	1	pasqual	pasqual	PROPN
chd-224	512	2	,	,	PUNCT
chd-224	512	3	e.a.-o	e.a.-o	PROPN
chd-224	512	4	.	.	PROPN
chd-224	512	5	,	,	PUNCT
chd-224	512	6	schonfeld	schonfeld	PROPN
chd-224	512	7	,	,	PUNCT
chd-224	512	8	s.a.-o	s.a.-o	NOUN
chd-224	512	9	.	.	PROPN
chd-224	512	10	,	,	PUNCT
chd-224	512	11	morton	morton	PROPN
chd-224	512	12	,	,	PUNCT
chd-224	512	13	l.a.-o	l.a.-o	PROPN
chd-224	512	14	.	.	PROPN
chd-224	512	15	,	,	PUNCT
chd-224	512	16	villoing	villoing	NOUN
chd-224	512	17	,	,	PUNCT
chd-224	512	18	d.a.-o	d.a.-o	PROPN
chd-224	512	19	.	.	PROPN
chd-224	512	20	,	,	PUNCT
chd-224	512	21	lee	lee	PROPN
chd-224	512	22	,	,	PUNCT
chd-224	512	23	c.a.-o	c.a.-o	PROPN
chd-224	512	24	.	.	PROPN
chd-224	512	25	,	,	PUNCT
chd-224	512	26	berrington	berrington	PROPN
chd-224	512	27	de	de	PROPN
chd-224	512	28	gonzalez	gonzalez	PROPN
chd-224	512	29	,	,	PUNCT
chd-224	512	30	a.a.-o	a.a.-o	NOUN
chd-224	512	31	.	.	PUNCT
chd-224	512	32	,	,	PUNCT
chd-224	512	33	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-224	512	34	e19	e19	VERB
chd-224	512	35	cancer	cancer	NOUN
chd-224	512	36	health	health	NOUN
chd-224	512	37	disparities	disparity	NOUN
chd-224	512	38	research	research	NOUN
chd-224	512	39	and	and	CCONJ
chd-224	512	40	kitahara	kitahara	NOUN
chd-224	512	41	,	,	PUNCT
chd-224	512	42	c.a.-o	c.a.-o	PROPN
chd-224	512	43	.	.	PUNCT
chd-224	513	1	association	association	NOUN
chd-224	513	2	between	between	ADP
chd-224	513	3	radioactive	radioactive	ADJ
chd-224	513	4	iodine	iodine	NOUN
chd-224	513	5	treatment	treatment	NOUN
chd-224	513	6	for	for	ADP
chd-224	513	7	pediatric	pediatric	ADJ
chd-224	513	8	and	and	CCONJ
chd-224	513	9	young	young	ADJ
chd-224	513	10	adulthood	adulthood	NOUN
chd-224	513	11	differentiated	differentiate	VERB
chd-224	513	12	thyroid	thyroid	NOUN
chd-224	513	13	cancer	cancer	NOUN
chd-224	513	14	and	and	CCONJ
chd-224	513	15	risk	risk	NOUN
chd-224	513	16	of	of	ADP
chd-224	513	17	second	second	ADJ
chd-224	513	18	primary	primary	ADJ
chd-224	513	19	malignancies	malignancy	NOUN
chd-224	513	20	.	.	PUNCT
chd-224	514	1	prete	prete	PROPN
chd-224	514	2	,	,	PUNCT
chd-224	514	3	a.	a.	PROPN
chd-224	514	4	,	,	PUNCT
chd-224	514	5	borges	borges	PROPN
chd-224	514	6	de	de	PROPN
chd-224	514	7	souza	souza	PROPN
chd-224	514	8	,	,	PUNCT
chd-224	514	9	p.	p.	NOUN
chd-224	514	10	,	,	PUNCT
chd-224	514	11	censi	censi	PROPN
chd-224	514	12	,	,	PUNCT
chd-224	514	13	s.	s.	PROPN
chd-224	514	14	,	,	PUNCT
chd-224	514	15	muzza	muzza	PROPN
chd-224	514	16	,	,	PUNCT
chd-224	514	17	m.	m.	NOUN
chd-224	514	18	,	,	PUNCT
chd-224	514	19	nucci	nucci	ADV
chd-224	514	20	,	,	PUNCT
chd-224	514	21	n.	n.	NOUN
chd-224	514	22	,	,	PUNCT
chd-224	514	23	and	and	CCONJ
chd-224	514	24	sponziello	sponziello	PROPN
chd-224	514	25	,	,	PUNCT
chd-224	514	26	m.	m.	NOUN
chd-224	514	27	(	(	PUNCT
chd-224	514	28	2020	2020	NUM
chd-224	514	29	)	)	PUNCT
chd-224	514	30	.	.	PUNCT
chd-224	515	1	update	update	NOUN
chd-224	515	2	on	on	ADP
chd-224	515	3	fundamental	fundamental	ADJ
chd-224	515	4	mechanisms	mechanism	NOUN
chd-224	515	5	of	of	ADP
chd-224	515	6	thyroid	thyroid	NOUN
chd-224	515	7	cancer	cancer	NOUN
chd-224	515	8	.	.	PUNCT
chd-224	516	1	front	front	ADJ
chd-224	516	2	endocrinol	endocrinol	NOUN
chd-224	516	3	(	(	PUNCT
chd-224	516	4	lausanne	lausanne	PROPN
chd-224	516	5	)	)	PUNCT
chd-224	516	6	11	11	NUM
chd-224	516	7	,	,	PUNCT
chd-224	516	8	102	102	NUM
chd-224	516	9	.	.	PUNCT
chd-224	517	1	rahbari	rahbari	PROPN
chd-224	517	2	,	,	PUNCT
chd-224	517	3	r.	r.	PROPN
chd-224	517	4	,	,	PUNCT
chd-224	517	5	zhang	zhang	PROPN
chd-224	517	6	,	,	PUNCT
chd-224	517	7	l.	l.	PROPN
chd-224	517	8	,	,	PUNCT
chd-224	517	9	and	and	CCONJ
chd-224	517	10	kebebew	kebebew	PROPN
chd-224	517	11	,	,	PUNCT
chd-224	517	12	e.	e.	PROPN
chd-224	517	13	(	(	PUNCT
chd-224	517	14	2010	2010	NUM
chd-224	517	15	)	)	PUNCT
chd-224	517	16	.	.	PUNCT
chd-224	518	1	thyroid	thyroid	NOUN
chd-224	518	2	cancer	cancer	NOUN
chd-224	518	3	gender	gender	NOUN
chd-224	518	4	disparity	disparity	NOUN
chd-224	518	5	.	.	PUNCT
chd-224	519	1	future	future	ADJ
chd-224	519	2	oncology	oncology	NOUN
chd-224	519	3	(	(	PUNCT
chd-224	519	4	london	london	PROPN
chd-224	519	5	,	,	PUNCT
chd-224	519	6	england	england	PROPN
chd-224	519	7	)	)	PUNCT
chd-224	519	8	6	6	NUM
chd-224	519	9	,	,	PUNCT
chd-224	519	10	1771	1771	NUM
chd-224	519	11	-	-	SYM
chd-224	519	12	1779	1779	NUM
chd-224	519	13	.	.	PUNCT
chd-224	520	1	rahib	rahib	NOUN
chd-224	520	2	,	,	PUNCT
chd-224	520	3	l.	l.	PROPN
chd-224	520	4	,	,	PUNCT
chd-224	520	5	smith	smith	PROPN
chd-224	520	6	,	,	PUNCT
chd-224	520	7	b.d	b.d	PROPN
chd-224	520	8	.	.	PROPN
chd-224	520	9	,	,	PUNCT
chd-224	520	10	aizenberg	aizenberg	PROPN
chd-224	520	11	,	,	PUNCT
chd-224	520	12	r.	r.	PROPN
chd-224	520	13	,	,	PUNCT
chd-224	520	14	rosenzweig	rosenzweig	PROPN
chd-224	520	15	,	,	PUNCT
chd-224	520	16	a.b	a.b	PROPN
chd-224	520	17	.	.	PROPN
chd-224	520	18	,	,	PUNCT
chd-224	520	19	fleshman	fleshman	NOUN
chd-224	520	20	,	,	PUNCT
chd-224	520	21	j.m	j.m	PROPN
chd-224	520	22	.	.	PROPN
chd-224	520	23	,	,	PUNCT
chd-224	520	24	and	and	CCONJ
chd-224	520	25	matrisian	matrisian	ADJ
chd-224	520	26	,	,	PUNCT
chd-224	520	27	l.m	l.m	PROPN
chd-224	520	28	.	.	PROPN
chd-224	520	29	(	(	PUNCT
chd-224	520	30	2014	2014	NUM
chd-224	520	31	)	)	PUNCT
chd-224	520	32	.	.	PUNCT
chd-224	521	1	projecting	project	VERB
chd-224	521	2	cancer	cancer	NOUN
chd-224	521	3	incidence	incidence	NOUN
chd-224	521	4	and	and	CCONJ
chd-224	521	5	deaths	death	NOUN
chd-224	521	6	to	to	ADP
chd-224	521	7	2030	2030	NUM
chd-224	521	8	:	:	PUNCT
chd-224	521	9	the	the	DET
chd-224	521	10	unexpected	unexpected	ADJ
chd-224	521	11	burden	burden	NOUN
chd-224	521	12	of	of	ADP
chd-224	521	13	thyroid	thyroid	NOUN
chd-224	521	14	,	,	PUNCT
chd-224	521	15	liver	liver	NOUN
chd-224	521	16	,	,	PUNCT
chd-224	521	17	and	and	CCONJ
chd-224	521	18	pancreas	pancreas	NOUN
chd-224	521	19	cancers	cancer	NOUN
chd-224	521	20	in	in	ADP
chd-224	521	21	the	the	DET
chd-224	521	22	united	united	PROPN
chd-224	521	23	states	states	PROPN
chd-224	521	24	.	.	PUNCT
chd-224	522	1	cancer	cancer	NOUN
chd-224	522	2	research	research	NOUN
chd-224	522	3	74	74	NUM
chd-224	522	4	,	,	PUNCT
chd-224	522	5	2913	2913	NUM
chd-224	522	6	-	-	SYM
chd-224	522	7	2921	2921	NUM
chd-224	522	8	.	.	PUNCT
chd-224	523	1	reitzel	reitzel	ADJ
chd-224	523	2	,	,	PUNCT
chd-224	523	3	l.r	l.r	PROPN
chd-224	523	4	.	.	PROPN
chd-224	523	5	,	,	PUNCT
chd-224	523	6	nguyen	nguyen	PROPN
chd-224	523	7	,	,	PUNCT
chd-224	523	8	n.	n.	PROPN
chd-224	523	9	,	,	PUNCT
chd-224	523	10	li	li	PROPN
chd-224	523	11	,	,	PUNCT
chd-224	523	12	n.	n.	PROPN
chd-224	523	13	,	,	PUNCT
chd-224	523	14	xu	xu	PROPN
chd-224	523	15	,	,	PUNCT
chd-224	523	16	l.	l.	PROPN
chd-224	523	17	,	,	PUNCT
chd-224	523	18	regan	regan	PROPN
chd-224	523	19	,	,	PUNCT
chd-224	523	20	s.d	s.d	PROPN
chd-224	523	21	.	.	PROPN
chd-224	523	22	,	,	PUNCT
chd-224	523	23	and	and	CCONJ
chd-224	523	24	sturgis	sturgis	PROPN
chd-224	523	25	,	,	PUNCT
chd-224	523	26	e.m	e.m	PROPN
chd-224	523	27	.	.	PROPN
chd-224	523	28	(	(	PUNCT
chd-224	523	29	2014	2014	NUM
chd-224	523	30	)	)	PUNCT
chd-224	523	31	.	.	PUNCT
chd-224	524	1	trends	trend	NOUN
chd-224	524	2	in	in	ADP
chd-224	524	3	thyroid	thyroid	NOUN
chd-224	524	4	cancer	cancer	NOUN
chd-224	524	5	incidence	incidence	NOUN
chd-224	524	6	in	in	ADP
chd-224	524	7	texas	texas	PROPN
chd-224	524	8	from	from	ADP
chd-224	524	9	1995	1995	NUM
chd-224	524	10	to	to	ADP
chd-224	524	11	2008	2008	NUM
chd-224	524	12	by	by	ADP
chd-224	524	13	socioeconomic	socioeconomic	ADJ
chd-224	524	14	status	status	NOUN
chd-224	524	15	and	and	CCONJ
chd-224	524	16	race	race	NOUN
chd-224	524	17	/	/	SYM
chd-224	524	18	ethnicity	ethnicity	NOUN
chd-224	524	19	.	.	PUNCT
chd-224	525	1	thyroid	thyroid	PROPN
chd-224	525	2	24	24	NUM
chd-224	525	3	,	,	PUNCT
chd-224	525	4	556	556	NUM
chd-224	525	5	-	-	SYM
chd-224	525	6	567	567	NUM
chd-224	525	7	.	.	PUNCT
chd-224	526	1	roche	roche	PROPN
chd-224	526	2	,	,	PUNCT
chd-224	526	3	a.m.	a.m.	ADV
chd-224	526	4	,	,	PUNCT
chd-224	526	5	fedewa	fedewa	PROPN
chd-224	526	6	,	,	PUNCT
chd-224	526	7	s.a	s.a	PROPN
chd-224	526	8	.	.	PROPN
chd-224	526	9	,	,	PUNCT
chd-224	526	10	and	and	CCONJ
chd-224	526	11	chen	chen	PROPN
chd-224	526	12	,	,	PUNCT
chd-224	526	13	a.y	a.y	PROPN
chd-224	526	14	.	.	PROPN
chd-224	527	1	(	(	PUNCT
chd-224	527	2	2016	2016	NUM
chd-224	527	3	)	)	PUNCT
chd-224	527	4	.	.	PUNCT
chd-224	528	1	association	association	NOUN
chd-224	528	2	of	of	ADP
chd-224	528	3	socioeconomic	socioeconomic	ADJ
chd-224	528	4	status	status	NOUN
chd-224	528	5	and	and	CCONJ
chd-224	528	6	race	race	NOUN
chd-224	528	7	/	/	SYM
chd-224	528	8	ethnicity	ethnicity	NOUN
chd-224	528	9	with	with	ADP
chd-224	528	10	treatment	treatment	NOUN
chd-224	528	11	and	and	CCONJ
chd-224	528	12	survival	survival	NOUN
chd-224	528	13	in	in	ADP
chd-224	528	14	patients	patient	NOUN
chd-224	528	15	with	with	ADP
chd-224	528	16	medullary	medullary	ADJ
chd-224	528	17	thyroid	thyroid	NOUN
chd-224	528	18	cancer	cancer	NOUN
chd-224	528	19	.	.	PUNCT
chd-224	529	1	jama	jama	PROPN
chd-224	529	2	otolaryngol	otolaryngol	PROPN
chd-224	529	3	head	head	NOUN
chd-224	529	4	neck	neck	NOUN
chd-224	529	5	surg	surg	NOUN
chd-224	529	6	142	142	NUM
chd-224	529	7	,	,	PUNCT
chd-224	529	8	763	763	NUM
chd-224	529	9	-	-	SYM
chd-224	529	10	771	771	NUM
chd-224	529	11	.	.	PUNCT
chd-224	530	1	rohrmann	rohrmann	PROPN
chd-224	530	2	,	,	PUNCT
chd-224	530	3	s.	s.	PROPN
chd-224	530	4	,	,	PUNCT
chd-224	530	5	nelson	nelson	PROPN
chd-224	530	6	,	,	PUNCT
chd-224	530	7	w.g	w.g	PROPN
chd-224	530	8	.	.	PROPN
chd-224	530	9	,	,	PUNCT
chd-224	530	10	rifai	rifai	PROPN
chd-224	530	11	,	,	PUNCT
chd-224	530	12	n.	n.	NOUN
chd-224	530	13	,	,	PUNCT
chd-224	530	14	brown	brown	PROPN
chd-224	530	15	,	,	PUNCT
chd-224	530	16	t.r	t.r	PROPN
chd-224	530	17	.	.	PROPN
chd-224	530	18	,	,	PUNCT
chd-224	530	19	dobs	dobs	PROPN
chd-224	530	20	,	,	PUNCT
chd-224	530	21	a.	a.	NOUN
chd-224	530	22	,	,	PUNCT
chd-224	530	23	kanarek	kanarek	PROPN
chd-224	530	24	,	,	PUNCT
chd-224	530	25	n.	n.	NOUN
chd-224	530	26	,	,	PUNCT
chd-224	530	27	yager	yager	NOUN
chd-224	530	28	,	,	PUNCT
chd-224	530	29	j.d	j.d	PROPN
chd-224	530	30	.	.	PROPN
chd-224	530	31	,	,	PUNCT
chd-224	530	32	and	and	CCONJ
chd-224	530	33	platz	platz	PROPN
chd-224	530	34	,	,	PUNCT
chd-224	530	35	e.a	e.a	PROPN
chd-224	530	36	.	.	PROPN
chd-224	530	37	(	(	PUNCT
chd-224	530	38	2007	2007	NUM
chd-224	530	39	)	)	PUNCT
chd-224	530	40	.	.	PUNCT
chd-224	531	1	serum	serum	NOUN
chd-224	531	2	estrogen	estrogen	PROPN
chd-224	531	3	,	,	PUNCT
chd-224	531	4	but	but	CCONJ
chd-224	531	5	not	not	PART
chd-224	531	6	testosterone	testosterone	NOUN
chd-224	531	7	,	,	PUNCT
chd-224	531	8	levels	level	NOUN
chd-224	531	9	differ	differ	VERB
chd-224	531	10	between	between	ADP
chd-224	531	11	black	black	ADJ
chd-224	531	12	and	and	CCONJ
chd-224	531	13	white	white	ADJ
chd-224	531	14	men	man	NOUN
chd-224	531	15	in	in	ADP
chd-224	531	16	a	a	DET
chd-224	531	17	nationally	nationally	ADV
chd-224	531	18	representative	representative	ADJ
chd-224	531	19	sample	sample	NOUN
chd-224	531	20	of	of	ADP
chd-224	531	21	americans	americans	PROPN
chd-224	531	22	.	.	PUNCT
chd-224	532	1	j	j	PROPN
chd-224	532	2	clin	clin	PROPN
chd-224	532	3	endocrinol	endocrinol	PROPN
chd-224	532	4	metab	metab	NOUN
chd-224	532	5	92	92	NUM
chd-224	532	6	,	,	PUNCT
chd-224	532	7	2519	2519	NUM
chd-224	532	8	-	-	SYM
chd-224	532	9	2525	2525	NUM
chd-224	532	10	.	.	PUNCT
chd-224	533	1	rood	rood	PROPN
chd-224	533	2	,	,	PUNCT
chd-224	533	3	k.	k.	PROPN
chd-224	533	4	,	,	PUNCT
chd-224	533	5	begum	begum	PROPN
chd-224	533	6	,	,	PUNCT
chd-224	533	7	k.	k.	PROPN
chd-224	533	8	,	,	PUNCT
chd-224	533	9	wang	wang	PROPN
chd-224	533	10	,	,	PUNCT
chd-224	533	11	h.	h.	PROPN
chd-224	533	12	,	,	PUNCT
chd-224	533	13	wangworawat	wangworawat	PROPN
chd-224	533	14	,	,	PUNCT
chd-224	533	15	y.c	y.c	PROPN
chd-224	533	16	.	.	PROPN
chd-224	533	17	,	,	PUNCT
chd-224	533	18	davis	davis	PROPN
chd-224	533	19	,	,	PUNCT
chd-224	533	20	r.	r.	PROPN
chd-224	533	21	,	,	PUNCT
chd-224	533	22	yamauchi	yamauchi	PROPN
chd-224	533	23	,	,	PUNCT
chd-224	533	24	c.r	c.r	PROPN
chd-224	533	25	.	.	PROPN
chd-224	533	26	,	,	PUNCT
chd-224	533	27	perez	perez	PROPN
chd-224	533	28	,	,	PUNCT
chd-224	533	29	m.c	m.c	PROPN
chd-224	533	30	.	.	PROPN
chd-224	533	31	,	,	PUNCT
chd-224	533	32	simental	simental	PROPN
chd-224	533	33	,	,	PUNCT
chd-224	533	34	a.a	a.a	PROPN
chd-224	533	35	.	.	PROPN
chd-224	533	36	,	,	PUNCT
chd-224	533	37	laxa	laxa	PROPN
chd-224	533	38	,	,	PUNCT
chd-224	533	39	r.t	r.t	PROPN
chd-224	533	40	.	.	PROPN
chd-224	533	41	,	,	PUNCT
chd-224	533	42	wang	wang	PROPN
chd-224	533	43	,	,	PUNCT
chd-224	533	44	c.	c.	PROPN
chd-224	533	45	,	,	PUNCT
chd-224	533	46	et	et	PROPN
chd-224	533	47	al	al	PROPN
chd-224	533	48	.	.	PROPN
chd-224	533	49	(	(	PUNCT
chd-224	533	50	2021	2021	NUM
chd-224	533	51	)	)	PUNCT
chd-224	533	52	.	.	PUNCT
chd-224	534	1	differential	differential	ADJ
chd-224	534	2	expression	expression	NOUN
chd-224	534	3	of	of	ADP
chd-224	534	4	noncoding	noncode	VERB
chd-224	534	5	rna	rna	NOUN
chd-224	534	6	signatures	signature	NOUN
chd-224	534	7	in	in	ADP
chd-224	534	8	thyroid	thyroid	NOUN
chd-224	534	9	cancer	cancer	NOUN
chd-224	534	10	between	between	ADP
chd-224	534	11	two	two	NUM
chd-224	534	12	ethnic	ethnic	ADJ
chd-224	534	13	groups	group	NOUN
chd-224	534	14	.	.	PUNCT
chd-224	535	1	28	28	NUM
chd-224	535	2	,	,	PUNCT
chd-224	535	3	3610	3610	NUM
chd-224	535	4	-	-	SYM
chd-224	535	5	3628	3628	NUM
chd-224	535	6	.	.	PUNCT
chd-224	536	1	sahar	sahar	PROPN
chd-224	536	2	,	,	PUNCT
chd-224	536	3	l.	l.	PROPN
chd-224	536	4	,	,	PUNCT
chd-224	536	5	foster	foster	PROPN
chd-224	536	6	,	,	PUNCT
chd-224	536	7	s.l	s.l	PROPN
chd-224	536	8	.	.	PROPN
chd-224	536	9	,	,	PUNCT
chd-224	536	10	sherman	sherman	PROPN
chd-224	536	11	,	,	PUNCT
chd-224	536	12	r.l	r.l	PROPN
chd-224	536	13	.	.	PROPN
chd-224	536	14	,	,	PUNCT
chd-224	536	15	henry	henry	PROPN
chd-224	536	16	,	,	PUNCT
chd-224	536	17	k.a	k.a	PROPN
chd-224	536	18	.	.	PROPN
chd-224	536	19	,	,	PUNCT
chd-224	536	20	goldberg	goldberg	PROPN
chd-224	536	21	,	,	PUNCT
chd-224	536	22	d.w	d.w	PROPN
chd-224	536	23	.	.	PROPN
chd-224	536	24	,	,	PUNCT
chd-224	536	25	stinchcomb	stinchcomb	PROPN
chd-224	536	26	,	,	PUNCT
chd-224	536	27	d.g	d.g	PROPN
chd-224	536	28	.	.	PROPN
chd-224	536	29	,	,	PUNCT
chd-224	536	30	and	and	CCONJ
chd-224	536	31	bauer	bauer	PROPN
chd-224	536	32	,	,	PUNCT
chd-224	536	33	j.e	j.e	PROPN
chd-224	536	34	.	.	PROPN
chd-224	536	35	(	(	PUNCT
chd-224	536	36	2019	2019	NUM
chd-224	536	37	)	)	PUNCT
chd-224	536	38	.	.	PUNCT
chd-224	537	1	giscience	giscience	NOUN
chd-224	537	2	and	and	CCONJ
chd-224	537	3	cancer	cancer	NOUN
chd-224	537	4	:	:	PUNCT
chd-224	537	5	state	state	NOUN
chd-224	537	6	of	of	ADP
chd-224	537	7	the	the	DET
chd-224	537	8	art	art	NOUN
chd-224	537	9	and	and	CCONJ
chd-224	537	10	trends	trend	NOUN
chd-224	537	11	for	for	ADP
chd-224	537	12	cancer	cancer	NOUN
chd-224	537	13	surveillance	surveillance	NOUN
chd-224	537	14	and	and	CCONJ
chd-224	537	15	epidemiology	epidemiology	NOUN
chd-224	537	16	.	.	PUNCT
chd-224	538	1	cancer	cancer	NOUN
chd-224	538	2	125	125	NUM
chd-224	538	3	,	,	PUNCT
chd-224	538	4	2544	2544	NUM
chd-224	538	5	-	-	SYM
chd-224	538	6	2560	2560	NUM
chd-224	538	7	.	.	PUNCT
chd-224	538	8	said	say	VERB
chd-224	538	9	abasse	abasse	PROPN
chd-224	538	10	,	,	PUNCT
chd-224	538	11	k.	k.	PROPN
chd-224	538	12	,	,	PUNCT
chd-224	538	13	essien	essien	PROPN
chd-224	538	14	,	,	PUNCT
chd-224	538	15	e.e	e.e	PROPN
chd-224	538	16	.	.	PROPN
chd-224	538	17	,	,	PUNCT
chd-224	538	18	abbas	abbas	PROPN
chd-224	538	19	,	,	PUNCT
chd-224	538	20	m.	m.	NOUN
chd-224	538	21	,	,	PUNCT
chd-224	538	22	yu	yu	PROPN
chd-224	538	23	,	,	PUNCT
chd-224	538	24	x.	x.	PROPN
chd-224	538	25	,	,	PUNCT
chd-224	538	26	xie	xie	PROPN
chd-224	538	27	,	,	PUNCT
chd-224	538	28	w.	w.	PROPN
chd-224	538	29	,	,	PUNCT
chd-224	538	30	sun	sun	PROPN
chd-224	538	31	,	,	PUNCT
chd-224	538	32	j.	j.	PROPN
chd-224	538	33	,	,	PUNCT
chd-224	538	34	akter	akter	PROPN
chd-224	538	35	,	,	PUNCT
chd-224	538	36	l.	l.	PROPN
chd-224	538	37	,	,	PUNCT
chd-224	538	38	and	and	CCONJ
chd-224	538	39	cote	cote	X
chd-224	538	40	,	,	PUNCT
chd-224	538	41	a.	a.	NOUN
chd-224	538	42	(	(	PUNCT
chd-224	538	43	2022	2022	NUM
chd-224	538	44	)	)	PUNCT
chd-224	538	45	.	.	PUNCT
chd-224	539	1	association	association	NOUN
chd-224	539	2	between	between	ADP
chd-224	539	3	dietary	dietary	ADJ
chd-224	539	4	nitrate	nitrate	NOUN
chd-224	539	5	,	,	PUNCT
chd-224	539	6	nitrite	nitrite	NOUN
chd-224	539	7	intake	intake	NOUN
chd-224	539	8	,	,	PUNCT
chd-224	539	9	and	and	CCONJ
chd-224	539	10	site	site	NOUN
chd-224	539	11	-	-	PUNCT
chd-224	539	12	specific	specific	ADJ
chd-224	539	13	cancer	cancer	NOUN
chd-224	539	14	risk	risk	NOUN
chd-224	539	15	:	:	PUNCT
chd-224	539	16	a	a	DET
chd-224	539	17	systematic	systematic	ADJ
chd-224	539	18	review	review	NOUN
chd-224	539	19	and	and	CCONJ
chd-224	539	20	meta	meta	ADJ
chd-224	539	21	-	-	PUNCT
chd-224	539	22	analysis	analysis	NOUN
chd-224	539	23	.	.	PUNCT
chd-224	540	1	nutrients	nutrient	NOUN
chd-224	540	2	14	14	NUM
chd-224	540	3	.	.	PUNCT
chd-224	540	4	satia	satia	PROPN
chd-224	540	5	,	,	PUNCT
chd-224	540	6	j.a	j.a	PROPN
chd-224	540	7	.	.	PROPN
chd-224	540	8	(	(	PUNCT
chd-224	540	9	2009	2009	NUM
chd-224	540	10	)	)	PUNCT
chd-224	540	11	.	.	PUNCT
chd-224	541	1	diet	diet	NOUN
chd-224	541	2	-	-	PUNCT
chd-224	541	3	related	relate	VERB
chd-224	541	4	disparities	disparity	NOUN
chd-224	541	5	:	:	PUNCT
chd-224	541	6	understanding	understand	VERB
chd-224	541	7	the	the	DET
chd-224	541	8	problem	problem	NOUN
chd-224	541	9	and	and	CCONJ
chd-224	541	10	accelerating	accelerate	VERB
chd-224	541	11	solutions	solution	NOUN
chd-224	541	12	.	.	PUNCT
chd-224	542	1	j	j	PROPN
chd-224	542	2	am	be	AUX
chd-224	542	3	diet	diet	PROPN
chd-224	542	4	assoc	assoc	PROPN
chd-224	542	5	109	109	NUM
chd-224	542	6	,	,	PUNCT
chd-224	542	7	610	610	NUM
chd-224	542	8	-	-	SYM
chd-224	542	9	615	615	NUM
chd-224	542	10	.	.	PUNCT
chd-224	543	1	schwartz	schwartz	PROPN
chd-224	543	2	,	,	PUNCT
chd-224	543	3	g.g	g.g	PROPN
chd-224	543	4	.	.	PROPN
chd-224	543	5	,	,	PUNCT
chd-224	543	6	and	and	CCONJ
chd-224	543	7	klug	klug	PROPN
chd-224	543	8	,	,	PUNCT
chd-224	543	9	m.g	m.g	PROPN
chd-224	543	10	.	.	PROPN
chd-224	543	11	(	(	PUNCT
chd-224	543	12	2019	2019	NUM
chd-224	543	13	)	)	PUNCT
chd-224	543	14	.	.	PUNCT
chd-224	544	1	thyroid	thyroid	NOUN
chd-224	544	2	cancer	cancer	NOUN
chd-224	544	3	incidence	incidence	NOUN
chd-224	544	4	rates	rate	NOUN
chd-224	544	5	in	in	ADP
chd-224	544	6	north	north	PROPN
chd-224	544	7	dakota	dakota	PROPN
chd-224	544	8	are	be	AUX
chd-224	544	9	associated	associate	VERB
chd-224	544	10	with	with	ADP
chd-224	544	11	land	land	NOUN
chd-224	544	12	and	and	CCONJ
chd-224	544	13	water	water	NOUN
chd-224	544	14	use	use	NOUN
chd-224	544	15	.	.	PUNCT
chd-224	545	1	int	int	PROPN
chd-224	546	1	j	j	PROPN
chd-224	546	2	environ	environ	PROPN
chd-224	546	3	res	res	PROPN
chd-224	546	4	public	public	ADJ
chd-224	546	5	health	health	NOUN
chd-224	546	6	16	16	NUM
chd-224	546	7	.	.	PUNCT
chd-224	547	1	shobab	shobab	PROPN
chd-224	547	2	,	,	PUNCT
chd-224	547	3	l.	l.	PROPN
chd-224	547	4	,	,	PUNCT
chd-224	547	5	gomes	gomes	PROPN
chd-224	547	6	-	-	PUNCT
chd-224	547	7	lima	lima	PROPN
chd-224	547	8	,	,	PUNCT
chd-224	547	9	c.	c.	NOUN
chd-224	547	10	,	,	PUNCT
chd-224	547	11	zeymo	zeymo	PROPN
chd-224	547	12	,	,	PUNCT
chd-224	547	13	a.	a.	NOUN
chd-224	547	14	,	,	PUNCT
chd-224	547	15	feldman	feldman	PROPN
chd-224	547	16	,	,	PUNCT
chd-224	547	17	r.	r.	PROPN
chd-224	547	18	,	,	PUNCT
chd-224	547	19	jonklaas	jonklaas	NOUN
chd-224	547	20	,	,	PUNCT
chd-224	547	21	j.	j.	PROPN
chd-224	547	22	,	,	PUNCT
chd-224	547	23	wartofsky	wartofsky	PROPN
chd-224	547	24	,	,	PUNCT
chd-224	547	25	l.	l.	PROPN
chd-224	547	26	,	,	PUNCT
chd-224	547	27	and	and	CCONJ
chd-224	547	28	burman	burman	NOUN
chd-224	547	29	,	,	PUNCT
chd-224	547	30	k.d	k.d	PROPN
chd-224	547	31	.	.	PROPN
chd-224	548	1	(	(	PUNCT
chd-224	548	2	2019	2019	NUM
chd-224	548	3	)	)	PUNCT
chd-224	548	4	.	.	PUNCT
chd-224	549	1	clinical	clinical	ADJ
chd-224	549	2	,	,	PUNCT
chd-224	549	3	pathological	pathological	ADJ
chd-224	549	4	,	,	PUNCT
chd-224	549	5	and	and	CCONJ
chd-224	549	6	molecular	molecular	ADJ
chd-224	549	7	profiling	profiling	NOUN
chd-224	549	8	of	of	ADP
chd-224	549	9	radioactive	radioactive	ADJ
chd-224	549	10	iodine	iodine	NOUN
chd-224	549	11	refractory	refractory	NOUN
chd-224	549	12	differentiated	differentiate	VERB
chd-224	549	13	thyroid	thyroid	NOUN
chd-224	549	14	cancer	cancer	NOUN
chd-224	549	15	.	.	PUNCT
chd-224	550	1	thyroid	thyroid	NOUN
chd-224	550	2	29	29	NUM
chd-224	550	3	,	,	PUNCT
chd-224	550	4	1262	1262	NUM
chd-224	550	5	-	-	SYM
chd-224	550	6	1268	1268	NUM
chd-224	550	7	.	.	PUNCT
chd-224	551	1	sickles	sickle	NOUN
chd-224	551	2	,	,	PUNCT
chd-224	551	3	c.k	c.k	PROPN
chd-224	551	4	.	.	PROPN
chd-224	551	5	,	,	PUNCT
chd-224	551	6	and	and	CCONJ
chd-224	551	7	gross	gross	ADJ
chd-224	551	8	,	,	PUNCT
chd-224	551	9	g.p	g.p	PROPN
chd-224	551	10	.	.	PROPN
chd-224	551	11	(	(	PUNCT
chd-224	551	12	2022	2022	NUM
chd-224	551	13	)	)	PUNCT
chd-224	551	14	.	.	PUNCT
chd-224	552	1	progeria	progeria	NOUN
chd-224	552	2	.	.	PUNCT
chd-224	553	1	in	in	ADP
chd-224	553	2	statpearls	statpearl	NOUN
chd-224	553	3	(	(	PUNCT
chd-224	553	4	treasure	treasure	NOUN
chd-224	553	5	island	island	NOUN
chd-224	553	6	(	(	PUNCT
chd-224	553	7	fl	fl	PROPN
chd-224	553	8	):	):	PUNCT
chd-224	553	9	statpearls	statpearl	NOUN
chd-224	553	10	publishing	publish	VERB
chd-224	553	11	copyright	copyright	NOUN
chd-224	553	12	©	©	PROPN
chd-224	553	13	2022	2022	NUM
chd-224	553	14	,	,	PUNCT
chd-224	553	15	statpearls	statpearls	PROPN
chd-224	553	16	publishing	publishing	PROPN
chd-224	553	17	llc	llc	PROPN
chd-224	553	18	.	.	PUNCT
chd-224	553	19	)	)	PUNCT
chd-224	553	20	.	.	PUNCT
chd-224	554	1	singh	singh	PROPN
chd-224	554	2	,	,	PUNCT
chd-224	554	3	a.	a.	NOUN
chd-224	554	4	,	,	PUNCT
chd-224	554	5	ham	ham	PROPN
chd-224	554	6	,	,	PUNCT
chd-224	554	7	j.	j.	PROPN
chd-224	554	8	,	,	PUNCT
chd-224	554	9	po	po	PROPN
chd-224	554	10	,	,	PUNCT
chd-224	554	11	j.w	j.w	PROPN
chd-224	554	12	.	.	PROPN
chd-224	554	13	,	,	PUNCT
chd-224	554	14	niles	nile	NOUN
chd-224	554	15	,	,	PUNCT
chd-224	554	16	n.	n.	PROPN
chd-224	554	17	,	,	PUNCT
chd-224	554	18	roberts	roberts	PROPN
chd-224	554	19	,	,	PUNCT
chd-224	554	20	t.	t.	PROPN
chd-224	554	21	,	,	PUNCT
chd-224	554	22	and	and	CCONJ
chd-224	554	23	lee	lee	PROPN
chd-224	554	24	,	,	PUNCT
chd-224	554	25	c.s	c.s	PROPN
chd-224	554	26	.	.	PROPN
chd-224	554	27	(	(	PUNCT
chd-224	554	28	2021	2021	NUM
chd-224	554	29	)	)	PUNCT
chd-224	554	30	.	.	PUNCT
chd-224	555	1	the	the	DET
chd-224	555	2	genomic	genomic	ADJ
chd-224	555	3	landscape	landscape	NOUN
chd-224	555	4	of	of	ADP
chd-224	555	5	thyroid	thyroid	NOUN
chd-224	555	6	cancer	cancer	NOUN
chd-224	555	7	tumourigenesis	tumourigenesis	NOUN
chd-224	555	8	and	and	CCONJ
chd-224	555	9	implications	implication	NOUN
chd-224	555	10	for	for	ADP
chd-224	555	11	immunotherapy	immunotherapy	NOUN
chd-224	555	12	.	.	PUNCT
chd-224	556	1	cells	cell	NOUN
chd-224	556	2	10	10	NUM
chd-224	556	3	.	.	PUNCT
chd-224	557	1	stroup	stroup	PROPN
chd-224	557	2	,	,	PUNCT
chd-224	557	3	a.m.	a.m.	ADV
chd-224	557	4	,	,	PUNCT
chd-224	557	5	harrell	harrell	PROPN
chd-224	557	6	,	,	PUNCT
chd-224	557	7	c.j	c.j	PROPN
chd-224	557	8	.	.	PROPN
chd-224	557	9	,	,	PUNCT
chd-224	557	10	and	and	CCONJ
chd-224	557	11	herget	herget	NOUN
chd-224	557	12	,	,	PUNCT
chd-224	557	13	k.a	k.a	PROPN
chd-224	557	14	.	.	PROPN
chd-224	557	15	(	(	PUNCT
chd-224	557	16	2012	2012	NUM
chd-224	557	17	)	)	PUNCT
chd-224	557	18	.	.	PUNCT
chd-224	558	1	long	long	ADJ
chd-224	558	2	-	-	PUNCT
chd-224	558	3	term	term	NOUN
chd-224	558	4	survival	survival	NOUN
chd-224	558	5	in	in	ADP
chd-224	558	6	young	young	ADJ
chd-224	558	7	women	woman	NOUN
chd-224	558	8	:	:	PUNCT
chd-224	558	9	hazards	hazard	NOUN
chd-224	558	10	and	and	CCONJ
chd-224	558	11	competing	compete	VERB
chd-224	558	12	risks	risk	NOUN
chd-224	558	13	after	after	ADP
chd-224	558	14	thyroid	thyroid	NOUN
chd-224	558	15	cancer	cancer	NOUN
chd-224	558	16	.	.	PUNCT
chd-224	559	1	j	j	PROPN
chd-224	559	2	cancer	cancer	NOUN
chd-224	559	3	epidemiol	epidemiol	PROPN
chd-224	559	4	2012	2012	NUM
chd-224	559	5	,	,	PUNCT
chd-224	559	6	641372	641372	NUM
chd-224	559	7	.	.	PUNCT
chd-224	560	1	suresh	suresh	PROPN
chd-224	560	2	,	,	PUNCT
chd-224	560	3	r.	r.	PROPN
chd-224	560	4	,	,	PUNCT
chd-224	560	5	sethi	sethi	PROPN
chd-224	560	6	,	,	PUNCT
chd-224	560	7	s.	s.	PROPN
chd-224	560	8	,	,	PUNCT
chd-224	560	9	ali	ali	PROPN
chd-224	560	10	,	,	PUNCT
chd-224	560	11	s.	s.	PROPN
chd-224	560	12	,	,	PUNCT
chd-224	560	13	giorgadze	giorgadze	NOUN
chd-224	560	14	,	,	PUNCT
chd-224	560	15	t.	t.	PROPN
chd-224	560	16	,	,	PUNCT
chd-224	560	17	and	and	CCONJ
chd-224	560	18	sarkar	sarkar	PROPN
chd-224	560	19	,	,	PUNCT
chd-224	560	20	f.h	f.h	PROPN
chd-224	560	21	.	.	PROPN
chd-224	560	22	(	(	PUNCT
chd-224	560	23	2015	2015	NUM
chd-224	560	24	)	)	PUNCT
chd-224	560	25	.	.	PUNCT
chd-224	561	1	differential	differential	ADJ
chd-224	561	2	expression	expression	NOUN
chd-224	561	3	of	of	ADP
chd-224	561	4	micrornas	microrna	NOUN
chd-224	561	5	in	in	ADP
chd-224	561	6	papillary	papillary	ADJ
chd-224	561	7	thyroid	thyroid	NOUN
chd-224	561	8	carcinoma	carcinoma	NOUN
chd-224	561	9	and	and	CCONJ
chd-224	561	10	their	their	PRON
chd-224	561	11	role	role	NOUN
chd-224	561	12	in	in	ADP
chd-224	561	13	racial	racial	ADJ
chd-224	561	14	disparity	disparity	NOUN
chd-224	561	15	.	.	PUNCT
chd-224	562	1	journal	journal	PROPN
chd-224	562	2	of	of	ADP
chd-224	562	3	cancer	cancer	PROPN
chd-224	562	4	science	science	PROPN
chd-224	562	5	&	&	CCONJ
chd-224	562	6	therapy	therapy	PROPN
chd-224	562	7	7	7	NUM
chd-224	562	8	,	,	PUNCT
chd-224	562	9	145	145	NUM
chd-224	562	10	-	-	SYM
chd-224	562	11	154	154	NUM
chd-224	562	12	.	.	PUNCT
chd-224	563	1	tariqi	tariqi	PROPN
chd-224	563	2	,	,	PUNCT
chd-224	563	3	a.q	a.q	PROPN
chd-224	563	4	.	.	PROPN
chd-224	563	5	,	,	PUNCT
chd-224	563	6	and	and	CCONJ
chd-224	563	7	naughton	naughton	PROPN
chd-224	563	8	,	,	PUNCT
chd-224	563	9	c.c	c.c	PROPN
chd-224	563	10	.	.	PROPN
chd-224	563	11	(	(	PUNCT
chd-224	563	12	2021	2021	NUM
chd-224	563	13	)	)	PUNCT
chd-224	563	14	.	.	PUNCT
chd-224	564	1	water	water	NOUN
chd-224	564	2	,	,	PUNCT
chd-224	564	3	health	health	NOUN
chd-224	564	4	,	,	PUNCT
chd-224	564	5	and	and	CCONJ
chd-224	564	6	environmental	environmental	ADJ
chd-224	564	7	justice	justice	NOUN
chd-224	564	8	in	in	ADP
chd-224	564	9	california	california	PROPN
chd-224	564	10	:	:	PUNCT
chd-224	564	11	geospatial	geospatial	ADJ
chd-224	564	12	analysis	analysis	NOUN
chd-224	564	13	of	of	ADP
chd-224	564	14	nitrate	nitrate	NOUN
chd-224	564	15	contamination	contamination	NOUN
chd-224	564	16	and	and	CCONJ
chd-224	564	17	thyroid	thyroid	NOUN
chd-224	564	18	cancer	cancer	NOUN
chd-224	564	19	.	.	PUNCT
chd-224	565	1	environ	environ	PROPN
chd-224	565	2	eng	eng	PROPN
chd-224	565	3	sci	sci	PROPN
chd-224	565	4	38	38	NUM
chd-224	565	5	,	,	PUNCT
chd-224	565	6	377	377	NUM
chd-224	565	7	-	-	SYM
chd-224	565	8	388	388	NUM
chd-224	565	9	.	.	PUNCT
chd-224	566	1	tortolero	tortolero	NOUN
chd-224	566	2	-	-	PUNCT
chd-224	566	3	luna	luna	PROPN
chd-224	566	4	,	,	PUNCT
chd-224	566	5	g.	g.	PROPN
chd-224	566	6	,	,	PUNCT
chd-224	566	7	torres	torre	NOUN
chd-224	566	8	-	-	PUNCT
chd-224	566	9	cintrón	cintrón	NOUN
chd-224	566	10	,	,	PUNCT
chd-224	566	11	c.r	c.r	PROPN
chd-224	566	12	.	.	PROPN
chd-224	566	13	,	,	PUNCT
chd-224	566	14	alvarado	alvarado	PROPN
chd-224	566	15	-	-	PUNCT
chd-224	566	16	ortiz	ortiz	PROPN
chd-224	566	17	,	,	PUNCT
chd-224	566	18	m.	m.	NOUN
chd-224	566	19	,	,	PUNCT
chd-224	566	20	ortiz	ortiz	PROPN
chd-224	566	21	-	-	PUNCT
chd-224	566	22	ortiz	ortiz	PROPN
chd-224	566	23	,	,	PUNCT
chd-224	566	24	k.j	k.j	PROPN
chd-224	566	25	.	.	PROPN
chd-224	566	26	,	,	PUNCT
chd-224	566	27	zavala	zavala	NOUN
chd-224	566	28	-	-	PUNCT
chd-224	566	29	zegarra	zegarra	PROPN
chd-224	566	30	,	,	PUNCT
chd-224	566	31	d.e	d.e	PROPN
chd-224	566	32	.	.	PROPN
chd-224	566	33	,	,	PUNCT
chd-224	566	34	and	and	CCONJ
chd-224	566	35	mora	mora	PROPN
chd-224	566	36	-	-	PUNCT
chd-224	566	37	piñero	piñero	PROPN
chd-224	566	38	,	,	PUNCT
chd-224	566	39	e.	e.	PROPN
chd-224	566	40	(	(	PUNCT
chd-224	566	41	2019	2019	NUM
chd-224	566	42	)	)	PUNCT
chd-224	566	43	.	.	PUNCT
chd-224	567	1	incidence	incidence	NOUN
chd-224	567	2	of	of	ADP
chd-224	567	3	thyroid	thyroid	NOUN
chd-224	567	4	cancer	cancer	NOUN
chd-224	567	5	in	in	ADP
chd-224	567	6	puerto	puerto	PROPN
chd-224	567	7	rico	rico	PROPN
chd-224	567	8	and	and	CCONJ
chd-224	567	9	the	the	DET
chd-224	567	10	us	us	PROPN
chd-224	567	11	by	by	ADP
chd-224	567	12	racial	racial	ADJ
chd-224	567	13	/	/	SYM
chd-224	567	14	ethnic	ethnic	ADJ
chd-224	567	15	group	group	NOUN
chd-224	567	16	,	,	PUNCT
chd-224	567	17	2011	2011	NUM
chd-224	567	18	-	-	SYM
chd-224	567	19	2015	2015	NUM
chd-224	567	20	.	.	PUNCT
chd-224	568	1	bmc	bmc	NOUN
chd-224	568	2	cancer	cancer	NOUN
chd-224	568	3	19	19	NUM
chd-224	568	4	,	,	PUNCT
chd-224	568	5	637	637	NUM
chd-224	568	6	.	.	PUNCT
chd-224	569	1	umar	umar	PROPN
chd-224	569	2	,	,	PUNCT
chd-224	569	3	h.	h.	PROPN
chd-224	569	4	,	,	PUNCT
chd-224	569	5	muallima	muallima	PROPN
chd-224	569	6	,	,	PUNCT
chd-224	569	7	n.	n.	NOUN
chd-224	569	8	,	,	PUNCT
chd-224	569	9	adam	adam	PROPN
chd-224	569	10	,	,	PUNCT
chd-224	569	11	j.m	j.m	PROPN
chd-224	569	12	.	.	PROPN
chd-224	569	13	,	,	PUNCT
chd-224	569	14	and	and	CCONJ
chd-224	569	15	sanusi	sanusi	NOUN
chd-224	569	16	,	,	PUNCT
chd-224	569	17	h.	h.	PROPN
chd-224	569	18	(	(	PUNCT
chd-224	569	19	2010	2010	NUM
chd-224	569	20	)	)	PUNCT
chd-224	569	21	.	.	PUNCT
chd-224	570	1	hashimoto	hashimoto	NOUN
chd-224	570	2	's	's	PART
chd-224	570	3	thyroiditis	thyroiditis	NOUN
chd-224	570	4	following	follow	VERB
chd-224	570	5	graves	grave	NOUN
chd-224	570	6	'	'	PART
chd-224	570	7	disease	disease	NOUN
chd-224	570	8	.	.	PUNCT
chd-224	571	1	acta	acta	PROPN
chd-224	571	2	med	med	PROPN
chd-224	571	3	indones	indone	NOUN
chd-224	571	4	42	42	NUM
chd-224	571	5	,	,	PUNCT
chd-224	571	6	31	31	NUM
chd-224	571	7	-	-	SYM
chd-224	571	8	35	35	NUM
chd-224	571	9	.	.	PUNCT
chd-224	572	1	walker	walker	PROPN
chd-224	572	2	,	,	PUNCT
chd-224	572	3	j.a	j.a	PROPN
chd-224	572	4	.	.	PROPN
chd-224	572	5	,	,	PUNCT
chd-224	572	6	illions	illion	NOUN
chd-224	572	7	,	,	PUNCT
chd-224	572	8	e.h	e.h	PROPN
chd-224	572	9	.	.	PROPN
chd-224	572	10	,	,	PUNCT
chd-224	572	11	huddleston	huddleston	PROPN
chd-224	572	12	,	,	PUNCT
chd-224	572	13	j.f	j.f	PROPN
chd-224	572	14	.	.	PROPN
chd-224	572	15	,	,	PUNCT
chd-224	572	16	and	and	CCONJ
chd-224	572	17	smallridge	smallridge	NOUN
chd-224	572	18	,	,	PUNCT
chd-224	572	19	r.c	r.c	PROPN
chd-224	572	20	.	.	PROPN
chd-224	572	21	(	(	PUNCT
chd-224	572	22	2005	2005	NUM
chd-224	572	23	)	)	PUNCT
chd-224	572	24	.	.	PUNCT
chd-224	573	1	racial	racial	ADJ
chd-224	573	2	comparisons	comparison	NOUN
chd-224	573	3	of	of	ADP
chd-224	573	4	thyroid	thyroid	NOUN
chd-224	573	5	function	function	NOUN
chd-224	573	6	and	and	CCONJ
chd-224	573	7	autoimmunity	autoimmunity	NOUN
chd-224	573	8	during	during	ADP
chd-224	573	9	pregnancy	pregnancy	NOUN
chd-224	573	10	and	and	CCONJ
chd-224	573	11	the	the	DET
chd-224	573	12	postpartum	postpartum	NOUN
chd-224	573	13	period	period	NOUN
chd-224	573	14	.	.	PUNCT
chd-224	574	1	obstet	obstet	PROPN
chd-224	574	2	gynecol	gynecol	PROPN
chd-224	574	3	106	106	NUM
chd-224	574	4	,	,	PUNCT
chd-224	574	5	1365	1365	NUM
chd-224	574	6	-	-	SYM
chd-224	574	7	1371	1371	NUM
chd-224	574	8	.	.	PUNCT
chd-224	575	1	wang	wang	PROPN
chd-224	575	2	,	,	PUNCT
chd-224	575	3	x.	x.	PROPN
chd-224	575	4	,	,	PUNCT
chd-224	575	5	teng	teng	PROPN
chd-224	575	6	,	,	PUNCT
chd-224	575	7	r.	r.	PROPN
chd-224	575	8	,	,	PUNCT
chd-224	575	9	liu	liu	PROPN
chd-224	575	10	,	,	PUNCT
chd-224	575	11	f.	f.	PROPN
chd-224	575	12	,	,	PUNCT
chd-224	575	13	liu	liu	PROPN
chd-224	575	14	,	,	PUNCT
chd-224	575	15	p.	p.	PROPN
chd-224	575	16	,	,	PUNCT
chd-224	575	17	and	and	CCONJ
chd-224	575	18	yang	yang	PROPN
chd-224	575	19	,	,	PUNCT
chd-224	575	20	y.	y.	PROPN
chd-224	575	21	(	(	PUNCT
chd-224	575	22	2022	2022	NUM
chd-224	575	23	)	)	PUNCT
chd-224	575	24	.	.	PUNCT
chd-224	576	1	effect	effect	NOUN
chd-224	576	2	of	of	ADP
chd-224	576	3	thyrotropin	thyrotropin	ADJ
chd-224	576	4	suppressive	suppressive	ADJ
chd-224	576	5	therapy	therapy	NOUN
chd-224	576	6	on	on	ADP
chd-224	576	7	lumbar	lumbar	NOUN
chd-224	576	8	bone	bone	NOUN
chd-224	576	9	mineral	mineral	NOUN
chd-224	576	10	density	density	NOUN
chd-224	576	11	in	in	ADP
chd-224	576	12	patients	patient	NOUN
chd-224	576	13	with	with	ADP
chd-224	576	14	differentiated	differentiated	ADJ
chd-224	576	15	thyroid	thyroid	NOUN
chd-224	576	16	cancer	cancer	NOUN
chd-224	576	17	:	:	PUNCT
chd-224	576	18	a	a	DET
chd-224	576	19	retrospective	retrospective	ADJ
chd-224	576	20	cohort	cohort	NOUN
chd-224	576	21	study	study	NOUN
chd-224	576	22	.	.	PUNCT
chd-224	577	1	gland	gland	NOUN
chd-224	577	2	surg	surg	NOUN
chd-224	577	3	11	11	NUM
chd-224	577	4	,	,	PUNCT
chd-224	577	5	432	432	NUM
chd-224	577	6	-	-	SYM
chd-224	577	7	441	441	NUM
chd-224	577	8	.	.	PUNCT
chd-224	578	1	weeks	week	NOUN
chd-224	578	2	,	,	PUNCT
chd-224	578	3	k.s	k.s	PROPN
chd-224	578	4	.	.	PROPN
chd-224	578	5	,	,	PUNCT
chd-224	578	6	kahl	kahl	PROPN
chd-224	578	7	,	,	PUNCT
chd-224	578	8	a.r	a.r	PROPN
chd-224	578	9	.	.	PROPN
chd-224	578	10	,	,	PUNCT
chd-224	578	11	lynch	lynch	PROPN
chd-224	578	12	,	,	PUNCT
chd-224	578	13	c.f	c.f	PROPN
chd-224	578	14	.	.	PROPN
chd-224	578	15	,	,	PUNCT
chd-224	578	16	and	and	CCONJ
chd-224	578	17	charlton	charlton	PROPN
chd-224	578	18	,	,	PUNCT
chd-224	578	19	m.e	m.e	PROPN
chd-224	578	20	.	.	PROPN
chd-224	578	21	(	(	PUNCT
chd-224	578	22	2018	2018	NUM
chd-224	578	23	)	)	PUNCT
chd-224	578	24	.	.	PUNCT
chd-224	579	1	racial	racial	ADJ
chd-224	579	2	/	/	SYM
chd-224	579	3	ethnic	ethnic	ADJ
chd-224	579	4	differences	difference	NOUN
chd-224	579	5	in	in	ADP
chd-224	579	6	thyroid	thyroid	NOUN
chd-224	579	7	cancer	cancer	NOUN
chd-224	579	8	incidence	incidence	NOUN
chd-224	579	9	in	in	ADP
chd-224	579	10	the	the	DET
chd-224	579	11	united	united	PROPN
chd-224	579	12	states	states	PROPN
chd-224	579	13	,	,	PUNCT
chd-224	579	14	2007	2007	NUM
chd-224	579	15	-	-	SYM
chd-224	579	16	2014	2014	NUM
chd-224	579	17	.	.	PUNCT
chd-224	580	1	cancer	cancer	NOUN
chd-224	580	2	124	124	NUM
chd-224	580	3	,	,	PUNCT
chd-224	580	4	1483	1483	NUM
chd-224	580	5	-	-	SYM
chd-224	580	6	1491	1491	NUM
chd-224	580	7	.	.	PUNCT
chd-224	581	1	xing	xing	PROPN
chd-224	581	2	,	,	PUNCT
chd-224	581	3	m.	m.	NOUN
chd-224	581	4	,	,	PUNCT
chd-224	581	5	haugen	haugen	PROPN
chd-224	581	6	,	,	PUNCT
chd-224	581	7	b.r	b.r	PROPN
chd-224	581	8	.	.	PROPN
chd-224	581	9	,	,	PUNCT
chd-224	581	10	and	and	CCONJ
chd-224	581	11	schlumberger	schlumberger	NOUN
chd-224	581	12	,	,	PUNCT
chd-224	581	13	m.	m.	NOUN
chd-224	581	14	(	(	PUNCT
chd-224	581	15	2013	2013	NUM
chd-224	581	16	)	)	PUNCT
chd-224	581	17	.	.	PUNCT
chd-224	582	1	progress	progress	NOUN
chd-224	582	2	in	in	ADP
chd-224	582	3	molecular	molecular	ADJ
chd-224	582	4	-	-	PUNCT
chd-224	582	5	based	base	VERB
chd-224	582	6	management	management	NOUN
chd-224	582	7	of	of	ADP
chd-224	582	8	differentiated	differentiated	ADJ
chd-224	582	9	thyroid	thyroid	NOUN
chd-224	582	10	cancer	cancer	NOUN
chd-224	582	11	.	.	PUNCT
chd-224	583	1	lancet	lancet	PROPN
chd-224	583	2	381	381	NUM
chd-224	583	3	,	,	PUNCT
chd-224	583	4	1058	1058	NUM
chd-224	583	5	-	-	SYM
chd-224	583	6	1069	1069	NUM
chd-224	583	7	.	.	PUNCT
chd-224	584	1	xu	xu	PROPN
chd-224	584	2	,	,	PUNCT
chd-224	584	3	l.	l.	PROPN
chd-224	584	4	,	,	PUNCT
chd-224	584	5	zhao	zhao	PROPN
chd-224	584	6	,	,	PUNCT
chd-224	584	7	y.p	y.p	PROPN
chd-224	584	8	.	.	PROPN
chd-224	584	9	,	,	PUNCT
chd-224	584	10	wang	wang	PROPN
chd-224	584	11	,	,	PUNCT
chd-224	584	12	w.b	w.b	PROPN
chd-224	584	13	.	.	PROPN
chd-224	584	14	,	,	PUNCT
chd-224	584	15	zhang	zhang	PROPN
chd-224	584	16	,	,	PUNCT
chd-224	584	17	t.p	t.p	PROPN
chd-224	584	18	.	.	PROPN
chd-224	584	19	,	,	PUNCT
chd-224	584	20	liao	liao	PROPN
chd-224	584	21	,	,	PUNCT
chd-224	584	22	q.	q.	PROPN
chd-224	584	23	,	,	PUNCT
chd-224	584	24	chen	chen	PROPN
chd-224	584	25	,	,	PUNCT
chd-224	584	26	g.	g.	PROPN
chd-224	584	27	,	,	PUNCT
chd-224	584	28	zhou	zhou	PROPN
chd-224	584	29	,	,	PUNCT
chd-224	584	30	l.	l.	PROPN
chd-224	584	31	,	,	PUNCT
chd-224	584	32	and	and	CCONJ
chd-224	584	33	shu	shu	PROPN
chd-224	584	34	,	,	PUNCT
chd-224	584	35	h.	h.	PROPN
chd-224	584	36	(	(	PUNCT
chd-224	584	37	2012	2012	NUM
chd-224	584	38	)	)	PUNCT
chd-224	584	39	.	.	PUNCT
chd-224	585	1	clinical	clinical	ADJ
chd-224	585	2	characteristics	characteristic	NOUN
chd-224	585	3	of	of	ADP
chd-224	585	4	hereditary	hereditary	ADJ
chd-224	585	5	and	and	CCONJ
chd-224	585	6	sporadic	sporadic	ADJ
chd-224	585	7	medullary	medullary	ADJ
chd-224	585	8	thyroid	thyroid	NOUN
chd-224	585	9	carcinoma	carcinoma	NOUN
chd-224	585	10	.	.	PUNCT
chd-224	586	1	zhongguo	zhongguo	PROPN
chd-224	586	2	yi	yi	PROPN
chd-224	586	3	xue	xue	PROPN
chd-224	586	4	ke	ke	PROPN
chd-224	586	5	xue	xue	PROPN
chd-224	586	6	yuan	yuan	PROPN
chd-224	586	7	xue	xue	PROPN
chd-224	586	8	bao	bao	PROPN
chd-224	586	9	34	34	NUM
chd-224	586	10	,	,	PUNCT
chd-224	586	11	401	401	NUM
chd-224	586	12	-	-	SYM
chd-224	586	13	404	404	NUM
chd-224	586	14	.	.	PUNCT
chd-224	587	1	yildirim	yildirim	PROPN
chd-224	587	2	simsir	simsir	PROPN
chd-224	587	3	,	,	PUNCT
chd-224	587	4	i.	i.	PROPN
chd-224	587	5	,	,	PUNCT
chd-224	587	6	cetinkalp	cetinkalp	PROPN
chd-224	587	7	,	,	PUNCT
chd-224	587	8	s.	s.	PROPN
chd-224	587	9	,	,	PUNCT
chd-224	587	10	and	and	CCONJ
chd-224	587	11	kabalak	kabalak	ADJ
chd-224	587	12	,	,	PUNCT
chd-224	587	13	t.	t.	PROPN
chd-224	587	14	(	(	PUNCT
chd-224	587	15	2020	2020	NUM
chd-224	587	16	)	)	PUNCT
chd-224	587	17	.	.	PUNCT
chd-224	588	1	review	review	NOUN
chd-224	588	2	of	of	ADP
chd-224	588	3	factors	factor	NOUN
chd-224	588	4	contributing	contribute	VERB
chd-224	588	5	to	to	ADP
chd-224	588	6	nodular	nodular	ADJ
chd-224	588	7	goiter	goiter	NOUN
chd-224	588	8	and	and	CCONJ
chd-224	588	9	thyroid	thyroid	NOUN
chd-224	588	10	carcinoma	carcinoma	NOUN
chd-224	588	11	.	.	PUNCT
chd-224	589	1	med	med	PROPN
chd-224	589	2	princ	princ	PROPN
chd-224	589	3	pract	pract	PROPN
chd-224	589	4	29	29	NUM
chd-224	589	5	,	,	PUNCT
chd-224	589	6	1	1	NUM
chd-224	589	7	-	-	SYM
chd-224	589	8	5	5	NUM
chd-224	589	9	.	.	PUNCT
chd-224	590	1	yoon	yoon	PROPN
chd-224	590	2	,	,	PUNCT
chd-224	590	3	j.h	j.h	PROPN
chd-224	590	4	.	.	PROPN
chd-224	590	5	,	,	PUNCT
chd-224	590	6	kim	kim	PROPN
chd-224	590	7	,	,	PUNCT
chd-224	590	8	e.k	e.k	PROPN
chd-224	590	9	.	.	PROPN
chd-224	590	10	,	,	PUNCT
chd-224	590	11	kwak	kwak	PROPN
chd-224	590	12	,	,	PUNCT
chd-224	590	13	j.y	j.y	PROPN
chd-224	590	14	.	.	PROPN
chd-224	590	15	,	,	PUNCT
chd-224	590	16	moon	moon	PROPN
chd-224	590	17	,	,	PUNCT
chd-224	590	18	h.j	h.j	PROPN
chd-224	590	19	.	.	PROPN
chd-224	590	20	,	,	PUNCT
chd-224	590	21	and	and	CCONJ
chd-224	590	22	kim	kim	PROPN
chd-224	590	23	,	,	PUNCT
chd-224	590	24	g.r	g.r	PROPN
chd-224	590	25	.	.	PUNCT
chd-224	590	26	(	(	PUNCT
chd-224	590	27	2014	2014	NUM
chd-224	590	28	)	)	PUNCT
chd-224	590	29	.	.	PUNCT
chd-224	591	1	sonographic	sonographic	ADJ
chd-224	591	2	features	feature	NOUN
chd-224	591	3	and	and	CCONJ
chd-224	591	4	ultrasonography	ultrasonography	NOUN
chd-224	591	5	-	-	PUNCT
chd-224	591	6	guided	guide	VERB
chd-224	591	7	fine	fine	ADJ
chd-224	591	8	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-224	591	9	e20	e20	NOUN
chd-224	591	10	cancer	cancer	NOUN
chd-224	591	11	health	health	NOUN
chd-224	591	12	disparities	disparity	NOUN
chd-224	591	13	research	research	NOUN
chd-224	591	14	needle	needle	NOUN
chd-224	591	15	aspiration	aspiration	NOUN
chd-224	591	16	of	of	ADP
chd-224	591	17	metastases	metastasis	NOUN
chd-224	591	18	to	to	ADP
chd-224	591	19	the	the	DET
chd-224	591	20	thyroid	thyroid	NOUN
chd-224	591	21	gland	gland	NOUN
chd-224	591	22	.	.	PUNCT
chd-224	592	1	ultrasonography	ultrasonography	NOUN
chd-224	592	2	(	(	PUNCT
chd-224	592	3	seoul	seoul	PROPN
chd-224	592	4	,	,	PUNCT
chd-224	592	5	korea	korea	PROPN
chd-224	592	6	)	)	PUNCT
chd-224	592	7	33	33	NUM
chd-224	592	8	,	,	PUNCT
chd-224	592	9	40	40	NUM
chd-224	592	10	-	-	SYM
chd-224	592	11	48	48	NUM
chd-224	592	12	.	.	PUNCT
chd-224	593	1	yu	yu	PROPN
chd-224	593	2	,	,	PUNCT
chd-224	593	3	g.p	g.p	PROPN
chd-224	593	4	.	.	PROPN
chd-224	593	5	,	,	PUNCT
chd-224	593	6	li	li	PROPN
chd-224	593	7	,	,	PUNCT
chd-224	593	8	j.c	j.c	PROPN
chd-224	593	9	.	.	PROPN
chd-224	593	10	,	,	PUNCT
chd-224	593	11	branovan	branovan	PROPN
chd-224	593	12	,	,	PUNCT
chd-224	593	13	d.	d.	PROPN
chd-224	593	14	,	,	PUNCT
chd-224	593	15	mccormick	mccormick	PROPN
chd-224	593	16	,	,	PUNCT
chd-224	593	17	s.	s.	PROPN
chd-224	593	18	,	,	PUNCT
chd-224	593	19	and	and	CCONJ
chd-224	593	20	schantz	schantz	PROPN
chd-224	593	21	,	,	PUNCT
chd-224	593	22	s.p	s.p	PROPN
chd-224	593	23	.	.	PROPN
chd-224	593	24	(	(	PUNCT
chd-224	593	25	2010	2010	NUM
chd-224	593	26	)	)	PUNCT
chd-224	593	27	.	.	PUNCT
chd-224	594	1	thyroid	thyroid	NOUN
chd-224	594	2	cancer	cancer	NOUN
chd-224	594	3	incidence	incidence	NOUN
chd-224	594	4	and	and	CCONJ
chd-224	594	5	survival	survival	NOUN
chd-224	594	6	in	in	ADP
chd-224	594	7	the	the	DET
chd-224	594	8	national	national	PROPN
chd-224	594	9	cancer	cancer	PROPN
chd-224	594	10	institute	institute	PROPN
chd-224	594	11	surveillance	surveillance	NOUN
chd-224	594	12	,	,	PUNCT
chd-224	594	13	epidemiology	epidemiology	NOUN
chd-224	594	14	,	,	PUNCT
chd-224	594	15	and	and	CCONJ
chd-224	594	16	end	end	VERB
chd-224	594	17	results	result	NOUN
chd-224	594	18	race	race	NOUN
chd-224	594	19	/	/	SYM
chd-224	594	20	ethnicity	ethnicity	NOUN
chd-224	594	21	groups	group	NOUN
chd-224	594	22	.	.	PUNCT
chd-224	595	1	thyroid	thyroid	NOUN
chd-224	595	2	20	20	NUM
chd-224	595	3	,	,	PUNCT
chd-224	595	4	465	465	NUM
chd-224	595	5	-	-	SYM
chd-224	595	6	473	473	NUM
chd-224	595	7	.	.	PUNCT
chd-224	596	1	zahedi	zahedi	PROPN
chd-224	596	2	,	,	PUNCT
chd-224	596	3	a.	a.	PROPN
chd-224	596	4	,	,	PUNCT
chd-224	596	5	bondaz	bondaz	PROPN
chd-224	596	6	,	,	PUNCT
chd-224	596	7	l.	l.	PROPN
chd-224	596	8	,	,	PUNCT
chd-224	596	9	rajaraman	rajaraman	NOUN
chd-224	596	10	,	,	PUNCT
chd-224	596	11	m.	m.	NOUN
chd-224	596	12	,	,	PUNCT
chd-224	596	13	leslie	leslie	PROPN
chd-224	596	14	,	,	PUNCT
chd-224	596	15	w.d	w.d	PROPN
chd-224	596	16	.	.	PROPN
chd-224	596	17	,	,	PUNCT
chd-224	596	18	jefford	jefford	PROPN
chd-224	596	19	,	,	PUNCT
chd-224	596	20	c.	c.	PROPN
chd-224	596	21	,	,	PUNCT
chd-224	596	22	young	young	ADJ
chd-224	596	23	,	,	PUNCT
chd-224	596	24	j.e	j.e	PROPN
chd-224	596	25	.	.	PROPN
chd-224	596	26	,	,	PUNCT
chd-224	596	27	pathak	pathak	PROPN
chd-224	596	28	,	,	PUNCT
chd-224	596	29	k.a	k.a	PROPN
chd-224	596	30	.	.	PROPN
chd-224	596	31	,	,	PUNCT
chd-224	596	32	bureau	bureau	PROPN
chd-224	596	33	,	,	PUNCT
chd-224	596	34	y.	y.	PROPN
chd-224	596	35	,	,	PUNCT
chd-224	596	36	rachinsky	rachinsky	PROPN
chd-224	596	37	,	,	PUNCT
chd-224	596	38	i.	i.	PROPN
chd-224	596	39	,	,	PUNCT
chd-224	596	40	badreddine	badreddine	PROPN
chd-224	596	41	,	,	PUNCT
chd-224	596	42	m.	m.	NOUN
chd-224	596	43	,	,	PUNCT
chd-224	596	44	et	et	PROPN
chd-224	596	45	al	al	PROPN
chd-224	596	46	.	.	PROPN
chd-224	597	1	(	(	PUNCT
chd-224	597	2	2020	2020	NUM
chd-224	597	3	)	)	PUNCT
chd-224	597	4	.	.	PUNCT
chd-224	598	1	risk	risk	NOUN
chd-224	598	2	for	for	ADP
chd-224	598	3	thyroid	thyroid	NOUN
chd-224	598	4	cancer	cancer	NOUN
chd-224	598	5	recurrence	recurrence	NOUN
chd-224	598	6	is	be	AUX
chd-224	598	7	higher	high	ADJ
chd-224	598	8	in	in	ADP
chd-224	598	9	men	man	NOUN
chd-224	598	10	than	than	ADP
chd-224	598	11	in	in	ADP
chd-224	598	12	women	woman	NOUN
chd-224	598	13	independent	independent	ADJ
chd-224	598	14	of	of	ADP
chd-224	598	15	disease	disease	NOUN
chd-224	598	16	stage	stage	NOUN
chd-224	598	17	at	at	ADP
chd-224	598	18	presentation	presentation	NOUN
chd-224	598	19	.	.	PUNCT
chd-224	599	1	thyroid	thyroid	NOUN
chd-224	599	2	30	30	NUM
chd-224	599	3	,	,	PUNCT
chd-224	599	4	871	871	NUM
chd-224	599	5	-	-	SYM
chd-224	599	6	877	877	NUM
chd-224	599	7	.	.	PUNCT
chd-224	600	1	zevallos	zevallo	NOUN
chd-224	600	2	,	,	PUNCT
chd-224	600	3	j.p	j.p	PROPN
chd-224	600	4	.	.	PROPN
chd-224	600	5	,	,	PUNCT
chd-224	600	6	hartman	hartman	PROPN
chd-224	600	7	,	,	PUNCT
chd-224	600	8	c.m	c.m	PROPN
chd-224	600	9	.	.	PROPN
chd-224	600	10	,	,	PUNCT
chd-224	600	11	kramer	kramer	PROPN
chd-224	600	12	,	,	PUNCT
chd-224	600	13	j.r	j.r	PROPN
chd-224	600	14	.	.	PROPN
chd-224	600	15	,	,	PUNCT
chd-224	600	16	sturgis	sturgis	PROPN
chd-224	600	17	,	,	PUNCT
chd-224	600	18	e.m	e.m	PROPN
chd-224	600	19	.	.	PROPN
chd-224	600	20	,	,	PUNCT
chd-224	600	21	and	and	CCONJ
chd-224	600	22	chiao	chiao	PROPN
chd-224	600	23	,	,	PUNCT
chd-224	600	24	e.y	e.y	PROPN
chd-224	600	25	.	.	PROPN
chd-224	600	26	(	(	PUNCT
chd-224	600	27	2015	2015	NUM
chd-224	600	28	)	)	PUNCT
chd-224	600	29	.	.	PUNCT
chd-224	601	1	increased	increase	VERB
chd-224	601	2	thyroid	thyroid	NOUN
chd-224	601	3	cancer	cancer	NOUN
chd-224	601	4	incidence	incidence	NOUN
chd-224	601	5	corresponds	correspond	VERB
chd-224	601	6	to	to	ADP
chd-224	601	7	increased	increase	VERB
chd-224	601	8	use	use	NOUN
chd-224	601	9	of	of	ADP
chd-224	601	10	thyroid	thyroid	NOUN
chd-224	601	11	ultrasound	ultrasound	NOUN
chd-224	601	12	and	and	CCONJ
chd-224	601	13	fine	fine	ADJ
chd-224	601	14	-	-	PUNCT
chd-224	601	15	needle	needle	NOUN
chd-224	601	16	aspiration	aspiration	NOUN
chd-224	601	17	:	:	PUNCT
chd-224	601	18	a	a	DET
chd-224	601	19	study	study	NOUN
chd-224	601	20	of	of	ADP
chd-224	601	21	the	the	DET
chd-224	601	22	veterans	veterans	PROPN
chd-224	601	23	affairs	affairs	PROPN
chd-224	601	24	health	health	NOUN
chd-224	601	25	care	care	NOUN
chd-224	601	26	system	system	NOUN
chd-224	601	27	.	.	PUNCT
chd-224	602	1	cancer	cancer	NOUN
chd-224	602	2	121	121	NUM
chd-224	602	3	,	,	PUNCT
chd-224	602	4	741	741	NUM
chd-224	602	5	-	-	SYM
chd-224	602	6	746	746	NUM
chd-224	602	7	.	.	PUNCT
chd-224	603	1	zhao	zhao	PROPN
chd-224	603	2	,	,	PUNCT
chd-224	603	3	s.	s.	PROPN
chd-224	603	4	,	,	PUNCT
chd-224	603	5	jia	jia	PROPN
chd-224	603	6	,	,	PUNCT
chd-224	603	7	x.	x.	PROPN
chd-224	603	8	,	,	PUNCT
chd-224	603	9	fan	fan	PROPN
chd-224	603	10	,	,	PUNCT
chd-224	603	11	x.	x.	PROPN
chd-224	603	12	,	,	PUNCT
chd-224	603	13	zhao	zhao	PROPN
chd-224	603	14	,	,	PUNCT
chd-224	603	15	l.	l.	PROPN
chd-224	603	16	,	,	PUNCT
chd-224	603	17	pang	pang	NOUN
chd-224	603	18	,	,	PUNCT
chd-224	603	19	p.	p.	PROPN
chd-224	603	20	,	,	PUNCT
chd-224	603	21	wang	wang	PROPN
chd-224	603	22	,	,	PUNCT
chd-224	603	23	y.	y.	PROPN
chd-224	603	24	,	,	PUNCT
chd-224	603	25	luo	luo	PROPN
chd-224	603	26	,	,	PUNCT
chd-224	603	27	y.	y.	PROPN
chd-224	603	28	,	,	PUNCT
chd-224	603	29	wang	wang	PROPN
chd-224	603	30	,	,	PUNCT
chd-224	603	31	f.	f.	PROPN
chd-224	603	32	,	,	PUNCT
chd-224	603	33	yang	yang	PROPN
chd-224	603	34	,	,	PUNCT
chd-224	603	35	g.	g.	PROPN
chd-224	603	36	,	,	PUNCT
chd-224	603	37	wang	wang	PROPN
chd-224	603	38	,	,	PUNCT
chd-224	603	39	x.	x.	PROPN
chd-224	603	40	,	,	PUNCT
chd-224	603	41	et	et	PROPN
chd-224	603	42	al	al	PROPN
chd-224	603	43	.	.	PROPN
chd-224	603	44	(	(	PUNCT
chd-224	603	45	2019	2019	NUM
chd-224	603	46	)	)	PUNCT
chd-224	603	47	.	.	PUNCT
chd-224	604	1	association	association	NOUN
chd-224	604	2	of	of	ADP
chd-224	604	3	obesity	obesity	NOUN
chd-224	604	4	with	with	ADP
chd-224	604	5	the	the	DET
chd-224	604	6	clinicopathological	clinicopathological	ADJ
chd-224	604	7	features	feature	NOUN
chd-224	604	8	of	of	ADP
chd-224	604	9	thyroid	thyroid	NOUN
chd-224	604	10	cancer	cancer	NOUN
chd-224	604	11	in	in	ADP
chd-224	604	12	a	a	DET
chd-224	604	13	large	large	ADJ
chd-224	604	14	,	,	PUNCT
chd-224	604	15	operative	operative	ADJ
chd-224	604	16	population	population	NOUN
chd-224	604	17	:	:	PUNCT
chd-224	604	18	a	a	DET
chd-224	604	19	retrospective	retrospective	ADJ
chd-224	604	20	case	case	NOUN
chd-224	604	21	-	-	PUNCT
chd-224	604	22	control	control	NOUN
chd-224	604	23	study	study	NOUN
chd-224	604	24	.	.	PUNCT
chd-224	605	1	medicine	medicine	NOUN
chd-224	605	2	98	98	NUM
chd-224	605	3	,	,	PUNCT
chd-224	605	4	e18213	e18213	NOUN
chd-224	605	5	.	.	PUNCT
chd-224	606	1	zheng	zheng	PROPN
chd-224	606	2	,	,	PUNCT
chd-224	606	3	h.	h.	PROPN
chd-224	606	4	,	,	PUNCT
chd-224	606	5	lai	lai	PROPN
chd-224	606	6	,	,	PUNCT
chd-224	606	7	v.	v.	PROPN
chd-224	606	8	,	,	PUNCT
chd-224	606	9	lu	lu	PROPN
chd-224	606	10	,	,	PUNCT
chd-224	606	11	j.	j.	PROPN
chd-224	606	12	,	,	PUNCT
chd-224	606	13	kang	kang	PROPN
chd-224	606	14	,	,	PUNCT
chd-224	606	15	j.k	j.k	PROPN
chd-224	606	16	.	.	PROPN
chd-224	606	17	,	,	PUNCT
chd-224	606	18	felger	felger	PROPN
chd-224	606	19	,	,	PUNCT
chd-224	606	20	e.a	e.a	PROPN
chd-224	606	21	.	.	PROPN
chd-224	606	22	,	,	PUNCT
chd-224	606	23	carroll	carroll	PROPN
chd-224	606	24	,	,	PUNCT
chd-224	606	25	n.m	n.m	PROPN
chd-224	606	26	.	.	PROPN
chd-224	606	27	,	,	PUNCT
chd-224	606	28	burman	burman	NOUN
chd-224	606	29	,	,	PUNCT
chd-224	606	30	k.d	k.d	PROPN
chd-224	606	31	.	.	PROPN
chd-224	606	32	,	,	PUNCT
chd-224	606	33	wartofsky	wartofsky	PROPN
chd-224	606	34	,	,	PUNCT
chd-224	606	35	l.	l.	PROPN
chd-224	606	36	,	,	PUNCT
chd-224	606	37	and	and	CCONJ
chd-224	606	38	rosen	rosen	PROPN
chd-224	606	39	,	,	PUNCT
chd-224	606	40	j.e	j.e	PROPN
chd-224	606	41	.	.	PROPN
chd-224	606	42	(	(	PUNCT
chd-224	606	43	2022	2022	NUM
chd-224	606	44	)	)	PUNCT
chd-224	606	45	.	.	PUNCT
chd-224	607	1	comparing	compare	VERB
chd-224	607	2	the	the	DET
chd-224	607	3	rate	rate	NOUN
chd-224	607	4	and	and	CCONJ
chd-224	607	5	extent	extent	NOUN
chd-224	607	6	of	of	ADP
chd-224	607	7	malignancy	malignancy	NOUN
chd-224	607	8	in	in	ADP
chd-224	607	9	surgically	surgically	ADV
chd-224	607	10	excised	excise	VERB
chd-224	607	11	thyroid	thyroid	NOUN
chd-224	607	12	nodules	nodule	NOUN
chd-224	607	13	across	across	ADP
chd-224	607	14	race	race	NOUN
chd-224	607	15	and	and	CCONJ
chd-224	607	16	ethnicity	ethnicity	NOUN
chd-224	607	17	.	.	PUNCT
chd-224	608	1	the	the	DET
chd-224	608	2	american	american	PROPN
chd-224	608	3	journal	journal	PROPN
chd-224	608	4	of	of	ADP
chd-224	608	5	surgery	surgery	NOUN
chd-224	608	6	223	223	NUM
chd-224	608	7	,	,	PUNCT
chd-224	608	8	617	617	NUM
chd-224	608	9	-	-	SYM
chd-224	608	10	623	623	NUM
chd-224	608	11	.	.	NOUN
chd-224	609	1	1	1	NUM
chd-224	609	2	.	.	X
chd-224	609	3	introduction	introduction	NOUN
chd-224	609	4	2	2	NUM
chd-224	609	5	.	.	PUNCT
chd-224	609	6	materials	material	NOUN
chd-224	609	7	and	and	CCONJ
chd-224	609	8	methods	method	NOUN
chd-224	609	9	3	3	NUM
chd-224	609	10	.	.	PUNCT
chd-224	610	1	risk	risk	NOUN
chd-224	610	2	factors	factor	NOUN
chd-224	610	3	potentially	potentially	ADV
chd-224	610	4	contributing	contribute	VERB
chd-224	610	5	to	to	ADP
chd-224	610	6	tc	tc	NUM
chd-224	610	7	health	health	NOUN
chd-224	610	8	disparities	disparity	NOUN
chd-224	610	9	3.1	3.1	NUM
chd-224	610	10	.	.	PUNCT
chd-224	611	1	genetic	genetic	ADJ
chd-224	611	2	factors	factor	NOUN
chd-224	611	3	hereditary	hereditary	ADJ
chd-224	611	4	conditions	condition	NOUN
chd-224	611	5	influencing	influence	VERB
chd-224	611	6	tc	tc	NUM
chd-224	611	7	health	health	NOUN
chd-224	611	8	disparities	disparity	NOUN
chd-224	611	9	3.2	3.2	NUM
chd-224	611	10	.	.	PUNCT
chd-224	612	1	environmental	environmental	ADJ
chd-224	612	2	factors	factor	NOUN
chd-224	612	3	3.2.1	3.2.1	NUM
chd-224	612	4	.	.	PUNCT
chd-224	613	1	radiation	radiation	NOUN
chd-224	613	2	exposure	exposure	NOUN
chd-224	613	3	in	in	ADP
chd-224	613	4	tc	tc	NOUN
chd-224	613	5	health	health	NOUN
chd-224	613	6	disparities	disparity	NOUN
chd-224	613	7	3.2.2	3.2.2	NUM
chd-224	613	8	.	.	PUNCT
chd-224	613	9	iodine	iodine	NOUN
chd-224	613	10	deficiency	deficiency	NOUN
chd-224	613	11	in	in	ADP
chd-224	613	12	tc	tc	NUM
chd-224	613	13	health	health	NOUN
chd-224	613	14	disparities	disparity	NOUN
chd-224	613	15	3.2.3	3.2.3	NUM
chd-224	613	16	.	.	PUNCT
chd-224	614	1	environmental	environmental	ADJ
chd-224	614	2	pollutants	pollutant	NOUN
chd-224	614	3	influencing	influence	VERB
chd-224	614	4	tc	tc	NUM
chd-224	614	5	health	health	NOUN
chd-224	614	6	disparities	disparity	NOUN
chd-224	614	7	3.3	3.3	NUM
chd-224	614	8	.	.	PUNCT
chd-224	615	1	socioeconomic	socioeconomic	ADJ
chd-224	615	2	factors	factor	NOUN
chd-224	615	3	3.3.1	3.3.1	NUM
chd-224	615	4	.	.	PUNCT
chd-224	616	1	radioiodine	radioiodine	NOUN
chd-224	616	2	treatment	treatment	NOUN
chd-224	616	3	3.3.2	3.3.2	NUM
chd-224	616	4	.	.	PUNCT
chd-224	617	1	diagnostic	diagnostic	ADJ
chd-224	617	2	differences	difference	NOUN
chd-224	617	3	in	in	ADP
chd-224	617	4	tc	tc	NUM
chd-224	617	5	health	health	NOUN
chd-224	617	6	disparities	disparity	NOUN
chd-224	617	7	3.4	3.4	NUM
chd-224	617	8	.	.	PUNCT
chd-224	617	9	metabolic	metabolic	NOUN
chd-224	617	10	factors	factor	NOUN
chd-224	617	11	obesity	obesity	NOUN
chd-224	617	12	,	,	PUNCT
chd-224	617	13	metabolic	metabolic	NOUN
chd-224	617	14	syndrome	syndrome	NOUN
chd-224	617	15	,	,	PUNCT
chd-224	617	16	and	and	CCONJ
chd-224	617	17	insulin	insulin	NOUN
chd-224	617	18	resistance	resistance	NOUN
chd-224	617	19	in	in	ADP
chd-224	617	20	tc	tc	NOUN
chd-224	617	21	health	health	NOUN
chd-224	617	22	disparities	disparity	NOUN
chd-224	617	23	3.5	3.5	NUM
chd-224	617	24	.	.	PUNCT
chd-224	618	1	behavioral	behavioral	ADJ
chd-224	618	2	factors	factor	NOUN
chd-224	618	3	lifestyle	lifestyle	NOUN
chd-224	618	4	and	and	CCONJ
chd-224	618	5	diet	diet	NOUN
chd-224	618	6	in	in	ADP
chd-224	618	7	tc	tc	NUM
chd-224	618	8	health	health	NOUN
chd-224	618	9	disparities	disparity	NOUN
chd-224	618	10	3.6	3.6	NUM
chd-224	618	11	.	.	PUNCT
chd-224	619	1	biological	biological	ADJ
chd-224	619	2	factors	factor	NOUN
chd-224	619	3	3.6.1	3.6.1	NUM
chd-224	619	4	.	.	PUNCT
chd-224	619	5	thyroid	thyroid	NOUN
chd-224	619	6	-	-	PUNCT
chd-224	619	7	stimulating	stimulate	VERB
chd-224	619	8	hormone	hormone	NOUN
chd-224	619	9	(	(	PUNCT
chd-224	619	10	tsh	tsh	NOUN
chd-224	619	11	)	)	PUNCT
chd-224	619	12	level	level	NOUN
chd-224	619	13	in	in	ADP
chd-224	619	14	tc	tc	NOUN
chd-224	619	15	health	health	NOUN
chd-224	619	16	disparities	disparity	NOUN
chd-224	619	17	3.6.2	3.6.2	NUM
chd-224	619	18	.	.	PUNCT
chd-224	619	19	sex	sex	NOUN
chd-224	619	20	in	in	ADP
chd-224	619	21	tc	tc	NOUN
chd-224	619	22	health	health	NOUN
chd-224	619	23	disparities	disparity	NOUN
chd-224	619	24	3.6.3	3.6.3	NUM
chd-224	619	25	.	.	PUNCT
chd-224	620	1	autoimmunity	autoimmunity	NOUN
chd-224	620	2	in	in	ADP
chd-224	620	3	tc	tc	NOUN
chd-224	620	4	health	health	NOUN
chd-224	620	5	disparities	disparity	NOUN
chd-224	620	6	3.6.4	3.6.4	NUM
chd-224	620	7	.	.	PUNCT
chd-224	621	1	thyroid	thyroid	PROPN
chd-224	621	2	nodule	nodule	NOUN
chd-224	621	3	size	size	NOUN
chd-224	621	4	in	in	ADP
chd-224	621	5	tc	tc	NOUN
chd-224	621	6	health	health	NOUN
chd-224	621	7	disparities	disparity	NOUN
chd-224	621	8	3.6.5	3.6.5	NUM
chd-224	621	9	.	.	PUNCT
chd-224	622	1	chromosomal	chromosomal	ADJ
chd-224	622	2	alterations	alteration	NOUN
chd-224	622	3	/	/	SYM
chd-224	622	4	non	non	ADJ
chd-224	622	5	-	-	ADJ
chd-224	622	6	hereditary	hereditary	ADJ
chd-224	622	7	conditions	condition	NOUN
chd-224	622	8	influencing	influence	VERB
chd-224	622	9	tc	tc	NUM
chd-224	622	10	health	health	NOUN
chd-224	622	11	disparities	disparity	NOUN
chd-224	622	12	4	4	NUM
chd-224	622	13	.	.	PUNCT
chd-224	622	14	conclusions	conclusion	NOUN
chd-224	622	15	5	5	NUM
chd-224	622	16	.	.	PUNCT
chd-224	622	17	limitations	limitation	NOUN
chd-224	622	18	6	6	NUM
chd-224	622	19	.	.	PUNCT
chd-224	623	1	future	future	ADJ
chd-224	623	2	directions	direction	NOUN
chd-224	623	3	acknowledgements	acknowledgement	NOUN
chd-224	623	4	funding	fund	VERB
chd-224	623	5	author	author	NOUN
chd-224	623	6	’s	’s	PART
chd-224	623	7	contribution	contribution	NOUN
chd-224	623	8	conflicts	conflict	NOUN
chd-224	623	9	of	of	ADP
chd-224	623	10	interest	interest	NOUN
chd-224	623	11	consent	consent	NOUN
chd-224	623	12	confirmation	confirmation	NOUN
